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v Preface 
 At present, most of the validated forensic DNA profi ling procedures are based on high-
resolution and high-throughput capillary electrophoresis separation and detection systems 
of PCR amplicons obtained from DNA genomic markers with different inheritance pat-
terns (autosomal, Y-chromosome or X-chromosome linked, and mitochondrial DNA). A 
high degree of standardization has been achieved in the fi eld of typing procedures for PCR 
products obtained with fl uorogenic labeled primers, separated by capillary electrophoresis, 
and detected by the fl uorescence emission induced by laser on a CCD camera. Current 
systems have acquired a high degree of accuracy and precision in the identifi cation of allelic 
variants (with a resolution of one base), and also an improvement in the sensitivity of PCR 
amplicon detection (with reproducible signals even from picograms of DNA template). 
Another advantage of current capillary electrophoresis systems (with 5–6 multichannel 
detection technology) is a greater capacity for simultaneous detection of multiple markers. 
It can be detected up to 15–26 short tandem repeats (STRs) multiallelic markers, perform 
simultaneously about 50 biallelic single nucleotide polymorphisms (SNPs) or detect 4-dye-
terminator sequencing reactions in a single capillary electrophoresis injection. 
 Human forensic identifi cation is currently performed using commercial kits for STR 
multiplexing. Basically there are two sets of standardized STR markers in the criminal DNA 
databases around the world: the European standard set of 12 STR markers and the USA 
CODIS standard of 13 STR markers. They form together a standard of 18 STR markers in 
total. Development of mini-STR markers and their recent incorporation into commercial 
kits have improved the application of these markers in severely degraded DNA samples. 
 Other source of human genetic variation used in forensic casework is the analysis of 
sex chromosome markers. The Y-chromosome STR haplotypes are of special interest in 
the specifi c analysis of the male component of DNA mixtures that are very frequently faced 
by forensic labs in sexual assault cases. Another application of Y-STR haplotyping using a 
commercial multiplex PCR system of 17 loci, is the identifi cation of human remains and 
missing persons checked against the appropriate reference samples of paternal relatives. As 
regards X-chromosome STR analysis, it provides complementary analysis in some kinship 
defi ciency cases. 
 The automated sequence analysis of mitochondrial DNA hypervariable regions is espe-
cially important in the analysis of forensic samples negative for nuclear DNA, or when it is 
necessary to identify human remains by comparing them with maternal relatives. 
 Multiplex PCR-CE assays of autosomal SNP markers have been developed for human 
individualization of degraded samples and as a complementary tool in paternity testing. 
The analysis of autosomal, Y-chromosome, and mtDNA SNPs with well-differentiated 
allele or haplotype frequencies among global population-groups has been also applied to 
the inference of likely ancestry. 
 DNA Electrophoresis Protocols for Forensic Genetics offers a comprehensive coverage of 
the most modern current electrophoretic protocols and interpretation guidelines used in 
forensic genetics for the analysis of amplifi ed human DNA fragments and DNA sequencing. 
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It includes protocols for profi ling of autosomal STRs ( see Chapters  1 – 3 , and  13 – 15 ), 
Y-STRs ( see Chapter  4 ), X-STRs ( see Chapter  5 ), autosomal SNPs and INDELS ( see 
Chapters  6 – 8 ,  10 ), Y-SNPs ( see Chapter  9 ), mtDNA-SNPs ( see Chapter  11 ), and mtDNA 
hypervariable regions HV1 and HV2 ( see Chapters  19 – 21 ). 
 Besides the use of DNA electrophoresis on different applications for human identifi ca-
tion (criminal investigations, kinship analysis, degraded samples, low template DNA, etc.) 
the book also covers some interesting electrophoretic protocols for molecular identifi cation 
of nonhuman species with interest in forensic botany ( see Chapters  17 and  18 ), forensic 
veterinary ( see Chapters  16 ,  22 , and  23 ), and microbial forensics ( see Chapter  26 ). 
 Finally the book explores novel forensic applications of capillary electrophoresis to 
 target messenger RNA markers for body fl uid identifi cation ( see Chapter  12 ), and some 
forensic applications of microchip capillary electrophoresis ( see Chapters  24 and  25 ). 
 DNA Electrophoresis Protocols for Forensic Genetics has been written by highly recog-
nized professionals and specialists from different forensic DNA laboratories around the 
world dealing with casework and using validated technology and high quality standards. 
This book was made possible, thanks to them.
Madrid, Spain Antonio Alonso 
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 Chapter 1 
 An Overview of DNA Typing Methods for Human 
Identifi cation: Past, Present, and Future 
 Robyn  Thompson ,  Silvia  Zoppis , and  Bruce  McCord  
 Abstract 
 This chapter presents a brief introduction to the historical development of current technologies used in 
DNA analysis for human identifi cation. The text describes the development of the PCR and short tandem 
repeats along with subsequent advances in instrumentation such as real-time PCR and capillary electro-
phoresis. These techniques have brought about a revolution in DNA typing methods through increased 
effi ciency and the application of multiplex fl uorescence detection. More recently the development of new 
STR based typing methods utilizing mini- and Y-STR PCR multiplexes has increased the fl exibility of the 
investigator, permitting the analysis of inhibited and degraded DNA. Future directions for DNA typing are 
also discussed, including the development of methods for touch samples based on low copy DNA analysis 
and the determination of tissue/cell type. 
 Key words:  Capillary electrophoresis ,  DNA typing ,  Forensic ,  PCR ,  Real-time PCR ,  Short tandem 
repeats 
 
 Deoxyribonucleic acid (DNA) typing is a powerful tool for human 
identity testing and is well established in the forensic community. 
It is used to aid in the identifi cation of perpetrators of violent 
crimes such as murder and rape, in burglary and paternity cases and 
in identifi cation of the remains of missing persons. More recently, 
technological advances such as capillary array electrophoresis have 
become routine in forensic laboratories around the world and stan-
dardized protocols have been validated for presumptive and confi r-
matory testing, DNA extraction, DNA quantitation, and analysis 
of short tandem repeats (STRs). 
 1.  Introduction: 
An Historic 
Perspective 
of DNA Typing
4 R. Thompson et al.
 Although the existence of variable loci in human DNA has 
been recognized for a long period of time, it was not until the late 
1970s and early 1980s that use of polymorphisms for large-scale 
mapping of human genes was proposed. Arlene Wyman and Ray 
White established the foundation for this concept, which used 
polymorphic DNA loci characterized by variable-length restriction 
fragments called restriction fragment length polymorphisms or 
RFLP  ( 1 ) . David Botstein et al. later initiated the use of RFLP in 
mapping genes of the human genome to indicate genetic differ-
ences among individuals  ( 2 ) . However, it was Sir Alec Jeffreys 
who became the fi rst to describe the scientifi c technique known 
today as “DNA fi ngerprinting” or “DNA typing.” Jeffreys, an English 
geneticist, discovered a set of genetic markers called minisatellites 
or variable number of tandem repeats (VNTRs), which are highly 
specifi c to an individual  ( 3 ) . VNTRs are highly polymorphic regions 
of DNA composed of a set of discrete repetitive sequences at a 
defi ned location in the genome that can be used to differentiate 
members of a population. 
 The technique used by Jeffreys to examine VNTRs was RFLP. 
In RFLP analysis, specifi c restriction enzymes were used to cut 
extracted DNA into smaller fragments at defi ned locations based 
on 4–6 bp sequence motifs. The fragments were separated by size 
using gel electrophoresis and then the DNA was transferred to a 
nylon membrane by the Southern blot technique. A radioactive 
probe targeting the VNTR sequence of interest was then hybridized 
to the single-stranded DNA (ssDNA) attached to the nylon mem-
brane for detection. The probed DNA was exposed to X-ray fi lm, 
producing a “DNA fi ngerprint.” Jeffreys proposed the use of  Hin fI 
restriction enzyme digests with multi-locus (oligonucleotide) 
probes to detect multiple fragments in human DNA  ( 3 ) . The band 
patterns obtained, while unique to an individual, were diffi cult to 
interpret; therefore subsequent methods with single locus probes 
that hybridize to only one UNTR were used. 
 The fi rst court cases in which Jeffreys’ DNA fi ngerprint meth-
odology was successfully used occurred in England during the mid 
1980s. These cases involved an immigration dispute and a double 
rape/homicide of teenage girls in 1985 and 1986, respectively 
 ( 4,  5 ) . The homicide case was prophetic in that it involved the 
fi rst use of DNA for the purposes of exoneration of an innocent 
suspect and the fi rst use of DNA databases, issues which are still 
in dispute today. 
 The next important milestone in DNA fi ngerprinting was the 
development of the Polymerase Chain Reaction (PCR) in 1985 by 
Kary Mullis. This procedure has lead to signifi cant progress in DNA 
analysis, especially in the forensic community. The PCR permits 
the production of multiple “copies” of a defi ned nucleic acid sequence 
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 in vitro  ( 6 ) . During the PCR reaction, a set of short oligonucleotide 
sequences known as primers bind to the single stranded DNA 
(ssDNA) template providing a location for a DNA polymerase to 
produce a copy of the opposite strand. This procedure is repeated 
multiple times in a three-step process of DNA denaturation, primer 
annealing, and extension. First the strands are denatured at 95°C, 
followed by cooling to a lower temperature (~55°C), which allows 
the primers to anneal to the single stranded template. The tem-
perature is then raised (~72°C) and a DNA polymerase enzyme 
extends the primers through incorporation of dinucleotide triphos-
phates (dNTPs). By doing this, synthesis of the dsDNA target is 
produced in a rapid cyclic process. In each cycle the PCR generates 
approximately a twofold increase in the target DNA, theoretically 
producing millions of copies of template over the course of the 
process which can involve 28 or more repetitive cycles. 
 The PCR requires a mixture of reaction components and 
amplifi cation parameters, which must be optimized to produce 
suffi cient amplifi cation products. The major components, included 
in a “master mix” which is aliquoted into each PCR tube, are as 
follows: buffer, dNTPs, polymerase, primers, and magnesium 
chloride.  Thermus aquaticus ( Taq ), a species of bacterium found in 
hot springs, is the source of the thermal stable polymerase used for 
PCR. The later development of a “hot-start” formulation of  Taq 
polymerase, which is inactive until heated to approximately 95°C, 
was another improvement permitting the amplifi cation of samples 
without the problems of mispriming and misextension that can 
occur if the reaction is left too long at room temperature  ( 7 ) . Other 
PCR components that may be included are non-acetylated bovine 
serum albumin (BSA) and dimethylsulfoxide, both of which 
improve the effi ciency of the reaction and reduce inhibition. 
 The PCR quickly became an important analytical method for 
forensic samples because of its sensitivity, specifi city, rapid analysis, 
and ease of automation. PCR amplifi cation technology permits the 
analysis of forensic samples with low quantities (<1 ng) of extracted 
DNA, unlike RFLP methods that require at least 50 ng  ( 8 ) . 
Additionally, many degraded DNA samples can be amplifi ed and 
subsequently typed because the alleles are much smaller in size 
compared to the alleles detected by RFLP analysis  ( 9 ) . PCR pro-
vides a valid and reliable approach for the analysis of biological 
evidence found at crime scenes. Historically, the fi rst PCR-related 
approach used for forensic purposes was the detection of sequence 
polymorphisms through the use of allele-specifi c oligonucleotide 
(ASO) hybridization probes  ( 10 ) . Approaches involving the detec-
tion of PCR amplifi ed length polymorphisms known as minisatel-
lites were also explored. For example, the locus D1S80 consisted 
of a 16-base sequence that repeated up to 41 times yielding allele 
sizes from 400 to greater than 800 bp in length  ( 11 ) . 
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 While these new techniques proved to be far more sensitive than 
the previously used RFLP procedures, problems with mixtures and 
DNA degradation ultimately led to the use of new markers known 
as STRs. STR loci differ from VNTRs by having a shorter repeat 
sequence (2–7 bp) resulting in improved sensitivity and better 
resistance to degradation. STR typing is the primary method pres-
ently used in forensic laboratories. Tetrameric and pentameric repeats 
are the most widely used type of STR and have been multiplexed 
with up to 16 loci co-amplifi ed in a single PCR reaction. When 
compared to other PCR-based methods, STR analysis is faster and 
reactions can be multiplexed, permitting multiple loci to be ampli-
fi ed in a single run. The STR regions are also highly polymorphic, 
providing an extremely high power of discrimination  ( 12 ) . 
 In 1997, the Federal Bureau of Investigation (FBI) Laboratory 
launched a nationwide effort to establish a set of core STR loci for 
use within a national DNA database known as CODIS (Combined 
DNA Index System)  ( 13 ) . The 13 loci selected were CSF1PO, FGA, 
TH01, TPOX, VWA, D3S1358, D5S818, D7S820, D8S1179, 
D13S317, D16S539, D18S51, and D21S11. Similar sets of STR 
markers were also selected in the European Union and elsewhere. 
In general, a DNA profi le obtained using 12 or more STR loci 
yields a composite genotype frequency of less than 1 in 10 −15  ( 12 ) . 
The incredibly small size of these numbers results from the inde-
pendent inheritance of the STR alleles, permitting their frequencies 
in the population to be multiplied together, making DNA typing a 
very powerful technique. 
 For convenience, most laboratories use large STR multiplex 
kits capable of amplifying up to 16 STR loci. Applied Biosystems 
(Foster City, California) and Promega Corporation (Madison, 
Wisconsin) are the two of the major vendors of multiplex STR kits. 
These manufacturers also provide allelic ladders containing mixtures 
of all common alleles present in each locus in their multiplex kits as 
standards for accurate genotyping. The kits also contain a locus in 
the Amelogenin gene that contains a 6 bp deletion in the X chromo-
some, permitting its use in sex determination as well  ( 14 ) . Overall, 
these sets of STR loci are more than adequate for addressing most 
problems in human identifi cation, including paternity testing, 
missing persons cases, violent crime, and mass disasters. Due to their 
high level of polymorphism and discrete allele sizes, STR multiplex 
kits are particularly useful in resolving DNA mixtures. 
 To prepare samples for analysis by STR typing, it is generally neces-
sary to collect and extract the DNA from various types of biological 
evidence. This evidence can include single source samples such as 
blood or semen stains as well as mixed samples such as rape kits in 
 2.  Short Tandem 
Repeat Loci: The 
Current 
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 2.1.  DNA Extraction 
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which the suspect and victims DNA are comingled. A variety of 
procedures exist to extract the DNA but all work on the same basic 
principle: the cell walls are lysed, the protein surrounding the DNA 
is removed, and the naked DNA is isolated, purifi ed, and quanti-
fi ed. The traditional procedure for DNA extraction is known as 
organic extraction and involves lysing the cell walls with detergent, 
reducing disulfi de bonds and digesting the proteins with enzymes 
and DTT, and performing a liquid–liquid extraction using phenol 
chloroform/isoamyl alcohol to remove lipids and proteins  ( 15 ) . 
This technique can also be modifi ed to extract mixtures of sperm 
and vaginal cells by eliminating the DTT in the fi rst step, which 
digests the vaginal cells, but leaves the strongly cross-linked proteins 
in the sperm head unchanged. The DNA from the vaginal cells can 
then be removed by centrifugation, DTT added and the extraction 
repeated to lyse and recover DNA from the sperm cells. This process 
is known as a differential extraction. 
 Alternative extraction procedures using chelex ion exchange 
resins or sucrose also exist and can sometimes produce better results 
depending on sample type  ( 16 ) . With the advent of robotic systems, 
solid phase extraction procedures using silica or ion exchange beads 
have become important. These techniques usually require a larger 
quantity of DNA than liquid–liquid extraction, but because the 
mass of the beads can be controlled, a more reproducible amount 
of DNA can be delivered, simplifying downstream processing. 
Typically, the DNA is bound to the bead, washed, and then the pH 
or salt content of the solution is changed, releasing the purifi ed 
sample. The washing step can be very useful for badly contaminated 
samples as it helps to remove PCR inhibitors that often create 
problems when using organic extraction techniques. 
 Once the DNA is isolated, it must be quantifi ed with a human-
specifi c technique. This step is important for several reasons. Firstly, 
multiplex STR typing is very sensitive to the quantity of input 
DNA with typical levels of input DNA ranging from 0.5 to 2 ng. 
Because 16 simultaneous PCR reactions are taking place in each 
tube, large excesses of DNA can produce imbalanced amplifi ca-
tions. Low levels of sample will also produce poor results. Secondly, 
because many DNA samples may be comingled with fungal and 
bacterial DNA, generic methods for quantifying DNA can produce 
misleading results. 
 Currently the best procedure for performing quantifi cation, 
utilizes real-time PCR. Real-time PCR is performed by measuring 
the rate of amplifi cation of one or more human-specifi c DNA 
sequences at an early stage of the PCR process  ( 17 ) . During this 
time, the quantity of amplifi ed DNA is proportional to the quan-
tity of original template as the relative level of sample and reagents 
is optimum. Measurements are made using specially designed PCR 
instruments that can determine the increase in dsDNA using 
 2.2.  DNA Quantitation
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 fl uorescent probes or intercalating dyes. The advantage of real-
time PCR over other previous developed techniques involving 
hybridization or fl uorescence detection is its sensitivity, wide 
dynamic range, and compatibility with automation  ( 18,  19 ) . 
 Genetic analyzers, using capillary gel electrophoresis, are the most 
popular systems for separating STR alleles, Fig.  1 . These systems 
have almost completely supplanted slab gel electrophoresis in 
forensics due to their ease of automation, high effi ciency, and speed 
 ( 20,  21 ) . Both single capillary and capillary array systems are avail-
able. The basic design of the capillary gel electrophoresis system 
involves the use of one or more narrow 50  m m id capillaries, vials 
fi lled with buffer, and sets of electrodes connected to a high-voltage 
power supply. A robotic autosampler fi lls the capillary with sieving 
polymer and utilizes an applied voltage to inject a PCR product 
that has been denatured through dilution in formamide. The 
amplifi ed DNA fragments are then separated in a solution of entan-
gled linear polymers dissolved in a TAPS buffer containing urea 
and other denaturants  ( 22 ) . The polymer solution coats the capil-
lary walls and acts as a sieve to separate ssDNA fragments by size as 
they move down the capillary under the infl uence of an applied 
electric fi eld  ( 23 ) . The smaller-sized DNA amplicons interact less 
with the sieving polymers and therefore elute fi rst from the column. 
Individual DNA amplicons, previously modifi ed with various fl uo-
rescent dyes at their 5 ¢ end, are detected by laser-induced fl uores-
cence near the distal end of the capillary. Different dye labels can 
be distinguished by through their specifi c emission spectrum and 
are visualized using a grating coupled to a charged coupled device 
(CCD)  ( 8 ) . Complex computer algorithms are then utilized to 
minimize problems with dye overlap that can produce ghost peaks 
known as pull-up in uncorrected or overloaded data. 
 2.3.  Separating STR 
Alleles by Capillary 
Electrophoresis
Buffer
Argon Ion
Laser
Deconvoluted
Result
Buffer
(Sample)
+ -
Capillary
15 kV
 Fig. 1.  Schematic of a capillary electrophoresis instrument. The capillary ends and electrodes 
(connected to a high-voltage power supply) are placed in vials of buffer solution. The sample 
replaces one of the buffers and is introduced into the capillary. When an electric current is 
passed across the capillary, analytes are separated based on size and detected by a 
 fl uorometric detector. The fl uorescent emission is collected and deconvoluted to produce 
allele peaks. 
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 Modern instruments can simultaneously detect up to fi ve dyes, 
permitting rapid detection of a wide variety of labeled PCR 
 products. Overall, the loci are distinguished by size and dye label, 
making the electrophoresis system capable of detecting all 16 genetic 
loci in a multiplex kit in a single run  ( 24 ) . The data are repre-
sented in the form of an electropherogram, where individual 
peaks represent the different alleles present at each particular 
locus (Fig.  2 ). 
 To maintain suffi cient precision to type each DNA fragment to 
the nearest basepair (+/−0.17 bp), commercial multiplex STR kits 
utilize allelic ladders and internal sizing standards to permit high-
precision typing and comparison of results in spite of the fact that 
samples may be run over different periods of time, in different 
laboratories, and on different days. To do this the allelic ladder is 
sized in comparison to the internal sizing standard and these values 
are then compared with similar data from the unknown sample. 
The amplifi ed alleles are then sized and compared to the allelic ladder 
results in order to determine the genotype  ( 24 ) . This is done through 
the use of software programs that are compatible with modern 
genetic analyzers. 
 Fig. 2.  Electropherogram of the genetic information of an alleged father compared to the mother and son in a paternity 
examination using AmpFlSTR ® Identifi ler ® PCR Amplifi cation Kit. Note that son shares a single allele with each parent. The colors 
represent the different fl uorescent dyes for each particular locus. The scales at the top of the peaks represent the number 
of basepairs and the scales to the left represent the intensity of the fl uorescent signal in relative fl uorescent units (RFUs). 
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 In spite of the advantages associated with STR analysis, there are 
several drawbacks. A larger number of STRs loci are required due 
to their lower discrimination power per locus when compared to 
VNTRs. Interpretation of mixtures is complicated by “stutter,” an 
artifact of the PCR process that produces “false” alleles one repeat 
shorter than the main allele. Another issue occurs when alleles con-
taining incomplete repeat units appear, resulting in small variations 
in  fragment size. Mutations in the fl anking regions of template 
DNA can result in poor binding of the primer to the DNA. These 
situations result in poor peak balance or allele dropout at heterozy-
gous loci  ( 8 ) . 
 Currently the manufacturers continue to upgrade their already 
validated and highly discriminatory STR systems to tolerate samples 
that have been highly degraded and inhibited in order to generate 
profi les that could not be previously amplifi ed. By further reducing 
the amplicon size, improved recovery of inhibited and degraded 
samples is possible  ( 21,  25 ) . These reduced-size STR loci can be par-
ticularly valuable in the determination of DNA from bone samples, 
yielding far more useful statistical results than alternative techniques 
such as mtDNA sequencing  ( 26 ) . Fig.  3 illustrates the application 
of reduced-size STRs in the analysis of DNA present on a cigarette 
left behind at a crime scene. 
 2.4.  Improvements 
in STR Technology
 Fig. 3.  Analysis of DNA extracted from a cigarette left behind at a crime scene using AmpFlSTR ® MiniFiler™ PCR 
Amplifi cation Kit. Amplicon sizes are reduced in this kit to permit enhanced detection of degraded DNA. 
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 An alternative approach recognizes that much of the problem 
of recovery of poor quality samples involves the presence of PCR 
inhibitors  ( 27,  28 ) . To deal with this problem, updated multiplex 
systems have been designed with improved buffer systems that 
minimize the impact of PCR inhibition. These next generation 
systems include Identifi ler + (Applied Biosystems and PowerPlex 
16 Hot-Start (HS) , Promega Corporation, Madison, WI), which 
can yield profi les from badly inhibited samples as well as improve 
sensitivity  ( 29,  30 ) . Other recent advances in the fi eld include the 
development of multiplex kits for typing Y-STRs  ( 31– 33 ) and cor-
responding multiplex methods for simultaneously detecting and 
quantifying autosomal and male DNA using real-time PCR  ( 18, 
 34,  35 ) . Y-STR typing permits the detection of small amounts of 
DNA in the presence of very large quantities of female DNA. This 
can be particularly useful in situations involving mixture evidence 
such as fi ngernail scrapings, bite marks, and rape kits resulting from 
aspermatic males. Fig.  4 illustrates the application of Y-STRs in the 
resolution of a mixture of male and female DNA. The Y-STR loci 
are separated by size and color and amplifi ed in a manner similar to 
that used in the autosomal STR kits. 
 Fig. 4.  Comparison between the Y-STR profi le obtained from a biological sample at a crime scene (Sample A) and the 
suspect’s profi le (AmpFlSTR ® Yfi ler ® PCR Amplifi cation Kit). 
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 The improved sensitivity of newly developed STR kits and the 
development of strategies for amplifi cation of low levels of DNA 
mean that samples which previously could not or were not analyzed 
can now produce results. In particular, there is an increasing trend 
toward the analysis of touch DNA. Such samples often contain 
very low levels of DNA and can also contain mixtures. This can 
make detection and interpretation very diffi cult. To deal with these 
types of samples, special processing techniques such as post-PCR 
cleanup, use of additional amplifi cation cycles and extended injec-
tion times can result in greatly improved sensitivity in electropho-
retic analysis  ( 36 ) . For example, Fig.  5 illustrates the difference 
between standard DNA analysis of a 65 pg DNA sample and that 
same sample following dialysis to remove salts. The enhancement 
in the signal intensity is due to intensifi cation of the electric fi eld 
during injection that results from the loss of interfering buffer salts 
during the fi ltration step. 
 Unfortunately, these low level samples suffer from stochastic 
sampling effects which can include peak imbalance, enhanced stutter, 
 3.  Future 
Directions
 Fig. 5.  The effect of post-PCR cleanup on a 65 pg DNA single source DNA sample. The fi rst two panels involve the analysis 
of a single source sample using the manufacturer’s recommended protocols for the AmpFlSTR ® Identifi ler ® PCR Amplifi cation 
Kit. The second two panels illustrate the detection of that same sample following post-PCR cleanup using spin fi ltration 
The enhancement in the signal intensity is due to intensifi cation of the electric fi eld during injection that results from the 
loss of interfering buffer salts during the fi ltration step. Note also the imbalance of heterozygous peaks due to stochastic 
sampling effects. 
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and allele loss or dropout.  ( 37– 39 ) . Several loci in Fig.  5 suffer 
from an imbalance in peak height. In some cases, these problems 
can reduce the quality of the results to the point that they become 
uninterpretable. In addition, because levels of DNA present on 
surfaces can be so low, competition for amplifi cation with trace 
levels of DNA deposited on the surface prior to the criminal activity 
may occur, giving rise to mixtures and unattributable alleles (allele 
drop-in). 
 Therefore, in order to properly interpret such samples, strict 
guidelines have been promulgated that include careful determination 
of analytical thresholds, the use of replicate analyzes in a profi le. 
Specially designed facilities and the requirement for a minimum num-
ber of heterozygous alleles  ( 38,  40 ) . Highly sensitive real-time PCR 
systems that target multicopy loci such ALU inserts are also required 
to make precise measurements of low levels of samples  ( 18,  38 ) . 
 To combat the problem of exogenous DNA, new analytical 
techniques such as laser microdissection and fl uorescence in situ 
hybridization are being developed, which are capable of identifying, 
capturing, and amplifying individual cells prior to electrophoresis 
 ( 41,  42 ) . With such systems, individual sperm cells may be collected 
eliminating much of the problem with exogenous and female DNA. 
However, the need for highly experienced personnel and ultraclean 
facilities will not be diminished by these new techniques. Overall, 
the challenge with developing guidelines for ultratrace DNA detec-
tion is to promulgate clear and universal laboratory practices while 
recognizing that a multitude of labs exist, each with its own specifi c 
protocols and personnel. 
 Other recently developed areas of research include improved 
screening of evidence and cell type through RNA expression 
 ( 43,  44 ) or epigenetics  ( 45 ) , and the use of genetic markers as 
probes of physical characteristics such as eye or skin color  ( 46,  47 ) . 
These techniques help to address the importance of defi ning the 
type of DNA found at a crime scene in verifying a witness’s story. 
 
 The development of DNA typing methods by capillary electropho-
resis has involved a progression of increasingly sensitive and specifi c 
polymorphic markers. The current application using multiplexed 
STR loci is a powerful tool for forensic identifi cation. Due to their 
high polymorphism and heterozygosity, STR loci are particularly 
useful for the resolution of mixed stains, and determination of 
relatedness of individuals. As we move into the second decade of 
use of STR typing new applications of these markers are being 
developed including Y-STR typing, low template analysis, and analysis 
of highly degraded samples. In addition, auxillary techniques such 
 4.  Conclusions
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as real-time PCR and laser microdissection will further improve 
our ability to extract information from forensic samples. Regardless 
of the result of these new and interesting procedures, it is clear that 
the utility of STR typing by electrophoresis will continue for years 
to come. 
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 Chapter 2 
 Capillary Electrophoresis and 5-Channel LIF Detection 
of a 26plex Autosomal STR Assay for Human Identifi cation 
 Carolyn  R.  Hill  
 Abstract 
 Multiplex polymerase chain reaction (PCR) is a common method used for DNA typing in forensic and 
paternity cases. There are numerous commercial short tandem repeat (STR) multiplex assays currently 
available to the forensic community. These assays amplify the core Combined DNA Index System (CODIS) 
STR loci for entry into the US. DNA database. Additional non-CODIS loci, which are considered geneti-
cally unlinked to the CODIS loci, can be useful in resolving challenging cases such as missing persons and 
mass disaster victim identifi cation, paternity testing, and immigration testing. An STR multiplex has been 
successfully developed with 25 non-CODIS autosomal loci plus the sex-typing locus amelogenin for a total 
of 26 loci in a single 26plex amplifi cation reaction. This chapter will focus on the preparation and the use 
of the 26plex assay with DNA samples for the purpose of human identifi cation. 
 Key words:  Multiplex PCR ,  Short tandem repeat ,  STR marker ,  Forensic DNA ,  PCR primers, 26plex, 
non-CODIS 
 
 Multiplex polymerase chain reaction (PCR) is commonly used for 
various forensic DNA typing purposes. This type of testing allows 
for simultaneous amplifi cation of specifi c target regions of the 
genome. Currently, there are two commercial short tandem repeat 
(STR) assays that can amplify 16 genetic loci in one reaction and 
are widely used in the forensic community. The AmpFlSTR ® 
Identifi ler ® (Applied Biosystems, Foster City, CA) and PowerPlex ® 
16 (Promega Corporation, Madison, WI) multiplex kits both 
include the 13 Combined DNA Index System (CODIS) STR loci 
that are required by the Federal Bureau of Investigation (FBI) for 
data entry into the national level of the US DNA database  ( 1,  2 ) . 
 1.  Introduction
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These 13 STR markers provide a random match probability of 
approximately 1 in 100 trillion  ( 1,  2 ) . With this level of discrimination, 
it may not seem necessary to go beyond the CODIS loci and use 
additional non-CODIS (NC) markers for forensic typing. Indeed, 
for general forensic matching of an evidence profi le to a suspect 
profi le, the 13 CODIS STR loci are currently deemed suffi cient. 
However, additional loci can be benefi cial for human identifi ca-
tion in scenarios involving relatives such as missing persons/mass 
disaster victim identifi cation, immigration testing with limited 
reference samples, defi cient parentage testing which is often 
needed if only one parent and child are tested, and in cases involv-
ing incest  ( 3– 7 ) . Forensic and kinship testing laboratories are 
being challenged to answer more diffi cult genetic questions, and 
it is important that the necessary tools are in place to address 
these issues. 
 We have previously characterized 26 NC reduced-size STR 
loci (miniSTR) and performed population analyses on US 
Caucasian, African American, Hispanic, and Asian samples  ( 8,  9 ) . 
These miniSTRs were designed to span unused chromosomal loca-
tions on the 22 autosomes and have been found to be genetically 
unlinked to the 13 CODIS loci  ( 8,  9 ) . Thus, the single-locus geno-
type probabilities for the 13 CODIS loci and the 26 NC loci can 
be multiplied to determine the profi le match probability. Originally, 
assays for the 26 miniSTR markers were developed as panels of 
three markers (triplexes) with product sizes below 140 base pairs 
(bp). These assays allowed for the recovery of genetic information 
from degraded DNA, which is often present in skeletonized miss-
ing persons remains or mass disaster victims  ( 3 ) . The loci were 
arranged into ten miniplexes for further characterization with US 
population samples. 
 After the initial testing of the 26 NC markers, it would have 
been ineffi cient to perform additional studies with the ten separate 
miniplexes. Combining all 26 loci into one multiplex reaction 
would facilitate this task and save resources. The NC markers have 
moderate-to-high heterozygosity values (>0.5) and narrow allele 
ranges (5–15 alleles), making them ideal for combining into a large 
multiplex for further testing  ( 8,  9 ) . The new NC multiplex does 
not just have utility in our laboratory; it can be benefi cial to the 
forensic community in several ways as well. A larger multiplex can 
be used for the generation of a high-throughput reference data-
base. Since most of these loci no longer exist as miniSTRs after 
primer redesign to fi t into the multiplex, the 26plex will likely have 
a limited utility on degraded samples. However, when high quality 
and quantity DNA samples are available, the 26plex assay could be 
useful for kinship analysis, complex criminal paternity testing, par-
entage testing, immigration testing, and in missing persons/mass 
disaster cases. 
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 A single amplifi cation, fi ve-dye multiplex has been developed 
to combine 25 of the NC STR loci (see Note 1) plus the sex-typing 
marker amelogenin  ( 10 ) in one reaction to enable rapid analysis of 
reference samples  ( 11,  12 ) . A concordance evaluation was per-
formed with the multiplex to compare genotypes obtained with 
the previously characterized miniSTR loci to determine null alleles 
present with the newly designed primer sets  ( 13 ) . The multiplex 
was also tested with ~400 father/son sample pairs to determine 
the individual mutation rates of each STR locus  ( 13 ) . Testing on 
an extended family sample study was performed to examine the 
potential statistical improvements to adding additional loci to the 
analysis  ( 13,  14 ) . 
 To make the information regarding the 26plex available to the 
forensic community, Standard Reference Material (SRM) 2391b 
(the PCR-based DNA Profi ling Standard) has been updated with 
certifi ed and reference values for all 26 of the new loci described 
 ( 15,  16 ) . Bins and panels for genotyping using GeneMapper ID 
v3.2 (Applied Biosystems) have been designed  ( 17 ) to allow for a 
fi ve-dye single amplifi cation multiplex for rapid reference sample 
typing. 
 
 The 26plex should be used with human DNA samples at a target 
amount of 1 ng; however, DNA concentrations as low as 100 pg 
can be amplifi ed with this multiplex assay. Samples with higher 
concentrations can be diluted to 1 ng using TE −4 buffer (10 mM 
Tris , 0.1 mM EDTA, pH 8) (see Notes 2 and 3). 
  1.  10× GeneAmp ® PCR Gold buffer (Applied Biosystems). 
  2.  25 mM GeneAmp ® MgCl 2 (Applied Biosystems). 
  3.  10 mM dNTPs (USB Corporation, Cleveland, OH). 
  4.  5 U/ μ L Taq Gold DNA Polymerase (Applied Biosystems). 
  5.  3.2 mg/mL Bovine Serum Albumin (BSA) (Sigma-Aldrich, 
St. Louis, MO) (see Note 4). 
  6.  Forward primers are labeled with fl uorescent dyes (Applied 
Biosystems), and reverse primers are unlabeled (Qiagen 
Operon, Alameda, CA). Primer sequences are listed in Table  1 
(see Note 5). 
  7.  TE -4 buffer (10 mM Tris, 0.1 mM EDTA, pH 8). 
  8.  Cary Spectrophotometer (Varian, Santa Clara, CA). 
  9.  GeneAmp® 9700 Thermal Cycler (Applied Biosystems). 
 2.  Materials
 2.1.  DNA Samples
 2.2.  PCR Reagents 
and Instrumentation
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 Table 1 
 26plex PCR primers used in this assay 
 Locus name  Forward dye label  Primer sequence (5 ¢ –3 ¢ )  (Primer),  m M 
 D1GATA113  PET  F - acattaagcacatgcctctttgt  1 
 R -  G atgaactcattggcaaaagga  1 
 D1S1627  NED  F - catgaggtttgcaaatactatcttaac  2 
 R -  G ttttaattttctccaaatctcca  2 
 D1S1677  6FAM  F - gcagtcagcttgattgatcc  3 
 R -  GTTTCTT agaatgcaatagcaaatatcagaatg  3 
 D2S441  NED  F - caaaaggctgtaacaagggcta  1 
 R -  G ttcactctccttcccaaatgtt  1 
 D2S1776  VIC  F - ttacctgtgagtatgtgtgcgta  1.5 
 R - ggtgctaggtgtgctcagga  1.5 
 D3S3053  VIC  F - tgacacaaatggaccaagaca  2 
 R -  GTTTCTT gagagagcccttgaaatagca  2 
 D3S4529  NED  F - cccaaaattacttgagccaat  0.75 
 R -  G agacaaaatgaagaaacagacag  0.75 
 D4S2364  VIC  F - ctaggagatcatgtgggtatgatt  0.75 
 R -  G cagtgaataaatgaacgaatgga  0.75 
 D4S2408  NED  F - agctgacatcttaccacatgttc  2 
 R -  G tgcttggcatatattaagacactgta  2 
 D5S2500  VIC  F - gtttactgataaaccaaatgatgtgc  2 
 R -  G taacttaaagggtaaatgtttgcag  2 
 D6S474  6FAM  F - ggttttccaagagatagaccaatta  1.5 
 R -  G tcctctcataaatccctactcatatc  1.5 
 D6S1017  NED  F - agatgggaacgatgcagaca  2 
 R - gcataaatggatgggtggat  2 
 D9S1122  VIC  F - gggtatttcaagataactgtagatagg  0.75 
 R -  G cttctgaaagcttctagtttacc  0.75 
 D9S2157  NED  F - gatcacgccacggta  5 
 R -  G ttctccatttcaaagatcat  5 
 D10S1248  6FAM  F - cagtaaaaagcaaacctgagca  1 
 R - gcttggcaaagagcagatg  1 
 D10S1435  VIC  F - cacgttgggtttcctgactt  1 
 R -  G cccagctacttgggatgcta  1 
 D11S4463  6FAM  F - ctgtcccaaggctgagtgtt  3 
 R -  GTTTCTT cgcagggcaaataaaaagaa  3 
 D12ATA63  6FAM  F - aggtggcagtgagctgtaac  1 
 R -  GTT tcttggattttgagggccta  1 
(continued)
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  1.  36 cm 3100/3130xl capillary array (Applied Biosystems), 16 
capillaries. 
  2.  Matrix Standard SD-33, G5 dye set (Applied Biosystems). 
  3.  Hi-Di ™ Formamide (Applied Biosystems). 
  4.  GS500 LIZ internal size standard (Applied Biosystems). 
  5.  A.C.E. ™ Sequencing Buffer, 10× Running Buffer (Ameresco, 
Solon, OH). 
  6.  POP ™ -4 or POP ™ -6 Polymer (Applied Biosystems). 
  7.  16-capillary ABI Prism ® 3130xl Genetic Analyzer (Applied 
Biosystems). 
  1.  GeneMapper ®  ID v3.2 (Applied Biosystems) (see Note 6). 
  2.  GeneMapper bins and panels (available on STRBase) (see 
Note 7). 
 2.3.  Capillary 
Electrophoresis 
Reagents and 
Instrumentation
 2.4.  Data Analysis 
Software
Table 1
(continued)
 Locus name  Forward dye label  Primer sequence (5 ¢ –3 ¢ )  (Primer),  m M 
 D14S14343  PET  F - ggctctgatttccaccactg  2 
 R -  G caactcttggaagcccagtc  2 
 D17S974  NED  F - ggaacacttgagcca  2 
 R - gtggactggggtaagg  2 
 D17S1301  PET  F - aagatgaaattgccatgtaaaaata  2 
 R -  G tgtgtataacaaaattcctatgatgg  2 
 D18S853  PET  F - acatatataatgtgagaaaggaggagt  2 
 R -  G ttaatgggtgcaacacacc  2 
 D20S482  PET  F - ctccattctctcacacccaat  1 
 R -  G cacttctggcttttctggttc  1 
 D20S1082  6FAM  F - acatgtatcccagaacttaaagtaaac  1 
 R -  G cagaagggaaaattgaagctg  1 
 D22S1045  6FAM  F - ccctgtcctagccttcttatagc  1 
 R -  G ctgtgcccaagttgagagaa  1 
 Amelogenin  PET  F - ccctttgaagtggtaccagagca  2 
 R - gcatgcctaatattttcagggaata  2 
 The fl uorescent dye labels are listed for the forward primers only. The reverse primers are unlabeled. 
The 5 ¢ guanine (G) residue for “PIGtail” (GTTTCTT) sequence in each reverse primer was added to 
promote adenylation  ( 3,  18 ) and is underlined in  bold print . The approximate primer concentrations are 
listed in  μ M (concentration in 20  μ L total volume), but must be empirically adjusted for locus-to-locus 
balance. Amelogenin primers that are used are from Haas-Rochholz et al.  ( 10 ) 
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  1.  Fluorescently labeled forward and unlabeled reverse primers 
are delivered lyophilized and must be reconstituted with TE −4 
buffer (see Note 8) to the following concentrations: 
 Unlabeled reverse primers = 200  μ M. 
 Labeled forward primers = 100  μ M. 
  2.  The unlabeled reverse primers come with specifi c quantifi ca-
tion information listed in pmol and are reconstituted based on 
this value. Once reconstituted, they are quantifi ed using a UV 
spectrophotometer absorbance reading at 260 nm. The dye-
labeled forward primers do not come with specifi c quantifi ca-
tion information (these primers are ordered at 10,000 pmol), 
so they are all reconstituted with the same amount of TE −4 buf-
fer to a fi nal concentration of 100  μ M and are not quantifi ed 
with a UV spectrophotometer (see Note 9). 
  3.  The target primer mix concentration is 2  μ M, but the primer 
concentrations should be empirically adjusted for locus-to-
locus balance (see Note 10). A sample primer mix preparation 
sheet is included as Table  2 . Note that the primer concentra-
tions used in the primer mix calculations are for the reverse 
primers since those are variable. The forward primers assume a 
100  μ M concentration for all markers. This example primer 
mix set-up is for a 100  μ L fi nal volume. 
  1.  PCR set-up should be performed in a sterile fume hood. 
  2.  Combine the PCR reagents listed in Subheading  2 for fi nal 
concentrations of the following: 
 2 mM MgCl 2 , 1× PCR buffer, 250  μ M dNTPs, 1 Unit Taq 
Gold, 0.16 mg/mL BSA, and 0.2  μ M primer set concentration. 
Fill remaining volume with deionized water (diH 2 O).
  3.  An example of a PCR template is included as Table  3 . The fi nal 
reaction volume in this example is 19  μ L Master Mix + 1  μ L 
DNA sample at 1 ng = 20  μ L. 
  4.  The PCR amplifi cation conditions using the GeneAmp 9700 
are: denaturation for 11 min at 95°C, amplifi cation for 30 
cycles of 45 s at 94°C, 2 min at 59°C, and 1 min at 72°C, 
extension for 60 min at 60°C, and a fi nal soak at 25°C. 
  1.  Prior to testing, a 36-cm capillary array must be installed on 
the 3130xl with POP-4 or POP-6 polymer and 1× A.C.E. buf-
fer (see Note 11). 
  2.  A 5-dye matrix should be run as the G5 spectral calibration 
under the “G5 fi lter” with the fi ve dyes of 6FAM, VIC, NED, 
PET, and LIZ. 
 3.  Methods
 3.1.  Primer Set 
Preparation
 3.2.  PCR Reagents 
and Conditions
 3.3.  Capillary 
Electrophoresis 
on the ABI 3130xl 
Genetic Analyzer
232 Capillary Electrophoresis and 5-Channel LIF Detection…
 Table 2 
 An example primer mix preparation sheet 
 Locus  Locus name 
 Stock reverse 
concentration ( m M) 
 Reverse singleplex 
( m L) 
Dye-labeled 
forward ( m L)  Water ( m L) 
 1  D1GATA113  143.6  0.70  1  98.30 
 2  D1S1627  195.9  1.02  2  96.98 
 3  D1S1677  98.1  3.06  3  93.94 
 4  D2S441  141.8  0.71  1  98.29 
 5  D2S1776  137.9  1.09  1.5  97.41 
 6  D3S3053  103.1  1.94  2  96.06 
 7  D3S4529  147.4  0.51  0.75  98.74 
 8  D4S2364  149.0  0.50  0.75  98.75 
 9  D4S2408  152.4  1.31  2  96.69 
 10  D5S2500  184.3  1.08  2  96.92 
 11  D6S474  190.9  0.79  1.5  97.71 
 12  D6S1017  153.6  1.30  2  96.70 
 13  D9S1122  184.4  0.41  0.75  98.84 
 14  D9S2157  79.5  6.29  5  88.71 
 15  D10S1248  154.2  0.65  1  98.35 
 16  D10S1435  154.8  0.65  1  98.35 
 17  D11S4463  161.7  1.86  3  94.64 
 18  D12ATA63  192.8  0.52  1  98.48 
 19  D14S1434  181.4  1.10  2  96.90 
 20  D17S974  78.4  2.55  2  95.45 
 21  D17S1301  212.5  0.94  2  97.06 
 22  D18S853  214.2  0.93  2  97.07 
 23  D20S482  180.0  0.56  1  98.44 
 24  D20S1082  200.0  0.50  1  98.50 
 25  D22S1045  146.1  0.68  1  98.32 
 Amel  Amelogenin  187.8  1.06  2  96.94 
       33.21  44.25  22.54 
 The unlabeled reverse primers are quantifi ed using a UV spectrophotometer absorbance reading at 260 nm. 
The dye-labeled forward primers are not quantifi ed and are all reconstituted with TE −4 to 100  μ M. The 
primer concentrations used in the primer mix calculations are for the reverse primers. The forward primers 
use 100  μ M for all calculations. This example primer mix set-up is for a 100  μ L fi nal volume. The target 
primer mix concentration is ~2  μ M, but should be empirically adjusted for locus-to-locus balance 
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  3.  Amplifi cation products are diluted in Hi-Di formamide by 
adding 1  μ L PCR product and 0.3  μ L GS500 LIZ internal size 
standard to 8.7  μ L of Hi-Di. 
  4.  The samples are run on the 16-capillary 3130xl without prior 
denaturation of the samples. 
  5.  The samples are injected electrokinetically for 10 s at 3 kV (see 
Note 12). 
  6.  The STR alleles are then separated at 15 kV at a run tempera-
ture of 60°C. 
  1.  Data from the ABI 3130xl are exported as .fsa fi les and are 
analyzed using GeneMapper ID v3.2 (see Note 6). 
  2.  Bins and panels have been written for use with POP-6 and 
POP-4 (see Note 7) and are available for download on STRBase 
( http://www.cstl.nist.gov/biotech/strbase/str26plex.
htm#Bins-and-Panels ). There are no ladders available for data 
analysis (see Note 13). 
  3.  The analytical threshold is set to 50 RFU for analysis in 
GeneMapper ID v3.2 (see Note 14). 
  4.  An example profi le for positive control 9947A is illustrated in 
Fig.  1 (see Note 15). 
  5.  More information about the 26plex assay can be found on 
STRBase:  http://www.cstl.nist.gov/biotech/strbase/str26plex.
htm . 
 3.4.  Analysis Software
 Table 3 
 An example of a PCR prep sheet for ten reactions 
 Stock 
Concentration  26plex 
 Desired PCR 
concentration 
 Volumes 
to add  Final volumes 
  Total volume of reaction =20ml      n =10 reactions 
 25 mM  Mg concentration  2 mM  1.6  μ L  16 ml 
 2  μ M  Primer concentration  0.2 mM  2  μ L  20 ml 
 5 U/ μ L  Units of Taq  1U  0.2  μ L  2 ml 
 10 mM  dNTP concentration  250 mM  0.5  μ L  5 ml 
 10×  PCR buffer  1´  2  μ L  20 ml 
 3.2 mg/mL  BSA  0.16 mg/mL  1  μ L  10 ml 
   Water to add    11.7  μ L  117 ml 
   Master Mix (MM) volume    19 ml  190 ml 
   Volume of added template ( μ L)  1 ml     
 Add 19  μ L MM + 1 μ L sample = 20  μ L 
rxn 
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  1.  In the fi nal 26plex, there were seven loci that used the original 
miniSTR primer sequences. The primers for the 19 remaining 
loci were redesigned to fi t into the multiplex. Amelogenin was 
added and the D8S1115 was removed for a total of 26 loci. 
The D8S1115 was removed due to incompatible primer 
sequences that consistently caused artifacts to occur in the 
resulting DNA profi les  ( 12 ) . 
  2.  A sensitivity study was performed  ( 12 ) to determine the opti-
mal amount of DNA template that can be reliably used with 
the 26plex. In this study, it was observed that the minimum 
amount of DNA that can be added without allelic drop-out is 
100 pg for 30 cycles. The target amount of input DNA to be 
added to this assay is 1 ng. Substantial spectral bleed-through 
between dye channels at several loci was observed with 2 ng of 
DNA template. 
  3.  At lower amounts of DNA template (<400 pg), there is a con-
sistent artifact peak present within the D4S2364 allele range at 
~70 bp (typically between 200 and 450 RFU). The size of the 
 4.  Notes
 Fig. 1.  The fi nal 26plex with 25 autosomal loci plus the sex-typing locus amelogenin for a total of 26 loci. Positive control, 
9947A, was used at 1 ng for 30 cycles  ( 12 ) . Primers for the loci were designed so that all of the amplicons present are 
distributed from 65 basepairs (bp) to less than 400 bp within a fi ve-dye chemistry design with the fi fth dye reserved for 
the sizing standard. 
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artifact is proportional to the size of the authentic allele peak 
heights. However, this artifact peak does not interfere with 
allele calling. The artifact peak is more apparent with less input 
DNA as the locus-specifi c peak heights decrease. The amelo-
genin peak heights are lower than the allele peaks of other loci 
with less than 300 pg of template DNA. 
  4.  It is important to use nonacetylated BSA because acetylated 
BSA interferes in the PCR process. 
  5.  Some of the reverse primers have an additional guanine base 
(G) or “PIG-tail” sequence (GTTTCTT) added to the 5 ¢ end 
to help promote full adenylation  ( 3,  18 ) and are noted in bold 
and underlined in Table  1 . 
  6.  The majority of the 26plex data have been analyzed with 
GeneMapper ID v3.2. However, GeneMapper ID-X v1.1 and 
v1.2 (Applied Biosystems) can also be used to analyze the data. 
The bins and panels were originally written in v3.2, but have 
been successfully imported into both versions of ID-X. 
  7.  The bins and panels were originally written for samples run on 
a 36-cm array with POP-6 polymer  ( 12 ) . However, the 26plex 
has since been run on a 36-cm array with POP-4 polymer. The 
bins and panels have been adjusted accordingly and both sets 
are available for download on STRBase. If any other 3130xl 
parameters are used (i.e., 50-cm array or POP-7 polymer), the 
bins and panels will have to be further adjusted to fi t the data 
because there are no allelic ladders available for the 26plex at 
time of publication. 
  8.  It is imperative to use TE −4 buffer to reconstitute the lyophilized 
primers instead of diH 2 O. It has been our experience that using 
TE −4 buffer reduces the presence of dye artifacts that are pres-
ent in the fi nal DNA profi le compared to diH 2 O. The dye arti-
facts can be recognized as being fairly broad peaks that possess 
the spectrum of one of the dyes used for genotyping  ( 12 ) . If 
dye artifacts are still present, these can be removed post-PCR 
using gel fi ltration cartridges such as Edge Columns (Edge 
Biosystems, Gaithersburg, MD). 
  9.  The initial primer sequences can be ordered at any concentra-
tion. The initial concentrations listed serve as guidelines only. 
The fi nal concentrations are listed as approximate values due to 
the fact that it is not possible to initially quantify the fl uores-
cent dye-labeled forward primers. 
  10.  The concentrations of the primer pairs were kept the same 
when preparing the primer mix. If it was necessary for the con-
centration of a locus to be adjusted, the forward and reverse 
primers were adjusted equally. The balancing of the primer mix 
is an essential step in the 26plex protocol and great care must 
be made in empirically increasing or decreasing the primers to 
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generate balanced PCR products (as demonstrated by peak 
heights). 
  11.  As mentioned in  Note 6 , POP-6 was originally used for the 
development of the 26plex. During the development of the 
26-plex, we used a single 3130xl instrument for fragment anal-
ysis and sequencing. This allowed for higher resolution separa-
tions to be achieved while eliminating the need to change the 
instrument between fragment analysis and sequencing. In 
addition, a 36-cm array was used, but was installed as a 50-cm 
array on the instrument. This is because there is no 36 cm, 
POP-6 module available within the Data Collection Software 
v3.0 that is installed with the 3130xl instrument. There is, 
however, a 50 cm, POP-6 module that was used for analysis. 
Also, as mentioned in Note 6, a 36-cm array with POP-4 can 
also be used to run the 26plex – this is the recommended 
human identifi cation (HID) confi guration. 
  12.  The injection time and voltage can be adjusted if off scale data 
and bleed-through between dye channels occur. Typically for a 
“low injection,” the samples were injected for 5 s at 2 kV. 
  13.  As of the time of publication, no allelic ladders are available for 
the 26plex data analysis. Instead, genotyping and allele 
sequencing were performed with Standard Reference Material 
(SRM) 2391b, PCR-based DNA Profi ling Standard for all the 
components including ten genomic DNA samples, and two 
cell lines (12 samples total) using the 26 additional loci. 
Certifi ed and reference values were assigned to all resulting 
alleles and the Certifi cate of Analysis was updated to include 
this new information  ( 15 ) . These values can serve as a way to 
calibrate the genotypes observed with analyzing data from the 
26plex  ( 16 ) . 
  14.  The analytical threshold for the 3130xl used at NIST was set at 
50 RFU. The analytical threshold and stochastic thresholds 
should be determined by the individual laboratory according 
to validation studies performed using their own instruments. 
  15.  The 26plex is a robust STR multiplex assay with balanced 
heterozygote peak heights and adequate interlocus peak bal-
ance. No PCR or fl uorescent dye artifacts were present at 1 ng 
for 30 cycles that could interfere in the correct genotyping of 
DNA samples. 
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 Chapter 3 
 Capillary Electrophoresis of MiniSTR Markers 
to Genotype Highly Degraded DNA Samples 
 Michael  D.  Coble 
 Abstract 
 The amplifi cation of short tandem repeat (STR) markers throughout the human nuclear DNA genome are 
used to associate crime scene evidence to the perpetrator’s profi le in criminal investigations. For highly 
challenged or compromised materials such as stains exposed to the elements, skeletal remains from missing 
persons cases, or fragmented and degraded samples from mass disasters, obtaining a full STR profi le may 
be diffi cult if not impossible. With the introduction of short amplicon STR or “miniSTR” typing, it is 
possible to obtain STR genetic information from highly challenged samples without the need to sequence 
the hypervariable regions of the mitochondrial DNA (mtDNA) genome. Non-Combined DNA Index 
System (CODIS) STR markers have been developed to obtain information beyond the core CODIS loci. 
This chapter will focus on the steps necessary to prepare and use one of the non-CODIS (NC) multiplexes, 
NC01 (Coble and Butler 2005), for analysis on capillary electrophoresis instrumentation. 
 Key words:  Mini-STRs ,  PCR ,  Degraded DNA ,  STR ,  DNA typing 
 
 Short tandem repeat (STR) markers amplifi ed by the polymerase 
chain reaction (PCR) and separated by capillary electrophoresis 
have greatly advanced the fi eld of forensic DNA profi ling over the 
last decade. In the United States, a set of 13 common core STR 
markers (known as CODIS, Combined DNA Index System) has 
been used for criminal casework and databasing for the National 
DNA database. Presently, there are two commercially available 
STR multiplex kits for DNA testing  ( 1,  2 ) . Each kit contains all 13 
CODIS markers, Amelogenin for sex determination, and two STR 
markers unique to each provider’s kit (D2S1338 and D19S433 
from Applied Biosystems (Foster City, CA); Penta D and Penta E 
from Promega Corporation (Madison, WI)). 
 1.  Introduction
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 For most crime scene samples containing high-quality DNA at 
a concentration of at least 1.0 ng/ μ L postextraction, a full STR 
profi le can (usually) easily be obtained with the commercial kits 
barring the presence of an inhibitor to the PCR process. When the 
sample quality is challenged due to chemical, enzymatic, or bacte-
rial damage (to note only a few), it is likely that only a partial DNA 
profi le may be obtained. With moderately degraded DNA sam-
ples, the high molecular weight markers (>250 bp) are typically 
absent from the STR profi le. For highly degraded samples, it may 
be possible to only recover a few of the lower molecular weight 
markers. The net effect of partial DNA profi les resulting from 
degraded DNA is that the random match probability increases, 
lowering the signifi cance of a match. For example, if only 4–5 loci 
are amplifi ed from a degraded sample, the random match proba-
bility between the evidence and the suspect (or a victim in an 
unidentifi ed unknown scenario) may only be in the thousands or 
tens of thousands. 
 Many of the highly challenged samples such as those encoun-
tered at crime scenes, at mass disasters, or with skeletal remains 
from missing persons investigations may require mitochondrial 
DNA (mtDNA) testing to generate a result. Although mtDNA 
testing can be a useful tool for human identifi cation, the process is 
costly, time-consuming, susceptible to contamination, and laborious 
to perform. MtDNA testing can also be limited by a low power of 
discrimination for common mtDNA types  ( 3 ) . Autosomal SNPs 
have been proposed as markers for obtaining genetic information 
from degraded samples  ( 4 ) since these targets can be made into 
small amplicons (typically under 100 bp). Limitations of using 
autosomal SNPs at this time include the lack of a national DNA 
database populated with SNP profi les and the diffi culty to conduct 
mixture deconvolution with biallelic SNPs  ( 5 ) . 
 As an alternative to mtDNA sequencing and autosomal SNP 
testing, reduced amplicon STRs or “miniSTRs” have been developed 
recently to obtain DNA profi les from challenged samples  ( 6– 10 ) . 
For large STR multiplexes, the goal is to space as many markers as 
possible into each dye channel. The primers for higher molecular 
weight amplicons are spaced at a distance away from the repeat 
(e.g., 400 bp in Fig.  1 ). MiniSTRs are created by placing the ampli-
fi cation primers as close to the core STR repeat as possible (Fig.  1 ). 
By placing the primers adjacent to the core repeats, one can generate 
a smaller PCR amplicon (e.g., 100 bp in Fig.  1 ) that has a greater 
possibility of being amplifi ed from a degraded DNA sample (and 
also retain the same information (genotype) as the longer-sized 
amplicon). 
 MiniSTRs have been critical for mass disaster victim identifi cation 
efforts such as the identifi cation of remains from the September 
11, 2001 attack on the World Trade Center  ( 9 ) where nearly 20% 
of the 850 DNA-only identifi cations were made with mini-STRs 
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 ( 11,  12 ) . Miniplexes of miniSTR loci can also be useful for sorting 
highly comingled remains in mass grave identifi cation  ( 13,  14 ) . 
MiniSTRs have been developed for the CODIS loci  ( 9 ) , non-
CODIS markers  ( 15,  16 ) , X-chromosomal STRs  ( 17,  18 ) , and 
Y-STRs  ( 19 ) . Both commercial vendors of STR kits in the US have 
miniSTR kits now available: MiniFiler (Applied Biosystems) for 
degraded samples  ( 20 ) and PowerPlex S5 (Promega) for use as a 
low-cost sorting tool  ( 21 ) . 
 The creation of a novel miniSTR multiplex can be performed 
in a two-step process consisting of “computer work” followed by 
“laboratory work” and is outlined in two publications from the 
human identity group at NIST  ( 16,  22 ) . First, using the computer, 
one identifi es candidate STR markers. One valuable resource is the 
Marshfi eld Maps from the Marshfi eld Clinic Center for Human 
Genetics ( http://research.marshfi eldclinic.org/genetics/Genetic
Research/compMaps.asp ). After selecting a set of loci, the next 
step is to download the sequence data (using the GenBank number 
from the Marshfi eld Maps) from the National Center for 
Biotechnology Information (NCBI) BLAST-nucleotide website 
( http://blast.ncbi.nlm.nih.gov/Blast.cgi ). It is highly suggested 
that one confi rms the exact chromosomal location of the sequence 
using the University of California Santa Cruz Genome Browser—
Human BLAT search of the sequence ( http://genome.ucsc.edu/
cgi-bin/hgBlat?command=start ). Next, a PCR primer design pro-
gram such as Primer 3 ( ( 23 ) ;  http://frodo.wi.mit.edu/primer3/ ) 
can be used to identify primer sites as close to the repeat region as 
possible and thus generate the smallest possible amplicon. Finally, 
once a set of primers has been identifi ed, it is recommended to use 
a software program such as AutoDimer ( ( 24 ) ;  http://www.cstl.nist.
gov/strbase/AutoDimerHomepage/AutoDimerProgram
Homepage.htm ) to avoid nonspecifi c primer–primer combinations 
GATAGATAGATA
Mini-STR primers
~100bp
STR primers from a high molecular weight marker
in a standard commercial kit
~400bp
 Fig. 1.  The concept of a “miniSTR.” In commercially available STR kits, each marker is 
effi ciently spaced apart to maximize the number of markers in a particular dye channel. 
High molecular weight marker primers can amplify regions around 400 bp. In samples 
that are highly degraded, these primers may fail to amplify enough copies to produce an 
allelic peak. By moving the primers as close to the core repeating motif as possible, the 
miniSTR primers can produce a substantially smaller amplicon (e.g., around 100 bp) while 
maintaining the same number of repeats amplifi ed with the commercial kit primers. 
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that may form dimerization products, which can reduce the 
efficiency of the PCR reaction. 
 Once the miniSTR primer sets have been ordered, the second 
stage of the process involves “laboratory work.” The fi rst step is to 
optimize the primer balance – fi rst in singleplex PCR reactions, 
and then in multiplex PCR reactions. It may be necessary to 
increase the primer pair concentration of one marker or lower the 
primer pair concentration of another in order to balance the fl uo-
rescent signal in each dye channel. The next step is to test the 
markers on a set of population samples to assess the number of 
alleles observed, allele frequency, heterozygosity, and other statisti-
cal parameters  ( 16 ) . If the markers are suitable for human identifi -
cation, then it is necessary to determine the allele sizes (i.e., the 
number of repeats) observed for each marker. 
 By selecting homozygous alleles from the population samples, 
it is possible to determine the number of repeats of the allele by 
sequencing. A pair of sequencing primers should be selected using 
the Primer 3 software to sequence the fl anking regions of the min-
iSTR amplicon. For example, if the homozygous allele is 140 bp, 
then one should sequence about 100 bp upstream and downstream 
of the amplicon. Thus, a region of about 340–400 bp with the 
homozygous allele in the “center” of the amplicon is produced. 
Sequencing the amplicon will determine the number of STR 
repeats and may also reveal SNPs in the miniSTR primer sequence 
that create null alleles. 
 Typically, at least two different alleles should be sequenced. 
Preferably, one should sequence an allele at the low end of the 
allele range and an allele at the high end of the range. Once the 
allele sizes in bp are correlated with the repeat numbers, one can 
create bins and panels for genotyping. It is not necessary to create 
allelic ladders. Allelic ladders are laborious to make and have the 
potential to contaminate the lab with amplifi ed PCR product. As 
an alternative to allelic ladders, one can determine the number of 
repeats by sequencing one (or several) positive controls such as 
9947A, 007, or the NIST SRM 2391b DNA samples. By correlat-
ing the number of repeats in the positive control DNA samples, 
genotyping can be performed by including the controls with each 
plate of samples. 
 The following protocol is meant to guide the user from the 
stage where the “computer work” ends and PCR primer sequences 
are identifi ed. The three non-CODIS markers described in Coble 
and Butler  ( 16 ) as part of NC01 (D10S1248, D14S1434, and 
D22S1045) are used as an example (see Fig.  2 ). Sequencing prim-
ers, methods, troubleshooting tips, and additional information can 
be found in Coble and Butler  ( 16 ) and Hill et al.  ( 22 ) . 
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 For convention, all forward primers were synthesized with fl uores-
cent dyes and reverse primers were unlabeled. Labeled forward 
primers were ordered from Applied Biosystems (Foster City, CA) 
with the fl uorescent dyes 6FAM (blue), VIC (green), and NED (yel-
low). Unlabeled reverse primers were purchased from Qiagen Operon 
(Alameda, CA). Primers were ordered lyophilized and desalted. 
 Table  1 contains the labeled and unlabeled primer sequences for 
the NC01 assay (see Note 1). 
 Primers were rehydrated in a solution of Tris Low EDTA buffer 
(10 mM Tris–HCl and 0.1 mM EDTA), pH = 8.0. 
 A NanoDrop 2000 (UV spectrophotometer) from Thermo Scientifi c 
(Wilmington, DE) was used to determine the concentration of rehy-
drated primer solutions. 
 2.  Materials
 2.1.  PCR Primers 
for MiniSTR 
Multiplex NC01
 2.1.1.  Ordering of PCR 
Primers
 2.1.2.  PCR Primer 
Sequences
 2.1.3.  Rehydration Buffer
 2.2.  UV 
Spectrophotomer
 Fig. 2.   An example of a sample amplifi ed with the NC01 miniSTR multiplex. Each marker of the NC01 multiplex (D10S1248, 
 blue channel  ; D14S1434;  green channel  ; D22S1045;  yellow (noted as  black )  channel  ) in this sample is heterozygous. Note 
that the size range of each marker falls under 120 bp, making these markers useful for degraded samples. 
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 AmpliTaqGold® DNA polymerase (5 U/ μ L), 25 mM MgCl 2 , and 
10× GeneAmp® PCR Gold buffer was purchased from Applied 
Biosystems. 
 A stock solution containing 10 mM of each deoxyribonucleotide 
triphosphate (dNTP) was purchased from USB Corporation 
(Cleveland, OH) (see Note 2). 
 Bovine serum albumin (BSA) fraction V lyophilized powder, 
molecular biology grade, nonacetylated was purchased from Sigma-
Aldrich (St. Louis, MO). A stock solution of 3.2 mg/mL was pre-
pared in nanopure water. 
 A GeneAmp® PCR System 9700 (Applied Biosystems) was used to 
amplify the NC01 miniSTR multiplex. The cycler was run in 9600 
emulation mode with a ramp rate of 1°C/s. 
 Either the ABI 310 or 3130xl Genetic Analyzers (Applied Biosystems) 
can be used for fragment separation. A 5-dye matrix should be 
established under the “G5 fi lter” with the dyes 6FAM, VIC, NED, PET, 
and LIZ using matrix standard set DS-33 (part number 4318159 
for the 310; part number 4345833 for the 3130 from Applied 
Biosystems). A 36-cm array was used for fragment separation. 
 Either performance optimized polymer POP-4 or POP-6 (Applied 
Biosystems) was used for fragment separation (see Note 3). 
 ACE 10× sequencing buffer commercially available from Amresco 
(Solon, OH) was used in a 1× concentration (diluted with 
dH 2 O). 
 2.3.  DNA Polymerase 
and Buffers for PCR
 2.4.  Deoxy-
ribonucleotide 
Triphosphates
 2.5.  Bovine Serum 
Albumin
 2.6.  Thermal Cycler
 2.7.  Capillary 
Electrophoresis
 2.8.  Separation 
Polymer
 2.9.  Electrophoresis 
Buffer
 Table 1 
 PCR primer sequences for the NC01 multiplex amplifi cation 
 Marker name  Primer type  Prime sequence (5 ¢ -3 ¢ ) 
 Amplicon 
size (bp) a 
 D10S1248  Forward  (FAM)-TTAATGAATTGAACAAATGAGTGAG  102 
 Reverse  G CAACTCTGGTTGTATTGTCTTCAT 
 D14S1434  Forward  (VIC)-TGTAATAACTCTACGACTGTCTGTCTG  88 
 Reverse  G AATAGGAGGTGGATGGATGG 
 D22S1045  Forward  (NED)-ATTTTCCCCGATGATAGTAGTCT  105 
 Reverse  G CGAATGTATGATTGGCAATATTTTT 
 a Based upon the size of the allele present in GenBank 
 The 5 ¢ guanine residue in each reverse primer (underlined and in bold font) was added to promote full 
adenylation of the amplicons (see Note 1 and ref.  ( 9 ) ) 
373 Capillary Electrophoresis of MiniSTR Markers to Genotype¼
 PCR amplicons were diluted in Hi-Di formamide purchased from 
Applied Biosystems prior to electrophoresis. 
 GeneScan™ 500 LIZ Size Standard was purchased from Applied 
Biosystems. 
 The commercial software package GeneMapper ID v3.2 (Applied 
Biosystems) was used for data analysis. Bins and panels for NC01 
are available on STRBase (see Subheading  3.7 ). There are no allelic 
ladders available for NC01. 
 
 Stock primer solutions were reconstituted at 100  μ M for labeled 
primers and 200  μ M for unlabeled primers. Primers were rehydrated 
with appropriate volumes of Tris Low EDTA buffer (see Note 4). 
 Unlabeled reverse primers were synthesized with specifi c concen-
tration information (in pmol) and were reconstituted from this 
value. Postrehydration, the primers were quantifi ed using a UV 
Spectrophotometer by determining the absorbance reading at 
260 nm. Forward primers do not come with specifi c concentration 
values. Labeled primers can be ordered at various scales depending 
on the amount of primer desired. Typically, for the fi rst time a 
primer is tested, the smallest scale is ordered (10,000 pmol). 
Therefore, the labeled primers were all reconstituted with the same 
amount of Tris Low EDTA buffer to a fi nal concentration of 
100  μ M and were not quantifi ed by UV spectrophotometer. 
 The multiplex primer mix concentration was 2  μ M for each primer 
pair. Initially, the concentration of each primer pair in the primer 
mix was equivalent (see Note 5). As an example, a 100  μ L fi nal 
volume primer mix for the three NC01 markers (D10S1248, 
D14S1434, and D22S1045) would be created by taking 1.0  μ L of 
each labeled forward primer (200  μ M solution) plus 0.5  μ L of each 
unlabeled reverse primer (total volume = 4.5  μ L) plus 95.5  μ L of 
dH 2 O (see Note 6). 
 PCR amplifi cation of the NC01 multiplex can be performed in a 
total volume of 10  μ L for high-quality samples or 25  μ L for 
degraded DNA samples (see Note 7). Final PCR reagent concen-
trations were: 1 U of AmpliTaqGold® DNA polymerase (degraded 
or inhibited DNA samples are typically amplifi ed with 2 U of poly-
merase), 1× Taq Gold PCR buffer, 250  μ M dNTPs, 5 mM MgCl 2 , 
0.16 mg/mL BSA fraction V (this is optional for high-quality sam-
ples), and 0.2  μ M of each amplifi cation primer pair (see Note 8). 
 2.10.  Formamide
 2.11.  DNA Sizing 
Standard
 2.12.  Software 
Fragment Analysis
 3.  Methods
 3.1.  Primers
 3.1.1.  Primer Rehydration
 3.1.2.  Quantifi cation 
of Primers
 3.1.3.  Multiplex Primer Mix
 3.2.  PCR Amplifi cation 
Conditions
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For high-quality samples, 1.0  μ L of DNA (0.5 ng/ μ L) is added to 
the reaction. For degraded DNA samples, 5.0  μ L of the total 25  μ L 
reaction is available for DNA (see Note 9). An example of a PCR 
preparation protocol is found in Table  2 . 
 Amplifi cation of the multiplex PCR reaction was performed in the 
GeneAmp 9700 thermal cycler using the following conditions:
 95°C for 10 min ●
 94°C for 1 min  –
 55°C for 1 min –
 72°C for 1 min  –
 (28–34 cycles of PCR)  –
 60°C for 45 min  ●
 25°C soak  ●
 For high-quality samples, amplifi cation of 28 cycles was per-
formed. For low template and challenged samples, up to 34 cycles 
can be amplifi ed (see Note 10). 
 3.3.  Thermal Cycling 
Conditions
 3.3.1.  PCR Thermal Cycling 
Conditions
 Table 2 
 PCR preparation worksheet 
 10  m L PCR  25 m L PCR 
 1× Reaction ( m L)  1× Reaction ( m L) 
 PCR buffer  ( n + ×) a × 1.0  ( n + ×) a × 2.5 
 MgCl 2  ( n + ×) × 0.8  ( n + ×) × 2.0 
 Primer mix  ( n + ×) × 2.0  ( n + ×) × 5.0 
 dNTPs  ( n + ×) × 0.25  ( n + ×) × 0.625 
 BSA b  ( n + ×) × 0.5  ( n + ×) × 1.25 
 TaqGold c  ( n + ×) × 0.2  ( n + ×) × 1.0 
 dH 2 O  ( n + ×) × 4.25  ( n + ×) × 8.125 
 Master Mix vol. + template ( μ L)  ( n + ×) × 9.0  ( n + ×) × 20.0 
 1.0 per sample  5.0 per sample 
 For high-quality genomic DNA, 10  μ L reactions can be used to conserve 
reagents. For degraded samples, 25  μ L reactions can be used to increase the 
amount of DNA in the reaction by adjusting the dH 2 O content 
  a  The ( n + ×) refers to the total number of samples ( n ) plus (×) additional sam-
ples for pipetting error. Typically, one additional sample is added for every 12 
samples tested. For example, with 96 samples, the ( n + ×) = (96 + 8) = 104 
reactions 
  b  BSA is optional for high-quality samples. If omitted, the amount of water can 
be increased to 4.75  μ L 
  c  For low template and challenged samples (25  μ L reactions), the amount of 
TaqGold can be increased to 2 U/ μ L 
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 The CE instrument (310 or 3130xl) with a 36 cm capillary array 
fi lled with either denaturing POP-4 or POP-6 polymer was utilized 
for DNA fragment separation. ACE buffer at 1× concentration was 
used as the running buffer for the CE instrument. The standard 
run module parameters were: Run temperature = 60°C, injection 
voltage = 3 kV, injection time = 10 s, run voltage = 15 kV, and run 
time = 1,800 s (see Note 11). 
 Samples were prepared for the ABI 3130 with 15- μ L Hi-Di forma-
mide (Applied Biosystems), 0.35- μ L GS500 LIZ size standard 
(Applied Biosystems), and 1- μ L PCR product. For samples sepa-
rated on the ABI 310, 19- μ L Hi-Di formamide, 0.75- μ L GS500 
LIZ size standard, and 1- μ L PCR product were used. Samples 
were prepared without prior denaturation and “snap cooling” of 
the PCR product. 
 For the commercially available STR typing kits, allelic ladders for 
each marker are included in the purchase of the kit and used in the 
automated genotyping of samples. For the non-CODIS minSTRs, 
NIST has genotyped the alleles present among commonly used 
positive controls and genotyped and certifi ed each component of 
SRM 2391b ( http://www.cstl.nist.gov/biotech/strbase/miniSTR/
miniSTR_NC_loci_types.htm ). It is recommended that these con-
trols be used for correctly genotyping population or casework 
samples rather than relying upon an allelic ladder. 
 Data fi les from the CE were exported as .fsa fi les and imported into 
GeneMapper ID v3.2 (Applied Biosystems). Bins and panels for all 
of the non-CODIS miniSTRs have been developed for use with 
POP-6 and are available on STRBase ( http://www.cstl.nist.gov/
biotech/strbase/miniSTR/miniSTR_Panels_NC_bins_bins.txt ) 
and ( http://www.cstl.nist.gov/biotech/strbase/miniSTR/min-
iSTR_Panels_Panels.txt ). 
 
  1.  Reverse primers lacking a guanine base (G) at the 5 ¢ end of the 
primer have an additional guanine base (G) or “pig-tail” 
sequence (GTTTCTT) added to the 5 ¢ end to promote full 
adenylation (see ref.  ( 9 ) for more details) and are noted in bold 
and underlined in Table  1 . 
  2.  Stock solutions of dNTPs (in about 1.5 mL) can be aliquoted 
into smaller volumes (e.g., 50  μ L) and stored at −20°C. For 
each new PCR mastermix, a fresh aliquot can be used to reduce 
the number of freeze–thaw cycles of the dNTPs. 
 3.4.  Capillary 
Electrophoresis 
Conditions
 3.5.  Preparation 
of the Samples for CE 
Separation and 
Detection
 3.6.  Allelic Ladders
 3.7.  Data Analysis
 4.  Notes
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  3.  In addition to POP-6, POP-4 and POP-7 can also be used as a 
separation medium. Depending on the polymer used, slight 
differences in the amplicon mobility may be observed. The 
bins and panels in the GeneMapper software should also be 
changed to refl ect any mobility change. 
  4.  Primers rehydrated in Tris Low EDTA buffer rather than in 
distilled water have better stability and fewer artifacts/dye 
blobs when stored at 4°C up to 18 months. 
  5.  Not all fl uorescent dyes are equivalent. For example, FAM 
tends to fl uoresce more strongly than PET dyes. Therefore, it 
may be necessary to adjust the primer concentrations to achieve 
balance among each dye channel. This is more of a qualitative 
exercise (using peak heights in each dye channel as a guide) 
that takes trial and error to achieve. 
  6.  It is recommended that primer mixes be stored out of the light 
and at 4°C instead of the freezer to avoid freeze–thaw cycles. 
As labeled primers and primer mixes age, the intensity of dye 
artifacts in the electropherogram increases. 
  7.  The increased volume (25  μ L reactions) for degraded/inhib-
ited samples can help to dilute inhibitors. 
  8.  It is important to use nonacetylated BSA rather than acetylated 
BSA since the latter can cause inhibition of the PCR process  ( 25 ) . 
  9.  For low quantities of DNA, up to 8.125  μ L of water in the 
PCR reaction can be substituted for template, giving a maxi-
mum input of 13.125  μ L of DNA added to the PCR. 
  10.  It should be noted that enhanced techniques, such as increased 
polymerase and extra PCR cycles, can give rise to exaggerated 
stochastic effects with low-template DNA. Proper interpreta-
tion guidelines  ( 26 ) , including replicate analyses of the data 
 ( 26,  27 ) , should be utilized to generate reliable results. 
  11.  Since the alleles of the NC01 miniSTR multiplex are all under 
150 bp, it is possible to shorten the run time module for data 
collection since the default run time collects data for amplicons 
up to 350–400+ bp fragments. Adjusting the data collection 
time can decrease the overall run time and increase genotyping 
throughput. 
 Acknowledgments/
Disclaimer 
 I would like to thank my colleagues at NIST for their assistance in 
the development of the NC01 multiplex: Dr. John Butler, Becky 
Hill, Margaret Kline, and Dr. Peter Vallone. Dr. Kristen Lewis 
413 Capillary Electrophoresis of MiniSTR Markers to Genotype¼
O’Connor and Erica Butts at NIST are appreciated for their editorial 
comments. I am also grateful to Dr. Antonio Alonso for the oppor-
tunity. Finally, I would like to acknowledge the National Institute 
of Justice for their funding to our NIST Group through the NIST 
Offi ce of Law Enforcement Standards interagency agreement 
2008-DN-R-121. 
 The opinions and assertions contained herein are solely those 
of the author and are not to be construed as offi cial or as views of 
the National Institute of Justice. Commercial equipment, instru-
ments, and materials are identifi ed in order to specify experimental 
procedures as completely as possible. In no case does such identifi -
cation imply a recommendation or endorsement by the National 
Institute of Justice, nor does it imply that any of the materials, 
instruments, or equipment identifi ed are necessarily the best available 
for the purpose. 
 References 
  1.  Collins PJ, Hennessy LK, Leibelt CS, Roby 
RK, Reeder DJ, Foxall PA (2004) 
Developmental validation of a single-tube 
amplifi cation of the 13 CODIS STR loci, 
D2S1338, D19S433, and amelogenin: the 
AmpFlSTR Identifi ler PCR Amplifi cation Kit. 
 J Forensic Sci.  49(6) : 1265–1277. 
  2.  Krenke BE, Tereba A, Anderson SJ, Buel E, 
Culhane S, Finis CJ, Tomsey CS, Zachetti JM, 
Masibay A, Rabbach DR, Amiott EA, Sprecher 
CJ (2002) Validation of a 16-locus fl uorescent 
multiplex system.  J Forensic Sci.  47(4) : 773–785. 
  3.  Coble MD, Just RS, O’Callaghan JE, Letmanyi 
IH, Peterson CT, Irwin JA, Parsons TJ (2004) 
Single nucleotide polymorphisms over the 
entire mtDNA genome that increase the power 
of forensic testing in Caucasians.  Int. J. Legal 
Med.  118 : 137–146 . 
  4.  Dixon LA, Murray CM, Archer EJ, Dobbins 
AE, Koumi P, Gill P (2005) Validation of a 
21-locus autosomal SNP multiplex for forensic 
identifi cation purposes.  Forensic Sci Int. 
 154(1) : 62–77. 
  5.  Gill P, Werrett DJ, Budowle B, Guerrieri R 
(2004) An assessment of whether SNPs will 
replace STRs in national DNA databases-Joint 
considerations of the DNA working group of 
the European Network of Forensic Science 
Institutes (ENFSI) and the Scientifi c Working 
Group on DNA Analysis Methods (SWGDAM). 
 Science&Justice  44(1) : 51–53. 
  6.  Hellmann A, Rohleder U, Schmitter H, Wittig 
M (2001) STR typing of human telogen hairs – 
a new approach,  Int. J. Legal Med.  114(4–5) : 
269–273. 
  7.  Wiegand P and Kleiber M (2001) Less is more – 
length reduction of STR amplicons using rede-
signed primers.  Int. J. Legal Med.  114
(4–5) : 285–287. 
  8.  Tsukada K, Takayanagi K, Asamura H, Ota M, 
Fukushima H (2002) Multiplex short tandem 
repeat typing in degraded samples using newly 
designed primers for the TH01,CSF1PO,and 
vWA loci.  Legal Medicine (Tokyo)  4 : 239–245. 
  9.  Butler JM, Shen Y, McCord BR (2003). The 
development of reduced size STR amplicons as 
tools for analysis of degraded DNA.  J Forensic 
Sci.  48(5) : 1054–1064. 
 10.  Opel KL, Chung DT, Drabek J, Tatarek NE, 
Jantz LM, McCord BR (2006) The application 
of miniplex primer sets in the analysis of 
degraded DNA from human skeletal remains, 
 J Forensic Sci.  51(2) : 351–356. 
 11.  Holland MM, Cave CA, Holland CA, Bille TW 
(2003) Development of a quality, high through-
put DNA analysis procedure for skeletal sam-
ples to assist with the identifi cation of victims 
from the World Trade Center attacks.  Croat 
Med J.  44 : 264–272. 
 12.  Biesecker LG, Bailey-Wilson JE, Ballantyne J, 
Baum H, Bieber FR, Brenner C, Budowle B, 
Butler JM, Carmody G, Conneally PM, 
Duceman B, Eisenberg A, Forman L, Kidd KK, 
Leclair B, Niezgoda S, Parsons TJ, Pugh E, 
Shaler R, Sherry ST, Sozer A, Walsh A (2005) 
DNA Identifi cations after the 9/11 World 
Trade Center attack.  Science  310(5751) : 
1122–1123. 
 13.  Parsons TJ, Huel R, Davoren J, Katzmarzyk C, 
Milos A, Selmanovic A, Smajlovic L, Coble 
42 M.D. Coble
MD, Rizvic A (2007) Application of novel 
“mini-amplicon” STR multiplexes to high vol-
ume casework on degraded skeletal remains, 
 Forensic Sci Int Genet.  1 : 175–179. 
 14.  Marjanović D, Durmić-Pasić A, Kovacević L, 
Avdić J, Dzehverović M, Haverić S, Ramić J, 
Kalamujić B, Lukić Bilela L, Skaro V, Projić P, 
Bajrović K, Drobnic K, Davoren J, Primorac D 
(2009) Identifi cation of skeletal remains of 
Communist Armed Forces victims during and 
after World War II: combined Y-chromosome 
(STR) and MiniSTR approach.  Croat Med J. 
 50(3) : 296–304. 
 15.  Ohtaki H, Yamamoto T, Yoshimoto T, Uchihi 
R, Ooshima C, Katsumata Y, Tokunaga K 
(2002) A powerful, novel, multiplex typing 
system for six short tandem repeat loci and the 
allele frequency distributions in two Japanese 
regional populations.  Electrophoresis  23(19) : 
3332–3340. 
 16.  Coble MD and Butler JM (2005) Characterization 
of new miniSTR loci to aid analysis of degraded 
DNA.  J Forensic Sci.  50(1) : 43–53. 
 17.  Asamura H, Sakai H, Kobayashi K, Ota M, 
Fukushima H (2006) MiniX-STR multiplex 
system population study in Japan and applica-
tion to degraded DNA analysis.  Int. J. Legal 
Med.  120(3) : 174–181. 
 18.  Diegoli TM and Coble MD (2011) 
Development and characterization of two mini-
X chromosomal short tandem repeat multi-
plexes.  Forensic Sci Int Genet. in press. 
 19.  Park MJ, Lee HY, Chung U, Kang SC, Shin KJ 
(2007) Y-STR analysis of degraded DNA using 
reduced-size amplicons.  Int. J. Legal Med. 
 121(2) : 152–157. 
 20.  Mulero JJ, Chang CW, Lagacé RE, Wang DY, 
Bas JL, McMahon TP, Hennessy LK (2008) 
Development and validation of the AmpFlSTR 
MiniFiler PCR Amplifi cation Kit: a MiniSTR 
multiplex for the analysis of degraded and/or 
PCR inhibited DNA.  J Forensic Sci.  53(4) : 
838–852. 
 21.  Poetsch M, Kamphausen T, Bajanowski T, 
Schwark T, von Wurmb-Schwark N (2011) 
Powerplex® ES versus Powerplex® S5--
casework testing of the new screening kit. 
 Forensic Sci Int Genet.  5(1) : 57–63. 
 22.  Hill CR, Kline MC, Coble MD, Butler JM 
(2008) Characterization of 26 miniSTR loci 
for improved analysis of degraded DNA sam-
ples.  J Forensic Sci.  53(1) : 73–80. 
 23.  Rozen S and Skaletsky HJ (2000) Primer3 on 
the WWW for general users and for biologist 
programmers. In: Krawetz S, Misener S (eds) 
 Bioinformatics Methods and Protocols: Methods 
in Molecular Biology. Humana Press, Totowa, 
NJ, pp 365–386. Source code available at 
 http://fokker.wi.mit.edu/primer3/ . 
 24.  Vallone PM, Butler JM (2004) AutoDimer: a 
screening tool for primer-dimer and hairpin 
structures. Biotechniques. 37(2): 226–231. 
 25.  Bell PA, Chaturvedi S, Gelfand CA, Huang 
CY, Kochersperger M, Kopla R, Modica F, 
Pohl M, Varde S, Zhao RB, Zhao XJ, Boyce-
Jacino MT (2002) SNPstream UHT: Ultra-
high throughput SNP genotyping for 
pharmacogenomics and drug discovery. 
 Biotechniques Suppl . pp 70–77. 
 26.  Gill P, Whitaker J, Flaxman C, Brown N, 
Buckleton J (2000) An investigation of the 
rigor of interpretation rules for STRs derived 
from less than 100 pg of DNA.  Forensic Sci Int. 
 112(1) : 17–40. 
 27.  Benschop CC, van der Beek CP, Meiland HC, 
van Gorp AG, Westen AA, Sijen T (2011) Low 
template STR typing: Effect of replicate num-
ber and consensus method on genotyping reli-
ability and DNA database search results. 
 Forensic Sci Int Genet. in press. 
43
Antonio Alonso (ed.), DNA Electrophoresis Protocols for Forensic Genetics, Methods in Molecular Biology, vol. 830,
DOI 10.1007/978-1-61779-461-2_4, © Springer Science+Business Media, LLC 2012
 Chapter 4 
 Interpretation Guidelines of a Standard Y-chromosome 
STR 17-plex PCR-CE Assay for Crime Casework 
 Lutz  Roewer and  Maria  Geppert  
 Abstract 
 Y-STR analysis is an invaluable tool to examine evidence in sexual assault cases and in other forensic casework. 
Unambiguous detection of the male component in DNA mixtures with a high female background is still 
the main fi eld of application of forensic Y-STR haplotyping. In the last years, powerful technologies including 
a 17-locus multiplex PCR assay have been introduced in the forensic laboratories. At the same time, statistical 
methods have been developed and adapted for interpretation of a nonrecombining, linear marker as the 
Y-chromosome which shows a strongly clustered geographical distribution due to the linear inheritance 
and the patrilocality of ancestral groups. Large population databases, namely the Y-STR Haplotype 
Reference Database (YHRD), have been established to assess the evidentiary value of Y-STR matches by 
means of frequency estimation methods (counting and extrapolation). 
 Key words:  Y-STR analysis ,  Sexual assault ,  Mixed stains ,  Haplotype frequency ,  Match probability , 
 Mixture analysis ,  Population database 
 
 Sexual assault cases represent a signifi cant percentage of cases examined 
by forensic laboratories. A notable portion of physical evidence 
submitted in such cases consists of mixtures of body fl uids from the 
victim and the assailant(s), often containing small quantities of 
DNA which might be highly degraded. Almost every DNA admixture 
is characterized by unbalanced proportions of a large female (victim’s) 
and a very small male (suspect’s) component. While the standard 
autosomal STR analysis doesn’t detect the male component in most 
of such cases, the Y-STR testing often provides probative results on 
the suspect. The Y-STR analysis is especially helpful when there is 
more than one male responsible for the assault, because the mixed 
male/male pattern can be resolved and a likelihood of donorship 
 1.  Introduction
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for each of the assailants can be calculated. Y-STR haplotype analysis 
is also used for nonsexual assault cases where mixed samples are 
collected from evidence. Performing Y-STR testing can help to 
identify all males who have contributed to the evidence. During 
the last years, the advent of highly sensitive Y-STR kits has prompted 
many forensic genetic laboratories to evaluate and modify their 
existing workfl ow for sexual assault and other casework samples 
where mixtures can be expected (e.g., vaginal swabs, fi ngernail 
scrapings, contact stains) aiming to produce additional probative 
results  ( 1,  2 ) . The detailed protocols to amplify Y-STRs in multiplex 
PCR reactions followed by capillary electrophoresis are analogous 
to autosomal STR analysis and provided by the manufacturers of 
forensic Y-STR kits. This article addresses the issue of interpreta-
tion and reporting of Y-chromosome data. Since all Y-chromosomal 
STRs constitute a single haplotype, a match between profi les can 
only be evaluated on the basis of the haplotype frequency instead 
of the genotype frequency  ( 3 ) . Multiplying the individual allele 
frequencies is not valid as for independently inherited autosomal 
STRs. Instead, the frequency of the full haplotype has to be assessed 
in the relevant population. To determine the match probability, a 
counting and/or an extrapolation (“frequency surveying”) method 
can be applied  ( 4– 6 ) . For both methods, large, representative, and 
quality-assessed databases of haplotypes sampled in appropriate 
reference populations are required. In this chapter, we will explain 
how to utilize the Y-chromosome haplotype reference database 
(YHRD), the largest curated forensic repository of multiregional 
population samples, for estimating the haplotype frequencies to be 
used in the decision-making process  ( 7 ) . This database does not 
work like an offender database as CODIS (USA), FSS (UK), DAD 
(Germany), or other. This is a population database and it is intended 
for use in estimating Y-STR haplotype population frequencies for 
forensic case work purposes. It cannot be used to identify a particular 
individual whose sample is in the database. Instead, the database is 
a searchable listing of anonymous 9- to 17-locus haplotypes of 
unrelated probands directly submitted by forensic, quality-assessed 
laboratories from around the world and mandatorily published in 
peer-reviewed journals  ( 8,  9 ) . Each haplotype has a population 
identifi er (geographical and ethnical) and thus it can be assigned to 
a larger set of samples of common origin and shared demographic 
history. This set of samples is called a metapopulation (MP)  ( 7 ) . 
Because between populations exist large differences in Y-chromosome 
haplotype proportions (resulting in the highest F st values of all 
forensic markers), a search in predefi ned metapopulation samples 
results in frequencies which are realistic estimates of the probability 
of occurrence and are less affected by population substructuring. 
It needs to be emphasized, that—due to the nonrecombining 
nature of Y-chromosomes—even a highly discriminating panel of 
17 Y specifi c STRs is not individual-specifi c but lineage-specifi c 
and a match concerns all men sharing patrilineal descent. This has 
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to be properly addressed in the match report. In contrast to a 
match, an exclusion of Y-STR profi les is unambiguous and the 
exclusion chance increases with the number of Y-STRs employed. 
Finally, we will address the issue of male–male mixtures and its 
statistical interpretation using a likelihood ratio calculation  ( 10 ) . 
 
  1.  AmpFlSTR ® Yfi ler Plus™ PCR Amplifi cation Kit. 
  2.  Y-Chromosome Haplotype Reference Database ( www.yhrd.
org and tools therein). 
 
 Figure  1a shows a typical example where a standard autosomal 
analysis with the AmpFlSTR ® SEfi ler Plus™ PCR Amplifi cation Kit 
was performed in a crime investigation. A clear female profi le was 
determined at the evidence (a condom). The occurrence of a small 
Y peak at the Amelogenin locus may indicate a minor male DNA 
contribution, but only the females’ STR signals could be recorded 
unequivocally. However, the amplifi cation of the same DNA extract 
with the AmpFlSTR ® Yfi ler Plus™ PCR Amplifi cation Kit generates 
a complete, single-source Y haplotype of the unknown suspect 
(Fig.  1b , Table  1 ). The high excess of female DNA doesn’t infl uence 
the outcome of the Y-STR analysis (see Note 4). 
 To estimate the frequency of this haplotype, the online YHRD 
was approached ( www.yhrd.org/Search/Haplotypes ) (see Note 1). 
The YHRD can be searched for all single alleles and all allele 
 combinations up to a maximum of 17 loci. Please note that the 
database size differs for different standard haplotype formats 
because reference samples have been submitted in a 9-locus (mini-
mal haplotype)  ( 11 ) , 12-locus (PowerPlex ® Y kit, Promega), or 
17-locus format (AmpFlSTR ® Yfi ler Plus™ PCR Amplifi cation Kit, 
Applied Biosystems). Release 34 of the YHRD from November 19, 
2010 was used here which includes 87,440 9-locus minimal haplo-
types (182 populations), 39,349 12-locus haplotypes, and 27,532 
17-locus haplotypes (the latter are subsets of the former less- specifi c 
haplotypes) (see Note 2). 
  1.  To search for a haplotype, enter the alleles of interest for 
each marker by using the drop-down menu. Enter any of the 
following value types:
 Standard ladder allele such as “14.”  ●
 2.  Material
 3.  Methods
 3.1.  Frequency 
Estimation
 3.1.1.  Instruction
 Database Query
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 Fig. 1.  ( a ) Standard 11-locus autosomal STR analysis of a DNA mixture. A predominant female DNA component is 
detected. ( b ) 17-locus Y-STR analysis of the same trace found at a condom. Despite the high female background, only the 
male DNA component is detected. 
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Fig. 1. (continued)
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 Intermediate allele values such as “17.2” or duplicated  ●
(triplicated, quadruplicated) loci such as “14,15” (see the 
list of intermediate and multiple alleles for each locus at 
 http://www.yhrd.org/Research/Loci ). 
 Null allele: enter “0” as the allele designation when the  ●
sample is believed to contain a null allele type created by 
mutation (and not by drop-out). 
 Leave a particular locus blank (default) to fi nd matches for  ●
any allele at this locus. 
 To search at duplicated locus DYS385, enter the desired  ●
alleles separated by a comma, select the smallest allele fi rst 
such as “11,14.” 
 Search in the “whole database” or select the ancestral  ●
group (metapopulation), a continent, or a national data-
base of interest from the appropriate boxes. A list of the 
predefi ned metapopulations within the database is  provided 
here  http:/ www.yhrd.org/Research/Metapopulations 
(see Note 3). 
  2.  Select the “search” button to query the database for the chosen 
haplotype. 
  1.  Haplotype frequencies can be estimated simply by counting or 
by extrapolation. Both methods rely on databases which com-
prise haplotypes sampled in populations. The latter approach 
also known as the “frequency surveying method”  ( 4– 6 ) is 
based upon the similarity and frequency relationships observed 
among haplotypes already included in the database. This approach 
ensures that rare haplotypes retain their high evidential power 
even when the database used for estimation is of realistic and 
therefore moderate size. 
  2.  When using the counting method for the frequency estimation, 
a 95% confi dence interval (CI) is added to the frequency value 
to correct for database size and sampling errors. Given the error 
percentile  α (0.05 in the case of 95% CI), the number of obser-
vations  n, and the database size  N , we calculate the lower and 
upper CI limits using the exact Clopper–Pearson method  ( 12 ) : 
  a a- -é - ùæ ö æ ö- + + -ç ÷ ç ÷ê úè ø è øë û
1 1 1, , 1 , , 1, .
2 2
B n N n B n N n  
  3.  Since the counting method may reduce the evidentiary power 
inadequately in cases of nonobservation (estimates are limited 
by the database size and impaired by sampling effects), we rec-
ommend the extrapolation method where the haplotype in 
question does not enter into the estimation process. For the 
frequency of a haplotype in question, the so-called “surveying 
method” yields a beta-type posterior distribution with mean 
 Frequency and Confi dence 
Interval Calculations
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(mean likelihood estimate) and mode points (maximum likelihood 
estimate). This posterior distribution is obtained by extrapolation 
from the structure and frequency of all other haplotypes in the 
relevant ancestral group (metapopulation). To extrapolate, 
search the haplotype fi rst and click on the button “Frequency 
surveying estimates.” The estimation process can only be 
conducted if at least full minimal haplotypes (9 loci) are entered 
and “whole database” is chosen. Estimates are currently avail-
able for 11 metapopulations, which reasonably meet the quality 
criteria (size, representativeness) (see Note 5). Two values are 
calculated, the “mean” and the “mode” of the a-posteriori hap-
lotype frequency distribution. We recommend using the “mean” 
value as a robust estimator of the haplotype frequency. Please 
note that two estimates are calculated, one with the haplotype 
included in the databases, the other without inclusion of the 
haplotype. We recommend the latter to avoid an unnecessary 
reduction of the evidentiary power. 
 Query for the example haplotype (Fig.  1b , Table  1 ) with three 
 different frequency estimations
  1.  The search result for the example haplotype is shown in Fig.  2a . 
The report (default) includes the number of matches in the 
whole database (0/27.532 17-locus haplotypes) and in 33 meta-
populations, e.g., 0/9,470 Eurasians or 0/10,632 East Asians 
(YHRD release 34 built at November 19, 2010). Other group-
ings of the databased samples are also available, namely seven 
continental and 104 national databases, which can be selected 
according to needs of the users from the toolbar. The frequency 
of the haplotype in question can be reported in the most conser-
vative way as the upper confi dence interval limit (1.34 × 10 −4 /
total database) or by adding the unobserved haplotype to the 
database (1/database + 1) resulting in a more truthful frequency 
estimate (3.6 × 10 −5 /total database). The latter approach also 
takes a very conservative position assuming that the next sam-
pled haplotype for the database is the example haplotype. 
  2.  In this example case, we recommend the extrapolation method 
because the origin of the DNA donor is known (Western 
Europe) and a large representative database is available for this 
ancestral pool. The mean frequency value is calculated with the 
program “Frequency Surveying Estimates” at the YHRD website. 
The value for the example haplotype is 7.0 × 10 −5 in the Western 
European metapopulation (haplotype not included in the data-
base) (Fig.  2b ). Because the method is based on the structural 
relatedness of haplotypes within an ancestral pool, information 
on the origin of the DNA donor must be available a-priori. 
The extrapolation can only be done for metapopulations for 
which a large and representative spectrum of population-specifi c 
haplotypes is available in the YHRD. This was tested and confi rmed 
 Fig. 2.  ( a ) Frequency calculation (counting method) using the YHRD release 34 for the 17-locus profi le amplifi ed from the 
evidence. Matches are grouped according to metapopulations. ( b ) Frequency calculation using the frequency surveying 
method of the YHRD. Estimates are listed for different metapopulations. 
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for the Western European, the Eastern European, the Southeastern 
European, the Afro-American, the Japanese, the Korean, the 
Chinese, the Indian, Arab, Turkic, and the Indo-Iranian MP  ( 6 ) . 
 A case with a mixture consisting of more than one 17-locus Y-STR 
profi le detectable in a trace is shown in Table  2 , Fig.  3 . 
 For the interpretation of such evidence, the YHRD offers a 
“mixture tool” ( www.yhrd.org/Mixture ) to calculate likelihood 
ratios for varying numbers of known and unknown male contribu-
tors  ( 10 ) . The database provides the population-dependent frequen-
cies of the haplotype profi les detected in the trace.
  1.  Enter all alleles detected in the  trace mixture separated by 
semicolons in the appropriate boxes (leave missing loci blank). 
Please note that all alleles at DYS385 have to be separated by 
semicolons as well. 
  2.  Please enter the profi le of the  putative donor (e.g., suspect). 
  3.  Choose the appropriate  metapopulation to which all contribu-
tors belong. 
  4.  Enter the number of  additional contributors . This is the num-
ber of all hypothetical contributors to the trace minus one (the 
putative donor). 
  5.  Press  calculate . 
 The result will be a likelihood of donorship vs. nondonorship 
of the putative donor to the trace. In the example case, the likelihood 
ratio (based on the Eurasian metapopulation with 9,470 17-locus 
haplotypes, YHRD release 34) is 2.4 × 10 3 (see Fig.  4 ). So, it is highly 
probable that the man who left the major DNA component has 
contributed to the trace. Note the following limitation: the haplo-
type of the suspect must occur in the selected metapopulation. 
Otherwise the calculation is not possible. Also the calculation cannot 
be accomplished, if the selected database is too small. In this case, 
a failure message will appear (see Note 6). 
 
  1.  A much more detailed description of the YHRD and its tools 
is published in the manual “YHRD 3.0, Directions for use,” 
which can be downloaded from the website  www.yhrd.org 
  2.  Because the YHRD is updated regularly, sample sizes and fre-
quencies change. The release number and date should thus be 
included in the query report. 
  3.  A similar database like YHRD (and partly overlapping with it) 
exists in the USA with national population samples typed for 
11–17 Y-STR loci ( http://usystrdatabase.org ). 
 3.2.  Male/Male Mixture 
Analysis
 4.  Notes 
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 Fig. 3.  17-Locus Y-STR analysis of an un-balanced male/male DNA mixture. 
  4.  While the different nature of underlying population structure 
has long been seen as an obstacle to combine the information 
obtained from lineage markers (Y and mtDNA) with recom-
bining loci (autosomal STRs) into a single likelihood ratio, a 
recent seminal review re-examines this issue. According to the 
authors a combination of likelihoods is allowed when represen-
tative databases are used ( 13 ). 
  5.  The public database YHRD relies on high scientifi c standards 
and transparency of the data collected within. All population 
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studies submitted to the database are subject of rigorous quality 
assessment by the curators. All population studies which are 
accepted for publication in YHRD will be published in parallel 
in the most renowned forensic journals  ( 8,  9 ) . All forensic labo-
ratories and institutions are invited to contribute to the YHRD. 
The resulting increase in the database size and the inclusion 
of geographically and ethnically varied population groups will 
augment the scientifi c and forensic effi cacy of the database. 
  6.  Various other applications (kinship, genealogical, DVI cases) 
can be solved with Y-STR analysis. The frequency estimation as 
outlined in this article is always the crucial step to interpret the 
results of such cases. 
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 Fig. 4.  Likelihood calculation using the online program “Mixture” of the YHRD. 
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 Chapter 5 
 Capillary Electrophoresis of an X-Chromosome 
STR Decaplex for Kinship Defi ciency Cases 
 Leonor  Gusmão ,  Cíntia  Alves ,  Iva  Gomes , and  Paula  Sánchez-Diz  
 Summary 
 During the two last decades, STR markers located on the autosomes have been gaining relevance and have 
nearly replaced the use of other type of markers in most cases of genetic identifi cation, paternity testing, as 
well as in other situations of kinship analysis. Nevertheless, in some complex cases, independently of the 
number of polymorphisms being typed, autosomal markers convey very little information. Depending on 
the parentage constellation available for analysis, as well as the gender of the subjects, this problem can 
sometimes be solved by using markers that have different modes of transmission. Therefore, most forensic 
laboratories are nowadays prepared to analyse lineage markers (Y chromosome and mtDNA) and many 
have recently set up methods for the analysis of X-STRs. In the present chapter, a method is described for 
the typing of ten X chromosome-specifi c markers in a single PCR amplifi cation reaction, followed by capillary 
electrophoresis separation and fl uorescent detection in an ABI Genetic Analyser apparatus. This typing 
strategy was developed and optimized for the simultaneous amplifi cation of ten X-linked specifi c STRs well 
distributed along the chromosome: DXS8378, DXS9902, DXS7132, DXS9898, DXS6809, DXS6789, 
DXS7133, GATA172D05, GATA31E08 and DXS7423. 
 Key words:  X chromosome ,  X-STR ,  PCR multiplex ,  Paternity cases ,  Kinship analysis 
 
 Due to their particular mode of transmission, genetic markers 
located on the non-recombining X-Y chromosome regions can 
represent an important source of information in some special cases 
of genetic identifi cation or kinship analyses  ( 1,  2 ) , whenever the 
information from the autosomes is insuffi cient for an unambiguous 
evaluation of the alternative hypotheses in question. 
 Since the X chromosome-specifi c portion is present in a single – 
non-recombining – copy in males, it is transmitted from the father 
 1.  Introduction
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to all daughters unchanged (unless a mutation occurs). Therefore, 
markers located on the X chromosome can be particularly useful in 
complex kinship cases where just few and/or distant related indi-
viduals are available for the genetic analysis  ( 1,  2 ) . 
 In the last few years, more than 50 X chromosome-specifi c 
STR ( Short Tandem Repeat ) polymorphisms have been described 
and the usefulness for parentage testing evaluated, namely in what 
concerns, sequence structure variation  ( 3– 6 ) , mutation rates  ( 7– 9 ) , 
allele frequencies in different populations and corresponding dis-
crimination power and exclusion capacity  ( 3,  7– 11 ) . 
 As a result of the evolutionary processes that gave rise to the dif-
ferentiation of the sex chromosomes in mammals  ( 12 ) , recombina-
tion between the X and Y chromosomes in humans is limited to 
two small portions in both tips of the short and long arms (the 
pseudoautosomal PAR1 and PAR2 regions) (see Fig.  1 ). The X 
chromosome transmission will depend on the gender of both the 
progenitor and the offspring (see Fig.  2 ). The father will pass on 
the single X chromosome copy only to daughters, without recom-
bination (along most of the chromosome), and therefore all sisters 
(even from different mothers) must share at least one allele per 
locus for the X chromosome (unless mutation occurs). From the 
maternal side, after recombination, one of the two X chromosomes 
from the mother will be transmitted with fi fty percent probability 
to both the male and female offspring, similar to autosomal marker 
transmission. Therefore, at each X chromosome locus, any two 
brothers will have the same probability of sharing or not the 
same maternal allele. This specifi c mode of transmission is respon-
sible for some of the main advantages of the application of X 
chromosome loci in kinship cases, allowing an effi cient comple-
mentation to the information provided by other type of genetic 
markers  ( 1,  2 ) . 
 In paternity cases (duos or trios) with female offspring, the Mean 
Exclusion Chance (MEC) for X chromosome STRs is higher than 
the MEC obtained for autosomal loci  ( 1,  13 ) which considerably 
improves the level of effi ciency by increasing the statistical power. 
However, in these scenarios, there is rarely the need to employ X 
chromosome markers since autosomal polymorphisms have the 
power to solve the case. 
 The main advantage of X chromosome STRs is based on 
their potential application in specifi c kinship cases normally when 
the analysis of autosomal markers is limited or insuffi cient  ( 1,  2, 
 14– 17 ) , namely:
 In a paternity case (duo or trio) when the child under dispute  –
is of female gender and the set of autosomal STRs routinely 
used is not suffi ciently informative. For example, when two or 
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X Chromosome –155 Mb
Y Chromosome
~60 Mb
- SRY 
Eucromatin
~30 Mb
Heterocromatin
Yp
Yq
PAR1 (2.6 Mb)
PAR2 (0.32 Mb)
Xp
Xq
XTR
XTR
 Fig. 1.  Schematic representation of X and Y human chromosomes.  PAR1 and PAR2 pseudo-
autosomal regions 1 and 2,  SRY sex-determining region of the Y,  XTR X-transposed region). 
X
Y
XX X
Y
XX
 Fig. 2.  X-chromosomal inheritance. Daughters inherit one paternal unchanged X chromo-
some because it does not undergo recombination (with exception for the pseudoauto-
somal regions). After recombination, both daughters and sons inherit one of the maternal 
X chromosomes. 
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three father/daughter incompatibilities are observed in a total 
of 17 autosomal STRs analysed, the result may be considered 
inconclusive given that these occurrences may have one of two 
possible explanations: a real mutation or the true father is a 
close relative of the analysed individual. If additional autosomal 
STRs are not available, the analysis of X-chromosomal STRs 
can be used to increase the informativity and solve this specifi c 
case scenario. 
 In paternity testing with a female descendant when the pre- –
sumed fathers are close relatives, for example, father and son. 
In such cases, the analysis of X chromosome markers is highly 
informative, since father and son do not share identical alleles 
by descent (the son inherits the X chromosome from his 
mother and consequently father and son do not share any X 
chromosome allele). 
 In paternity testing in sexual assaults with pregnancy interrup- –
tion, the foetal material may be subjected to testing. In most of 
these cases, foetal material is contaminated by maternal com-
ponent. If the foetus is of female gender, X chromosome mark-
ers can be used, in addition to autosomal markers, presenting 
higher power of exclusion a priori, increasing the informative 
power of the analyses. 
 In maternity mother/son testing, X chromosome polymor- –
phisms also present a higher MEC than autosomal STRs; this is 
the same for father/daughter paternity analysis. Although these 
types of scenarios are not so common, they are highly repre-
sented in mass disaster cases because identifi cation of remains is 
usually achieved by testing the family members of the victim(s). 
In such cases, relationships such as mother/son (or mother/
daughter) are considered to be more reliable since, in the pres-
ent society, there is a high number of illegitimate paternities 
(registered fathers that are not the biological ones). 
 Finally, in incomplete paternity testing, X-STRs are particularly  –
valuable. Normally, these types of kinship testing refer to scenarios 
when the presumed father is not available for genetic analysis 
and, consequently, testing close blood relatives is necessary. In 
fact, such cases are very common because fi nancial inheritance 
disputes are frequently the motif for an individual’s request to 
prove his/her affi liation to the deceased alleged father or simply 
due to physical similarities (appearances) that substantiate the 
need to answer questions about possible common ancestry. The 
reencounter of family members is more signifi cant in certain 
contexts such as wars, mass disasters and generalized interna-
tional migration. In these cases, because paternal and/or mater-
nal relatives must be studied, X chromosome markers are of 
great relevance due to their possible higher effi ciency over auto-
somal markers (depending on the case). For example, if two 
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sisters or half sisters question their paternity, the analysis of X 
chromosome markers alone allows the exclusion of paternity 
without the need to use other family relatives. This result can-
not be achieved when using autosomal markers. Every sister 
shares the paternal X chromosome haplotype and therefore the 
non-shared alleles are from maternal origin. 
 It is important to underline that in cases of incomplete paternity, 
the central key fi gure is the mother of the presumed and non-
available father (presumed paternal grandmother). In fact, when 
the alleged paternal grandmother is tested, the kinship testing will 
not be an “incomplete” paternity analysis given that all the X chro-
mosome alleles of the alleged father are present in his mother. To 
a certain extent, it is also possible to reconstruct the alleged pater-
nal grandmother’s profi le through other sons and daughters. In 
this case, if the brothers of the alleged father have a different allele 
at a given locus, then this means that the mother’s genotype is 
heterozygous at that locus. On the other hand, if they present 
identical alleles, the mother can either be homozygous or heterozy-
gous for the given locus. In this case, if there are linked loci, the 
probability of homozygosity of the original locus will be assessed 
by haplotyping. 
 The use of the X chromosome markers only recently was intro-
duced in some laboratories for routine parentage testing. So far, 
only a small number of STRs have been validated for forensic use 
when compared with the number of those currently available for 
the autosomes and the Y chromosome  ( 1,  2 ) . At present, 55 
X-STRs have been included in the online available database, at 
 www.chrx-str.org  ( 18 ) . However, there is only complete and exten-
sive information available for 15 X chromosome polymorphisms, 
namely DXS6789, DXS6809, DXS7132, DXS7133, DXS7423, 
DXS8378, DXS9902, DXS9898, DXS10074, DXS10101, 
DXS10134, DXS10135, GATA172D05, GATA31E08 and 
HPRTB, mostly due to the fact that these markers are included in 
multiplex systems widely used by forensic laboratories. The 
DXS7132, DXS7423, DXS8378, DXS10074, DXS10101, 
DXS10134, DXS10135 and HPRTB loci are included in one of 
the fi rst forensic genotyping kits for X chromosome STRs, the 
Argus X-8 Mentype ® (Biotype AG)  ( 19 ) . This set of eight X-STRs 
is grouped into four pairs of closely located loci with low recombi-
nation rate among them. Each of these pairs is located in one of the 
four “core” sets of clusters, four distinct linkage groups located 
along the X chromosome  ( 1,  19 ) (see Fig.  3 ): group 1 (Xp22)-
DXS8378 and -DXS10135; group 2 (Xq11)-DXS7132 and 
-DXS10074; group 3 (Xq26)-HPRTB and -DXS10101; group 4 
(Xq28)-DXS10134 and -DXS7423 . Due to their genetic proxim-
ity, the markers belonging to the same linkage group must be 
treated as haplotypes and not as independent loci, as a matter of 
 1.3.  X Chromosome 
STR Markers and 
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caution, when estimating the allele distribution in different popu-
lations and when calculating the powers of discrimination and 
exclusion a priori in paternity testing. More recently, the number 
of loci in this multiplex was increased to twelve, the Investigator 
Argus X-12 (Qiagen, Hilden, Germany) (see Fig.  3 ), by including 
an extra marker inside each of the four different linkage groups, 
namely DXS10148, DXS10079, DXS10103 and DXS10146. 
 The X chromosome markers DXS8378, DXS9902, DXS7132, 
DXS9898, DXS6809, DXS6789, DXS7133, GATA172D05, 
GATA31E08 and DXS7423 have also been widely studied for 
forensic applications  ( 4,  5,  7,  10,  11 ) . These loci are included in a 
multiplex system developed and optimized in a collaborative study 
of the GHEP-ISFG group (Spanish and Portuguese Speaking 
working group of the International Society for Forensic Genetics)  ( 11 ) . 
DXS10146
DXS10134
DXS7423
DXS10148 
DXS10135
DXS8378
DXS7132
DXS10079
DXS10074
DXS10103
HPRTB
DXS10101
GD ≈ 71 cM
GD ≈ 59 cM
GD ≈ 34 cM
DXS8378
DXS9902
DXS7132
DXS9898
DXS6809
DXS6789
DXS7133
GATA172D05
GATA31E08
DXS7423
G1
G2
G3
G4
X-DECAPLEX Mentype® Argus X-12
 Fig. 3.  Schematic representation of an X chromosome with location of the several com-
monly used X-STRs. On the left side of the chromosome are the STRs included in the 
X-Decaplex developed by the GHEP-ISFG  ( 11 ) . On the right are the markers included in 
the Investigator Argus X-12 (Qiagen, Hilden, Germany), with indication of the four linkage 
groups (G1–G4)  ( 1,  19 ) and respective genetic distances (GD) between groups. GDs 
were determined using the online regression-based smoothed Rutgers map v.2 of 
the human genome ( http://compgen.rutgers.edu/map-interpolator/ ) and using physical 
distances from NC_000023 human X chromosome reference sequence (NCBI build 36, 
last updated: 03 March 2008). 
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In contrast to the genetic markers included in the above-mentioned 
commercial kits, the markers of the X-Decaplex are spread through-
out the X chromosome at relatively far distances (see Fig.  3 ). This 
chapter will continue by focusing on the typing techniques and 
protocols necessary to analyse samples with this X Chromosome 
STR decaplex. 
 
  1.  PCR reagents: QIAGEN Multiplex PCR kit (Qiagen); 10× 
Primer set (including labelled and non-labelled oligonucleotide 
primers listed in Table  1 ). The following disposable material is 
also required: plates and/or tubes and caps, gloves, pipette tips. 
All amplifi cation reagents must be stored at −15 to −25°C in a 
constant temperature freezer. The labelled primer solutions are 
light-sensitive and therefore must be kept in the dark. 
 2.  Materials
 Table 1 
 Primer sequences and fl uorescent dye labels 
 Locus  Primer sequence (5 ¢ –3 ¢ ) and dye label  Ref. 
 DXS8378  6-FAM_TTAGGCAACCCGGTGGTCC  ( 3 ) 
 ACAAGAACGAAACTCCAACTC 
 DXS9898  6-FAM_CGAGCACACCTACAAAAGCTG  ( 10 ) 
 TAGGCTCACCTCACTGAGCA 
 DXS7133  6-FAM_CACTTCCAAAAGGGGAAAAA  ( 11 ) 
 ACTTGTACTTGGTGGGAGGAA 
 GATA31E08  6-FAM_GCAAGGGGAGAAGGCTAGAA  ( 11 ) 
 TCAGCTGACAGAGCACAGAGA 
 GATA172D05  VIC_TAGTGGTGATGGTTGCACAG  ( 3 ) 
 ATAATTGAAAGCCCGGATTC 
 DXS7423  VIC_GTCTTCCTGTCATCTCCCAAC  ( 3 ) 
 TAGCTTAGCGCCTGGCACATA 
 DXS6809  VIC_TCCATCTTTCTCTGAACCTTCC  ( 10 ) 
 TGCTTTAGGCTGATGTGAGG 
 DXS7132  NED_TCCCCTCTCATCTATCTGACTG  ( 10 ) 
 CACTCCTGGTGCCAAACTCT 
 DXS9902  NED_CTGGGTGAAGAGAAGCAGGA  ( 11 ) 
 GGCAATACACATTCATATCAGGA 
 DXS6789  NED_CTTCATTATGTGCTGGGGTAAA  ( 10 ) 
 ACCTCGTGATCATGTAAGTTGG 
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  2.  Analysis of the amplifi ed products can be performed using any 
ABI Genetic Analyzer instrument (AB Applied Biosystems, 
Foster City, CA). The following material is described for an 
ABI 3130 Genetic Analyzer (according to the instrument 
manufacturer’s instructions): plates and septa (AB Applied 
Biosystems); internal size standard GeneScan™-600 LIZ (AB 
Applied Biosystems); dry heating block or thermal cycler; cap-
illaries; Performance Optimized Polymer 7, POP-7 (AB 
Applied Biosystems); Hi-Di formamide (AB Applied 
Biosystems); and ice. 
 Note that:
 To prevent cross-contaminations, it is recommended to use  –
disposable gloves and aerosol-resistant pipette tips. Pre- and 
post-PCR samples, reagents, and instruments should be used 
and stored separately. 
 If PCR amplifi cation reagents are on the workbench for a long  –
period while setting up the reaction, it is suggested to keep the 
solutions on ice, especially if room temperature is high. 
 The fl uorescent dyes attached to the primers and size standard  –
are light-sensitive. Primer solutions, amplifi ed DNA and 
GeneScan™-600 LIZ should be protected from light particu-
larly when not in use. 
 Formamide is potentially hazardous (irritant and a teratogen)  –
and should be handled accordingly. 
 
 The following method described consists in the simultaneous PCR 
amplifi cation of ten X chromosome STRs. This X-Decaplex method 
was optimized in a GeneAmp ® PCR System 9700 Thermal Cycler 
(AB Applied Biosystems) and detection performed on an ABI 
PRISM ® 3130 Genetic Analyzer. Note that protocols may need to 
be optimized for different instruments and even the same instru-
ment model may need slight protocol adjustments. 
 The loci included in the X-Decaplex were selected taking into 
account the gene diversity values reported in different populations 
(e.g.  ( 4,  20– 28 ) ) and the potential for multiplexing. Preference was 
given to simple rather than complex STRs, following the ISFG rec-
ommendations concerning locus selection for forensic applications 
 ( 29 ) . In order to reduce the potential PCR-generated slippage arte-
facts, loci comprising trinucleotide repeats were avoided. In Table  2, 
the repeat sequence structures and the allele range for the loci 
included in the X-STR decaplex here described are showed. 
 3.  Methods
 3.1.  Loci Information
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 Different technical methods were investigated with the aim of 
optimizing the multiplex systems for the simultaneous PCR ampli-
fi cation and genotyping of the following ten X chromosome STRs: 
DXS8378, DXS9902, DXS7132, DXS9898, DXS6809, DXS6789, 
DXS7133, GATA172D05, GATA31E08 and DXS7423. The best 
results were obtained when using between 0.5 and 5 ng template 
DNA in a 10  μ L reaction volume containing 1× Qiagen multiplex 
PCR master mix, and all primers at a concentration of 0.2  μ M. 
 Primer sequences and references are listed in Table  1 . For those 
systems with overlapping allele size ranges, the primers were 
labelled with different dyes (see allele size ranges in Table  2 ) to 
allow an unambiguous typing of all the markers (see Fig.  4 ). Various 
primer concentrations were tested and the best co-amplifi cation 
results were obtained when using all primers at a concentration of 
0.2  μ M. A 10× primer mix can be prepared for a large number of 
reactions and stored at −15 to −20°C until needed for PCR setup. 
From initial 100  μ M primer stocks, an X-Decaplex 10× primer mix 
can be prepared, for example for 100 PCR amplifi cation reactions 
by pipetting 2  μ L of each forward and reverse primers and by add-
ing 60  μ L of sterile molecular biology grade water for completing 
100  μ L fi nal volume. For studies requiring a large number of sam-
ples to be typed (e.g. population studies), it is recommended to 
 3.2.  PCR Amplifi cation
 3.2.1.  Primer Mix Setup
 Table 2 
 Repeat structure of the ten X-STRs included in the Decaplex, and corresponding 
references 
 Locus  STR sequence structure  Ref.  Allele range  Size range (bp) 
 DXS8378  (CTAT)  n   ( 20 )  8–14  106–134 
 DXS9902  (TAGA)  n   ( 11 )  8–16  170–202 
 DXS7132  (CTAT)  n  (CAT) 0–1 (CTAT) 0–2  ( 20 )  9–18.3  116–155 
 DXS9898  (TATC) 2 atc (TATC)  n  (ATC) 0–1 (TATC)  m   ( 23 )  7–16  145–181 
 DXS6809  (CTAT)  n  (ATCT) 3 atcatctat (TATC)  m  
(ATCT) attatctatc (ATCT)  p  
 ( 21 )  27–39.1  230–279 
 DXS6789  (TATC) 0–1 (TATG)  n  (TATC)  m   ( 22 )  10–26  233–297 
 DXS7133  (ATAG)  n   ( 20 )  6–14  181–213 
 GATA172D05  (TAGA)  n   ( 3 )  6–17  209–253 
 GATA31E08  (AGGG) 2–3 (AGAT)  n   ( 4 )  7–16  224–260 
 DXS7423  (TCCA) 3 (tctgtcct) 0–1 (TCCA)  n   ( 28 )  8–18  159–199 
 In small caps are indicated the bases not included in the repeat number counting for allele nomenclature 
purposes 
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prepare larger volumes of 10× primer mix in a single tube, mix the 
fi nal solution by thoroughly vortexing, and distribute smaller vol-
umes into different tubes, before storing at −15 to −20°C (e.g. 
prepare a primer mix of 500  μ L and distribute 50  μ L by ten tubes, 
each one containing enough volume for typing 50 samples). This 
has the advantage of reducing pipetting errors for small volumes 
and allows better homogeneity between different samples, as well 
as in different PCR reactions for the same DNA sample. It also 
reduces possible effects on primer quality by less freeze/defreeze 
events and less loss of product will occur if necessary to discard the 
primer mix solution, for example, due to contamination. 
 To set up the amplifi cation, prepare a PCR master mix for all samples 
by determining the number of reactions and adding one or two 
reactions to this number to compensate for pipetting errors. 
 According to the stock concentrations, the following volumes 
are indicated for the PCR reagents per sample reaction (1×): 
 2× Qiagen Multiplex PCR Master Mix  5  μ L 
 10× Primer mix (2  μ M of each primer)  1  μ L 
 Distilled water  3.5  μ L 
 Template DNA (1–10 ng/ μ L)  0.5  μ L 
 Final volume = 10  μ L 
 If stock solutions with different concentrations are used, the 
volumes must be adjusted to keep the same fi nal concentration of 
each reagent in the fi nal reaction solution. 
 Note that the total fi nal reaction volume should be 10  μ L and 
that changes in template DNA volume should be compensated by 
changing the volume of water volume (see Notes 1 and 2). The 
inclusion of a “negative control” (PCR mix plus water instead of 
DNA template) is important for detection of possible PCR con-
tamination by external DNA. 
 3.2.2.  Amplifi cation 
Procedure
100 bp 200 bp 300 bp 340 bp
DXS7133 GATA31E08
DXS7132 DXS9902
DXS7423GATA172D05 DXS6809
DXS6789
DXS8378 DXS9898
 Fig. 4.  Schematic representation of the size range distribution of the X-STRs included in the X-Decaplex.  First line : markers 
labelled with 6-FAM;  second line , with VIC and;  third line , with NED (see Table  1 for primer details, and Table  2 for alleles’ 
size ranges). 
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 The thermal cycling conditions were optimized in a GeneAmp ® 
PCR System 9700 Thermal Cycler (AB Applied Biosystems). 
Although signifi cant changes to PCR performance are not expected, 
the use of other instruments may require some adjustments on 
denaturing, annealing, and extension steps. The annealing tempera-
ture is the most frequent parameter varying between apparatus that 
may need some adjustment, because lowering annealing tempera-
tures usually increases the amplifi cation of unspecifi c products. 
 The number of cycles can also be adjusted for different input 
DNA (see Note 1). In forensic DNA samples, it is not recommended 
to increase the total number of cycles for more than 35–40 cycles. 
 Thermo cycling conditions are: pre-incubation for 15 min at 
95°C; followed by 10 cycles of 30 s at 94°C, 90 s at 60°C, 60 s at 72°C; 
and 20 cycles of 30 s at 94°C, 90 s at 58°C, 60 s at 72°C; with a fi nal 
incubation for 60 min at 72°C (see Note 3). 
 The detection analysis was optimized on an ABI PRISM ® 3130 
Genetic Analyser (AB Applied Biosystems). When using other ABI 
platforms, consult the instrument’s user’s manual for appropriate 
adjustments on sample preparation and electrophoresis conditions. 
 For sample preparation, it is recommended to make one loading 
mixture for all the samples to be analysed (13.75  μ L of Hi-Di for-
mamide and 0.25  μ L of LIZ 600 internal size standard per sam-
ple). When preparing the loading mixture, add one or two samples 
extra in the calculations to compensate for pipetting errors. 
Dispense 14  μ L of the loading mixture into each ABI 3130 plate 
slots and add 1  μ L of the PCR product. Before loading, denature 
the samples by heating them at 95°C for 3 min and immediately 
placing them on ice for at least 5 min. 
 Separation and detection can be performed in various types of ABI 
Genetic Analysers (Applied Biosystems), following manufacturer’s 
instructions. On an ABI PRISM ® 3130 Genetic Analyzer, samples 
are analysed by electrophoresis using Performance Optimized 
Polymer 7 (POP-7; AB Applied Biosystems) and fi lter set G5. 
Although this multiplex was optimized for typing with an internal 
size standard GeneScan-600 LIZ (Applied Biosystems) and fi lter 
G5, other platforms allowing for the detection of dyes with maxi-
mum fl uorescence at only four different wavelengths may be used: 
size standard GeneScan-600 ROX and Filter D are recommended. 
 Fragment sizes are determined automatically using the 
GeneMapper ID ® Analysis Software, version 3.2, and samples should 
be typed by comparison with sequenced allelic ladders. The use of 
sequenced ladders is especially important for DXS9898, DXS9902 
and DXS7132 (see Notes 4 and 5) in order to allow the unequivocal 
typing of intermediate alleles detected in most populations. 
 3.2.3.  Thermal Cycling 
Conditions
 3.3.  Analysis of 
Amplifi ed Fragments
 3.3.1.  Sample Preparation
 3.3.2.  Analysis Conditions
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 It is important to use DNA reference samples (e.g. 9947A, 
9948 and NA3657) as genotyping controls, which have been pre-
viously typed for all markers included in the X-Decaplex (see 
Table  3 ). 
 The use of sequenced allelic ladders is very successful for com-
parison purposes in forensic and other studies, and it is thus rec-
ommended by the DNA Commission of the International Society 
for Forensic Genetics  ( 32 ) . The general strategy for ladder con-
struction is primarily to isolate and sequence different-sized STR 
alleles found in a fi rst screening of a population sample. After 
identifying the different alleles by sequence analysis, the samples 
can be mixed and amplifi ed together to produce a ladder. The 
volume of each individual sample in the mixture must be adjusted 
to produce a well-balanced ladder. For multiplex analysis, the 
best strategy is to produce single ladders for each locus and mix 
them together to make up the fi nal multiplex ladder. Single-locus 
ladders can be re-amplifi ed using 1  μ L (in a 50- μ L fi nal reaction 
volume) of between 1:1000 and 1:10.000 dilutions of the origi-
nal ladder (see Note 6). 
 3.4.  Allelic Ladders
 Table 3 
 X-STR profi les of standard DNA samples used as references 
by the participating laboratories 
   9947A  9948  NA3657  Refs. 
 DXS8378  10/11  11  12  ( 30 ) 
 DXS9898  12/15  13  –  ( 4 ) 
 DXS7133  9/10  11  9  ( 30 ) 
 GATA31E08 a  13  12  –  ( 11 ) 
 GATA172D05  10  6  9  ( 30 ) 
 DXS7423  14/15  14  13  ( 30 ) 
 DXS6809  31/34  31  29  ( 30 ) 
 DXS7132  12  13  12  ( 30 ) 
 DXS9902 b  12  13  13  ( 11 ) 
 DXS6789  21/22  20  23  ( 30 ) 
 a Genotypes were changed by adding two repeats to the previously reported by 
Shin et al.  ( 31 ) 
 b Genotypes were changed by adding one repeat to the previously reported by 
Szibor et al.  ( 30 ) 
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 Besides those already mentioned, some other problems can arise 
during the X-Decaplex set up, as follows:
  1.  Peak heights between 1,000 and 2,000 relative fl uorescent 
units are ideal. If peak heights are too high for some loci, 
reduce the PCR primer concentration of those loci. If this hap-
pens to all the loci included in the multiplex, use less DNA or 
reduce the number of PCR cycles. 
  2.  An excess of DNA during PCR will improve the amplifi cation 
of smaller-sized loci and a reduction in the amplifi cation of 
larger Alleles can be observed. 
  3.  An amplifi ed fragment may show a second peak (−1 bp) because 
of the incomplete 3’ adenine base addition. This artefact can 
be reduced with the increase of the PCR fi nal extension step or 
by switching the dye label to the other primer. 
  4.  For DXS9902 locus, intermediate alleles can be present due to 
a T insertion in a tract of 9 Ts ending 5 bases upstream the 
GATA repeat  ( 5 ) . To ensure the correct typing of these alleles, 
it is very important to use sequenced ladders including the 
most frequent intermediate alleles 12.1 and 13.1. 
  5.  Allele 8.3 at DXS9898 is described as having a high frequency 
in all European populations studied until now (e.g.  ( 23– 25, 
 28,  33 ) ). In a previous study by Gusmão et al.  ( 11 ) , it was 
observed that allele 8.3 differed in approximately 6 bp from 
allele 10, and allele 7 differed in approximately 4 bp from allele 
8.3, which can lead to genotyping errors if sequenced allelic 
ladders are not used. The same kind of typing problem was 
observed for some DXS7132 alleles, in the same size range of 
DXS9898 alleles 7 and 8.3. This was found to be caused by a 
sizing problem when using GeneScan-500 LIZ size standard 
for fragments in the range of 139–150 bp. This is why we rec-
ommend the use of GeneScan-600 LIZ size standard which 
does not show this problem. Whichever size standard is cho-
sen, to ensure the correct typing of these two STRs, sequenced 
ladders should be used, including the most frequent alleles at 
these loci. 
  6.  Amplifi cation of stutter products (with one repeat less) can 
appear because of the enzyme slippage during amplifi cation. 
For the multiplex described here, no signifi cant stutter peaks 
were observed. However, special attention should be given in 
successive re-amplifi cation of the ladders. Usually, with ladder 
re-amplifi cation, the larger alleles amplify less effi ciently with 
the simultaneous increase of stutter amplifi cation. This effect 
has been sometimes responsible for a one repeat less drift in 
 4.  Notes
70 L. Gusmão et al.
the correct allele typing. Therefore, after re-amplifi cation, the 
ladder should be tested by comparison with the original one or 
by using sequenced control samples. 
 The X-specifi c STR typing by PCR amplifi cation and fragment 
size determination follows the same principles as autosomal STR 
typing. Therefore, recommendations concerning STR typing 
should be followed, including samples, apparatus, and reagent 
handling (see other chapters on STR typing). User’s manuals for 
commercial STR multiplex amplifi cation kits can also be useful for 
consulting additional topics on troubleshooting. 
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 Chapter 6 
 A 48-plex Autosomal SNP GenPlex™ Assay for Human 
Individualization and Relationship Testing 
 Carmen  Tomas ,  Claus  Børsting , and  Niels  Morling  
 Abstract 
 SNPs are being increasingly used by forensic laboratories. Different platforms have been developed for 
SNP typing. We describe the GenPlex™ HID system protocol, a new SNP-typing platform developed by 
Applied Biosystems where 48 of the 52 SNP for ID SNPs and amelogenin are included. The GenPlex™ 
HID system protocol has been successfully tested by a number of forensic laboratories using both ordinary 
and forensic samples. 
 Key words:  Autosomal SNPs ,  SNP for ID consortium ,  GenPlex™ ,  OLA reaction ,  ZipChute™ probes 
 
 In recent years, the usefulness of SNPs in forensic genetics has 
been pointed out and an increasing number of laboratories are 
implementing SNP typing as a complementary analysis to STR typ-
ing  ( 1– 6 ) . Some of the properties of SNPs make them especially 
suitable for forensic applications (a) SNPs can be analyzed from 
short amplicons, which makes it possible to analyze SNPs in partly 
degraded DNA samples  ( 7– 9 ) and (b) SNPs have a low mutation 
rate, which is an important advantage in kinship analysis  ( 1 ) . Many 
platforms can be used for the analysis of SNPs  ( 3,  10– 13 ) . The 
most widely used one is the single base extension assay (SBE) using 
the SNaPshot ® kit (Applied Biosystems). However, the SNaPshot ® 
kit has some drawbacks that can make it a challenge to analyze the 
results  ( 2 ) . Applied Biosystems developed the GenPlex™ HID sys-
tem, which is a new SNP-typing platform based on a modifi cation 
of the SNPlex™ System  ( 14 ) . The assay includes 48 of the 52 SNPs 
in the SNP for ID 52-plex  ( 15 ) and amelogenin. Briefl y, the 
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GenPlex™ HID system protocol includes (see Fig.  1 ) an initial 
multiplex PCR reaction followed by a PCR reaction clean-up with 
Exonuclease I and Shrimp Alkaline Phosphatase. An oligo ligation 
assay (OLA) using a locus and two allele specifi c oligonucleotides 
(LSOs and ASOs) is performed on the purifi ed PCR products. The 
biotinylated OLA products are bound to a solid phase, and 
ZipChute ™ probes are hybridized to the zipcode sequences of the 
OLA products. After elution, the ZipChute ™ probes are analyzed 
by capillary electrophoresis (CE). Each zipchute has a unique 
color/mobility characteristic and they can be uniquely identifi ed 
by analysis of the CE data. There are two zipchutes per SNP, one 
for each of the two possible alleles. A number of laboratories have 
successfully tested the GenPlex™ HID System and demonstrated 
that it is a sensitive and reproducible SNP-typing method  ( 16,  17 ) . 
Also, full or nearly full profi les could be obtained when samples 
with partially degraded DNA were analyzed (  ( 18 ) , see Fig.  2 ). 
 
 Some of the reagents used in this protocol are hazardous and must be 
handled with appropriate clothing and gloves. Waste materials must 
be discarded in the appropriate waste containers. Follow always 
the security and storage recommendations of the manufaturer. 
  1.  GenPlex™ Multiplex PCR Primer Mix (Applied Biosystems, 
Foster City, CA, USA). Store at −15 to −25°C. 
  2.  QIAGEN Multiplex PCR Kit (catalog number 206143, Qiagen 
GmbH, Hilden, Germany). Store at −15 to −25°C. 
  3.  Nuclease-free water. 
  1.  ExoSAP-IT ® (catalog number 78201, USB Corp., Cleveland, 
OH, USA). Store at −15 to −25°C. 
  1.  Oligonucleotide Ligation Assay (OLA) Oligo Mix (catalog 
number 4383847, Applied Biosystems). Store at −15 to 
−25°C. 
  2.  OLA Master Mix SNPlex™ System (catalog number 4362268, 
Applied Biosystems). Store at −15 to −25°C. 
  3.  dATP (100×) SNPlex™ System (catalog number 4362268, 
Applied Biosystems). Store at −15 to −25°C. 
  1.  SNPlex™ System Hybridization Plates, 96-Well (catalog number 
4357279, Applied Biosystems). 
  2.  Hybridization Wash Buffer (10×) SNPlex™ System (catalog 
number 4349301, Applied Biosystems). 
 2.  Materials
 2.1.  PCR Reaction
 2.2.  PCR Product 
Clean-up
 2.3.  Phosphorylation 
of the Oligonucleotide 
Ligation Assay Oligos 
and Oligonucleotide 
Ligation Assay 
Reaction
 2.4.  Immobilization 
of the OLA Products 
on the Hybridization 
Plate
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 Fig. 1.  General overview of the GenPlex™ protocol. 
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  3.  Deionized water. 
  4.  Hybridization Binding Buffer SNPlex™ System (catalog number 
4349304, Applied Biosystems). 
  5.  Positive Hybridization Controls SNPlex™ System (catalog num-
ber 4349361, Applied Biosystems). Store at −15 to −25°C. 
  1.  Denaturant SNPlex™ System (catalog number 4349361, 
Applied Biosystems). Store at −15 to −25°C. 
  2.  ZipChute™ Mix, 48-plex SNPlex™ System (catalog number 
4349361, Applied Biosystems). Store at −15 to −25°C. Protect 
from light. 
  3.  ZipChute™ Dilution Buffer SNPlex™ System (catalog number 
4349306, Applied Biosystems). 
  4.  Hybridization Wash Buffer (10×) SNPlex™ System (catalog 
number 4349301, Applied Biosystems). 
  1.  Hybridization Wash Buffer (10×) SNPlex™ System (catalog 
number 4349301, Applied Biosystems). 
  2.  Sample Loading Reagent SNPlex™ System (catalog number 
4349351, Applied Biosystems). Store at −15 to −25°C. 
  3.  Size Standard, 48-plex SNPlex™ System (catalog number 
4349351, Applied Biosystems). Store at −15 to −25°C. Protect 
from light. 
  1.  Allelic Ladder, 48-plex SNPlex™ System (catalog number 
4349351, Applied Biosystems). Store at −15 to −25°C. Protect 
from light. 
  2.  96-well Plate Septa and accessories (catalog number 4315933, 
Applied Biosystems). 
  3.  36- or 50-cm capillary array (catalog number depending on 
the DNA Analyzer and the number of capillaries, Applied 
Biosystems). 
  4.  SNPlex™ System Array Conditioning Kit (catalog number 
4352018, Applied Biosystems). 
 2.5.  Hybridization 
of the ZipChute™ 
Oligos
 2.6.  Elution 
of the ZipChute™ 
Oligos
 2.7.  Capillary 
Electrophoresis
 Fig. 2.  Electropherograms of two samples analyzed with the GenPlex™ HID System. ( a ) Reference sample; ( b ) Sample with 
partly degraded DNA. 
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  5.  10× Running Buffer with EDTA (catalog number 4335613, 
Applied Biosystems). 
  6.  POP-7™ polymer for 3730/3730xl (catalog number 4363929, 
Applied Biosystems) or for 3130xl (catalog number 4352759, 
Applied Biosystems). Store at 2–8°C. 
  7.  DS-40 Spectral Calibration Standard Kit (Dye Set S) (catalog 
number 4349365, Applied Biosystems). Store at −15 to −25°C. 
Protect from light. 
  8.  Applied Biosystems 3730/3730xl or 3130xl DNA Analyzer. 
  9.  Data Collection Software v2.0 (Applied Biosystems) or higher 
and necessary fi les associated: run module (HTSNP36_POP7; 
HTSNP50_POP7) and Dye Set S (S.zip). 
  1.  GeneMapper ® Software v4.0 (Applied Biosystems). 
  2.  GeneMapper ® data analysis fi les for 3730/3730xl or 3130xl 
platforms (available from Applied Biosystems website):
 (a)  Analysis method: SNPlex_Rules_3130.xml or SNPlex_
Rules_3730.xml; GenPlex_NoCluster. 
 (b)  Bins and panels: SNPlex_48plex_3130_Bins.txt and 
SNPlex_48plex_3130_Panels.txt or SNPlex_48plex_3730_
Bins.txt and SNPlex_48plex_3730_Panels.txt. 
 (c)  Assay Information File (AIF): SNP_for_ID_48.xlm. 
 (d)  Size standard: SNPlex_48plex_v1.xlm. 
 
 The GenPlex™ HID system protocol includes a large number of 
pipetting steps. It is recommended to use a pipetting robot when a 
medium or large number of samples are processed (see Note 1). 
Before starting with the protocol, design the sample plate layout. 
Include, together with the samples, a positive and a negative con-
trol per plate and one allelic ladder per injection. The location of 
the allelic ladder will depend on the Genetic Analyzer used to run 
the electrophoresis. The GenPlex™ protocol contains a number of 
steps where the plate layout needs to be taken into account. An 
overview of the procedure is shown in Fig.  1 . 
 It is recommended to work on ice while setting up the PCR 
reaction.
  1.  Thaw the GenPlex™ Multiplex PCR Primer Mix and the 
QIAGEN Multiplex PCR Kit. Vortex the tubes and spin them 
briefl y (see Note 2). 
  2.  Prepare the master mix by adding 5  μ L of Qiagen Multiplex 
PCR Kit, 2.5  μ L of GenPlex™ Multiplex PCR Primer Mix and 
 2.8.  Data Analysis
 3.  Methods
 3.1.  PCR Reaction
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0.5  μ L of nuclease-free water. Scale the volumes to the desired 
number of samples (see Note 3). 
  3.  Dispense 8  μ L/well of master mix into a labeled MicroAmp ® 
Optical 96-Well Reaction Plate. Leave the wells for the allelic 
ladder empty. 
  4.  Add 2  μ L of DNA (0.5–2 ng) to each well with master mix. 
Add 2  μ L nuclease-free water to the well for the negative 
control. 
  5.  Seal the plate with MicroAmp ® Clear Adhesive Film. Make 
sure that the plate is completely sealed in order to avoid evapo-
ration of the master mix during the PCR reaction (see Note 4). 
Vortex the plate and spin it briefl y at a speed around 
800 rpm. 
  6.  Place the reaction plate in the thermal cycler (see Note 5). 
  7.  Cover the plate with the thermal cycler heated lid. Set the reac-
tion volume to 10  μ L and use the following thermal cycling 
conditions: Denaturation at 95°C for 15 min; 30 cycles of 
94°C for 15 s, 57°C for 30 s, and 72°C for 30 s; hold at 72°C 
for 10 min; hold at 4°C. 
  8.  When the PCR run is complete, remove the plate from the 
thermal cycler. The plate may be stored at 4°C for a few days 
or at −20°C for several weeks. 
  1.  Spin the PCR plate briefl y before removing the adhesive fi lm. 
Remove the fi lm carefully in order to avoid cross-contamination. 
Add 2  μ L of ExoSAP-IT ® to each well. 
  2.  Seal the plate with a new MicroAmp ® Clear Adhesive Film. 
Vortex the plate briefl y to mix the contents and spin the plate. 
  3.  Place the reaction plate in the thermal cycler. Cover the plate, 
set the reaction volume to 12  μ L and run the following pro-
gram: hold at 37°C for 30 min; hold at 99.9°C for 30 min and 
hold at 4°C. 
  4.  When the run is complete, remove the plate from the thermal 
cycler. The plate may be stored at 4°C during few days or at 
−20°C for several weeks. 
  1.  Thaw the OLA Oligo Mix, the OLA Master Mix, and the 
dATP. Vortex the tubes and spin them shortly (see Note 2). 
  2.  Mix 10  μ L of OLA Master Mix, 0.1  μ L of dATP, and 0.1  μ L 
of OLA Oligo Mix. Scale the volumes to the desired number 
of samples. Vortex the tube and spin it briefl y. 
  3.  Dispense 10  μ L/well of mix into a Microamp ® Optical 96-Well 
Reaction Plate (see Note 7). Follow the same plate layout as 
the one used for the PCR reaction. 
 3.2.  PCR Product 
Clean-up with ExoSAP
 3.3.  Phosphorylation 
of the OLA Oligos 
( see  Note 6 )
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  4.  Seal the plate with MicroAmp ® Clear Adhesive Film. Make 
sure that the plate is completely sealed, vortex the plate, and 
spin it briefl y. 
  5.  Place the reaction plate in a thermal cycler. Cover the plate, set 
the reaction volume to 10  μ L and run the following program: 
Hold at 48°C for 30 min; hold at 90°C for 20 min; hold at 
4°C. 
  6.  When the run is complete, remove the plate from the thermal 
cycler. It is recommended to immediately proceed with the 
next step. 
  1.  Spin the reaction plates from Subheading  3.2 (ExoSAP) and 
 3.3 (phosphorylation). Remove the fi lms carefully and transfer 
10  μ L of phosphorylated OLA oligos into the plate containing 
ExoSAP-treated PCR products by following the plate layout. 
Discard the phosphorylation plate. 
  2.  Seal the plate containing ExoSAP-treated PCR products and 
phosphorylated OLA oligos with a clean MicroAmp ® Clear 
Adhesive Film. Make sure that the plate is completely sealed in 
order to avoid evaporation. Vortex the plate and spin it 
shortly. 
  3.  Place the reaction plate in the thermal cycler. Set the reaction 
volume to 22  μ L and run the following program: 25 cycles of 
94°C for 15 s and 54°C for 30 s; hold at 99°C for 10 min; hold 
at 4°C. 
  4.  After the run is complete, spin the plate briefl y. The OLA 
products may be stored at −20°C. 
  1.  Dilute the Hybridization Wash Buffer (10×) 10 times with 
deionized water (1:9). 
  2.  Thaw the Positive Hybridization Control (PHC; see Note 8). 
Vortex and quick-spin the tube. 
  3.  Mix 25  μ L of Hybridization Binding Buffer with 0.0125  μ L of 
PHC in a 5 mL tube. Scale the volumes to the desired number 
of samples. Vortex the mix. 
  4.  Wash the wells of the SNPlex™ Hybridization Plate 3 times by 
adding and removing 200  μ L Hybridization Wash Buffer (1×) 
per well (see Note 9). Make sure that the hybridization plate is 
empty before proceeding with the next step. 
  5.  Dispense 25  μ L Binding Buffer mixed with PHC into each 
well of the hybridization plate. Follow the sample plate layout 
of the experiment. Leave the wells for the allelic ladder empty. 
  6.  Transfer 5–10  μ L (see Note 10) of OLA product to the wells 
containing Hybridization Binding Buffer and PHC and seal 
 3.4.  OLA Reaction
 3.5.  Immobilization 
of the OLA Products 
on the Hybridization 
Plate
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the hybridization plate with adhesive fi lm. The remaining OLA 
products may be stored at −20°C. 
  7.  Incubate the hybridization plate at room temperature for 
60 min on a shaking rotary shaker (at a speed around 
700 rpm). 
  8.  Spin the plate briefl y, remove the fi lm carefully, and remove the 
supernatant. The supernatant can be removed by inverting the 
plate on a stack of paper towels (see Note 11). 
  1.  Set the temperature of the rotary shaker (or the oven) to 
37°C. 
  2.  Wash the wells of the SNPlex™ Hybridization Plate 4 times 
with 200  μ L of Wash Buffer (1×). Make sure that the wells are 
completely empty before proceeding with the next step. 
  3.  Thaw the denaturant and ZipChute™ Mix. Vortex gently the 
ZipChute™ Mix and spin the tube. 
  4.  Mix 11.25  μ L denaturant, 13.7  μ L ZipChute™ Dilution 
Buffer, and 0.05  μ L ZipChute™ Mix. Scale the volumes to the 
desired number of samples. Vortex and spin the mix. 
  5.  Dispense 25  μ L of the hybridization master mix into each well 
of the SNPlex™ Hybridization Plate according to the plate 
layout. Leave the wells for the allelic ladder empty. 
  6.  Cover the plate with Aluminum PCR Sealing fi lm. Incubate 
the plate for 60 min at 37°C on a shaking rotary shaker (at a 
speed around 700 rpm). Protect the plate from the light during 
the incubation. 
  1.  Spin the hybridization plate briefl y, remove the fi lm carefully, 
and remove the supernatant. 
  2.  Wash the wells of the hybridization plate 5 times with 200  μ L 
of Wash Buffer (1×). 
  3.  Invert the plate onto a stack of paper towels and centrifuge at 
1600 ×  g for 30 s. 
  4.  Thaw the Sample Loading reagent and the size standard. 
Vortex the size standard gently. 
  5.  Mix 16.9  μ L Sample Loading reagent and 0.6  μ L size stan-
dard. Scale the volumes according to the number of samples 
and allelic ladders. 
  6.  Dispense 17.5  μ L of Sample Loading reagent mixed with size 
standard into each well of the hybridization plate. Follow the 
plate layout and let the wells for the allelic ladder empty. 
  7.  Cover the hybridization plate with Aluminum PCR Sealing 
fi lm and incubate at 37°C for 5 min. 
 3.6.  Hybridization 
of the ZipChute™ 
Oligos
 3.7.  Elution of the 
ZipChute™ Oligos
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 Before running the fi rst GenPlex™ electrophoresis plate, (1) import 
the run modules into the Data Collection Software; (2) install Dye 
Set S in the DNA Analyzer and perform a spectral calibration using 
the SNPlex™ Matrix Standard DS-40; (3) create an instrument 
protocol by selecting the imported run module and Dye Set S; (4) 
eventually, precondition the array by using the SNPlex™ System 
Array Conditioning Kit, if a new array is used (see Note 12).
  1.  Spin the hybridization plate briefl y and remove the aluminum 
fi lm carefully. 
  2.  Prepare a 96-well electrophoresis plate according to the proto-
col corresponding to the DNA analyzer. 
  3.  Transfer 10–17.5  μ L (depending on the signal strength) of the 
Sample Loading Mix from the hybridization plate into the 
96-well electrophoresis plate (except for the allelic ladder wells), 
according to the plate layout. Discard the hybridization plate. 
  4.  Pipette 15  μ L/well of Sample Loading reagent mixed with size 
standard to the wells for the allelic ladder. Add 1.25  μ L/well 
of allelic ladder to these wells. 
  5.  Assemble the electrophoresis plate and load it on the 
3730/3730xl or 3130xl DNA Analyzer. 
  6.  Run the plate using the adequate instrument protocol. 
 Before starting with the data analysis, GeneMapper ® v.4.0 must be 
confi gured for the GenPlex™ data analysis by importing the rele-
vant data analysis fi les.
  1.  Export the FSA fi les to the computer where GeneMapper ® 
v.4.0 is installed. 
  2.  Open a new SNPlex™ project and add the sample fi les. 
  3.  Identify the allelic ladders in the Sample Type column. 
  4.  Select the appropriate Analysis Method (SNPlex_Rules_3130, 
SNPlex_Rules_3730, or GenPlex_NoCluster). A clustering 
method (see Fig.  3 ) or a nonclustering method can be chosen 
(see Note 13). 
  5.  Select the appropriate Panel, SNPlex_48plex_Panel_3130, or 
SNPlex_48plex_Panel_3730, in the Panel column. 
  6.  Select SNPlex_48plex_v1 in the Size Standard column. 
  7.  Select SNP_for_ID_48 in the SNP set column. 
  8.  Analyze the data (click the green arrow). 
  9.  Review the quality of the size standard. 
  10.  Review the data and export the genotypes as a table. If the data 
is analyzed using the nonclustering method, peak height ratios 
can be analyzed manually by exporting the data to a spread-
sheet software application (see Note 13). 
 3.8.  Capillary 
Electrophoresis
 3.9.  Data Analysis
 Fig. 3.  GeneMapper ® Cluster analysis.  Blue squares  : homozygotes of allele 1;  red circles  : homozygotes of allele 2;  green 
triangles : heterozygotes. ( a ) Cluster analysis performed with reference samples. In this case, the clusters for homozygotes 
and heterozygotes are well-defi ned. ( b ) Cluster analysis performed including samples containing small amounts of DNA. 
Note the intermediate position of some of the samples between homozygotes and heterozygotes. 
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  1.  A detailed description of the use of a Biomek-3000 for the 
GenPlex™ protocol can be found in reference  ( 19 ) . 
  2.  It is important to completely thaw the reagents in order to 
keep the expected concentration of the components. Vortex 
the primer and oligo mixes gently. 
  3.  When scaling the number of samples, prepare extra volume in 
order to compensate for pipetting losses. 
  4.  The effi ciency of the reaction will be reduced if the master mix 
evaporates during the PCR reaction. In order to avoid evapo-
ration, e.g., an ABI Prism ® Optical Cover Compression Pad 
(catalog number 4312639, Applied Biosystems) can be used. 
  5.  The protocol was optimized for a GeneAmp ® PCR System 
9700 thermal cycler with gold block (Applied Biosystems). 
The use of other thermal cyclers will probably require a reop-
timization of the protocol. 
  6.  Time can be saved by combining Subheadings  3.3 and  3.4 (phos-
phorylation and OLA reaction) in a single step. Nevertheless, 
better results were observed when two steps were performed. 
  7.  Instead of dispensing the mix in a 96-well plate, the phospho-
rylation step can be performed in a 1.5 mL Eppendorf tube. 
A heating block may be used at 48 and 90°C. 
  8.  The use of a positive hybridization control will help if trouble-
shooting is needed. If the only peak observed in the electro-
pherogram is that corresponding to the PHC, it indicates that 
the hybridization did work and that the PCR and/or OLA 
reactions need to be optimized. 
  9.  The exact volume of Wash Buffer used to wash the wells is not 
crucial. In the protocol defi ned for the Biomek-3000, a volume 
of 140  μ L of Wash Buffer per well was used. 
  10.  The volume of OLA product needed will depend on the 
amount of PCR products. If more than 500 pg of DNA are 
used in the PCR reaction, a volume of 5  μ L of OLA product 
will most probably be suffi cient. 
  11.  It is recommended to perform the GenPlex™ procedure in 
two separated areas (1) a pre-PCR area (see Subheading  3.1 ) 
and (2) a post-PCR area (see Subheadings  3.2 – 3.8 ). There are 
many steps where the tubes containing PCR and OLA prod-
ucts are opened and handled, therefore extreme care is required 
in order to avoid contaminations. 
  12.  The resolution of the CE machine can be tested by running a 
diluted solution of the SNPlex ZipChute™ Mix (1:224) and the 
internal size standard. 
 4.  Notes
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  13.  The peak height ratio of two alleles in heterozygotes varies 
depending on the SNP, the amount of DNA used in the PCR 
reaction and the electrophoretic conditions. The same is 
applicable for peak high ratios in homozygotes (peak ratio 
between the real allele and any spurious peak). Each SNP 
behaves differently under different conditions and criteria 
for allele calling must be established by each laboratory by 
calculating independent cut off values for homozygotes and 
heterozygotes. For this reason, it is highly recommendable 
to run a set of samples (around 100 samples) that can be 
used as reference for future experiments. This set of reference 
samples can be both used with the Cluster and noncluster 
methods.  If the Cluster method is chosen, import the refer-
ence samples to the project containing the samples of the 
experiment. GeneMapper ® will use all the samples to defi ne 
clusters for homozygotes and heterozygotes. 
 If the noncluster method is used, export the peak heights 
of the reference samples to a spreadsheet software applica-
tion and calculate peak height ratios and cut off values for 
homozygotes and heterozygotes. Export the peak heights 
of the samples of the experiment to a spreadsheet software 
application, calculate peak height ratios and evaluate them 
according to the cut off values calculated from the reference 
samples. Take into account that it may be necessary to 
update the set of reference samples if changes in the proto-
col are introduced or a new CE machine is used. 
 It is not recommendable to use the Cluster method if poor 
quality samples are analyzed (i.e., when less than 100 pg of 
DNA are used in the PCR reaction). When low amounts of 
DNA are used, peak height ratios change in an unpredictable 
way and some of the SNPs can be miscalled. An example is 
shown in Fig.  3b where a small amount of DNA was used in 
the PCR reaction and no clear clusters could be defi ned for 
homo- and heterozygotes. A manual scrutiny of the peak 
height ratios using a spreadsheet software application is recom-
mended when undefi ned clusters are observed. As a general 
rule, SNP types that show unexpected peak height ratios should 
be failed. 
 Unusual peak height ratios can also be observed in samples 
wwwwith DNA mixtures. Results with a high overall signal 
(high RFUs) and unusual peak height rations most probably 
indicate the presence of a DNA mixture in the sample. Unusual 
peak height rations in low signal samples may be due to the use 
of small amounts of DNA in the PCR reaction. 
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 Chapter 7 
 Typing of 49 Autosomal SNPs by Single Base Extension 
and Capillary Electrophoresis for Forensic Genetic Testing 
 Claus  Børsting ,  Carmen  Tomas , and  Niels  Morling 
 Abstract 
 We describe a method for simultaneous amplifi cation of 49 autosomal single nucleotide polymorphisms 
(SNPs) by multiplex PCR and detection of the SNP alleles by single base extension (SBE) and capillary 
electrophoresis. All the SNPs may be amplifi ed from only 100 pg of genomic DNA and the length of the 
amplicons range from 65 to 115 bp. The high sensitivity and the short amplicon sizes make the assay very 
suitable for typing of degraded DNA samples, and the low mutation rate of SNPs makes the assay very useful 
for relationship testing. Combined, these advantages make the assay well suited for disaster victim identi-
fi cations, where the DNA from the victims may be highly degraded and the victims are identifi ed via 
investigation of their relatives. The assay was validated according to the ISO 17025 standard and used for 
routine case work in our laboratory. 
 Key words:  SNP typing ,  Multiplex PCR ,  Single base extension ,  Capillary electrophoresis ,  Forensic 
genetics ,  SNP for ID ,  ISO 17025 standard ,  Accreditation 
 
 There are fi ve main reasons why single nucleotide polymorphisms 
(SNPs) may be preferred to the standard short tandem repeats 
(STRs) loci used in most forensic genetic investigations. First, SNPs 
may be amplifi ed on short amplicons, which increase the chance 
of obtaining results from highly degraded DNA and make the 
amplifi cation of the loci very effi cient. Second, SNPs have low 
mutation rates (approximately 10 −8 ), which is a major advantage in 
relationship testing. A mutation will often lead to a genotype that 
is incompatible with Mendel’s law of inheritance and may result 
in comparable likelihoods for different family scenarios. Third, 
most SNPs are bi-allelic, and thus, relatively few database samples 
 1.  Introduction
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are required to obtain reasonable estimates of the allele frequencies 
in a population. Fourth, SNPs may become an important investi-
gative tool for the police when SNP packages for physical charac-
teristics or ethnic origin are fully developed and validated. Fifth, 
the highly automated, high-throughput SNP genotyping technologies 
are interesting for the forensic community, because of the dramatic 
increase in sample numbers and the demand for faster and cheaper 
forensic genetic investigations that many forensic laboratories have 
experienced in recent years. 
 The SNP for ID consortium ( www.snpforid.org ) developed a 
SNP typing assay for human identifi cation purposes that made it 
possible to amplify 52 SNPs from diminutive amounts of genomic 
DNA  ( 1 ) . All SNP loci were amplifi ed in one PCR and the SNPs 
were analysed by two single base extension (SBE) reactions. In the 
SBE reaction, the SBE primers hybridized to the PCR products 
and were extended with a labelled ddNTP complimentary to the 
nucleotide in the SNP position. The SBE products were analysed 
by capillary electrophoresis, where the length of the extended 
SBE primer identifi ed the SNP locus and the colour of the ddNTP 
label identifi ed the SNP allele. The two SBE reactions were injected 
into the same capillary with 5 min intervals and analysed in one 
data fi le  ( 1,  2 ) . 
 The main criteria for selection of the SNP loci in the SNP for ID 
multiplex were high levels of heterogeneity in European, Asian and 
African population groups and a minimum distance of 100 kb 
between the SNPs and neighbouring genes. The SNPs were shown 
to be polymorphic in populations from four different continents 
and there was not found any evidence of linkage disequilibrium for 
any pair of SNPs in the multiplex  ( 1 ) . 
 The sensitivity and the overall robustness of the SNP for ID 
multiplex assay were improved when the assay was validated for 
forensic genetic case work according to the ISO 17025 standard. 
In the validation process, the number of SNPs typed with the assay 
was reduced from 52 to 49 to allow optimization of the SBE primer 
design and simplifi cation of the analysis of the electropherograms 
 ( 2 ) . With the improved assay, full SNP profi les were obtained from 
only 100 pg of genomic DNA  ( 3 ) . The length of the PCR ampli-
cons in the SNP for ID multiplex ranged from 65 to 115 bp and full 
SNP profi les were generated from highly degraded DNA samples 
(Fig.  1 ), where it was not possible to amplify any or just a few STR 
loci with the commercial STR kits ( ( 1,  4 ) , unpublished results). 
The mean match probability ranged from 10 −14 to 10 −21 and the pater-
nity indices ranged from 10 5 to 10 6 for trios  ( 1,  2,  5– 9 ) . More than 
75 population groups have been typed for these SNPs since the 
assay was developed and the allele frequencies are freely available at 
the SNP for ID homepage  ( 10 ) . 
 Here, we describe the SNP typing protocols used for routine 
case work in our laboratory. The SNP for ID multiplex is used in 
 Fig. 1.  A corpse was washed up on a beach after an unknown period of time in the water and DNA was extracted from a nail. 
The sample was typed with the SNP for ID multiplex ( a ) and the AmpF l STR ® SEfi ler plus™ PCR amplifi cation kit (Applied 
Biosystems) ( b ). The same amount of DNA was used in the two PCRs. ( a ) The results from SBE reaction A (see Subheading  3.3 ) 
with 21 of the 49 SNPs are shown. Allele calls are shown in  boxes , e.g. “A22G”, which is the G allele of SNP number A22 
(rs733164). “PU” is a pull-up and “PC1” is a ddATP-extended PCR fragment. A full SNP profi le was obtained from the sample. 
The match probability was 1.6 × 10 −21 . ( b ) Amelogenin and two STR loci (D3S1358 and D19S433) were typed with the 
AmpF l STR ® SEfi ler plus™ PCR amplifi cation kit. Possible allele drop-outs were observed at two other STR loci (D8S1179 
and vWA). Allele calls are shown in  boxes . No PCR fragments longer than 164 basepairs were observed and no fragments with 
a PET ® ( red ) dye were detected. The match probability based on the results from D3S1358 and D19S433 was 9.0 × 10 −3 . 
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relationship cases where the standard typing of 15 STRs does not 
provide suffi cient information or leads to an ambiguous conclusion. 
 
  1.  5 U/ μ L AmpliTaq Gold ® DNA polymerase (Applied Biosystems 
(AB), Carlsbad, USA). The enzyme must be stored at −20°C 
( see  Note 1 ). 
  2.  10× GeneAmp PCR buffer I with 15 mM MgCl 2 (AB, Carlsbad, 
USA). The buffer must be stored at −20°C. 
  3.  25 mM MgCl 2 (AB, Carlsbad, USA). The solution must be 
stored at −20°C. 
  4.  10 mM dNTP mix (GE healthcare, Pollards Wood, UK). The 
solution must be stored at −20°C ( see  Note 2 ). 
  5.  High-performance liquid chromatography (HPLC) purifi ed 
oligonucleotides (DNA Technology, Aarhus, Denmark) ( see 
 Note 3 ). Prepare the PCR primer mix according to Table  1 . 
The primer mix must be stored at −20°C ( see  Note 2 ). 
  6.  Purifi ed human genomic DNA ( see  Note 4 ). 
  1.  ExoI-SAP solution. Mix 2  μ L 10 U/ μ L Exonuclease I (GE 
healthcare, Pollards Wood, UK) and 50  μ L 1 U/ μ L Shrimp 
Alkaline Phosphatase (SAP) (GE healthcare, Pollards Wood, 
UK). The enzymes must be stored at −20°C ( see  Note 5 ). 
  1.  ABI Prism SNaPshot™ Multiplex Kit (AB, Carlsbad, USA) 
with DNA polymerase, buffer and labelled ddNTPs. The kit 
must be stored at −20°C. The ABI Prism SNaPshot™ Multiplex 
Kit is sensitive to light and the tube should be wrapped in 
aluminium foil when it is outside the freezer. 
  2.  High-performance liquid chromatography (HPLC) purifi ed 
oligonucleotides (DNA Technology, Aarhus, Denmark) ( see 
Note 3). Prepare the SBE primer mix A and B according to 
Tables  2 and  3 , respectively. The primer mixes must be stored 
at −20°C ( see  Note 2 ). 
  3.  Ammonium sulphate (Sigma). 
  1.  1-U/ μ L Shrimp Alkaline Phosphatase (GE healthcare, Pollards 
Wood, UK). The enzyme must be stored at −20°C. 
  1.  GeneScan™: 120 LIZ™ size standard (AB, Carlsbad, USA). 
The size standard must be stored at 2–8°C. 
  2.  Hi-Di™ formamide (AB, Carlsbad, USA). The formamide 
must be stored at −20°C. 
 2.  Materials
 2.1.  Multiplex PCR
 2.2.  Degradation 
of dNTPs and PCR 
primers
 2.3.  Multiplex SBE
 2.4.  Degradation 
of ddNTPs
 2.5.  Capillary 
Electrophoresis
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  3.  Performance Optimized Polymer 4™ (POP-4) (AB, Carlsbad, 
USA) ( see  Note 6 ). POP-4 must be stored at 2–8°C. At room 
temperature, e.g., on the capillary electrophoresis instrument, 
POP-4 is only stable for 1 week. 
  4.  3730 10× running buffer (AB, Carlsbad, USA). The buffer 
must be stored at 2–8°C. At room temperature, e.g., on the 
capillary electrophoresis instrument, the buffer is only stable 
for two days. 
  5.  DS-02 (dye set E5) Matrix Standard with dR110, dR6G, 
dTAMRA™, dROX™ and LIZ ® dyes (AB, Carlsbad, USA). 
The matrix standard must be stored at −20°C. 
  6.  3130xl/3100 Genetic Analyzer Capillary Array, 36 cm 16-capillary 
array (AB, Carlsbad, USA). 
  7.  Capillary electrophoresis instrument, e.g. AB310, AB3100, 
AB3100 Avant, AB3130, AB3130XL or AB3500 genetic analyzers 
(AB, Carlsbad, USA). 
  1.  GeneScan ® 3.7.1 software (AB, Carlsbad, USA). 
  2.  Genotyper™ 3.7 software (AB, Carlsbad, USA). 
  3.  Microsoft ® Excel ® spreadsheet software (Microsoft Corporation, 
Redmond, USA). 
 
 The methods described below outline (1) the multiplex PCR, (2) deg-
radation of the dNTPs and the PCR primers left over from the 
PCR, (3) the multiplex SBE reaction, (4) degradation of the ddNTPs 
left over from the SBE reaction, (5) capillary electrophoresis, 
and (6) analysis of the SBE products. 
 PCRs should be mixed in dedicated pre-PCR work areas and pref-
erable in benches with laminar air fl ow to avoid contamination ( see 
 Note 7 ). The protocol shown below was designed for FTA-card 
samples, where a 1.2-mm disk was punched out of the FTA-card 
into a 96-well PCR plate, washed with ddH 2 O and dried  ( 11,  12 ) . 
However, liquid DNA preparations ( see  Note 4 ) may also be used 
with a few adjustments.
  1.  Thaw the reagents. Except for the AmpliTaq Gold ® DNA poly-
merase, the reagents should be shaken briefl y on a Vortex mixer 
and placed on ice. The AmpliTaq Gold ® DNA polymerase 
should only be removed from the freezer in a container cooled 
down to −20°C. 
  2.  Make a reaction mixture with 0.4  μ L 5 U/ μ L AmpliTaq Gold ® 
DNA polymerase, 2.5  μ L 10× GeneAmp PCR buffer I, 6.5  μ L 
 2.6.  Analysis 
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25 mM MgCl 2 , 1.75  μ L 10 mM dNTP mix, 13  μ L PCR primer 
mix (Table  1 ) and 0.85  μ L nuclease-free water for each sample. 
If the sample is a liquid preparation of DNA, no water should 
be added to the reaction mixture. The reaction mixture should 
be shaken briefl y on a Vortex mixer and placed on ice. 
  3.  Add 25  μ L reaction mixture to each well in the PCR plate with 
a washed and dried FTA-card punch. If the sample is a liquid 
preparation of DNA, add 24  μ L reaction mixture and 1–4  μ L 
sample to each well. Include a positive (sample with known SNP 
profi le) and a negative (water instead of DNA) sample control. 
  4.  Seal the PCR plate with adhesive seal and spin it briefl y in a 
plate centrifuge at 600 rpm. 
  5.  Place the PCR plate in a PCR thermocycler ( see  Note 1 ) and run 
the following PCR cycle programme: Denaturation at 95°C 
for 10 min followed by 35 cycles of 95°C for 30s, 60°C for 30 s 
and 65°C for 30 s followed by 6 min at 65°C ( see  Note 8 ). 
 Unused dNTPs and PCR primers from the PCR must be removed 
prior to the SBE reaction. In the method described below, 
exonuclease I (ExoI) degrades single-stranded DNA molecules, 
e.g., PCR primers, and SAP dephosphorylates dNTPs to dNMPs 
( see  Note 9 ).
  1.  Pipette 5- μ L amplifi ed DNA from Subheading  3.1 to a new PCR 
plate. The remaining 20- μ L amplifi ed DNA may be stored 
at −20°C. 
  2.  Add 2- μ L ExoI-SAP solution. 
  3.  Seal the PCR plate with adhesive seal, shake it briefl y on a Vortex 
mixer and spin it briefl y in a plate centrifuge at 600 rpm. 
  4.  Place the PCR plate in a PCR thermocycler and run the 
following programme: 37°C for 60 min followed by 75°C 
for 15 min. 
  1.  Thaw and mix the reagents on a Vortex mixer before placing 
them on ice. 
  2.  Make a reaction mixture A with 4- μ L ABI Prism SNaPshot™ 
Multiplex Ready Reaction Mix, 2- μ L nuclease-free water and 
1- μ L SBE primer mix A (Table  2 ) for each sample. The reac-
tion mixture should be shaken on a Vortex mixer and placed 
on ice. 
  3.  Make a reaction mixture B with 4- μ L ABI Prism SNaPshot™ 
Multiplex Ready Reaction Mix, 2- μ L ddH 2 O and 1- μ L SBE 
primer mix B (Table  3 ) for each sample. The reaction mixture 
should be shaken on a Vortex mixer and placed on ice. 
  4.  Mix 7- μ L reaction mixture A and 1- μ L amplifi ed DNA from 
Subheading  3.2 in a new PCR plate. 
 3.2.  Degradation 
of dNTPs and PCR 
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  5.  Mix 7- μ L reaction mixture B and 1- μ L amplifi ed DNA from 
Subheading  3.2 in a new PCR plate. The remaining 5- μ L ampli-
fi ed DNA from Subheading  3.2 may be stored at −20°C. 
  6.  Seal the PCR plates with adhesive seal, shake them briefl y on a 
Vortex mixer and spin them briefl y in a plate centrifuge at 
600 rpm. 
  7.  Place the PCR plates in a PCR thermocycler ( see  Note 1 ) and 
run the following cycle programme: 30 cycles of 96°C for 10 s, 
55°C for 5 s and 60°C for 30 s. 
 Unused ddNTPs from the SBE reaction gives a lot of signals in the 
electropherogram. In the method described below, the ddNTPs 
are degraded by SAP.
  1.  Add 1  μ L 1 U/ μ L SAP to each well in the PCR plates from 
Subheading  3.3 . 
  2.  Seal the PCR plates with adhesive seal, shake them briefl y on a 
Vortex mixer and spin them briefl y in a plate centrifuge at 
600 rpm. 
  3.  Place the PCR plates in a PCR thermocycler and run the 
following cycle programme: 37°C for 30 min followed by 
75°C for 15 min. 
 A spectral calibration using the DS-02 Matrix Standard (dye set E5) 
must be approved prior to electrophoresis of the SBE products.
  1.  Make a size standard mixture of Hi-Di™ formamide and 
GeneScan™ – 120 LIZ™ size standard in a ratio of 100:1. 
  2.  Pipette 20- μ L size standard mixture into each well of the elec-
trophoresis plate. 
  3.  Add 1- μ L SBE products from Subheading  3.4 . 
  4.  Prepare the plate for electrophoresis and spin it briefl y in a 
plate centrifuge at 600 rpm. 
  5.  Denature the samples at 95°C for 3 min and cool them immedi-
ately by placing the plate in a container cooled down to 4°C. 
  6.  Run the electrophoresis with the following settings ( see  Note 10 ). 
 Oven temperature:  60°C 
 PreRun voltage:  15 kV 
 PreRun time:  180 s 
 Injection voltage:  3 kV 
 Injection time:  22 s 
 Run voltage:  15 kV 
 Run time:  1,000 s 
 3.4.  Degradation 
of ddNTPs
 3.5.  Capillary 
Electrophoresis
102 C. Børsting et al.
 Analysis should be performed independently by two people and 
their results compared (see  step 7 below).
  1.  Import the data fi les into GeneScan ® 3.7.1 ( see  Note 11 ) and 
analyse the results with the following analysis parameters: 
 Size call range:  Full range 
 Smooth option:  None 
 Peak detection:  50 RFU for all colours 
 Minimum peak half width:  2 
 Polynomial degree:  3 
 Peak window size:  15 
 Slope threshold for peak start:  0 
 Slope threshold for peak end:  0 
 Size calling method:  Local Southern 
 Baselining window size:  51 
  2.  Save the GeneScan analysis fi le and close GeneScan ® 3.7.1. 
  3.  Import the GeneScan analysis fi le into Genotyper™ 3.7 and 
label all relevant peaks with allele name, length and peak height 
( see  Note 12 ). 
  4.  Generate a text fi le with sample ID, allele calls and peak 
heights. 
  5.  Open the text fi le in Microsoft Excel ® and test the quality of 
the allele calls against the expected peak height ratios for 
heterozygote allele calls and the expected signal/noise ratio for 
homozygous allele calls ( see  Note 13 ). 
  6.  Re-analyse the allele calls that were not approved in  step 5 in 
Genotyper™ 3.7 and decide whether the allele call is correct or 
if the allele call should be failed ( see  Notes 14 and  15 ). 
  7.  Compare the results of two independent analyses. If the results 
differ, the results should be re-analysed independently by both 
analysts and compared again. If the analysts disagree after the 
second round of analyses, the allele calls should be failed. 
 
  1.  Alternative DNA polymerases, buffer systems and thermocy-
clers may be used. However, this will most likely require further 
optimization and balancing of the PCR and SBE reactions ( ( 13 ) , 
unpublished results). We have successfully used the GeneAmp ® 
PCR system AB9600, the GeneAmp ® PCR system AB9700, 
 3.6.  Analysis 
of the SBE Products
 4.  Notes
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the AB2720 thermal cycler, and the Eppendorf Mastercycler ® 
gradient thermocycler. 
  2.  Repeated thawing and freezing of dNTPs and primer mixes 
will reduce the performance of the assay. dNTPs and primer 
mixes should be stored in small aliquots suitable for one or two 
experiments. 
  3.  High-quality oligonucleotides are essential for all multiplex 
reactions  ( 13 ) . In our experience, there is a large difference in 
primer quality between vendors and it is important to choose 
the right one. Most vendors perform quality analyses of their 
oligonucleotides by MALDI-TOF mass spectrometry. It is 
usually possible to get access to the mass spectra and they can 
be very helpful in a troubleshooting process or for selection of 
the best vendor. 
  4.  The SNP for ID multiplex has been used successfully on genomic 
DNA purifi ed by many different extraction protocols, including 
Chelex resin, phenol/chloroform, Proteinase K/Laurylsarcosin/
EDTA/QIAquick PCR purifi cation kit, QIAsymphony 
DNA Investigator kit, QIAamp DNA Investigator kit, EZ1 DNA 
Investigator kit, MagAttract DNA mini M48 kit and more. The 
SNP for ID multiplex has also been used successfully on buccal 
swabs or blood placed on FTA-cards. 
  5.  The ExoI-SAP solution may be stored at +4°C for 5 days. 
However, it may increase the background noise from PCR 
primers extended with labelled ddNTPs in the SBE reaction 
and we recommend making a fresh solution for each experi-
ment. The ExoI-SAP solution may be bought as a mixture, but 
that is more expensive than buying the enzymes separately. 
  6.  POP-6™ and POP-7™ may also be used. Most forensic genetic 
applications use POP-4™ and it is convenient to use the same 
polymer for all assays performed in the laboratory. 
  7.  PCR is a highly effi cient method for amplifi cation of DNA. 
However, the extreme sensitivity of PCR also makes the 
technique susceptible to contamination problems  ( 14,  15 ) . 
Laboratories performing PCR routinely need laboratory 
protocols to avoid and check for cross-contamination  ( 16– 18 ) . 
These protocols are included in the accredited laboratory 
standards for testing laboratories (ISO 17025) recommended 
by the International Society of Forensic Genetics (ISFG)  ( 19 ) . 
It is essential to physically separate pre-PCR work areas from 
post-PCR work areas and to ensure that all traffi c of reagents 
and, if possible, laboratory workers is unidirectional from the 
pre-PCR work area to the post-PCR work area. Each desig-
nated work area must be fully equipped with the necessary 
instruments, laminar air fl ow benches, laboratory disposables, 
laboratory coats, etc. Good laboratory behaviour must be 
104 C. Børsting et al.
conducted in all areas. Thus, work stations must be cleaned 
with 10% freshly prepared bleach before and after each labora-
tory step, reusable trays and racks must be immersed in 10% 
bleach before they are cleaned and reused, the laboratory 
workers must wear laboratory coats and gloves at all times, and 
used disposables and reagents must be removed from the 
designated areas in closed containers. Furthermore, it is recom-
mended to build pre-PCR work areas with positive air pressure 
and post-PCR work areas with negative air pressure. 
  8.  In the multiplex PCR described here, the Mg 2+ concentration 
is unusually high and the elongation temperature is unusually 
low compared to standard singleplex PCR conditions. This is 
done to optimize and balance the multiplex PCR. There are 
other ways to improve amplifi cation effi ciency in multiplex 
PCR, including the concentrations of the buffer, dNTPs, and 
PCR primers, primer annealing temperature and PCR primer 
design  ( 13,  20– 22 ) . 
  9.  Unused dNTPs and PCR primers may also be removed by 
various PCR purifi cation kits. This is advantageous if the PCR 
products are going to be used in down-stream applications 
that are more sensitive, such as mass spectrometry  ( 23 ) , or 
if the down-stream application employs enzymes that are 
inactive in the buffer systems used for the multiplex PCR. 
However, with some of the PCR purifi cation kits, the pore size 
of the fi lter is too big and the smallest PCR products may be 
lost. We have successfully purifi ed fragments down to a size of 
44 bp with the standard protocol for the MinElute™ PCR 
purifi cation kit  ( 24 ) . 
  10.  It is possible to inject the products of two (or more) SBE reac-
tions sequentially without injection of polymer in between and 
without any carry-over from the previous injection to the next 
one. This allows the collection of all results from one sample in 
only one data collection fi le  ( 1,  2 ) . The run time of the SNP36_
POP4_DefaultModule must be changed to 300 s to reduce 
the time between the two injections. For the second injection, 
another module must be created, where three washing steps 
are added and where the capillary polymer fill stage and 
pre-run is removed. The run time of the second injection must 
be 1,000 s. 
  11.  GeneMapper ® software may also be used for the analysis. 
  12.  Allele windows for all possible alleles should be pre-defi ned in 
the Genotyper™ 3.7 template. These windows are usually relatively 
narrow (0.3–0.6 nucleotides) compared to allele windows 
for PCR products (e.g. STR alleles), because the extended SBE 
primers have the same basepair composition in every experi-
ment  ( 2 ) . Allele windows for ddNTP-extended PCR products 
1057 Typing of 49 Autosomal SNPs by Single Base Extension…
should also be pre-defi ned to simplify the analysis process  ( 2 ) . 
Also, defi ne windows that are 2–3 nucleotides shorter and 
longer than the smallest and longest allele window in each colour, 
respectively. This will ensure that all allele calls will appear 
in the text fi le. Allele calls that are shorter or longer than the 
defi ned allele windows will not appear in the text fi le. Check 
the positive and the negative control before the rest of the 
samples are analysed. The SNP profi le of the positive control 
should be identical to results from previous experiments. There 
will be peaks in the negative control. They originate from 
SBE of primer-dimers and the peaks will not necessarily be the 
same from experiment to experiment. However, the negative 
control should not look like a sample profi le and the few peaks 
that may be detected in the electropherogram should be low. 
  13.  Results from inter-laboratory exercises conducted by the 
SNP for ID consortium  ( 25 ) and the European DNA Profi ling 
Group  ( 26 ) revealed that simple misinterpretation of the 
electropherograms was the most common mistake made by 
the participating laboratories. Small-sized peaks from PCR 
products or PCR primers extended with ddNTPs in the SBE 
reaction were called as true alleles and small-sized peaks were 
accepted as homozygous allele calls even though there was a 
high risk of allele drop-out. These problems were addressed 
when the SNP for ID multiplex was validated for forensic case 
work  ( 2 ) and a protocol for analysis of the electropherograms 
was described that include a quality check of each allele call 
based on the peak height of that allele. A set of guidelines for 
allele calling was developed from the duplicate typing of 216 
individuals from Danish paternity cases and acceptable peak 
height ratios for heterozygote allele calls and acceptable signal/
noise ratio for homozygous allele calls were defi ned  ( 2 ) . 
  14.  There are many reasons why an allele call may be acceptable 
even though it does not fulfi l the guidelines for allele calling 
( see  Note 13 ). For homozygous allele calls, the noise in the relevant 
part of the electropherogram may be lower than the average 
maximum noise level defi ned previously  ( 2 ) and the true signal/
noise ratio may therefore be acceptable. For heterozygous allele 
calls, the noise in one colour may be higher than the noise in 
the other colour or the signal from one allele may be saturated. 
This may lead to peak height ratios that were not acceptable 
even though the allele calls were correct. However, it is impor-
tant to be cautious at this step in the protocol and experience 
and training are required. 
  15.  If the maximum peak height was less than 3,500 RFU or there 
were many unacceptable homozygous allele calls, it indicates 
that the PCR amplifi cation was weak and it may be prudent 
to re-type the sample with more DNA input in the PCR. 
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For weakly amplifi ed samples, there will also be many unacceptable 
heterozygous allele calls, because the RFU scale is sigmoidal. 
If there are many unacceptable heterozygous allele calls, it 
indicates that the sample is a mixture or that the sample is 
contaminated  ( 2 ) . We have observed examples of unusual peak 
height ratios that are reproducible and in some cases inherit-
able  ( 2,  5,  7 ) . Some of these were identifi ed as partial null 
alleles, where one allele was weakly amplifi ed because of a mutation 
in the PCR primer binding site. However, the partial null 
alleles are rare, and in mixtures, there are ten or more unusual 
peak height ratios which clearly indicate that the sample 
contains DNA from more than one individual. 
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 Chapter 8 
 A 34-plex Autosomal SNP Single Base Extension Assay 
for Ancestry Investigations 
 C.  Phillips ,  M.  Fondevila , and  Maria  Victoria  Lareau  
 Abstract 
 Ancestry inference based on autosomal markers remains a niche approach in forensic analysis: most 
laboratories feel more secure with a review of the cumulative STR profi le frequencies in a range of relevant 
populations with the possible additional analysis of mitochondrial and/or Y-chromosome variability. 
However, a proportion of autosomal single nucleotide polymorphisms (SNPs) show very well-differentiated 
allele frequencies among global population-groups. Furthermore, such ancestry informative marker SNPs 
(AIM-SNPs) lend themselves to relatively straightforward typing with short-amplicon PCR and multi-
plexed single base extension reactions using the same capillary electrophoresis detectors required for the 
sequencing and STR genotyping of mainstream forensic markers. In this chapter, we describe a 34 AIM-
SNP multiplex that is robust enough for the analysis of challenging, often highly degraded DNA typical 
of much of routine forensic casework. We also outline in detail the in-silico procedures necessary for 
collecting parental population reference data from the SPSmart SNP databases and performing ancestry 
inference of single AIM-SNP profi les or large-scale population data using the companion ancestry analysis 
website of  Snipper . Two casework examples are described that show, in both cases, that an inference of 
likely ancestry using AIM-SNPs helped the identifi cation of highly degraded skeletal material. 
 Key words:  Genetic ancestry ,  SNP, AIM-SNP ,  Population genetics ,  Population admixture ,  Bayesian 
analysis 
 
 Although typing of ancestry informative marker-single nucleotide 
polymorphisms (AIM-SNPs) is widely used in the study of ancestry 
for medical and population genetics, their application to forensic 
analysis has been much more tentative. This is due in part to the 
fact that the AIM-SNPs typed must be components of relatively 
small-scale multiplexes, ranging from 20 to 35 markers, to be able 
 1.  Introduction
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to work effi ciently with restricted levels of DNA. Such limited 
AIM-SNP numbers mean the most informative markers must be 
selected and combined to maximize the power to differentiate 
populations. In addition, methods of analysis that permit a reliable 
inference of ancestry from the observed patterns of allelic variation 
are often perceived to have less statistical value compared to the 
levels of profi le matching probabilities routinely generated for indi-
vidual identifi cation. Lastly, population admixture, a signifi cant 
characteristic of most urban populations of the Western World, acts 
to erode the differentiations observed in the unadmixed parental 
populations used as reference data to make inferences of individual 
ancestry for a SNP profi le. In this context, parental population data 
signify genotypes found in component populations of the fi ve 
global population-groups of Africa, East Asia, Europe, The 
Americas, and Oceania (herein AFR, E ASN, EUR, AME, OCE). 
These fi ve groups largely correspond to the geography of the major 
continental regions and they have been shown to be genetically 
distinct by an extensive body of work, of which Rosenberg et al. 
 ( 1 ) arguably represents the landmark publication of such studies. 
In fact the fi ve major groups are bound more by geographic barri-
ers than continental margins, for example North African popula-
tions show a stronger affi nity to European populations than those 
of sub-Saharan Africa, south of the Sahel. Similarly, South Asian 
populations are more closely related to Europeans than East Asians 
in the absence of signifi cant geographic barriers in central Asia. 
Therefore, the meta-population covering regions of Europe across 
to Central-South Asia (comprising Europeans, Middle East-North 
Africans, South Asians) can be more appropriately referred to as 
Eurasian. 
 At the time of writing, three autosomal AIM-SNP multiplexes 
specifi cally designed for the analysis of forensic DNA have been 
described in the literature  ( 2– 4 ) . All three publications list the 
primer sequences along with multiplex details, enabling users to 
assess alternative approaches for simple ancestry analysis of forensic 
DNA. The methods of Phillips et al. and Lao et al.  ( 2,  3 ) use 
SNaPshot assays, while Halder et al.  ( 4 ) use  SNPstream technol-
ogy, but all show forensic levels of sensitivity while the 34-plex 
assay of Phillips et al., described in this chapter, has been observed 
to show particular sensitivity with challenging DNA  ( 5,  6 ) . 
Furthermore, the  in-silico analytical method of the 34-plex assay 
includes a simple statistical system available at the  Snipper web por-
tal [ http://mathgene.usc.es/snipper/ ] to assign a likely ancestry 
to the SNP profi le generated, but more importantly, this is now 
extendible to any SNP set for which comparative parental popula-
tion data exist. 
 The most popular approach for ancestry analysis of genotype 
data from multiple populations is the  structure algorithm  ( 1,  7 ) 
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(see Note 1). In particular,  structure is the method of choice for 
the analysis of admixture since one of its strengths lies in the abil-
ity to accurately gauge the components of admixture per indi-
vidual, especially when the contributor populations are well 
differentiated by the markers typed. In addition,  structure is a 
fl exible approach—different types of markers such as STRs, SNPs, 
and indels can be readily combined in the same genotype input 
fi le. However,  structure analysis of single individual profi les is not 
so straightforward since the whole set of parental data plus the 
unknown profi le must be analyzed in combination each time and 
this can be both time-consuming and cumbersome to perform 
for a small number of casework samples in turn. For this reason, 
 Snipper was developed to provide a simple alternative for making 
ancestry assignments of single profi les in real-time, rather than 
the more computationally intensive and slower process of assess-
ing the whole data set each time with  structure. Both  structure 
and  Snipper use a naïve Bayesian analysis which, put simply, 
equates likelihood of membership of a class (in this case ancestry) 
directly to the observed frequency of variables in each class (in 
this case allele frequencies). Therefore, both algorithms require 
reference data from which to calculate the allele frequencies and 
then compare these to the alleles found in the unknown profi le(s). 
In the case of  Snipper, the reference data allow construction of 
training sets from which to calculate allele frequencies and these 
sets can comprise fi xed three group data (African, East Asian, 
European) in place for 34 SNPs and ready to use or can be data 
for any populations and SNP set where reference genotypes are 
available, which can then be uploaded as a custom data set. Each 
algorithm makes the same prior assumption, often untested 
(hence naïve): that the variables, i.e., the component loci, are 
independent. So uni-parental data are not readily incorporated 
into either analysis system, though  structure has scope for the 
analysis of linked loci. 
 In the following sections, we describe: (1) how to obtain 
parental population reference data for AIM-SNPs to use with 
either  structure or  Snipper ; (2) how to use  Snipper to analyze a 
34-plex AIM-SNP profi le using a simple fi xed three group train-
ing set; (3) how this approach can be extended to analyze cus-
tom data with an example of the 34 SNPs of the standard forensic 
assay supplemented with an additional 24 SNP multiplex 
designed to differentiate South Asians from Europeans and; (4) 
how to quickly assess the ancestry of multiple profi les. In conclu-
sion, we briefl y review the potential in the future of our advo-
cated approach to forensic ancestry analysis: mixed marker tests 
that combine STR and AIM-SNP genotypes from the same 
forensic case to make the most robust inference of ancestry from 
the available DNA data. 
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  1.  Snipper portal:  http://mathgene.usc.es/snipper/default3_34_
new.html 
  2.  Structure software can be downloaded at:  http://pritch.bsd.
uchicago.edu/structure.html 
  3.  SPSmart home:  http://spsmart.cesga.es/ 
  4.  SPSmart SNP for ID 52-plex and 34-plex variability browser: 
 http://spsmart.cesga.es/snpforid.php 
  5.  Entire genome interface for exploring SNPs (ENGINES) a 
1,000 genomes variability browser enabling a review of all SNP 
sites found from 1093 (more due in 2012) complete genome 
sequences:  http://spsmart.cesga.es/search.php?dataSet=engine 
  6.  pop.STR:  http://spsmart.cesga.es/popstr.php 
 
 The chemistry of the SNaPshot single base extension assay is well 
covered in other chapters and this section therefore just briefl y cov-
ers additional observations from use of the 34-plex genotyping assay 
in routine forensic casework found since original publication  ( 2 ) . At 
the time of writing, the NIST 2391b standard reference material 
( https://www-s.nist.gov/srmors/view_detail.cfm?srm=2391B ) is 
being genotyped and data will be made available to potential users 
by publication and in the SPSmart SNP for ID pages.
  1.  The 34-plex AIM-SNP assay uses the same primers as those 
listed in Phillips et al.  ( 2 ) . For guidance, Table  1 lists the observed 
average sizes in basepairs (bp) for the composite SNPs using 
POP-6 with a 3130 detector. Table  2 gives the ratios by volume 
of the components of the PCR and extension multiplex primer 
mixes. Users may need to adjust these depending on the 
observed peak height ratios following experimental runs of 
new primer stock combinations. 
  2.  Standardized rules for the interpretation of heterozygote peak 
imbalances observed using SNaPshot dyes and previously 
established for the 52plex ID-SNP multiplex by The SNP for ID 
Consortium  ( 8 ) . Briefl y these are: the blue G signal is 4 times 
greater or less than the yellow/red C/T signal and 2 times greater 
or less than the green A signal. There are two outlier heterozy-
gote patterns in the 34-plex that often show greater imbal-
ances than the above rules of interpretation: SNPs rs2304925 
 2.  Materials
 3.  Methods
 3.1.  The 34-plex 
AIM-SNP SNaPshot 
Assay
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 Table 1 
 Observed basepair sizes of 34-plex component SNPs at the developing laboratory 
 ( 2 ) , using an AB 3130 genetic analyzer and POP-4 or POP-6 polymer in a 50-cm 
capillary array 
 POP-4  SNP (mobility order)  POP-6 
 G  A  C  T  G  A  C  T 
 22.95  25.76  rs2304925  19.69  21.37 
 24.63  23.44  rs5997008  21.57  20.38 
 26.62  28.48  rs1321333  23.75  24.92 
 29.45  30.26  rs2814778  24.56  26.02 
 26.25  28.78  rs917118  24.58  26.19 
 28.16  30.11  rs1024116  26.7  28.19 
 31.34  32.62  rs7897550  28.74  29.85 
 33.86  36.08  rs722098  32.51  34.36 
 37.07  38.36  rs10843344  33.1  34.17 
 38.9  40.4  rs239031  37.05  37.96 
 40.11  40.71  rs12913832  38.42  39.09 
 43.06  44.08  rs1978806  41.33  42.22 
 44.18  45.41  rs2040411  42.17  43.1 
 46.37  46.76  rs773658  44.18  45.08 
 48.69  49.44  rs10141763  47.05  47.51 
 49.21  50.52  rs182549  48.23  49.53 
 50.29  51.19  rs1573020  48.94  49.7 
 53.13  54.1  rs896788  52.01  52.88 
 54.9  55.78  rs2065160  53.46  54.27 
 56.43  57.46  rs2572307  55.59  56.36 
 58.59  59.25  rs2303798  57.25  58.03 
 61.07  61.81  rs2065982  60.15  60.93 
 62.27  63.44  rs3785181  60.95  61.89 
 63.61  65.49  rs881929  63.24  64.52 
 65.8  65.62  rs1498444  65.07  64.9 
 69.72  70.45  rs2026721  68.79  69.47 
 68.9  69.43  rs1426654  68.18  68.85 
 72.91  72.88  73.28  rs4540055  72.31  71.91  72.35 
(continued)
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Table 1
(continued)
 POP-4  SNP (mobility order)  POP-6 
 G  A  C  T  G  A  C  T 
 77.96  78.38  rs1335873  75.47  76.04 
 78.32  78.36  rs16891982  77.22  77.47 
 79.98  80.34  rs1886510  79.16  79.49 
 79.92  80.28  rs730570  79.55  80.25 
 83.26  84.41  84  rs5030240  83.11  84.4  83.6 
 88.3  87.55  rs727811  87.66  86.87 
 Table 2 
 PCR and extension primer ratios for the preparation of multiplex reaction 
components 
 PCR  EXT 
 2 × 25  m M primer 
stock  m L 
 Final concentration 
( m M) 
 25  m M primer stock 
 m l 
 Final concentration 
( m M) 
 rs2304925  4  0.9425  2.5  1.1489 
 rs7897550  2  0.4713  1  0.4596 
 rs773658  3.2  0.7540  3  1.3787 
 rs239031  0.5  0.1178  1  0.4596 
 rs5997008  1.9  0.4477  1.3  0.5974 
 rs2040411  1.8  0.4241  1  0.4596 
 rs10141763  3  0.7069  1.15  0.5285 
 rs2572307  1.5  0.3534  1.1  0.5055 
 rs2026721  3.2  0.7540  1.75  0.8042 
 rs2303798  4.3  1.0132  3.5  1.6085 
 rs1573020  0.5  0.1178  1.25  0.5744 
 rs2065160  0.8  0.1885  1.3  0.5974 
 rs896788  1.5  0.3534  1.25  0.5744 
 rs2065982  2  0.4713  1.35  0.6204 
 rs10843344  3  0.7069  1.25  0.5744 
 rs1498444  5  1.1781  3  1.3787 
(continued)
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(red T less than 1/4 of the blue G signal strength) and 
rs12913832 (very strong blue:green imbalance likely due to a 
long-standing observation of poor extension of the A allele for 
this SNP). 
  3.  Three persistent nonspecifi c peaks occur in the green channel 
at fi xed positions 64.33, 82.19, and 87.14 bp (POP-6). These 
peaks are close to SNPs rs1498444, rs730570, and rs727811 
with the 64.33 bp peak closer than a single base interval to the 
A allele of rs1498444, but all are easily distinguishable as the 
nonspecifi c signals always run to the same position and are 
generally lower than extension product peak heights. 
Table 2
(continued)
 PCR  EXT 
 2 × 25  m M primer 
stock  m L 
 Final concentration 
( m M) 
 25  m M primer stock 
 m l 
 Final concentration 
( m M) 
 rs4540055  1.2  0.2828  1.1  0.5055 
 rs182549  6.2  1.4609  6.5  2.9871 
 rs3785181  1.25  0.2945  0.75  0.3447 
 rs2814778  1.2  0.2828  2  0.9191 
 rs1335873  0.75  0.1767  1.6  0.7353 
 rs1886510  1.5  0.3534  1  0.4596 
 rs917118  1  0.2356  2  0.9191 
 rs722098  2.3  0.5419  4  1.8382 
 rs1978806  1  0.2356  2  0.9191 
 rs16891982  1.2  0.2828  1.75  0.8042 
 rs12913832  3  0.7069  3  1.3787 
 rs1321333  2.75  0.6480  1.5  0.6893 
 rs5030240  2  0.4713  2  0.9191 
 rs727811  2  0.4713  2.5  1.1489 
 rs1024116  3  0.7069  2.1  0.9651 
 rs730570  1.3  0.3063  2.2  1.0110 
 rs1426654  3  0.7069  4  1.8382 
 rs881929  3  0.7069  2.5  1.1489 
 H 2 O  109.6    H 2 O  6.27 
     NH 3 SO 4 (200 mM)  33.33 
 Total  179.45    Total  108.8 
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 A statistical analysis of a 34-plex profi le with fi xed AFR-EUR-E 
ASN training sets can be made immediately the profi le genotypes 
are uploaded, but other population analyses require the user to 
collect and input reference data for the parental populations to be 
compared. This process previously required locus-by-locus scru-
tiny of dbSNP or HapMap SNP databases  ( 9 ) , but luckily SPSmart 
 ( 10,  11 ) now makes the task much more straightforward for any 
number of AIM-SNPs. The SPSmart population-variation browser 
suite currently includes four components: a SNP browser for the 
SNP for ID forensic SNP sets (52-plex ID-SNPs and 34-plex AIM-
SNPs); a browser for HapMap, Perlegen, and Stanford/Michigan 
CEPH-HGDP (see Note 2) SNP repositories; a browser for the 
1,000 genomes SNP repository and; an STR browser initially based 
on the 20 core forensic markers and the 51 CEPH-HGDP popula-
tions. Note 3 lists the four URLs for direct access to the search 
pages of each browser.
  1.  Choose the database(s) to search or opt for SEARCH in the 
SNP for ID “global map” homepage. If opting to review mul-
tiple databases, e.g., HapMap and Perlegen, only one popula-
tion grouping can be made. 
  2.  Choose the populations to merge into groups by ticking 
selections—the maximum number of separate groups from a 
single database is fi ve, but the same process can be repeated 
multiple times if more groupings are required. Populations are 
already arranged into sets of genetic diversity based on 
Rosenberg’s original structure analyses of the CEPH-HGDP 
populations  ( 1,  12 ) , though it should be noted that the Eurasian 
meta-population has been subdivided into three subgroups. 
  3.  Add the SNP RefSeq (rs-number) identifi ers in the search by 
SNP window. There is no maximum number, but long lists can 
slow the query. Click the “next” button below. 
  4.  Select or ignore the fi lter options presented. MAF is minimum 
allele frequency and  I  n  is Rosenberg’s AIM informativeness 
metric  ( 13 ) . When reviewing SNP data from multiple data-
bases, it is best not to tick option: “Filter SNPs not genotyped 
on every compared dataset.” 
  5.  In the downloads tab are the genotype fi les ready to download, 
then copy and paste into Excel or notepad. The recommended 
steps being: download, choose all, copy into Excel, invert the 
data into rows = samples and columns = SNPs (copy > select new 
cell > paste special > transpose). This must be completed for 
each group while taking care to label each set of sample rows 
with the appropriate description, e.g., African, South Asian, 
etc. 
  6.  The genotypes can be formatted for input to  structure or 
 Snipper custom data analysis (outlined in previous paragraph ). 
 3.2.  Obtaining 
Reference Population 
AIM-SNP Data from 
SPSmart
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SNaPshot genotypes may need checking against the reference 
data if each represents different typing platforms, e.g., a 
SNaPshot C/T SNP may be an A/G SNP in HapMap requir-
ing base inversions of one dataset. For this reason, symmetrical 
SNPs (C/G and A/T) require particular care (see Note 4). 
 The  Snipper portal was originally designed to provide a real-time 
ancestry assignment system for 34-plex profi les with reference to 
default pretyped AFR-EUR-E ASN training sets and this still rep-
resents the simplest approach for assessment of a single casework 
profi le requiring an immediate overview of ancestry. The portal 
can be accessed directly ( http://mathgene.usc.es/snipper/
default3_34_new.html ) or via the homepage by selecting the link: 
“Classifi cation as Europ.-Afr.-E. Asian (34 SNPs).” An assignment 
is made on the basis of three likelihood ratios (AFR:EUR, AFR:E 
ASN, EUR:E ASN) using three ancestry probabilities derived from 
the reference data (AFR: Mozambican and Somali data, EUR: 
Danish and NW Spanish or Galician, E ASN: Taiwanese and 
Chinese, 60 each population). Figure  1 describes a casework example 
 3.3.  Making an 
Ancestry Inference 
from a 34-plex SNP 
Profi le—A Simple 
Three Population-
Group Comparison
 Fig. 1.  Casework example 1: Simple 34-plex analysis of challenging material. DNA extracted from burnt muscle (1) and 
molar dentine (2) taken from badly charred cadaver (3, 4) found in burnt fl at. Police investigation sought to exclude the 
possibility of an itinerant from Africa, common in the area. A 32/34 AIM-SNP profi le, shown  top-left , was obtained from the 
dentine extract and a comparison of the profi le to fi xed three-group training sets comprising Danish/NW Spain (EUR), 
Mozambican/Somali (AFR) and Chinese/Taiwanese (E ASN) indicated a person 18 quintillion and three trillion times more 
likely to be European than African or East Asian, respectively. 
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using the fi xed training set option of  Snipper to identify a badly 
charred corpse found in a fl at in Spain where it was important to 
exclude the possibility that the body was an itinerant from Africa. 
  1.  Choose the order of genotypes in the submitted profi le: 
SNaPshot mobility order or rs-number order. 
  2.  A profi le can be built by concatenating data in Excel (using the 
“&” operand) allowing individual scrutiny of composite geno-
types before direct copy-pasting into the query window left of 
the “classify” button. 
  3.  Each missing genotype is entered as two Ns per SNP, so only 
ACGTN characters are permitted. Format errors from incor-
rect bases (either due to incorrect SNP order or inverted bases) 
are fl agged by the portal with a warning for the relevant SNP 
position(s), e.g.,  Error: SNP A30 (number 34) has possible 
alleles AC but your profi le has fi rst allele G in this SNP (global 
position 67). Please curate your profi le. 
  4.  Results returned from a submission comprise: the submitted 
profi le; the -log likelihoods and percentiles for the three train-
ing set groups; the likelihood ratios in verbose format and pre-
dicted ancestry; the apparent success and; a list of the composite 
SNPs in descending order of three group divergence (these 
values are a variant of Rosenberg’s  I  n  ) . 
  5.  Missing SNP genotypes are fl agged in red in the divergence list 
to allow some assessment of the potential contribution of gaps 
in the profi le; in other words, assignments made with several 
red SNPs at the top of the list will be much less reliable than 
those with gaps at the bottom—though this will be clear from 
the probabilities obtained. 
  6.  Apparent success measures the rate of correct assignment of 
training set samples using the SNPs of the profi le. These values 
are 100% for a complete set of 34 SNPs, but drop when signifi -
cant numbers of gaps occur in the submitted profi le – particularly 
for EUR:E ASN comparisons. 
 In order to extend ancestry analyses beyond the default three pop-
ulation-group comparisons and 34 SNPs using  Snipper, select the 
homepage red links: (1) “Classifi cation with a custom Excel fi le of 
populations” and (2) “Thorough analysis of population data with 
a custom Excel fi le.” Respectively, these allow: (1) ancestry assign-
ment of a profi le comprising any SNPs (up to 100 markers) using 
training sets of the same loci for populations defi ned by the user 
based on collected data or generated from population samples rel-
evant for the laboratory, and (2) analysis of the training sets to 
gauge characteristics of the component SNPs. The latter analysis 
option is a useful aid to assessing the informativeness of new can-
didate AIM-SNPs for ancestry inference. A key factor in following 
 3.4.  Making 
an Ancestry Inference 
from any SNP Profi le: 
Specialized Analyses 
Using Custom SNP and 
Population Data
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both the above analysis options is careful preparation of the Excel 
fi le containing the custom training set profi les and precise match-
ing of unknown profi les to training set profi les in terms of bases 
and locus order—therefore it is recommended to sort component 
SNPs into ascending rs-number order as an aid to data checking. 
 Figure  2 describes a second casework example where standard 
34-plex AIM-SNP analysis was supplemented with a custom SNP 
set of markers chosen in order to differentiate European and South 
Asian ancestry. This was relevant to the identifi cation of scant skel-
etal remains washed ashore in northern Spain, where biometrical 
measurements of the skull found suggested a possible South Asian 
ancestry and it was necessary to check records of missing merchant 
seamen of various geographic origins. 
  1.  Download the example fi le demonstrating the required format 
of the Excel fi le of custom data (see Note 5). 
  2.  Following the example arrangement and format (e.g., only 
ACGTN characters, etc.), compose a fi le of reference popula-
tion profi les for the SNPs of interest obtained from SPSmart 
queries or in-house genotyping. Any reasonable number of 
populations can be compiled as sets of rows and up to 100 
SNPs can be compiled as columns. 
 Fig. 2.  Casework example 2: Custom analysis of 34-plex data supplemented with a custom AIM-SNP set of 24 additional 
markers. Skeletal remains (1, 2) were found washed ashore in La Coruña harbor (3) and DNA was extracted from a molar 
visible in right mandible. Biometrical analyses of skull dimensions suggested South Asian rather than European origin. 
A genotype profi le of 47/58 AIM-SNPs was obtained and analyzed in  Snipper comparing three parental datasets as custom 
training sets: (a) SPSmart CEPH-HGDP AFR, E ASN, AME, OCE plus the European, Middle Eastern (ME) and S Asian (S ASN) 
components of Eurasia; (b) CEPH AFR, E ASN, European plus in-house genotypes from Iranian/Iraqi (ME) and Indian (S ASN) 
samples, and (c) genotype data of ii. without ME samples. Ancestry likelihoods show the individual is much more likely to 
be European or Middle East in origin than South Asian. Although cross-validation revealed a zero misclassifi cation with S 
ASN vs. ME or European, there was less success differentiating ME from European; therefore, this data was interpreted just 
to infer Eurasian ancestry outside of South Asia, directing the investigation towards missing European and Middle Eastern 
merchant seamen. 
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  3.  Choose the second link: “Thorough analysis of population 
data with a custom Excel fi le.” Upload the Excel fi le of custom 
data and choose: “Perform a verbose cross-validation analysis 
of my population data with the best _ SNPs” adding the rele-
vant number of markers to assess. Cross-validation removes 
each component sample in turn, recalculates the allele frequen-
cies in the training set, and then assigns ancestry for the 
removed profi le. The other options of “classifi cation of all indi-
viduals in the sample,” “non-verbose cross validation,” and 
“bootstrapping” are alternative assignment error estimators 
that can also be chosen. 
  4.  “Do calculations” returns a ranked divergence list and the 
individual ancestry likelihoods for each sample assigned to the 
populations defi ned in the custom fi le. The accompanying pre-
diction is listed, and when incorrect, shows four stars on the 
right along with missing SNP data for that sample. The total 
success rate in each training set is summarized in a reclassifi ca-
tion table at the base of the results page. 
  5.  As a simple “walkthrough,” try collecting AFR (choosing MKK 
and YRI only to avoid incomplete coverage), EUR, and E ASN 
HapMap data from SPSmart for markers rs1426654 and 
rs12075, then compile the 3-population, 2-SNP profi les into a 
custom fi le for Snipper. There should be 309 AFR, 223 EUR, 
364 E ASN, and cells A1, B1, C1 should hold values: 896 (total 
training set samples/rows), 2 (SNPs), 3 (populations compared). 
Once submitted and analyzed, note that despite using just two 
AIM-SNPs the majority of samples in each training set are cor-
rectly assigned. Although AFRs have a low success rate of 
65.37%, E ASNs are correctly assigned in almost 100% of cases—
refl ecting the near-fi xed allele frequency distributions shown by 
the pie charts of SPSmart in the selected populations. 
  6.  Once the custom training set has been assessed for effective-
ness, users can choose “classifi cation with a custom Excel fi le of 
populations” by uploading matching single profi les from 
unknown samples to compare to the custom reference data 
and assigning ancestry in a similar fashion to the 34-plex fi xed 
training set approach. 
  7.  In the casework example given in Fig.  2 , the 34-plex data were 
compiled into a custom training set fi le from the SPSmart 
SNP for ID pages and combined with additional custom SNP 
data obtained from the SPSmart Stanford/Michigan browser 
for the same CEPH-HGDP populations. However, when pop-
ulation coverage is “patchy,” i.e., some SNPs are not typed in 
all populations of a database, then data can be collated in com-
plimentary geographic regions, e.g., HapMap Yoruba AFR 
(YRI) plus Perlegen European American EUR and Han 
Chinese E ASN when either database has incomplete population 
coverage. 
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 When large numbers of AIM-SNP profi les have been prepared 
from samples of unknown origin, it is sometimes convenient to 
make a simple, rapid check of the pattern of ancestries in the set 
without initiating a potentially lengthy  structure analysis. This can 
be achieved with  Snipper by including the unknowns in a custom 
training set fi le and performing a cross-validation as outlined in 
Subheading  2 , item 4. Appropriate reference data can be included 
each time—for example, to check for ancestry outliers among case 
and control samples in a South American study sample, it would 
be prudent to include European and Native American reference 
populations but also include a comparative analysis of African 
parental data.
  1.  Label the unknown profi les in the custom fi le with the same 
name as one of the reference populations and perform a cross-
validation. In the results, identify any samples assigned to other 
populations—this procedure may need repeating with alterna-
tive population labels for the unknowns if the majority do not 
match their fi rst assigned population. 
  2.  Pairwise charts that compare two ancestries can be made to 
enable a simple comparison of the range of likelihoods observed 
in the unknowns alongside their closest parental population vs. 
alternative populations. The charts are made in Excel by con-
verting the  Snipper likelihoods to whole numbers (using 
the = EXP formula in Excel), then making each pairwise ratio 
(e.g., lk EUR/lk AFR) and ranking the values obtained in 
descending order. Charting these with a log scale provides a 
simple visual check of the range of divergence between the 
populations compared as points with varying distances from 
the midline of 1 (a ratio value meaning balanced odds of ances-
try assignment to either population). The most distant points 
from midline represent the strongest assignments. In popula-
tions without admixture, the points are fully separated; when 
admixture occurs, a signifi cant proportion of values are close 
to or cross the midline. 
  3.  Figure  3 shows an example plot based on a custom data set of 
46 AIM-SNPs informative for Native American and European 
ancestry. The EUR:AME likelihood ratio values are plotted for 
50 HapMap Europeans from Utah (CEU) and 50 Individuals 
with Mexican ancestry from Los Angeles (MEX). The broad 
range of MEX likelihoods, mainly in the EUR upper side, but 
close to the line and crossing into the AME lower side, sug-
gests admixed ancestry between European and American con-
tributing populations applies to most of the samples with just 
10% showing comparable ancestry probabilities to CEU and 
14% showing predominantly American ancestry. The rest are 
admixed with a dominant European contribution with fewer 
showing more equal contributions from both parental populations. 
 3.5.  Multiple Profi le 
Ancestry Analysis 
with Snipper
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Though a more detailed analysis can be achieved with  structure 
and the reliability of interpretations is dependent on the level 
of differentiation shown by the AIM-SNPs used, such popula-
tion snapshots are easily accomplished in real time using the 
custom data options of  Snipper . 
 Several studies indicate that STRs, locus for locus, are more ancestry 
informative than most SNPs  ( 13– 15 ) . The term “most” here is an 
important qualifi cation as clearly the best AIM-SNPs: those mark-
ers showing fi xed or near-fi xed allele frequency differences between 
populations will be the most informative loci of all and allele fi xa-
tion in STRs is much rarer or the fi xed alleles themselves are rare. 
In fact, D9S1120  ( 16 ) is the only mainstream STR characterized 
to date that exhibits a common allele exclusively found in one 
population-group—Native Americans. Perhaps, it is more important 
to consider the strategy of using all available DNA information in 
a forensic case as contributing factors towards building a more 
broadly based and thus more reliable prediction of the likely ances-
try of a sample. STRs by themselves are not suffi ciently informative 
to provide good differentiation of all fi ve population-groups  ( 17 ) , 
 3.6.  Concluding 
Remarks: Moving 
Towards Forensic 
Ancestry Analysis 
with Mixed Marker 
Approaches
 Fig. 3.  Section of a pairwise plot showing EUR:AME likelihood ratio values from 46 AIM-SNPs from which HapMap data was 
collectable in SPSmart. Fifty HapMap Europeans from Utah (CEU) and 50 Individuals with Mexican ancestry from Los 
Angeles (MEX) are plotted, but the CEPH American data with which they were compared is not shown. The broad range of 
MEX likelihoods, noticeably lower in all but fi ve cases than those of CEU Europeans, is strongly indicative of admixed 
ancestry between European and American contributing populations with the European component dominant in all but 
10–12 samples, of which only seven in total have predominantly Native American ancestry. 
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while a small set of AIM-SNPs by themselves will not be informative 
enough in every case—notably they can lack power in small num-
bers when extending comparisons to many diverse potential ances-
tries or to closely related populations  ( 6 ) . Therefore, it is logical 
to combine both marker sets if these have been characterized as 
part of the forensic analyses made in a case. The  structure algo-
rithm allows straightforward combinations of SNP genotype col-
umns alongside STR genotype columns. Until now,  Snipper has 
been focussed exclusively on SNPs, but with the launch of pop.
STR, a browser listing STR data for the CEPH-HGDP popula-
tions dispersed across all geographic regions, the opportunity now 
exists to use this data to construct training sets comprising SNPs 
and STRs. 
 One problem is the paucity of STR genotype profi les for mak-
ing training sets since published population studies report just allele 
frequencies, while release of STR genotypes suggests the possibility, 
however remote, of database searching, potentially compromising 
the anonymity of population study donors. For this reason, we have 
developed an allele frequency based input method for  Snipper to 
allow users to upload their own frequencies, those obtained from 
sites such as SPSmart, taken from publications, or combinations of 
all three sources. STRs present the challenge of dealing with much 
more extensive allelic ranges—even in loci such as CSF1PO, we 
intend to designed custom data input fi les as Excel fi les with tabs for 
each marker holding columns for each allele and rows for each pop-
ulation (see Note 6). In this way, binary SNPs or indels can be 
included alongside as simplifi ed two column tabs and uploaded as a 
single fi le of all markers typed. Evidence from  structure analysis of 
the CEPH-HGDP  ( 17 ) already suggests that the 34-plex AIM-
SNP assay described in this chapter is enhanced considerably by 
combination with 15–20 standard identifi cation STRs. 
 
  1.  Structure software can be downloaded at:  http://pritch.bsd.
uchicago.edu/structure.html and additional information can 
be found in the help fi le (documentation for structure soft-
ware: Version 2.3) included in the software folder. A forum 
devoted to  structure is also running at:  http://groups.google.
com/group/structure-software?pli=1 . Furthermore, the origi-
nal article describing the algorithm Pritchard et al.  ( 7 ) plus 
those outlining enhancements to the method: Falush et al. 
 ( 18,  19 ) ; Hubisz et al.  ( 20 ) , are strongly recommended. 
  2.  The CEPH-HGDP (Human Genome Diversity Panel) is a cell-
line DNA set of 944 samples with wide currency in population 
genetics studies. The geographic coverage is patchy in certain 
 4.  Notes
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regions, but all continents and all major genetic ancestry 
groups defi ned by studies of variability are represented, the 
smallest numbers being 28 Oceanians from two populations 
and just six San from Namibia. There is freely accessible and 
downloadable genotype data from 650,000 SNPs for each 
CEPH-HGDP sample in the Stanford and Michigan University 
options within SPSmart. Both studies represent the most 
extensive coverage of population diversity so far achieved, 
though 1,000 genomes will extend to all sequence variation 
down to a likely minimum SNP allele frequency of 1% and are 
planned to go well beyond 1,000 samples from four continents 
(no OCE donors have been studied to date) during 2011–
2012. The ENGINES browser in SPSmart (see Note 3) allows 
scrutiny of the fi rst 178 whole sequences from African, 
European, and East Asian samples previously used to make the 
HapMap common-variant SNP catalog. 
  3.  SPS (SNPs for population studies) comprises a group of vari-
ability browsers focussed on SNPs, but now also including 
forensic STRs, with four main components:
 SPSmart home:   ● http://spsmart.cesga.es/ . 
 SPSmart SNP  ● for ID 52-plex and 34-plex variability browser: 
 http://spsmart.cesga.es/snpforid.php . 
 ENGINES (Entire Genome Interface for Exploring SNPs)  ●
a 1,000 genomes variability browser, enabling a review of 
all SNP sites found from 178 (more due in 2011) com-
plete genome sequences:  http://spsmart.cesga.es/search.
php?dataSet=engine . 
 Pop.STR:   ● http://spsmart.cesga.es/popstr.php . 
  4.  Symmetrical base SNPs, comprising an A/C on one strand and 
a T/G on the other, are a particular problem and source of 
error when comparing genotypes generated on different plat-
forms or listed in different databases. The SPSmart SNP for ID 
browser makes allowance for most base inversions by showing 
the HapMap (or other) allele frequency summary charts with 
different allele segments if these differ from the strand inter-
rogated by the 34-plex (or 52-plex) EXT primers. For example, 
rs2304925 is listed as a SNP for ID GT SNP but a HapMap AC 
SNP and this applies equally to GC or AT SNPs as shown by 
rs10141763. The SPSmart help fi le provides a clear and care-
fully worded guide in the “Symmetrical Bases” section. There 
are four symmetrical bases in the 34-plex: rs773658, 
rs10141763, rs1335873, and rs16891982. The last of these is 
the most informative SNP for differentiating component pop-
ulations within Eurasia, so it is particularly important to be 
clear about differences between SNaPshot and database allele 
calls for this marker. 
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  5.  The custom data input fi le must be in .xls format, not the more 
recent xml format of .xlxs. Rows 2–5 can be left blank, row 1 
must contain total sample (cell A1), total SNPs (A2), and total 
populations compared (A3). Cells A4 onwards contain the rs-
number or users alternative SNP descriptors. It is sometimes 
necessary to “clean” the fi le by removing blank rows at the 
bottom of the data block and blank columns to the right—just 
highlight and delete 10–20 of each. 
  6.  Classifi cation with Snipper using frequencies alone is available 
at:  http://mathgene.usc.es/snipper/frequencies.html . 
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 Chapter 9 
 SNaPshot ® Minisequencing Analysis of Multiple Ancestry-
Informative Y-SNPs Using Capillary Electrophoresis 
 Maria  Geppert and  Lutz  Roewer 
 Abstract 
 This protocol describes a strategy for analyzing phylogenetic Y-SNPs in a hierarchical multiplex assay by 
utilizing the SNaPshot ® Multiplex System. Step by step, the protocol assists in the appropriate selection of 
SNPs, the primer design, the set up of PCR/SBE reactions as well as in the analysis of the results. 
Furthermore, a forensic approach is highlighted, in which the most probable ancestry of an unknown male 
DNA is inferred by the geographical distribution of the assigned Y-SNP haplogroup. 
 Key words:  Multiplex PCR ,  Capillary electrophoresis ,  SNaPshot ® ,  Minisequencing ,  Y-SNP ,  AIM 
 
 For the analysis of SNPs, various technologies have been 
established over the last years (for a review see ref.  ( 1 ) ). SNaPshot ® 
minisequencing became one of the most accepted techniques to type 
several SNPs of interest in a multiplex assay, because the method is 
uncomplicated, universally applicable  ( 2– 4 ) , and can be accom-
plished with the standard devices that exist in a routine forensic lab 
(thermocycler, sequencer).The principle of the SNaPshot ® minise-
quencing approach is the allele-specifi c extension of a primer that 
anneals adjacent to the position of the relevant SNP. Fluorescently 
labeled didesoxynucleotides (ddNTPs), which are known from the 
Sanger sequencing method, inhibit a further elongation, because 
of lacking the required hydroxyl group. Subsequently, the extended 
single base extension (SBE) primers which are different in length 
and color are analyzed by capillary electrophoresis (CE). 
 SNPs are frequent throughout the genome. For the Y chromo-
some alone, the dbSNP-Database comprises at the moment about 
 1.  Introduction
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80,000 SNPs, although the number of validated markers is 
considerably smaller (approximately 600)  ( 5 ) . The mutation rate of 
SNPs is low in comparison to the STRs (about 10 −8 vs. 10 −3 ). 
Combinations of SNP alleles located on the nonrecombinant 
portion of the Y chromosome usually pass unchanged from genera-
tion to generation and can easily be used to construct a unique 
phylogenetic tree  ( 6 ) . The succession of accumulating binary genetic 
markers as SNPs reveals a cascade of differentiation that randomly 
coincides with various population origin episodes, each with a 
specifi c temporal and geographical context  ( 7 ) . Thus, Y-SNPs are 
ancestry-informative markers (AIM) bearing information on the 
geographic ancestry of a DNA. The Y Chromosome Consortium 
 ( 8 ) has published updated versions of the maximum parsimonious 
phylogenetic tree of human Y chromosomes and has proposed a 
universal nomenclature ( http://ycc.biosci.arizona.edu ). The major 
clades (haplogroups) are labeled with a capital letter (e.g., R) and 
subhaplogroups are designated alternately with numbers and small 
letters (e.g., R1b). Usually the terminal SNP is included to deter-
mine the branch unequivocally (R-M343 alias R1b). The most 
recent phylogenetic tree from 2008 consists of 311 haplogroups, 
which are defi ned by 600 SNPs  ( 9 ) . Nevertheless, the 1,000 
Genomes Project Consortium has recently detected not less than 
2,870 variable sites at the Y chromosome (74% novel), which sup-
port the already existing clades, but identifi ed novel differentiation 
within established branches, e.g., in O2b (frequent in China, Japan) 
or R1b (Europe)  ( 5 ) . 
 The unmatched phylogenetic, geographical, and chronological 
resolution of the Y chromosome  ( 10 ) provides insights into ques-
tions that are of interest to paleontologists, anthropologists, 
linguists, and historians and increasingly to forensic analysts. Each 
of the numerous population studies published weekly make our 
knowledge on geographical distributions of Y chromosomes more 
precise. Thus, the stage is set for an application of Y-SNPs in the 
fi eld of forensics. The combination of a sensitive minisequencing 
method to analyze SNPs even from strongly degraded DNA  ( 11 ) 
with population databases mapping the genetic differentiation 
among world populations (e.g., the Y Chromosome Haplotype 
Reference Database (YHRD);  http://www.yhrd.org ) helps to 
obtain information from biological material on the most probable 
geographical ancestry of missing persons or unknown suspects. 
 In this article, we will present a protocol for the analysis of 
Y-chromosomal SNPs with a hierarchical approach, in which the 
markers are typed according to their position in the phylogenetic 
tree of the YCC 2008, as it has been already proven for several 
population-specifi c Y-SNPs  ( 12– 14 ) . Starting with a generic 
typing to assign the test sample to one of the major haplogroups, 
only the specifi c—and more geographically restricted—clades of 
the already detected major haplogroup have to be tested afterwards. 
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In this way, the number of markers that have to be analyzed is limited 
to the minimum and the consumption of DNA material can be 
reduced. Two different multiplexes comprising 17 Y-SNPs, which 
were designed to detect the most common major haplogroups in 
samples from Germany, will serve as examples. Multiplex I covers 
the markers CT-M168, DE-M145, D-M174, E-P170, FT-M213, 
G-M201, I-M170, J-P209, and KT-M9 (see Fig.  1 ). Multiplex II 
includes the SNPs N-M231, N-Tat, O-M175, P-M45, R-M207, 
R-M198, and R-M343 (see Fig.  1 ) and for confi rmation also SNP 
M9  ( 15 ) . The result of the Multiplex I places the Y chromosome 
either in the part of the tree topology comprising the haplogroups 
 Fig. 1.  Phylogenetic tree according to  ( 9 ) .  Solid lines with marker indicate haplogroups, which can be typed by the two 
presented multiplexes. Multiplex I is marked in  green and Multiplex II in  blue . SNP M9 is marked  black , because it is 
included in both assays.  Dotted lines indicate haplogroups, which are not included in the multiplexes. The length of each 
branch has no signifi cance. 
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A-J or (if M9 is found derived) in the branches K-T. If the latter is 
the case, Multiplex II can be applied to defi ne the clades down-
stream to M9 (see Fig.  1 ). 
 
 When working with chemicals always wear suitable protective cloth 
and gloves. Use ultrapure water to prepare all solutions and mas-
termixes. Avoid multiple thawing and freezing for all reagents 
which are stored at −20°C. 
  1.  dbSNP-Database ( http://www.ncbi.nlm.nih.gov/projects/
SNP/ ). 
  2.  NCBI BLAST ( http://blast.ncbi.nlm.nih.gov/Blast.cgi ). 
  3.  Family Tree DNA Y Chromosome Browser ( http://ymap.
ftdna.com/ ). 
  4.  Primer Quest ( http://eu.idtdna.com/Scitools/Applications/
Primerquest/ ). 
  5.  Primer3Plus ( http://www.primer3plus.com ). 
  6.  Oligocalculator ( http://www.basic.northwestern.edu/
biotools/oligocalc.html ). 
  7.  UCSC BLAT Search Genome ( http://genome.ucsc.edu/ ). 
  8.  UCSC In-Silico PCR ( http://genome.ucsc.edu/ ). 
  1.  AmpliTaq Gold ® DNA Polymerase (Applied Biosystems, Inc., 
Foster City, CA, USA). 
  2.  GeneAmp ® 10× PCR Buffer (Applied Biosystems). 
  3.  dNTPs. 
  4.  MgCl 2 . 
  5.  Multiplex PCR Kit (Qiagen ® , Hilden, Germany). 
  1.  Agarose. 
  2.  Tris-Borate-EDTA (TBE) buffer. 
  3.  Ethidium bromide. 
  4.  3× Concentrate loading buffer: 10% glycerol, 2.5% Ficoll 400, 
0.025% bromophenol blue, 0.025% xylene cyanol. For a 3× 
concentrated 10 mL solution loading buffer weight 25 mg 
bromophenol blue, 25 mg xylene cyanol, 1 mL glycerol, 0.25 g 
Ficoll 400, 8.8 mL ultrapure water. 
  5.  Hyperladder™ V (Bioline, Luckenwalde, Germany). 
 2.  Materials
 2.1.  Selection of 
Y-SNPs, PCR-, and SBE 
Primer Design
 2.2.  PCR Reactions
 2.3.  Agarose 
Gel Components
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  1.  It is ExoSAP-IT® (USB ® —Affymetrix, Cleveland, OH, USA). 
  2.  ABI Prism ® SNaPshot ® Multiplex Kit (Applied Biosystems). 
  3.  Shrimp Alkaline Phosphatase (SAP, USB ® ). 
  1.  ABI Prism ® Genetic Analyzer 3130 or 3130xl with 36-cm 
capillaries (Applied Biosystems). 
  2.  SNaPshot ® Matrix Standard Set DS-02 (dR110, dRGG, 
dTAMRA™, dROX™, LIZ ® ). 
  3.  Performance Optimized Polymer (POP-4 or POP-7; Applied 
Biosystems). 
  4.  GeneScan™ LIZ™ 120 size standard (Applied Biosystems). 
  5.  Hi-Di™ Formamide (Applied Biosystems). 
  1.  Genemapper ® ID 3.2.1. 
  2.  Y Chromosome STR Haplotype Reference Database (YHRD) 
 http://www.yhrd.org . 
 
  1.  The selection of Y-SNPs has to be made with respect to the 
population(s) under study, e.g., branch R-specifi c SNPs for the 
study of European or branch O-specifi c SNPs for East Asian 
lineages. Already published studies help to determine the most 
common population-specifi c haplogroups and the appropriate 
markers. For samples from Germany, the haplogroups DE, E, 
G, I, J, N, O, R1a, and R1b are most common  ( 16– 18 ) for 
which the relevant SNP markers should be arranged in multi-
plex PCRs (see Fig.  1 ). 
  2.  Subsequently, the primers have to be designed to run in a 
multiplex assay (see Note 1). To fi nd suitable primers, pick the 
sequences, which are 200 bp up- and downstream of the rel-
evant SNPs. While having a SNP with Reference SNP ID (rs 
number), the search using the dbSNP-Database is quick and 
uncomplicated. Obtaining the results for SNPs that are not 
registered in the NCBI is more diffi cult. An alternative 
approach for those SNPs is to BLAST primer sequences of the 
SNPs of interest, which have already been published, or to 
interrogate the Family Tree DNA Y Chromosome Browser. 
Only those markers should be selected which are well studied 
and known to have no paralogous sequence variants  ( 16,  17 ) . 
In our opinion, it gives more reliable results, if the relevant 
SNPs are distributed to more than one but hierarchically 
 2.4.  PCR Cleanup, 
SNaPshot  ® Single 
Base Extension 
Reaction, and SBE 
Reaction Cleanup
 2.5.  Capillary 
Electrophoresis
 2.6.  Data Analysis
 3.  Methods
 3.1.  Selection of 
Y-SNPs, PCR-, and SBE 
Primer Design
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applicable multiplex instead of designing a very large multi-
plex covering all SNPs. 
  3.  Amplicons of the SNPs should be as short as possible to utilize 
the full potential of the SNPs especially to amplify degraded 
DNA. The size of the primers should be between 20 and 25 
nucleotides depending on the sequence, because the melting 
temperature should be theoretical between 58 and 62°C at a 
salt concentration of 180 mM by considering that the GC/AT 
content is more or less equal. The variance of melting tempera-
tures within a multiplex assay should be kept small. Amplicons 
of the different SNPs should differ in size at least 3–5 nucleotides 
to allow for a clear electrophoretic separation. 
  4.  Primers should be checked for possible extendable hairpin 
structures (loops) within each primer and for primer dimers. In 
a multiplex assay with about ten markers, it is not possible to 
avoid all theoretical primer inter- and intracontacts, but the 
most precarious ones. Particularly those should be excluded 
which lead to free extendable 3 ¢ ends. Primer Quest, Primer3Plus, 
and OligoCalulator were used to design and check the primers 
for secondary structures. NCBI BLAST, UCSC BLAT Search 
Genome, and UCSC In-Silico PCR were used to check binding 
sites of the primers in the genome to assure that all PCR prim-
ers are specifi c for the Y chromosome. 
  5.  The design of SBE primers can be conducted with the same 
software as it has been used for the PCR primers. Depending 
on the fl anking sequence of the SNP, primers can be designed 
to anneal to the forward or reverse strand (see Note 2). In the 
capillary electrophoresis, the single SNPs are differentiated by 
the color of the added nucleotide and by the length of the 
primer. To separate several SNPs of a multiplex reaction, both 
variables have to be used. SBE primers are extended to a cer-
tain length with polynucleotide tails or an unspecifi c nonhu-
man sequence  ( 18 ) . The latter is more stable and less affected 
by degradation (see Note 3). The melting temperature of the 
SBE primers should be at least 50°C, which corresponds with 
a length of the specifi c part of 17–18 nucleotides. Aiming to 
separate 8–12 SNPs in a range of ~60 nucleotides, the distance 
between SBE primers and their order is crucial. While short 
primers (17–30 nucleotides) should differ between 5 and 7 
nucleotides in length, longer primers can have only 4 nucle-
otides distance to each other, because the resolution of the CE 
increases with the length of the fragments. Primers can be set 
to the same length, if the corresponding SNP mutations do 
not share the same nucleotides (e.g., G/C and A/T), because 
these can be easily distinguished by the specifi c colors. SBE 
primers should be HPLC purifi ed  ( 19 ) . 
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  1.  Testing primers by singleplex PCR 
 For testing the functionality of the designed primers, each pair 
should be amplifi ed in a singleplex reaction by preparing a pos-
itive control of a well-known DNA sample, a female control, 
and a negative control. In a fi nal volume of 12.5  μ L, mix 1 U 
Taq Gold, 0.25 mM dNTPs, 1× PCR buffer, 1 mM MgCl, 
0.5  μ M of each primer, and 1 ng DNA and fi ll up with ultra-
pure water. 
 Cycle the PCR with the following protocol: 95°C for 
10 min followed by 8 cycles of 95°C for 30 s, 60°C for 30 s, 
72°C for 30 s, 26 cycles of 95°C for 30 s, 58°C for 30 s, 72°C 
for 30 s, and a fi nal extension of 72°C for 5 min. 
  2.  SNaPshot ® multiplex PCR 
 The multiplex PCR reaction is performed in a total volume of 
6  μ L. Prepare for one reaction a mix of primers (see Table  1 ) 
with 1× concentrated Multiplex PCR Mastermix. Add 1  μ L 
genomic DNA of a single individual and ultrapure water to 
obtain the fi nal volume. The amount of 1 ng/reaction was 
tested to work well. Vortex briefl y and centrifuge the content 
to the bottom before thermocycling. Always include a positive 
and a negative control into your calculation and take pipetting 
mistakes into account (see Note 4). 
 Cycle the PCR with the following protocol: 95°C for 
15 min followed by 32 cycles of 94°C for 30 s, 60°C for 90 s, 
72°C for 60 s, and a fi nal extension of 72°C for 10 min. 
  1.  For the electrophoretic control of the singleplex amplifi cation, 
a minigel of 1.4% agarose and 0.035% Ethidium bromide can 
be used. Run 2  μ L of the sample with 4  μ L of the 1× concen-
trated loading buffer for 20 min at 100 V. Visualize the bands 
under UV transillumination. 
  2.  For the electrophoretic separation of multiplex PCR products, 
prepare a gel (20 cm length) containing 2.5–3% agarose and 
0.035% Ethidium bromide. Run 2  μ L of the sample with 4  μ L 
of the 1× concentrated loading buffer for approximately 2 h at 
100 V or until a good resolution is reached. Visualize the bands 
under UV transillumination (see Note 5; Fig.  2 ). 
 Before SBE, clean up the PCR product with ExoSAP-IT ® (USB) 
to remove PCR primers and not incorporated dNTPs, which 
would participate in subsequent reactions. Because of the high 
glycerol concentration, vortex briefl y and incubate the reaction 
60 min at 37°C followed by 15 min at 75°C to inactivate the 
enzymes  ( 19 ) . 
 3.2.  PCR Reactions
 3.3.  Gel 
Electrophoresis 
for Singleplex and 
Multiplex PCR Control
 3.4.  PCR Cleanup
   Ta
bl
e 
1 
  PC
R 
pr
im
er
 in
fo
rm
at
io
n 
gr
ou
pe
d 
by
 m
ul
tip
le
xe
s 
an
d 
so
rt
ed
 b
y 
th
e 
ac
co
rd
in
g 
br
an
ch
   
 SN
P 
 Br
an
ch
  F
or
w
ar
d 
pr
im
er
 (5
 ¢ –
3 ¢
 ) 
 bp
 
 Re
ve
rs
e 
pr
im
er
 (5
 ¢ –
3 ¢
 ) 
 bp
 
 Am
pl
ic
on
 
(b
p)
 
 SN
P 
 Co
nc
en
-
tr
at
io
n 
( m
 M
) 
 M
16
8 
 M
14
5 
 M
17
4 
 P1
70
 
 M
21
3 
 M
20
1 
 M
17
0 
 P2
09
 
 M
9 
 C
T
 
 D
E
 
 D
 
 E
 
 FT
 
 G
 
 I  J  K
-T
 
 T
G
T
T
T
T
G
C
A
G
A
G
A
G
C
T
T
G
G
A
 
 G
C
A
T
A
C
T
T
G
C
C
T
C
C
A
C
G
A
C
T
 
 T
T
C
T
C
C
G
T
C
A
C
A
G
C
A
A
A
A
A
T
G
 
 C
C
T
C
C
T
G
T
G
C
C
T
C
T
T
T
C
A
G
A
 
 G
G
C
C
A
T
A
T
A
A
A
A
A
C
G
C
A
G
C
A
 
 TA
T
G
C
AT
T
T
G
T
T
G
A
G
TA
TA
T
G
T
C
 
 T
T
G
C
A
G
C
T
C
T
T
A
T
T
A
A
G
T
T
A
T
G
 
 T
A
G
T
C
A
A
G
A
A
G
G
C
A
G
A
A
T
A
G
C
 
 G
C
A
G
C
A
T
A
T
A
A
A
A
C
T
T
T
C
A
G
G
 
 20
 
 20
 
 21
 
 20
 
 20
 
 23
 
 21
 
 21
 
 21
 
 T
G
A
C
T
G
T
T
C
A
G
T
T
T
T
A
T
T
C
C
A
C
A
A
A
 
 C
C
A
G
G
A
G
C
T
C
A
C
A
G
T
C
A
C
A
A
 
 A
T
G
C
A
A
A
A
G
G
A
G
A
A
G
G
A
C
A
A
G
A
 
 A
C
A
G
C
A
G
C
A
A
G
C
A
G
G
T
C
T
T
T
 
 T
G
A
A
T
G
G
C
A
A
A
T
T
G
A
T
T
C
C
A
 
 G
T
T
C
T
G
A
A
T
G
A
A
A
G
T
T
C
A
A
A
C
G
 
 T
A
A
A
C
T
T
G
C
C
A
A
T
T
A
C
T
T
T
C
A
A
C
 
 G
T
A
A
G
G
T
A
T
A
T
T
A
C
T
G
A
A
T
C
C
A
C
 
 A
A
A
A
C
C
T
A
A
C
T
T
T
G
C
T
C
A
A
G
C
 
 25
 
 20
 
 22
 
 20
 
 20
 
 22
 
 23
 
 23
 
 21
 
 15
0 
 17
3 
 18
6 
 24
3 
 20
8 
 32
6 
 16
7 
 29
9 
 34
0 
 C
/
T
 
 G
/
A
 
 T
/
C
 
 G
/
A
 
 T
/
C
 
 G
/
T
 
 A
/
C
 
 T
/
C
 
 C
/
G
 
 0.
22
 
 0.
22
 
 0.
22
 
 0.
5 
 0.
34
 
 0.
22
 
 0.
5 
 0.
5 
 0.
5 
 M
ul
tip
le
x 
I 
 M
9 
 M
23
1 
 T
at
 
 M
17
5 
 M
45
 
 M
20
7 
 M
19
8 
 M
34
3 
 K
T
 
 N
 
 N
1c
 
 O
 
 P  R
 
 R
1a
1a
 
 R
1b
 
 G
C
A
G
C
A
T
A
T
A
A
A
A
C
T
T
T
C
A
G
G
 
 C
C
T
A
T
T
A
T
C
C
T
G
G
A
A
A
A
T
G
T
G
G
 
 G
A
C
T
C
T
G
A
G
T
G
T
A
G
A
C
T
T
G
T
G
A
 
 T
A
A
A
C
T
C
T
C
T
G
A
A
T
C
A
G
G
C
A
C
A
T
G
 
 G
A
G
A
G
A
G
G
A
T
A
T
C
A
A
A
A
A
T
T
G
G
 
 C
T
A
T
G
G
G
G
C
A
A
A
T
G
T
A
A
G
T
C
 
 A
T
T
C
C
A
G
T
C
A
T
G
A
T
G
A
G
G
T
G
G
 
 T
C
T
G
A
T
T
C
G
C
A
C
A
A
G
G
C
T
C
 
 21
 
 22
 
 22
 
 24
 
 22
 
 20
 
 21
 
 19
 
 A
A
A
A
C
C
T
A
A
C
T
T
T
G
C
T
C
A
A
G
C
 
 G
A
A
T
G
G
T
G
G
C
C
A
G
A
G
T
C
T
T
T
 
 G
A
A
G
G
T
G
C
C
G
T
A
A
A
A
G
T
G
T
G
A
A
 
 C
T
A
C
T
G
A
T
A
C
C
T
T
T
G
T
T
T
C
T
G
 
 T
A
G
C
T
T
A
C
A
A
C
A
C
A
A
G
G
A
T
T
C
 
 T
G
A
A
G
G
A
A
A
A
G
T
G
G
A
G
T
C
T
G
 
 A
T
G
C
C
G
T
T
T
G
C
C
T
A
G
G
T
T
A
G
 
 C
A
C
C
T
T
T
G
T
C
C
T
C
T
T
G
C
T
C
 
 21
 
 20
 
 22
 
 21
 
 21
 
 20
 
 20
 
 19
 
 34
0 
 21
9 
 11
2  71
 
 22
9 
 12
9 
 13
8 
 19
4 
 C
/
G
 
 G
/
A
 
 T
/
C
 
 −5
 b
p 
(T
/A
) 
 G
/
A
 
 A
/
G
 
 C
/
T
 
 C
/
A
 
 0.
33
 
 0.
33
 
 0.
33
 
 0.
33
 
 0.
33
 
 0.
33
 
 0.
33
 
 0.
33
 
 M
ul
tip
le
x 
II
 
1359 SNaPshot® Minisequencing Analysis of Multiple Ancestry-Informative¼
  1.  Singleplex SBE reaction for control 
 Before running all SBE primers in one analysis, we recommend 
to run each SBE primer in a single extension reaction. 
Therefore, mix 1.5  μ L SNaPshot ® Multiplex Ready Reaction 
Mix (Applied Biosystems), 1.5  μ L of the cleaned up singleplex 
or multiplex PCR product, and SBE primer (see Table  2 ). Add 
ultrapure water to a total volume of 5  μ L (see Note 6). 
Thermocycling conditions are described in the subsequent sec-
tion of the multiplex SBE reaction. 
  2.  Multiplex SBE reaction 
 The multiplex SBE reaction is performed in a fi nal volume of 
5  μ L, consisting of 1.5  μ L SNaPshot ® M ultiplex Ready Reaction 
Mix (Applied Biosystems), 1.5  μ L cleaned up PCR product, 
SBE primers (see Table  2 ), and ultrapure water (see Note 7). 
Setting up the SBE reaction should be performed on ice or in 
a frozen rack and it should be fi nished within 20 min to avoid 
a higher background in the capillary electrophoresis  ( 19 ) . 
 3.5.  SBE Reaction
 Fig. 2.  Control of multiplex PCRs by gel electrophoresis (inverted image). Hyperladder ® V 
was used as a size marker. 
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 Cycle the SBE reaction with following conditions: 96°C 
for 10 s, 50°C for 5 s and 60°C for 30 s, for 25 cycles  ( 19 ) . 
 Not incorporated ddNTPs have to be removed to avoid unspecifi c 
dye blobs during capillary electrophoresis. Therefore, the SBE 
reaction is cleaned up with 1 U of shrimp alkaline phosphatase 
(USB) by incubating the thoroughly mixed reaction at 37°C for 
60 min and inactivating the enzyme at 85°C for 15 min  ( 19 ) . 
 To run the SNaPshot ® reaction, mix 15  μ L Hi-Di formamide and 
0.1  μ L Gene Scan 120 Liz/sample and apply 15  μ L of the mix to 
each well. Add 1  μ L of the purifi ed SBE sample and mix thor-
oughly (see Note 8). Denaturation prior to running the analyzer is 
not necessary. Default run module for SNPs was used as supplied 
for 36 cm capillaries either with POP-4 or POP-7. 
  1.  Genemapper ® analysis 
 For analyzing the SNaPshot ® results, it is useful to create a 
panel with the appropriate bin set of a multiplex to allow for an 
automated allele calling  ( 20 ) . The singleplex SBE runs should 
be used for setting up the bins. 
  2.  Data interpretation 
 After evaluating the SNP alleles, the haplogroup of a test sample 
can be determined. An example is shown in Fig.  3 . In the fi rst 
multiplex (see Fig.  3a ), only the generic markers CT-M168, 
FT-M213, and KT-M9 are mutated (derived state), thus a further 
testing was required. In Multiplex II ( see Fig.  3b ), the SNPs 
P-M45, R-M207, and R-M343 show the derived state, which 
leads to the assignment of the sample to haplogroup R1b with the 
fi nal marker M343. Searching the actual YHRD release 34, 707 
R1b chromosomes, out of 6,246 reference samples with haplo-
group information, can be found in 31 of total 88 worldwide 
populations. The geographical distribution indicates the highest 
frequency of R-M343 in the Western and Central part of Europe 
(compare Fig.  4 ), which is in agreement with the published litera-
ture  ( 10,  21– 23 ) . The frequent occurrence in South America can 
lead back to European emigration. The most probable geographic 
origin of the ancestors of the tested man is therefore Europe. 
 
  1.  Be careful with using primers or complete assays, which have 
already been published. Always check for correctness of the primer 
sequences by using BLAST and if the primers are consistent with 
your requirements. Check the primer sequences, amplicon length, 
annealing temperature, and characteristics of the SNP. 
 3.6.  SBE Reaction 
Cleanup
 3.7.  Capillary 
Electrophoresis 
(Avant 3130/3130xl)
 3.8.  Data Analysis
 4.  Notes
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  2.  Consider that with changing the direction of the sequencing 
primer, the nucleotides of the ancestral and derived status of 
the SNP are changing as well. 
  3.  In our experiments, poly (dC) tails showed a tendency to 
degrade rapidly and generate incorrect elongations. 
  4.  For setting up a new assay, primers should be tested with 
equal concentrations (e.g., 0.3  μ M/primer). Afterwards, the 
primer concentrations should be adjusted to their perfor-
mance, aiming that all amplicons show similar intensity in 
the gel electrophoresis. 
  5.  If there are samples without visible amplifi cation products, 
nevertheless it is worthwhile to go on in the protocol. The 
electrophoresis is not sensitive enough to image weak products, 
that is why in some of the cases you will gain a SNP profi le. 
 Fig. 3.  Electropherograms of the test sample assigned to haplogroup R-M343. ( a ) Multiplex I shows three SNPs with 
derived state—M168, M213, M9. ( b ) Multiplex II shows four markers with derived state—M9 (like in Multiplex I), M45, 
M207, and M343. The  gray boxes above the peaks indicate the size range of both allele-specifi c primers of a SNP according 
to the bins.  Peak colors indicate the didesoxynucleotide (ddNTP) which annealed to the according SBE primer.  Colors of the 
bins match with the allele-specifi c nucleotide they are calling. Labels give information about the branch that the SNP is 
defi ning, the name of the SNP, the allele status of the SNP, the RFU signal, and the length of the primer. 
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  6.  Using the SBE singleplex analyses, the factual length of the 
primers can be checked in CE and compared to the theoretical 
one. Especially short SBE primers between 17 and 30 nucleotides 
can show enormous differences. 
  7.  The fi rst multiplex SBE attempt with all primers should be done 
with equal primer concentrations (e.g., 0.2  μ M). Subsequently, 
the concentrations can be fi nally adapted. A well-balanced 
multiplex increases the chance to gain results even from 
compromised samples. 
  8.  Depending on the sensitivity of the Genetic Analyzer, the required 
quantity of the size standard and the sample have to be adjusted. 
If peaks in CE are higher than 5,000 RFU, cleaned up SBE prod-
ucts can be diluted to allow for a clear determination of alleles. 
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 Fig. 4.  Search result and map of the geographical distribution of haplogroup R-M343 (R1b) in the Y Chromosome Haplotype 
Reference Database (YHRD) ( http://www.yhrd.org ).  Red boxes depict geopositions where the questioned haplogroup 
matched. The proportion of  red/blue in a single box correlates with the relative frequency.  Blue boxes indicate geopositions, 
where haplotypes with SNP information are available, but the questioned haplogroup does not occur. 
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 Chapter 10 
 Capillary Electrophoresis of 38 Noncoding Biallelic 
Mini-Indels for Degraded Samples and as Complementary 
Tool in Paternity Testing 
 Rui  Pereira and  Leonor  Gusmão  
 Abstract 
 This work describes the main advantages and the steps involved in the optimization of a multiplex system 
able to characterize 38 noncoding biallelic  Insertion Deletion Polymorphisms (Indels). With this methodology, 
all markers are amplifi ed in a single PCR, using short amplicons (up to 160 bp) in order to improve its 
performance in degraded samples. Alleles are easily detected using capillary electrophoresis. 
 The Indel multiplex typing strategy here described has the same desirable characteristics of forensic SNP 
assays, including genetic markers (a) with low mutation rates, increasing their usefulness in some kinship cases 
where few or single incompatibilities can be explained by mutation, and (b) that can be typed using a short 
amplicon strategy, increasing their usefulness in cases where degraded samples are available. Moreover, this 
approach uses simple and well-established methodologies already applied in forensic STR assays. 
 Key words:  Insertion deletion polymorphism ,  Indel ,  DIP ,  Multiplex PCR ,  Human identifi cation , 
 Paternity testing ,  Forensic genetics 
 
 The human DNA sequence encompasses distinct types of variation, 
each presenting desirable characteristics to address different 
biological questions. For example, STRs present high degrees of 
length polymorphism in human populations and are predominantly 
multiallelic. Because they are highly diverse, this type of genetic 
markers is very informative and widely used in population and 
forensic genetics. Conversely, mutational events such as nucleotide 
substitutions, insertions, or deletions occur with a very low frequency, 
possibly only once in the recent evolutionary past of modern 
humans. By their nature, these mutations create polymorphisms 
 1.  Introduction
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with two allelic states (ancestral and mutant) and are called binary 
or biallelic polymorphisms. These genetic markers present lower 
genetic diversity than STRs, which is a disadvantage regarding 
forensic applications, but they also have several desirable features as 
genetic markers in this fi eld. The usefulness of SNPs in forensics is 
well patent in many publications (e.g.,  see ref.  ( 1– 6 ) ) or in other 
chapters of this book, and here we dedicate special attention to 
insertion deletion (Indel) polymorphisms, particularly in the analy-
sis of degraded samples and as complementary tool in paternity 
testing. 
 The studies by Weber et al.  ( 7 ) and Mills et al.  ( 8 ) contributed 
fundamentally to our knowledge on Indel polymorphisms and 
highlighted the utility of Indels for most genetic studies given their 
abundance in the genome and ease of analysis. In 2002, Weber 
et al.  ( 7 ) identifi ed and characterized ~2,000 human biallelic Indels 
with different length variation and measured the allele frequencies 
in Europeans, Africans, Japanese, and Native Americans. In asso-
ciation with this work, Marshfi eld Clinic created an Insertion/
Deletion Polymorphism online database ( http://www.marshfi eldclinic.
org/mgs ) including information regarding the type of polymor-
phism (biallelic or multiallelic), allele length differences, amplifi ca-
tion primers, position in the chromosome, as well as allele 
frequencies in different population groups. Later in 2006, an initial 
map of Indel variation in the human genome was reported  ( 8 ) , 
comprising more than 415,000 polymorphisms. According to 
Mills et al.  ( 8 ) , insertion/deletions represent ~16% of all human 
DNA polymorphisms and are widely spread throughout the 
genome, with an average density of one Indel per 7.2 kb. Moreover, 
a particular class of apparently random DNA sequences comprises 
about 41% of all Indels and shows a wide range of allele length 
variation, from 2 up to ~10 kb, with nearly 99% being under 100 bp 
 ( 8 ) . Of great interest as genetic markers, these small length Indels 
are abundant in the human genome and amenable to simple analysis 
through PCR amplifi cation and electrophoresis, or using method-
ologies already developed for SNPs  ( 7– 9 ) . 
 Another important aspect is that Indel data from these and 
other studies have been compiled in the free access online database 
dbSNP from NCBI (under the MARSHFIELD and DEVINE_
LAB submitter handle, respectively, for refs.  ( 7 ) and  ( 8 ) ), which 
enables a much easier access to the available information. 
 In the last few years, there was an increasing interest of the 
scientifi c community in the use of Indel polymorphisms in differ-
ent research projects, as for example when studying the genetic 
structure of human populations  ( 10– 12 ) , as ancestry informative 
markers  ( 9,  13 ) , in X-chromosome specifi c panels  ( 14– 16 ) , and 
more recently in human identifi cation studies  ( 17,  18 ) . 
 1.1.  Insertion Deletion 
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 Considering the above-mentioned aspects, it becomes clear that 
some types of Indels combine interesting characteristics of other 
genetic markers commonly used in forensics (STRs and SNPs):
 Indels are abundant and widely distributed along the genome.  –
 The genotyping of small Indels is relatively easy and inexpen- –
sive with a simple PCR and electrophoresis approach. 
 Small Indels can be analyzed in short amplicons, improving  –
successful amplifi cation of degraded DNA and, in the other 
hand, opening perspectives for good multiplexing levels. 
 Small Indels are also suitable for automation and analysis with  –
high-throughput technologies. 
 Indels show very low mutation rates (occurring at low frequency,  –
the polymorphism most likely derives from a single nonrecurrent 
mutation event in the evolutionary time of modern humans). 
 Many Indels have signifi cant divergences in allele frequencies  –
among geographically separated population groups (therefore, 
they can be used as Ancestry Informative Markers). 
 Some of these characteristics are the basis behind the recent inter-
est in Indels for forensic applications. The most relevant is the pos-
sibility of analysis in much shorter amplicons when compared with 
standard STRs. This was defi nitely the main reason for introducing 
SNPs in forensic practice, aiming to overcome the major drawback 
of STR analysis: its weak performance with highly degraded sam-
ples due to the long template DNA needed for amplifi cation. In 
this work, we focus on mini-Indels with small length variation 
between alleles (2–5 bp), which likewise SNPs can be analyzed in 
very short amplicons (under 160 bp) thus improving the amplifi ca-
tion success with challenging DNA  ( 17,  19 ) . The advantage of this 
approach is that the detection of alleles is accomplished simply by 
fragment separation with capillary electrophoresis, conversely to 
laborious SNP typing protocols. In summary, Indels ideally allow 
combining a short amplicon strategy (see Fig.  1a ) with a simple 
analytic workfl ow ( see Fig.  1b ). 
 In paternity or other biological relationship testing situations, it 
can happen that few mendelian transmission incompatibilities are 
observed for STRs; and it is necessary to compare the probability of 
the different hypothesis assuming exclusion vs. the occurrence of a 
mutation. Nevertheless, after that assessment, the conclusion can 
sometimes remain unclear or need stronger support. Due to the 
high mutation rates of most STRs, this is not an uncommon sce-
nario in paternity testing. In such cases, the complementary study 
of a large set of Indels or SNPs showing low mutation rates and 
therefore being more stable than microsatellites can help circumvent 
diffi culties  ( 4,  5,  19 ) . Characterizing a high number of markers can 
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unveil further transmission incompatibilities, favoring the exclusion 
hypothesis or, in case of inclusion, increase the paternity index 
values to more confi dent levels supporting paternity (see  Note 1 ). 
 The multiplex described in the present work includes 38 Indels 
that were previously found to be polymorphic and very informative 
in human population groups from Africa, Europe, and East Asia, 
with an average heterozygosity of 0.45 for the set. No statistically 
signifi cant deviations from Hardy–Weinberg expectations were 
found in the studied populations and linkage disequilibrium tests 
also did not reveal statistically signifi cant allelic association between 
the different loci pairs in the same populations  ( 17 ) . 
 Regarding forensic effi ciency parameters, the 38 Indel set 
proved to be highly informative in African, European, and East 
Asian populations, with accumulated random match probabilities 
ranging in orders of magnitude from 10 −14 to 10 −15 and accumu-
lated discrimination power reaching 99.999999999994% in the 
less diverse group. Despite being less powerful than standard STR 
kits (when full profi les are obtained), the Indel set appears to be 
enough informative in most forensic cases. Even more, it exceeds 
the effi ciency parameters of the mini-STR kit Minifi ler (Applied 
Biosystems), which likewise the mini-Indel multiplex is indicated 
to the analysis of highly degraded samples  ( 17 ) . 
 The analytical workfl ow of the Indel assay is very simple and, 
in comparison to the most widely available SNP typing methods, 
reduces considerably the steps needed to genotype a large set of 
informative biallelic markers for identifi cation purposes. This is 
advantageous in terms of time and cost-effectiveness of the assay, 
and more importantly, it minimizes manipulation and risks of con-
tamination or samples’ mix up. Furthermore, the use of the same 
methodology as in standard STR genotyping makes this assay easy 
to implement in any forensic laboratory. 
 1.5.  General 
Considerations 
About the Indel Assay
 Fig. 1.  Insertion deletion (Indel) polymorphism analysis in short amplicon and simple workfl ow: ( a ) Indels, like SNPs, are 
amenable to analysis in much shorter amplicons than standard STRs or even the re-engineered mini-STRs; ( b ) Indels, like 
STRs, can be easily typed with a PCR and capillary electrophoresis, conversely to the laborious protocol most widely used 
in forensic SNPs typing (SNaPshot; Applied Biosystems). 
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  1.  A number of free access online databases and computer programs 
were used in the selection of Indel markers and development of 
the multiplex here described (see Table  1 for details). 
 2.  Materials
 Table 1 
 Online databases and computer programs used in developing the Indel multiplex 
 Diallelic insertion/deletion polymorphisms database from Marshfi eld Clinic Mammalian Genotyping 
Service 
  http://www.marshfi eldclinic.org/mgs/ 
 Contains information regarding the type of polymorphism (biallelic or multiallelic), validation status, 
allele length differences, amplifi cation primers, position in the chromosome, and allele frequencies 
in different population groups 
 dbSNP or EntrezSNP 
  http://www.ncbi.nlm.nih.gov/projects/SNP/ or  http://www.ncbi.nlm.nih.gov/snp 
 dbSNP is the NCBI database of genetic variation. It is now incorporated into NCBI’s Entrez system 
and can be queried using the same approach as the other Entrez databases such as PubMed and 
GenBank. dbSNP also includes Indels (or DIPs) and integrates data from various submitters. 
Contains general information about the polymorphism, similarly to the Marshfi eld database, but 
with extra features and search possibilities. Using custom queries or the “Limits” tab allows 
restricting your search by chromosome, SNP class, and other criteria (such as heterozygosity, etc.), 
for example, to select markers with forensic relevant characteristics 
 UCSC Genome Browser’s “Get DNA in Window” tool 
  http://genome.ucsc.edu/cgi-bin/hgGateway 
 The “Get DNA in Window” tool included in UCSC Genome Browser allows obtaining a DNA 
sequence provided the chromosome coordinates. From inside of your target assembly, set the region 
and submit. Then click on “DNA” in the top blue navigation bar. Of interest is the possibility of using 
extended case/color options to highlight relevant annotations in that sequence, for example, all SNPs 
included in dbSNP. This will allow knowing polymorphic positions to avoid during primer design 
 Primer 3 
  http://frodo.wi.mit.edu/primer3/ 
 BatchPrimer3 
   http://probes.pw.usda.gov/batchprimer3/index.html 
 Primer 3 is a primer design program available online. It allows designing primers for one input 
sequence following the parameters indicated by the user. If the sequence includes lowercase letters 
and the option Lowercase masking is checked, candidate primers having lowercase letter exactly at 
3 ¢ end are rejected 
 BatchPrimer3 is a comprehensive web primer design program to develop different types of primers in 
a high-throughput manner. It uses the same algorithm as Primer 3 and has the advantage of 
allowing primer design for a batch of sequences. This can be useful when designing primers for a 
high number of markers 
(continued)
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Table 1
(continued)
 Autodimer 
  http://www.cstl.nist.gov/biotech/strbase/AutoDimerHomepage/AutoDimerProgramHomepage.htm 
 Autodimer is a screening tool for primer-dimer and hairpin structures. The program evaluates the 
possible occurrence of secondary structures between the primers included in the input fi le. It gives 
a schematic representation, Tm and  Δ G predictions for the possible interactions. It is of particular 
interest when designing large multiplexes to avoid strong interactions between any primers and 
assure a successful amplifi cation of all markers 
 BLAST 
  http://www.ncbi.nlm.nih.gov/blast/ 
 BLAT 
   http://genome.ucsc.edu/cgi-bin/hgBlat 
 BLAST and BLAT are online tools to perform homology searches against sequences deposited in the 
databases. They allow querying PCR primers to know if other similar sequences are found in the 
genome, indicating possible mispriming sites that could reduce the effi ciency of the PCR amplifi cation 
 UCSC Genome Browser’s In-Silico PCR tool 
  http://genome.ucsc.edu/cgi-bin/hgPcr 
 In-Silico PCR tool, included in UCSC Genome Browser, searches a sequence database with a pair of 
PCR primers using an indexing strategy for fast performance. It allows choosing a template genome 
sequence and test in-silico for the PCR products which would be obtained with a given pair of 
primers. In summary, it permits a quick check for the possible occurrence of unspecifi c products in 
the PCR, considering a maximum product size. The default maximum product size is 4,000 bp, but 
it can be defi ned by the user 
  2.  Unlabeled and dye-labeled primers. In order to increase the 
multiplexing level of the technique, a fi ve dye chemistry was 
used. In this particular case, the forward primers were labeled 
using one of the fl uorochromes 6-FAM™ (blue), VIC ® (green), 
NED™ (yellow), or PET ® (red) (Applied Biosystems). 
Delivered lyophilized primers were brought to 100  μ M using 
molecular grade water and stored in the dark at −20°C. 
Information on primer sequences is available upon request. 
  3.  Primer mix working solution containing all primers at 1  μ M, 
except for markers rs2308137 (2  μ M) and rs3047269 (3  μ M). 
A stock solution for a large number of reactions can be prepared 
and then divided in smaller aliquots (of volume adequate to 
process the number of reactions desired per PCR) which are 
stored in the dark at −20°C (see  Note 2 ). 
  4.  QIAGEN Multiplex PCR Kit (Qiagen). 
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  5.  Hi-Di™ Formamide (Applied Biosystems). 
  6.  GeneScan™ 500 LIZ ® Size Standard (Applied Biosystems). 
 Equipment required:
 Capillary Electrophoresis instrument supporting fi ve dye  –
chemistry (e.g., ABI 310, 3100, or 3130 Genetic Analyzers; 
Applied Biosystems). 
 Fragment analysis software (e.g., GeneMapper ID v3.2 or  –
GeneMapper v4.0; Applied Biosystems). 
 To prevent cross-contaminations, it is recommended that one 
should use disposable gloves and aerosol-resistant pipette tips. 
Pre- and post-PCR samples, reagents, and instruments should be 
used and stored separately. Formamide is potentially hazard (irritant 
and teratogen) and should be handled accordingly. 
 
 The method described was previously optimized by Pereira et al. 
 ( 17 ) . Here, it is presented an overview of the stages involved in the 
development of the Indel multiplex and full details on the geno-
typing protocol. 
 The Indel markers were chosen from a pool of ~4,000 biallelic 
Indels initially characterized by  Weber et al.  ( 7 ) and included in the 
Marshfi eld Diallelic Insertion/Deletion Polymorphisms database 
website ( http://www.marshfi eldclinic.org/mgs/ ). Having in mind 
their application in genetic identifi cation studies in forensic con-
text, the markers were selected to fulfi ll the following criteria:
 Autosomal, biallelic Indels.  –
 Minimum Allele Frequency   – ³ 0.25 in European, African, and 
Asian population groups. 
 Average Heterozygosity   – ³ 0.40. 
 Allele length variation of 2–5 bp.  –
 Localization in intergenic regions (see Note –  3). 
 In summary, the aim was fi nding noncoding biallellic Indels 
amenable to analysis in short amplicons, with an expected high 
degree of polymorphism in most human population groups and 
widely spread throughout the genome. 
 The stages involved in constructing the Indel multiplex are sum-
marized in Fig.  2 (see ref.  ( 17 ) for details). Here the workfl ow is 
reviewed highlighting relevant aspects to consider when construct-
ing large Indel multiplexes for forensic applications ( see Table  1 for 
 3.  Methods
 3.1.  Selecting 
Indels for Human 
Identifi cation 
Purposes
 3.2.  Constructing 
the Multiplex Assay
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details on online databases and computer programs used; on the 
topic “constructing multiplex assays”  see also ref.  ( 20 ) ). 
 The fl anking sequences (±150 bp) of the preselected Indels, 
including annotations of sequence variants within that region, were 
obtained using the “Get DNA in Window” tool included in UCSC 
Genome Browser (human Mar. 2006 assembly; table snp128). 
This template was used for primer design, and knowing polymor-
phic positions helped avoiding primer-binding problems and 
potential null alleles. Furthermore, fl anking sequences showing 
length polymorphisms other than the target, as well as mononucle-
otide tracts ( ³ 7 bp), were curated in order to prevent its inclusion 
in the amplicon range and get unexpected length variations. 
 Primers were designed with Primer3 using parameters aiming 
short amplicon sizes (60–160 bp), optimum Tm around 60°C, 
and 45% as minimum CG content. After this, all primer pairs were 
checked for nonspecifi c hybridizations in other genome regions 
using NCBI’s BLAST, and markers with primers presenting 100% 
homology in unexpected locations were excluded. 
 At this stage, it was necessary to multiplex as many Indels as 
possible, having simultaneously in mind several aspects of forensic 
interest:
 Secondary structures screening between primers, allowing an  –
effi cient coamplifi cation. 
 Balanced distribution throughout the human genome, covering  –
all autosomes. 
 Fig. 2.  Schematic representation of the different stages involved in the development of 
Indel multiplexes: from marker selection to PCR multiplex setup. 
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 Position along the chromosomes, avoiding Linkage disequilibrium  –
between markers at the same chromosome. 
 Multicolor dye-labeling and distribution of the markers according  –
to the expected amplicon sizes so that they can be typed in a 
single electrophoretic run. 
 At the end of the process, 38 Indels distributed across the 22 
human autosomes ( see Fig.  3 ) were successfully multiplexed in a 
single genotyping reaction. All markers were organized by the 
expected amplicon length and assigned to four different dye-label-
ing fl uorochromes, enabling a genotyping analysis via a single PCR 
and electrophoresis. When necessary, tails of random nucleotides 
were added to the designed primers, aiming to adjust the fi nal 
amplicon size ( see  Note 5 ). 
 The 38 Indels included in the assay are presented in Table  2 . 
 The amplifi cation of the 38 Indels is performed in a single multi-
plex PCR using 1× Qiagen Multiplex PCR kit (Qiagen), 0.1  μ M of 
all primers, except rs2308137 (0.2  μ M) and rs3047269 (0.3  μ M), 
and 0.3–5 ng of genomic DNA in a 10  μ L fi nal reaction volume 
 ( 17 ) . In Table  3 , volumes are indicated for all PCR reagents per 
reaction, according to the concentration of stock solutions. If a 
different fi nal volume is used, adjust all reagents accordingly. 
 The use of a negative control and a positive control sample 
with known genotype is recommended in every PCR. As reference, 
the genotypes of 9947A and 9948 human cell lines DNA samples 
are presented in Table  4 . 
 Thermal cycling conditions are: initial incubation at 95°C for 
15 min; followed by 10 cycles at 94°C for 30 s, 60°C for 90 s, and 
 3.3.  Loci Information
 3.4.  Multiplex PCR 
Amplifi cation
 Fig. 3.  Distribution of the 38 Indel polymorphisms along the 22 human autosomes. 
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 Table 2 
 Indel polymorphisms included in the multiplex 
 Int. 
code  MID  rs Number  Chromosome 
 Position (bp) 
 Alleles 
 Amplicon 
size (S–L)  Build 36.3  Build 37.1 
 B1  MID-2719  rs34541393  20  30165066  30701405  −/AACT  57–61 
 B2  MID-185  rs16624  2  234681130  235016391  −/GT  65–67 
 B3  MID-1493  rs2307689  19  48896180  44204340  −/TTC  74–77 
 B4  MID-2946  rs35769550  8  76681235  76518680  −/TGAC  89–93 
 B5  MID-1504  rs2307700  22  25120901  26790901  −/TCAC  101–105 
 B6  MID-520  rs140809  10  6027167  5987163  −/CAA  115–118 
 B7  MID-2305  rs3047269  1  161077452  162810828  −/CTGA  126–130 
 B8  MID-3221  rs33972805  11  125794082  126288872  −/CT  135–137 
 B9  MID-2698  rs33917182  20  11643625  11695625  −/CA  142–144 
 B10  MID-116  rs16402  9  38396788  38406788  −/TTAT  150–154 
 G1  MID-785  rs1610871  5  171020572  171087970  −/TAGG  61–65 
 G2  MID-1151  rs2067238  12  113772931  115288548  −/GCT  71–74 
 G3  MID-1209  rs2067294  9  70504241  71314421  −/CTT  80–83 
 G4  MID-1514  rs2307710  6  47929222  47821263  −/AGGA  92–96 
 G5  MID-2050  rs2308242  3  8591709  8616709  −/CT  106–108 
 G6  MID-1384  rs2307580  9  104626014  105586193  −/AATT  120–124 
 G7  MID-743  rs1160956  5  65414216  65378460  −/AGA  128–131 
 G8  MID-3097  rs34511541  18  34677042  36423040  −/CTCTT  143–148 
 G9  MID-1782  rs2307978  7  83121850  83283913  −/GA  156–158 
 Y1  MID-2648  rs3051300  17  10076666  10135941  −/GTAT  63–67 
 Y2  MID-2890  rs10629077  21  30294208  31372337  −/AT  74–76 
 Y3  MID-3277  rs10688868  11  258180  268180  −/CT  81–83 
 Y4  MID-1120  rs2067208  16  83139788  84582287  −/GCCAG  93–98 
 Y5  MID-1383  rs2307579  1  245878706  247812083  −/ATG  104–107 
 Y6  MID-1824  rs2308020  15  51268809  53481517  −/TT  127–129 
 Y7  MID-3114  rs3080855  18  21507205  23253207  −/AATT  133–137 
 Y8  MID-834  rs1610919  12  14801263  14909996  −/AT  142–144 
 Y9  MID-1643  rs2307839  6  117200251  117093558  −/GA  152–154 
 R1  MID-1945  rs2308137  6  149655891  149614198  −/GA  61–63 
 R2  MID-2592  rs36040336  19  1353662  1402662  −/AT  65–67 
 R3  MID-649  rs1160886  10  54112392  54442386  −/ACT  75–78 
 R4  MID-1830  rs2308026  4  119404855  119185407  −/CA  83–85 
 R5  MID-1330  rs2307526  5  5178112  5125112  −/ACAC  95–99 
 R6  MID-3220  rs34811743  11  30134266  30177690  −/TG  108–110 
 R7  MID-1997  rs2308189  14  28106508  29036757  −/AACTA  119–124 
 R8  MID-3031  rs5895447  8  138489776  138420594  −/CA  128–130 
 R9  MID-1979  rs2308171  13  43778155  44880155  −/TCTG  135–139 
 R10  MID-2806  rs35605984  21  14556736  15634865  −/TAAAG  151–156 
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 Table 3 
 PCR amplifi cation mix 
 Water  3  μ L 
 Qiagen Multiplex PCR master mix (2×)  5  μ L 
 Primer mix (10×)  1  μ L 
 Template DNA 0.3–5 ng/ μ L  1  μ L 
 Total reaction volume  10  μ L 
 Note : To prevent contamination, it is recommended 
to use gloves and pipette tips with fi lter 
72°C for 60 s; plus 20 cycles at 94°C for 30 s, 58°C for 90 s, and 
72°C for 60 s (see  Note 6 ); and a fi nal extension at 72°C for 60 min 
( see  Note 7 ). 
 PCR products are prepared for capillary electrophoresis by adding 
1  μ L of each amplifi ed product to 10  μ L Hi-Di™ Formamide 
(Applied Biosystems) and 0.3  μ L of internal size standard 
GeneScan™ 500 LIZ ® (Applied Biosystems). 
 3.5.  Analysis 
of Amplifi ed Products
 Table 4 
 Genetic profi les for the reference samples 9947A and 9948 
 DNA 
marker 
 9947A 
 1  2  3  4  5  6  7  8  9  10 
 B  SS  SL  SL  SL  SL  LL  SL  LL  SL  SL 
 G  SL  SL  SL  LL  SL  SL  SS  SL  LL 
 Y  LL  LL  SL  SL  SL  SL  SL  SL  SS 
 R  SS  SL  SL  LL  LL  SS  SL  SL  SL  SL 
 DNA 
marker 
 9948 
 1  2  3  4  5  6  7  8  9  10 
 B  SL  SS  SS  SS  SL  SL  SL  SL  SL  LL 
 G  LL  SL  LL  SL  LL  SS  SS  SL  LL 
 Y  SL  SS  LL  LL  LL  SL  SL  SL  SL 
 R  SL  SS  LL  SL  SL  SS  SL  SS  LL  SL 
 S Short allele;  L long allele 
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 Separation and detection are performed by a capillary electro-
phoresis system. During the optimization of the present method, 
an Applied Biosystems 3130 Genetic Analyzer was used, with G5 
fi lter set and Performance Optimized Polymer 7 (POP-7™; Applied 
Biosystems). Analysis conditions were: Module: “FragmentAnalysis 
36_POP7”; Oven temperature: 60°C; Injection Voltage: 1.2 kV; 
Injection Time: 16 s; Run Voltage: 15 kV; Run time: 1,200 s. Data 
collected are analyzed using a multicomponent matrix ( see  Note 8 ). 
 Finally, the electropherograms are visualized with a fragment 
analysis software and fragment sizes are determined in order to 
genotype the samples. In this case, GeneMapper ID v3.2 or 
GeneMapper v4.0 (Applied Biosystems) were used. It is recom-
mended to create genotyping panels including all markers with the 
respective allelic bin sets in order to automate allele calling and 
facilitate the genotyping of a large number of samples. The genotype 
data can be easily exported to text documents for further treatment 
and databasing. 
 An example electropherogram is shown in Fig.  4 . 
 Fig. 4.  Example of an electropherogram of the 38 Indel multiplex. 
 
15310 Capillary Electrophoresis of 38 Noncoding Biallelic Mini-Indels…
 Depending on the particular characteristics of a case, there are 
important aspects to consider when selecting the best analytical 
approach, namely the amount of sample available for analysis, the 
DNA quality (good quality or highly degraded?), and/or the 
presence of inhibitors. Some recommendations/tips are suggested 
that might help improving the results, particularly when dealing 
with challenging DNA:
 In cases of very low DNA quantity or when analyzing highly  –
degraded samples (low template DNA), test increasing the total 
number of PCR cycles to 32 and/or increasing the primer mix 
concentration to 1.5 or 2× in the PCR reaction (see Note 9). 
 Using larger fi nal volumes in the PCR reaction (e.g., 25   – μ L) may 
also improve the results when analyzing highly degraded samples. 
 In the presence of PCR inhibition, if enough DNA is available  –
use dilution series of the original sample (e.g., 1:2, 1:5, 1:10; 
1:20; 1:50, 1:100). While diminishing the quantity of template 
DNA in the reaction, it also dilutes possible inhibitors, which is 
sometimes the only way to obtain a successful amplifi cation. 
 Occasionally, dye artifacts (“dye-blobs”) can appear in electro-
pherograms. Such artifacts are usually due to a poor quality of the 
primers, produced by an incomplete fl uorochrome attaching during 
manufacturing  ( 20 ) . Also, the primers can suffer degradation with 
time and freeze – thaw cycles, leading to a reduced performance 
and the presence of more residual dye artifacts. Minor “dye-blobs” 
are frequently observed in electropherograms, but usually do not 
interfere with genotyping. Nevertheless, sometimes they can appear 
in regions with possible alleles thus hindering genotyping. In these 
cases, a complementary purifi cation step prior to electrophoresis 
(e.g., with Sephadex™ G-50 DNA Grade; GE Healthcare) can 
improve considerably the overall electropherogram by eliminating 
exceeding primers and dye residues. 
 If electropherograms present unusually strong peaks, with pull-
ups that can be confused with alleles and/or interfere with the internal 
size standard alignment, testing one of the following is recommended: 
further dilute the DNA samples; reduce the number of PCR thermal 
cycles (see  Note 6 ); and apply less PCR product or use less injection 
time in the capillary electrophoresis system. Good results are usually 
obtained within the range of 1,000–5,000 rfu, in average. 
 
  1.  The simultaneous use of STRs and Indels in calculating PI 
must consider the LD status between the markers under study. 
Therefore, at least for markers at the same chromosome, 
an LD test must be performed in the reference population to 
 3.6.  Additional 
Considerations
 4.  Notes
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discard possible associations between markers (and therefore 
safely use the product rule in PI calculations); otherwise, linked 
loci pairs must be treated as haplotypes. 
  2.  Dye-labeled primers are light-sensitive and frequent 
freeze – thaw cycles can accelerate breakdown of the dye attach-
ment to the oligonucleotide and cause an overall deterioration 
of the primers leading to weaker performance with time. 
  3.  The noncoding Indels localized only in intergenics regions 
cannot be found directly in dbSNP. In order to do that, fi rst 
query the Entrez SNP database for all human Indels fulfi lling 
the criteria: previously validated by assessing allele frequencies, 
heterozygosity values between 0.40 and 0.50, mapping only 
once in the human genome, and submitted to the database 
under the MARSHFIELD handle. Afterwards, obtain the 
intragenic Indels (obtained by checking-in all  Function Class 
search fi eld limits “coding nonsynonymous, intron, coding 
synonymous, locus region, mrna utr, splice site”). Finally, go to 
the “History” tab and subtract the results of the fi rst search minus 
the second (#1 NOT #2). This delivers a list of Indels located 
only in intergenic regions. To know more about searching for 
markers of forensic interest in Online databases,  see ref.  ( 21 ) . 
  4.  The fi nal stages in Fig.  2 (signaled with arrows) are intercon-
nected and the process runs somehow simultaneously: markers 
can be excluded for different reasons at different stages and 
there may be the possibility to rescue an old marker because its 
prior excluding reason no longer applies (e.g., marker A has 
confl icting primers with markers B, C, and D and is preliminarily 
excluded to keep these three; markers B, C, D, E are closely 
located in a chromosome and only one can be selected to avoid 
LD; Marker E is selected from the cluster, so Marker A can be 
rescued). The fi nal aim is obtaining the maximum markers in a 
single reaction and fulfi lling all criteria. 
  5.  More recently, we started to employ the Brownstein et al.  ( 22 ) 
“PIG tailing” approach which was originally developed to 
overcome genotyping problems created by the nonspecifi c 
adenylation of amplifi ed products by DNA polymerases, which 
generates confusing double peaks appearing in the electro-
pherogram (−A,+A). This strategy can be used aiming a dual 
function of adjusting amplicon sizes while at the same time 
homogenizing nontemplate adenylation of all products in 
order to obtain a uniform electropherogram. The unlabeled 
primers of amplicons that do not need mobility adjustments 
remain unchanged, or a G is added at the 5 ¢ end if there is not 
already a G in that position. In the cases requiring little mobil-
ity adjustments, a 5 ¢ tail GTTT or partial tails of the original 
sequences GTTTCTT or GTGTCTT are attached to the unla-
beled primer. 
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  6.  The number of thermal cycles can be adjusted for different 
input DNA, depending on the quality and/or concentration of 
the samples being processed. Samples with a good quantity/
quality DNA can provide well-balanced results with a total of 
27 cycles, avoiding unusually strong peaks and possible pull-
ups, and minimizing adenylation issues. On the contrary, when 
dealing with very low amounts of DNA (e.g., low copy num-
ber DNA) or highly degraded samples, the reaction can benefi t 
of using up to 32 cycles. 
  7.  Double peaks differing in a single bp (−A,+A) can appear due 
to an incomplete adenylation, usually when high amounts of 
DNA are present in the PCR reaction. In these cases, apart 
from reducing the amount of DNA, the fi nal extension step 
may be extended to 80 min in order to complete adenylation 
of the amplifi ed products. 
  8.  DS-33 (Dye Set G5) Matrix Standard (Applied Biosystems) is 
used to generate the multicomponent matrix required when 
analyzing 6-FAM™, VIC ® , NED™, PET ® , and LIZ ® dye-labeled 
DNA (for details see the Applied Biosystems 3130 Genetic 
Analyzer User’s Manual). 
  9.  Regularly, concentrations of 0.1  μ M are used for all primers in 
the PCR reaction (except for the two primer pairs needing 
reinforcement rs2308137 and rs3047269) following the 
Qiagen Multiplex PCR kit User’s Manual, which suggests that 
for multiplex amplifi cation reactions with more than ten PCR 
products, a decrease of primer concentration to 0.1  μ M may 
lead to a more uniform product yield (Appendix F: Optimization 
of Reaction Conditions for Special Multiplex PCR Applications; 
Large number of PCR products). Nonetheless, the 0.2  μ M 
concentration of each primer, originally suggested at the User’s 
Manual, can be used in cases where the template DNA is scarce 
or highly degraded, since having more primer available 
enhances the probability of molecules to encounter and anneal 
to attain amplifi cation. 
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 Chapter 11 
 Capillary Electrophoresis of an 11-Plex mtDNA Coding 
Region SNP Single Base Extension Assay for Discrimination 
of the Most Common Caucasian HV1/HV2 Mitotype 
 Peter  M.  Vallone   
 Abstract 
 The typing of single nucleotide polymorphisms (SNPs) located throughout the human mitochondrial 
genome assists in resolving individuals with an identical HV1/HV2 haplotype. A set of 11 sites which were 
selected for distinguishing individuals of a common Western European Caucasian HV1/HV2 mitotype 
was incorporated into a single base extension (SBE) assay. The assay was optimized for multiplex detection 
of sequence polymorphisms at positions 3010, 4793, 10211, 5004, 7028, 7202, 16519, 12858, 4580, 
477, and 14470 in the mitochondrial genome. PCR primers were designed to allow for multiplex amplifi -
cation of unique regions in the mitochondrial genome followed by an 11-plex SBE reaction using the 
SNaPshot ® reagent kit. Separation and detection can be accomplished with a capillary-based electrophore-
sis platform commonly found in most forensic laboratories. 
 Key words:  Single nucleotide polymorphism ,  PCR ,  Mitochondrial DNA ,  Multiplex 
 
 The limitations of mitochondrial DNA’s (mtDNA) power of 
discrimination have been addressed by identifying single nucle-
otide polymorphisms (SNPs) from the entire mitochondrial 
genome that provide maximal discrimination among individuals 
who would otherwise match in HV1/HV2  ( 1– 6 ) . The targeted 
common HV1/HV2 sequences or “types” comprise ~23% of the 
Western European Caucasian population. The  most common 
Western European Caucasian HV1/HV2 type accounts for ~8% of 
that population. This most common HV1/HV2 type can be 
defi ned as having a G polymorphism at position 263 and a C base 
 1.  Introduction
160 P.M. Vallone
insertion at position 315 (for further details see Table  1 in ref.  ( 2 ) ). 
Polymorphic sites were identifi ed by sequencing the entire mito-
chondrial genome of 241 individuals matching the most common 
HV1/HV2 types in a population derived from Western European 
Caucasians  ( 2 ) . From the amount of variation detected, specifi c 
panels of SNP sites were proposed as candidates to improve foren-
sic discrimination of specifi c common HV1/HV2 sequences  ( 2 ) . 
 An effi cient SNP assay protocol for these 11 sites allows practi-
cal application in improving the discrimination of mtDNA testing 
 ( 7 ) . This protocol details the use of a multiplex single base exten-
sion (SBE) assay that targets the most useful discriminatory SNP 
panel identifi ed by Coble et al.  ( 2 ) for a common Western European 
Caucasian HV1/HV2 type (263-G, 315.1 ins C). This panel tar-
gets 11 sites, 9 from the mtDNA coding region and 2 from the 
control region outside of HV1/HV2. The SNaPshot ® or minise-
quencing  ( 8 ) assay consists of a multiplex PCR followed by a mul-
tiplex SBE reaction using fl uorescently labeled dideoxynucleotide 
triphosphates (ddNTPs). The fragments are separated and detected 
by capillary electrophoresis, an instrument common to most foren-
sic laboratories. 
 
 Oligonucleotides for PCR and SBE assays were purchased from 
Qiagen Operon (Alameda, CA). Primers were ordered lyophilized, 
desalted, and unlabeled. 
 The primer design aspects of the PCR and SBE assays are fully 
described in Vallone et al.  ( 7 ) . Tables  1 and  2 contain the PCR and 
SBE primer sequences for the assay, respectively. 
 A NanoDrop 2000 (UV spectrophotometer) from Thermo 
Scientifi c (Wilmington, DE) was used to accurately quantitate 
primer solutions. 
 A GeneAmp ® PCR System 9700 (Applied Biosystems, Foster City, 
CA) was used for thermal cycling and temperature incubation 
steps. The cycler was run in 9600 emulation mode with a ramp rate 
of 1°C/s. 
 AmpliTaqGold ® DNA polymerase, 5 mM Mg 2+ , and 10× Taq Gold 
PCR buffer were purchased from Applied Biosystems. 
 A stock solution containing 10 mM of each deoxyribonucleotide 
triphosphates (dNTP) was purchased from Promega Corporation 
(Madison, WI) (see Note 1). 
 2.  Materials
 2.1.  Primers
 2.1.1.  Ordering of Primers
 2.1.2.  PCR and SBE Primer 
Sequences
 2.2.  UV 
Spectrophotomer
 2.3.  Thermal Cycler
 2.4.  DNA Polymerase 
and Buffers for PCR
 2.5.  Deoxyribo-
nucleotide 
Triphosphates
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 Bovine serum albumin (BSA) fraction V lyophilized powder, suitable 
for molecular biology, non-acetylated (see Note 2) was purchased 
from Sigma-Aldrich (St. Louis, MO). A stock solution of 3.2 mg/mL 
was prepared in nanopure water. 
 ABI Prism ® SNaPshot ® Multiplex Kit was purchased from Applied 
Biosystems. The reagent is a ready-made mix of buffers, fl uores-
cently labeled ddNTPs, and polymerase. The kit is supplied as a 5× 
concentration master mix. 
 ExoSAP-IT ® and shrimp alkaline phosphatase (SAP) were both 
purchased from USB Corporation (Cleveland, OH) (see Note 3). 
 Amplifi cation of PCR products was confi rmed with a FlashGel ® 
system purchased from Lonza (Basel, Switzerland). 
 2.6.  Bovine Serum 
Albumin
 2.7.  SNaPshot  ® 
Reagents
 2.8.  Exonuclease I 
(Exo I) and Shrimp 
Alkaline Phosphatase
 2.9.  FlashGel ® 
 Table 1 
 PCR primer sequences for multiplex amplifi cation of 11 
mitochondrial SNP (mtSNP) sites 
 Locus  PCR primer sequence  Amplicon size (bp) 
 477-F  CTTTTGGCGGTATGCACTTT  122 
 477-R  GGTGTGTGTGTGCTGGGTA 
 3010-F  GCGCAATCCTATTCTAGAGTCC  124 
 3010-R  TCACGTAGGACTTTAATCGTTGA 
 4580-F  TCTTTGCAGGCACACTCATC  130 
 4580-R  GCAGCTTCTGTGGAACGAG 
 4793-F  CAACCGCATCCATAATCCTT  186 
 4793-R  ATGTCAGAGGGGTGCCTTG 
 5004-F  TCCATCATAGCAGGCAGTTG  124 
 5004-R  TGGTTATGTTAGGGTTGTACGG 
 7028-F  GGCCTGACTGGCATTGTATT  125 
 7028-R  AAGCCTCCTATGATGGCAAA 
 7202-F  ACGCCAAAATCCATTTCACT  126 
 7202-R  TTCATGTGGTGTATGCATCG 
 10211-F  ACCACAACTCAACGGCTACA  143 
 10211-R  GGAGGGCAATTTCTAGATCAAA 
 12858-F  ATGATACGCCCGAGCAGA  126 
 12858-R  TGTGGGTCTCATGAGTTGGA 
 14470-F  CAAGACCTCAACCCCTGACC  129 
 14470-R  GGGGGAGGTTATATGGGTTT 
 16519-F  ACCACCATCCTCCGTGAAAT  183 
 16519-R  AGACCTGTGATCCATCGTGA 
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 The ABI PRISM ® 3130xl Genetic Analyzer (Applied Biosystems) 
was used for fragment separation with fi lter set E5 in order to pro-
cess the data from the fi ve fl uorescent dyes dR110, dR6G, 
dTAMRA, dROX, and LIZ. An appropriate spectral matrix was 
created using materials from the matrix standard set DS-02 (Applied 
Biosystems). A 36-cm array was used for fragment separation (see 
Note 4). 
 The performance optimized polymer (POP-6, Applied Biosystems) 
separation polymer was used for SBE fragment separation (see 
Note 5). 
 A.C.E.™ 10× sequencing buffer purchased from Amresco (Solon, 
OH) was used in a 1× concentration (diluted with nanopure 
water). 
 SBE products were diluted in Hi-Di™ formamide purchased from 
Applied Biosystems prior to electrophoresis. 
 GeneScan™ 120 LIZ ® Size Standard was purchased from Applied 
Biosystems (see Note 6). 
 2.10.  Capillary 
Electrophoresis
 2.11.  Separation 
Polymer
 2.12.  Electrophoresis 
Buffer
 2.13.  Formamide
 2.14.  DNA Sizing 
Standard
 Table 2 
 Single base extension (SBE) primers for the 11 mtSNP sites 
 Locus  SNP  Primer sequence  [ m M] a 
 3010-F  G/A  TGTTGGATCAGGACATCCC  0.4 
 4793-R  A/G  (T) 4 —TCAGAAGTGAAAGGGGGC  11.5 
 10211-R  C/T  (T) 10 —ACTAAGAAGAATTTTATGGA  15.5 
 5004-F  T/C  (T) 14 —A G ACCCAGCTACGCAAAATC 
b  12.4 
 7028-F  C/T  (T) 18 —GACACGTACTACGTTGTAGC  5.8 
 7202-F  A/G  (T) 22 —CCACAACACTTTCTCGGCCT  1.0 
 16519-R  T/C  (T) 24 —TGTGGGCTATTTAGGCTTTATG  5.4 
 12858-F  C/T  (T) 27 —GCAGCCATTCAAGCAATCCTATA  5.2 
 4580-R  G/A  (T) 29 —TGGTTAGAACTGGAATAAAAGCTAG  6.0 
 477-F  T/C  (T) 38 —CCCTCCCACTCCCATACTAC  5.6 
 14470-R  T/A c  (T) 41 —GGGAATGATGGTTGTCTTTGG  10.0 
 The orientation relative to the revised Cambridge Reference Sequence (rCRS)  ( 9 ) of each SBE 
primer is indicated (F or R) after the site name. Poly-T tails of varying (increasing) lengths were 
added to each SBE primer to enable electrophoretic separation 
 a The concentrations listed are for preparing a  working stock solution of the 11 SBE primers (see 
Subheading  3.6 ) 
 b Underlined base in 5004 is actually an “A” in the rCRS and did not affect the binding of the SBE 
primer 
 c Note that site 14470 has been observed to also have a C variant 
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 The commercial software package GeneMapper ® HID v3.2 
(Applied Biosystems) was used for data analysis (see Note 7). 
 
 Stock primer solutions (100  μ M) were prepared by rehydrating 
primers with appropriate volumes of a low salt Tris-EDTA buffer 
(10 mM Tris–HCl and 0.1 mM EDTA) (see Note 8). 
 2  μ L of a primer stock solution can be quantitated after blanking 
the instrument with the appropriate buffer (in this case 10 mM 
Tris–HCl and 0.1 mM EDTA). The quantitation allows for a more 
accurate measurement of primer concentration and assists in repro-
ducibility of results when new lots of primers are required. The low 
volume capability of the NanoDrop limits the consumption of the 
main primer stock solution. 
 Multiplex PCR amplifi cation of the 11 unique amplicons was car-
ried out in a total volume of 15  μ L (see Note 9). Final PCR reagent 
concentrations were: 1 unit of AmpliTaqGold ® DNA polymerase, 
1× Taq Gold PCR buffer, 250  μ M dNTPs, 5 mM MgCl 2 , 0.16 mg/
mL BSA fraction V, 0.5  μ M of each amplifi cation primer pair (22 
total primers). 
 The PCR thermal cycling conditions represent a “reverse touch-
down” approach. Cycling conditions are a slight modifi cation of a 
protocol previously described for 12-plex amplifi cation reactions 
 ( 10 ) . 
 PCR thermal cycling conditions
 95°C for 10 min.
 3 Cycles of 95°C for 30 s, 50°C for 55 s, 72°C for 30 s. 
 19 Cycles of 95°C for 30 s,  50°C for 55 s +0.2°C per cycle, 72°C 
for 30 s. 
 11 Cycles of 95°C for 30 s, 55°C for 55 s, 72°C for 30 s. 
 72°C for 7 min. 
 25°C hold. 
 Thermal cycling conditions for SBE reactions were carried out 
exactly as described in the SNaPshot ® multiplex kit manual. 
 SBE thermal cycling conditions
 25 Cycles of 96°C for 10 s, 50°C for 5 s, 60°C for 30 s. 
 2.15.  Software for SBE 
Assay Analysis
 3.  Methods
 3.1.  Primers
 3.1.1.  Primer Rehydration
 3.1.2.  Quantitation 
of Primers
 3.2.  PCR Amplifi cation 
Conditions
 3.3.  Thermal Cycling 
Conditions
 3.3.1.  PCR Thermal Cycling 
Conditions
 3.3.2.  SBE Thermal Cycling 
Conditions
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 Confi rmation of multiplex PCR products is optional, but the presence 
of amplicons can be checked on a FlashGel ® cassette. The 1.2% 
agarose, 13-lane cassettes were used according to the manufactur-
er’s instructions. The system can separate 10–4,000 bp DNA frag-
ments in 2–7 min with a self-contained detection system. 
 Due to the similarity in amplicon sizes, one cannot typically 
uniquely distinguish between all 11 products. This process acts as 
a general confi rmation of PCR success before continuing with the 
SBE reaction (see Note 10). 
 Following PCR thermal cycling, unincorporated primers and 
dNTPs were degraded and inactivated by adding 6  μ L of 
ExoSAP-IT ® to the 15  μ L post-PCR reaction (2  μ L of ExoSAP-IT ® 
per 5  μ L of post-PCR reaction). Reactions were mixed briefl y and 
incubated at 37°C for 90 min and then 80°C for 20 min. An 
extended incubation at 37°C was required to ensure digestion of 
all unincorporated PCR primers (see Note 11). 
 Multiplex primer extension reactions were carried out in a total 
volume of 10  μ L. Typically in our work with reference samples, a 
one-half (1/2×) reaction equivalent of the SNaPshot ® reagent was 
used for SBE reactions (see Note 12). SBE reaction components 
per reaction were as follows: 2.5  μ L of SNaPshot ® multiplex kit 
mix, 0.5  μ L of the 10× AmpliTaqGold ® PCR buffer, 3  μ L of 
multiplex PCR products (see Note 13), 3  μ L of deionized water, 
and 1  μ L of the  working stock solution of SBE primers (see Table  2 
for SBE  working stock primer concentrations). 
 Excess fl uorescently labeled ddNTPs were inactivated by addition 
of 1 unit of SAP. Reactions were mixed briefl y and incubated at 
37°C for 30 min then 80°C for 20 min (see Note 14). 
 Fluorescently labeled SBE products were prepared for CE analysis 
by mixing 14  μ L of Hi-Di formamide, 0.4  μ L of the LIZ-120 
internal sizing standard, and 1.0  μ L of SAP-treated SBE 
products. 
 A 36-cm capillary array fi lled with denaturing POP-6 polymer 
was utilized for DNA fragment separation. A.C.E. capillary elec-
trophoresis running buffer was used in 1× concentration. The run 
module parameters were: Run temperature = 60°C, capillary fi ll 
volume = 184 steps, prerun voltage = 15 kV, prerun time = 60 s, 
injection voltage = 1 kV, injection time = 13 s, run voltage = 15 kV, 
data delay = 200 s, and run time = 1,200 s. 
 Data were imported into GeneMapper HID v3.2. The appropriate 
size standard (LIZ-120) and custom panel for the mitochondrial 
 3.4.  Confi rmation 
of PCR Products
 3.5.  PCR Product 
Purifi cation
 3.6.  SBE Conditions
 3.7.  SBE Product 
Purifi cation
 3.8.  Preparation 
of SBE Products 
for Electrophoretic 
Separation 
and Detection
 3.9.  Capillary 
Electrophoresis 
Conditions
 3.10.  Data Analysis
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SNP analysis were applied (see Fig.  1 ). This resulted in labeling of 
the peaks of interest with the corresponding allele calls. It is pos-
sible to manually determine allele calls by careful visual inspection, 
but the automated process is less time-consuming and error prone 
(see Note 15). 
 
  1.  Once obtained from the manufacturer, the stock solution of 
dNTPs (in about 1.5 mL) was aliquoted into smaller volumes 
(e.g., 50  μ L) and stored at −20°C. A fresh aliquot was used for 
each PCR mastermix. This technique reduced the number of 
freeze–thaw cycles for the main stock and helped preserve the 
integrity of the dNTPs. 
  2.  It has been suggested in the literature  ( 11 ) that acetylated BSA 
has the potential to inhibit the PCR reaction. Highly purifi ed 
non-acetylated BSA should be used in PCR assays. 
 4.  Notes
 Fig. 1.  An example electropherogram for the 11-plex SBE assay. Eleven unique SBE primers were separated and detected. 
The  numbers at the top of the plot indicate the position of the polymorphism in the mitochondrial genome (3010, 4793, 
etc.). The fragment size is defi ned by the length of the SBE primer sequence (typically between 20 and 70 nucleotides). 
Below each peak is the base call for that specifi c locus. The base call is defi ned by the fl uorescent dye detected ( Blue = G, 
 Black = C,  Red = T, and  Green = A). Note that for sites 4793, 10211, 16519, 4580, and 14470, the SBE primer binds to the 
PCR products in the  reverse orientation. Therefore, the complimentary dideoxynucleotide triphosphates (ddNTPs) were 
enzymatically added to the reverse SBE primers. Allele calls for the fi ve reverse binding SBE primers were adjusted in 
GeneMapper. 
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  3.  ExoSAP-IT reagent can also be prepared by combining 
Exonuclease I (1.4  μ L where 1  μ L = 10 units) and SAP (2.6  μ L 
where 1  μ L = 1 unit). Results can be compared to the commer-
cial ExoSAP-IT reagent to confi rm activity. 
  4.  A 22-cm multicapillary array (Applied Biosystems) may be 
used if the instrument is dedicated to SBE assays and not 
sequencing or STR fragment separation. The shorter array 
length results in faster separation times and slightly less poly-
mer usage. 
  5.  POP-4 and POP-7 can also be used. Note that the mobility of 
the SBE fragments will slightly change depending on the poly-
mer. The bins and panels in the GeneMapper software will also 
have to be appropriately adjusted to refl ect any mobility 
changes. 
  6.  Allelic ladders are not required for this SBE SNP detection 
assay. Ideally, a set of control samples containing all expected 
allelic variations may be used to construct the proper bins and 
panels for automated analysis. 
  7.  The newer GeneMapper ® ID-X (or higher) software does not 
support the creation of bins and panels for SNP markers. 
Alternatively, a copy of the older GeneScan/Genotyper soft-
ware or GeneMapper 4.0 (Applied Biosystems) can be used for 
SNP analysis. 
  8.  Primer storage in a low salt buffer at 4°C resulted in primer 
stability over a period of 12–18 months with no changes in 
assay performance. 
  9.  The PCR reaction volume can be increased to 25  μ L if needed. 
Increased PCR volumes can assist in diluting out effects of 
PCR inhibitors found in casework samples. 
  10.  Any preferred method of separation and detection of PCR 
products can be used for this purpose [e.g., Bioanalyzer 2100 
(Agilent), agarose gel, etc.]. Do not use UV spectroscopy for 
the detection of PCR products unless the PCR reaction has 
been physically purifi ed (microscreen fi lter, microcon, or cen-
tricon). Absorbance interference from dNTPs and PCR prim-
ers (degraded or nondegraded) will skew results. 
  11.  It is important that all PCR primers are fully degraded prior to 
performing the SBE reaction. Remaining PCR primers will 
compete for SBE reagents and will be extended as SBE prim-
ers. Unwanted extension of PCR primers will result in interfer-
ing peaks in the fragment range of approximately 20 (±5) 
nucleotides. 
  12.  A 1× equivalent of the SNaPshot reagent can be used for 
enhanced sensitivity or if a higher level multiplex (more loci) is 
being developed. 
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  13.  The volume of post-PCR products required can vary slightly 
depending on the effi ciency of the multiplex PCR. Experiments 
should be performed to empirically determine the optimal vol-
ume of PCR products required for input into the SBE 
reaction. 
  14.  If not fully degraded by the SAP treatment, the unincorpo-
rated ddNTPs will migrate along with the SBE products, com-
plicating data interpretation. 
  15.  The paper  ( 7 ) describing this 11-plex assay in addition to 
GeneMapper ® bins and panel for running the SBE assay with 
POP-6 can be found online at:  http://www.cstl.nist.gov/biotech/
strbase/mtDNA.htm ). 
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 Chapter 12 
 Capillary Electrophoresis of a Multiplex Reverse 
Transcription-Polymerase Chain Reaction to Target 
Messenger RNA Markers for Body Fluid Identifi cation 
 Cordula  Haas ,  Erin  Hanson , and  Jack  Ballantyne  
 Abstract 
 The analysis of cell-specifi c mRNA expression is a promising new method for the identifi cation of body 
fl uids. A number of mRNA markers have been identifi ed for the forensically most relevant body fl uids: 
blood, saliva, semen, vaginal secretions, and menstrual blood. Apart from a signifi cant improvement in 
specifi city compared to conventional protein-based methods, other important advantages of body fl uid 
identifi cation by mRNA profi ling include the possibility of simultaneously isolating RNA and DNA from 
the same piece of stain and the ability to multiplex numerous RNA markers for the identifi cation of one or 
several body fl uids. RNA profi ling can be incorporated into current DNA analysis pipelines. 
 Key words:  Forensic science ,  mRNA profi ling ,  Body fl uid identifi cation 
 
 Identifi cation of the tissue source of a biological stain can be an 
important issue in forensic casework. The presence of biological 
material such as blood, semen, and saliva stains can indicate the 
location of potential sources of DNA that, once recovered, is 
used to identify the donor of the biological material. Often the 
identifi cation of biological material is crucial to the investigation 
and prosecution of the case. 
 Conventional methods for body fl uid stain analysis involve 
the use of enzymatic or immunologic tests performed in a serial 
(as opposed to parallel) manner. There are additional disadvantages 
associated with conventional testing to confi rm the presence of a 
particular body fl uid including poor timeliness and limited specifi city 
 1.  Introduction
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(i.e., cross-reactivity with other species or tissues). Furthermore, 
no such tests are available for the defi nitive identifi cation of vaginal 
secretions, menstrual blood, urine, and skin cells. Messenger 
RNA (mRNA) profi ling is a promising new technique for the iden-
tifi cation of body fl uids in biological stains. It is based on the premise 
that each single tissue type is comprised of cells that have a unique 
transcriptome or gene expression (i.e., mRNA) profi le. A number 
of markers have been identifi ed for the forensically most relevant 
body fl uids: blood, saliva, semen, vaginal secretions, and menstrual 
blood (see Table  1 )  ( 1– 23 ) . 
 RNA is notorious for its rapid postmortem and in vitro decay 
 ( 24 ) , but several reports have pointed out an unexpectedly high 
stability of RNA in forensic stains  ( 25– 27 ) . Since casework material 
is often limited, an important advantage of body fl uid identifi ca-
tion by mRNA profi ling is the possibility of simultaneously isolating 
RNA and DNA from the same stain  ( 5,  20,  23 ) . A list of success-
fully applied extraction protocols is shown in Table  2 , two of which 
are described in detail in the Material and Methods sections. 
 It is benefi cial to quantify the RNA and put a defi ned amount 
(around 1–10 ng) into the reverse transcription (RT) reaction in 
order to avoid false positive and negative signals. In our experience, 
the Nanodrop Spectrophotometer and the Agilent Bioanalyzer are 
not suitable for assessing the RNA quantity and quality in forensic 
samples  ( 17 ) . The quantity of the extracted RNA from forensic 
stains is usually below the detection limit of the Nanodrop spectro-
photometer. Although the RNA quality of forensic samples, as 
assessed with an Agilent Bioanalyzer, is often poor (according to the 
RIN metric), after reverse transcription and marker-specifi c ampli-
fi cation, electropherograms nevertheless reliably showed fragments 
of the expected sizes. Two sensitive and convenient fl uorescence-
based RNA quantifi cation methods  ( 7,  22 ) are described in the 
Material and Methods sections, but might have limited casework 
utility because they are not human-specifi c. Thus, bacterial RNA, 
which is found in abundance in buccal or vaginal swabs, will result 
in an underestimate of the amount of human RNA in these sample 
types. Accurate quantifi cation of human total RNA in forensic 
samples awaits the development of a sensitive and robust human-
specifi c RNA quantifi cation system that employs a consistently 
expressed housekeeping gene. 
 For the RT reaction, several kits are available and their suitability 
for use with forensic biological samples has been demonstrated (see 
Table  2 )  ( 19,  23 ) . One method is described in detail in the Material 
and Methods section. A RT minus control (no reverse transcriptase 
added) can be used to detect possible DNA contamination. 
 Another advantage of mRNA profi ling is the ability to multiplex 
numerous markers for the identifi cation of one or several body fl uids. 
The development of a multiplex PCR can be a challenge, in that not 
all PCR products are amplifi ed with equal effi ciency, and nonspecifi c 
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background products are often observed. Development of a robust 
multiplex system involves the consideration and optimization of 
numerous factors such as marker abundance (high, medium, low), 
primer annealing temperatures, amplicon sizes, labeling dyes, 
buffer composition, cycle number, and amount of input template. 
In the Material and Methods section, an easy-to-use commercially 
available multiplex PCR kit is described and an example singleplex 
protocol is provided. 
 Post-PCR purifi cation can increase peak heights (depending 
on the elution volume) and eliminate dye blobs and primer peaks 
 ( 28 ) . It does not allow for detection of additional markers that 
were not observed prior to post-PCR purifi cation, but results in 
increased peak heights and reduced baseline signal noise. Therefore, 
the use of post-PCR purifi cation is recommended for low template 
samples. 
 A positive control consisting of a marker expressed in all tissue 
types would confi rm a successful analysis. However, currently no 
housekeeping gene has been described that is suitable for the 
detection of all body fl uids. Saliva and semen, for example, show 
very little or no expression of common housekeeping genes 
(GAPDH, 18S rRNA, TEF, UCE), presumably because of limited 
cell metabolism in spermatozoids and in the desquamated cells of 
the cheek mucosa  ( 16,  20 ) . Additionally, the high abundance of 
housekeeping genes relative to mRNA may result in the titration 
of critical PCR components, thereby affecting the overall sensitivity 
of the multiplex system. Coextracted DNA might serve as a positive 
control for the presence of human cells. A concurrent negative 
 Table 2 
 List of successfully applied RNA extraction and RT methods from two collaborative 
exercises  ( 19,  23 ) 
 RNA extraction  Reverse transcription (RT) 
 Allprep RNA/DNA mini-Kit (Qiagen)*  SuperScript III (Invitrogen)* 
 mirVana miRNA Isolation Kit, RNA + DNA 
(Ambion) 
 RETROscript Kit (Ambion) 
 RNeasy mini-Kit (Qiagen)  First-Strand cDNA Synthesis Kit (Novagen) 
 RNeasy micro-Kit (Qiagen)  MMLV RT (Ambion) 
 RNAqueous Kit (Ambion)  High capacity cDNA RT Kit (AB) 
 NucleoSpin RNA XS (Macherey-Nagel)  SuperScript VILO cDNA Synthesis kit (Invitrogen) 
 PureLink RNA mini-Kit (Invitrogen)  ProtoScript First-Strand cDNA Synthesis Kit (NEB) 
 Guanidine isothiocyanate-Phenol/Chloroform 
(manual)* 
 PrimeScript (Takara) 
 Methods marked with an  asterisk (*) are described in detail in the Material and Methods sections 
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RNA result would suggest that the tested body fl uid is absent or that 
any body fl uid-specifi c mRNA is degraded and is undetectable. In the 
case of degradation, housekeeping genes would also be affected. 
 
  1.  RNaseZap (Ambion/Applied Biosystems AB). 
  2.  Spin baskets (e.g., Promega). 
  3.  Microcentrifuge tubes (e.g., DNA LoBind tubes, Vaudaux-
Eppendorf,  see  Note 2 ). 
  4.  Tweezers, scissors, and/or scalpels (single use or cleaned thor-
oughly between handling of different samples). 
  1.  Denaturing solution: 4 M guanidine thiocyanate, 0.02 M 
sodium citrate dihydrate, 0.5% sarkosyl, in nuclease-free water. 
  2.  2 M Sodium acetate solution, pH 4.0, in nuclease-free water. 
  3.  Wash solution: 75% ethanol/25% DEPC-treated water. 
  4.  Acid phenol chloroform (Ambion). 
  5.  GlycoBlue carrier (Ambion). 
  6.  Isopropanol. 
  7.  RNAsecure Resuspension Solution (Ambion). 
  8.  DNase treatment: TURBO DNA-free kit (Ambion). 
  1.  Buffers RPE, AW1, and AW2 (supplied as concentrate; replen-
ished with ethanol before use according to manufacturer’s 
instructions). 
  2.  β -Mercaptoethanol (added to Buffer RLT Plus before use: 10  μ L 
 β -mercaptoethanol per 1 mL Buffer RLT Plus; stable for 1 month 
at room temperature). 
  3.  Optional ( see  Note 1 ): Carrier-RNA working solution (from 
Qiagen RNA micro-Kit): dilute stock solution (310 ng/ μ L) to 
a fi nal concentration of 4 ng/ μ L in RLT Plus-Buffer. 
  4.  On-column DNase digestion using the RNase-free DNase Set 
(Qiagen): To prepare DNase I stock solution, add 550  μ L RNase-
free water to the vial using an RNase-free needle and syringe, 
mix gently by inverting the vial (do not vortex!). Aliquots can 
be stored for up to 9 months at −20°C. 
  1.  Quant-iT RiboGreen RNA Kit (Invitrogen), to use with a 
fl uorescence microplate reader, low-range assay 1–50 ng/mL, 
high-range assay 20–1,000 ng/mL. 
  2.  Quant-iT RNA Assay (Invitrogen), to use with the Qubit 
fl uorometer (Invitrogen), assay range 20–500 ng/mL. 
 2.  Materials
 2.1.  General Supplies 
and Equipment
 2.2.  Manual RNA 
Extraction
 2.3.  DNA/RNA 
Coextraction with 
the AllPrep DNA/RNA 
Mini-Kit (Qiagen)
 2.4.  RNA 
Quantifi cation, 
Reverse Transcription, 
and PCR
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  3.  Superscript III First-Strand Synthesis System (Invitrogen). 
  4.  Multiplex PCR kit (Qiagen). 
  5.  Singleplex reagents: 10× PCR Buffer I, dNTPs (2.5 mM each), 
AmpliTaq Gold DNA-Polymerase 5 U/ μ L (all from AB) (see 
Table  3 ). 
  1.  MinElute PCR Purifi cation Kit (Qiagen). 
  2.  Hi-Di Formamide (AB). 
  3.  GeneScan-500 LIZ or ROX Size Standard (AB). 
  4.  Performance-optimized polymers POP-4, POP-6, POP-7 (AB). 
 
 Special precautions have to be taken to avoid the degradation of 
RNA by the ubiquitously present RNases, namely a separate working 
place only for RNA, separate pipettes, RNase-free plastic ware, 
cleaning of the whole working area with RNaseZap, and the regular 
changing of gloves. 
  1.  Preheat 500  μ L denaturing solution + 3.6  μ L  β -mercaptoethanol 
per sample at 56°C for 10 min. 
  2.  Cut a piece of stain (on swab/textile) with a sterile scalpel/
scissors/tweezers and transfer to a 1.5 mL LoBind Tube ( see 
 Note 2 ). 
  3.  Add 503  μ L solution to each tube, vortex, and incubate at 
56°C for 30 min. 
  4.  Transfer swab/textile with clean tweezers into spin basket 
and centrifuge 5 min at 13,000 rpm. Discard the spin basket 
including the swab/textile ( see  Note 3 ). 
  5.  Add 50  μ L 2 M sodium acetate and 600  μ L acid phenol 
chloroform to each sample, invert to mix, and incubate at 4°C 
for 30 min to 1 h. Centrifuge for 20 min at 13,000 rpm. 
  6.  Pipet RNA-containing aqueous phase (upper phase,  see 
 Note 4 ) into new 1.5 mL LoBind tube. Discard bottom layer. 
  7.  Add 2  μ L GlycoBlue carrier ( see  Note 5 ) and 500  μ L isopro-
panol to aqueous layer, invert to mix, precipitate at −20°C for 
at least 1 h (or overnight). 
  8.  Centrifuge for 20 min at 13,000 rpm. Remove and discard 
supernatant. 
  9.  Wash pellet with 900  μ L wash solution, centrifuge for 10 min 
at 13,000 rpm, then remove supernatant. Dry sample in vacuum 
centrifuge for 3–5 min or at room temperature for several 
hours (in fume hood or otherwise protected from environment). 
 2.5.  Post-PCR 
Purifi cation 
and Capillary 
Electrophoresis
 3.  Methods
 3.1.  Manual RNA 
Extraction
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 Table 3 
 Primers for the amplifi cation of gene-specifi c sequences 
 Gene  Primer sequence  Size (bp)  References 
 Blood 
 HBB  f: GCA CGT GGA TCC TGA GAA C  61  ( 16 ) 
 r: ATG GGC CAG CAC ACA GAC 
 HBA  f: ACG CTG GCG AGT ATG GT  112  ( 22 ) 
 r: CCC TTA ACC TGG GCA GAG 
 ALAS2  f: TGT GTC CGT CTG GTG TAG TA  133  ( 19 ) 
 r: AAA CTT ACT GGT GCC TGA GA 
 CD3G  f: GTC GAG AGC TTC AGA CAA GC  154  ( 22 ) 
 r: AGG AGG AGA ACA CCT GGA CT 
 ANK1  f: GGC ATG CCC TAT TCT GTG  165  ( 22 ) 
 r: CTT AGA AGC CAG ATG CAA GC 
 PBGD  f. TGG ATC CCT GAG GAG GGC AGA AG  177  ( 7 ) 
 r: TCT TGT CCC CTG TGG TGG ACA TAG CAA T 
 SPTB  f: AGG ATG GCT TGG CCT TTA AT  247  ( 7 ) 
 r: ACT GCC AGC ACC TTC ATC TT 
 Glyco A  f: CAG ACA AAT GAT ACG CAC AAA CG  188  ( 20 ) 
 r: CCA ATA ACA CCA GCC ATC ACC 
 Saliva 
 HTN3  f: GCA AAG AGA CAT CAT GGG TA  134  ( 7 ) 
 r: GCC AGT CAA ACC TCC ATA ATC 
 STATH  f: TTT GCC TTC ATC TTG GCT CT  93  ( 16 ) 
 r: CCC ATA ACC GAA TCT TCC AA 
 MUC7  f: CTA AAA GCA AGC AAC TGG AT  197  ( 29 ) 
 r: AAG TGA GAT TTG GGT GAT TG 
 S. salivarius  f: GTG TTG CCA CAT CTT CAC TCG CTT CGG  544  ( 18 ) 
 r: CGT TGA TGT GCT TGA AAG GGC ACC ATT 
 Semen 
 PRM1  f: GCC AGG TAC AGA TGC TGT CGC AG  153  ( 7 ) 
 r: TTA GTG TCT TCT ACA TCT CGG TCT 
 PRM2  f: GGC GCA AAA GAC GCT CC  91  ( 7 ) 
 r: GCC CAG GAA GCT TAG TGC C 
 TGM4  f: TGA GAA AGG CCA GGG CG  215  ( 20 ) 
 r: AAT CGA AGC CTG TCA CAC TGC 
 PSA  f: TGT CCG TGA CGT GGA TTG  82  ( 17 ) 
 r: GGT TGG GAA TGC TTC TCG 
 SEMG1  f: TCG GTA ACC ATG TGA AAG GA  120  ( 17 ) 
 r: GTG TCA TCC ATG GAC CAA GA 
 Vaginal secretions 
 MUC4  f: GGA CCA CAT TTT ATC AGG AA  235  ( 7 ) 
 r: TAG AGA AAC AGG GCA TAG GA 
 HBD1  f: CCC AGT TCC TGA AAT CCT GA  215  ( 16 ) 
 r: CAG GTG CCT TGA ATT TTG GT 
 L. crispatus  f: CAG AGC AAG CGG AAG CAC A  279  ( 21 ) 
 r: CAT CTC TGC ATT GGG TTC CC 
 L. gasseri  f: GAG AAA GCC AAG CGG AAG C  253  ( 21 ) 
 r: TTG CTT ACT TAC TGC TCC CCG 
(continued)
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 Gene  Primer sequence  Size (bp)  References 
 Menstrual blood 
 MMP7  f: TCA ACC ATA GGT CCA AGA AC  240  ( 7 ) 
 r: CAA AGA ATT TTT GCA TCT CC 
 MMP10  f: ACA GGG AAG CTA GAC ACT GA  227  ( 29 ) 
 r: CTG GAG AAT GTG AGT GGA GT 
 MMP11  f: GGT GCC CTC TGA GAT CGA C  92  ( 16 ) 
 r: TCA CAG GGT CAA ACT TCC AGT 
 Primers are designed to overlap exon-exon-junctions or span an intron in order to ensure that the obtained 
products are not due to the presence of contaminating DNA 
Table 3
(continued)
  10.  Resuspend the RNA pellet in 20  μ L nuclease-free water or 
preheated RNAsecure Resuspension Solution ( see  Note 6 ), at 
60°C for 10 min. 
  11.  DNase treatment ( see  Note 7 ): Add 2  μ L 10× Buffer and 1  μ L 
DNase to 20  μ L RNA in a 0.5 mL tube and incubate at 37°C 
for 20–30 min. Add 2.3  μ L Inactivation Reagent and mix well. 
Incubate at room temperature for 5 min, mixing occasionally. 
Centrifuge for 1.5 min at 10,000 rpm and pipet ~20  μ L RNA 
into new tube. 
 Perform all steps of the procedure at room temperature and all 
centrifugation steps in a standard microcentrifuge at 20–25°C.
  1.  Cut a piece of stain (on swab/textile) with a sterile scalpel/
scissors/tweezers and transfer to a 1.5 mL LoBind Tube ( see 
 Note 2 ). 
  2.  Add 350  μ L RLT Plus-Buffer (containing  β -ME). 
  3.  Optional: add 5  μ L Carrier-RNA working solution ( see  Note 1 ). 
  4.  Vortex 30 s and incubate up to 3 h at 56°C ( see  Note 8 ). 
  5.  Transfer swab/textile with clean tweezers into spin basket 
and centrifuge 5 min at 13,000 rpm. Discard the spin basket 
including the swab/textile ( see  Note 3 ). 
  6.  Transfer the lysate into a new AllPrep DNA spin column (purple) 
and centrifuge 30 s at 11,000 rpm. 
  7.  Place the AllPrep DNA spin column in a new 2 mL collection 
tube and store at room temperature for later DNA purifi cation 
 steps 16–20 . Use the fl ow-through for RNA purifi cation  steps 
8–15 . 
 RNA purifi cation:
  8.  Add 350  μ L 70% Ethanol to the fl ow-through and mix well by 
pipetting. 
 3.2.  DNA/RNA 
Coextraction with 
the Qiagen AllPrep 
DNA/RNA Mini-Kit
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  9.  Transfer all 700  μ L to an RNeasy spin column (pink) and 
centrifuge 15 s at 11,000 rpm. Discard fl ow-through. 
  10.  Add 350  μ L Buffer RW1 to the RNeasy spin column and cen-
trifuge 15 s at 11,000 rpm. Discard fl ow-through. 
  11.  On-column DNase digestion ( see  Note 7 ): per sample, mix 
10  μ L DNase I stock solution with 70  μ L Buffer RDD and add 
the DNase I incubation mix (80  μ L) directly to the RNeasy 
spin column membrane. Incubate at room temperature for 
15 min. 
  12.  Add 350  μ L Buffer RW1 to the RNeasy spin column. Centrifuge 
15 s at 11,000 rpm. Discard fl ow-through. 
  13.  Add 500  μ L Buffer RPE to the RNeasy spin column. Centrifuge 
15 s at 11,000 rpm. Discard fl ow-through. 
  14.  Add 500  μ L Buffer RPE to the RNeasy spin column. Centrifuge 
2 min at 11,000 rpm. Discard fl ow-through and collection 
tube. Place the RNeasy spin column in a new 2-mL collection 
tube and centrifuge 1 min at full speed. 
  15.  Place the RNeasy spin column in a 1.5-mL collection tube. 
Add 30  μ L RNase-free water directly to the RNeasy spin column 
membrane. Centrifuge 1 min at 11,000 rpm to elute the RNA. 
Discard the column. 
 DNA purifi cation:
  16.  Add 500  μ L Buffer AW1 to AllPrep DNA spin column from 
 step 7 . Centrifuge 15 s at 11,000 rpm. Discard fl ow-through. 
  17.  Add 500  μ L Buffer AW2, centrifuge 2 min at max speed. 
  18.  Place AllPrep DNA spin column in new 1.5-mL collection tube. 
  19.  Add 40–50  μ L Buffer EB directly to the AllPrep DNA spin 
column membrane and incubate 1 min at room temperature. 
Centrifuge 1 min at 11,000 rpm to elute the DNA. 
  20.  Repeat  step 19 . Discard the column. The resulting 80–100  μ L 
DNA can be used in downstream analyses (quantifi cation, STR 
profi ling). 
 Quant-iT RiboGreen RNA Kit:
  1.  Prepare fresh RiboGreen Reagent working solution ( see 
 Note 10 ): dilute concentrated DMSO stock solution (Compo-
nent A) 1:200 in TE Buffer. 
  2.  Quantifi cation mix (per sample): 
 1× TE Buffer  98  μ L 
 DNase I-treated RNA extract  2  μ L 
 RiboGreen Reagent working solution  100  μ L 
 Total  200  μ L 
 3.3.  RNA 
Quantifi cation 
( see  Note 9 )
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  3.  Mix well and incubate for 2–5 min at room temperature, 
protected from light. 
  4.  Measure the sample fl uorescence using a microplate reader 
equipped for fl uorescence measurements (excitation 480 nm, 
emission 520 nm). 
  5.  The RNA concentrations in the samples are calculated using an 
appropriate standard curve (16S and 23S ribosomal RNA) as 
described by the manufacturer. 
 Quant-iT RNA Assay: 
  1.  Prepare fresh Quant-iT working solution ( see  Note 10 ): dilute 
Quant-iT RNA reagent (Component A) 1:200 in Quant-iT 
RNA Buffer (Component B). 
  2.  Prepare the standards (standard 1: 0 ng/ μ L, standard 2: 
10 ng/ μ L) and samples as follows: 
 Standards  Per sample  RNA Extract  Per sample 
 Quant-iT working 
solution 
 190  μ L  Quant-iT working 
solution 
 198  μ L 
 Standard  10  μ L  DNase I-treated 
RNA extract 
 2  μ L 
 Total  200  μ L  Total  200  μ L 
  3.  Mix well and incubate for 2 min at room temperature, 
protected from light. 
  4.  Run new calibration on the Qubit fl uorometer using the two 
standards. 
  5.  Measure the sample fl uorescence. 
 Half of the RNA is used as RT minus control (without reverse 
transcriptase) to detect genomic DNA contamination.
  1.  Place 1–10 ng RNA (max. 16  μ L,  see  Note 11 ) in a 0.2 or 
0.5 mL tube ( see  Note 2 ). 
  2.  Add 2  μ L random hexamer (50 ng/ μ L) and 2  μ L 10 mM 
dNTPs. 
  3.  Incubate at 65°C for 5 min, place on ice for 1 min, and briefl y 
centrifuge. 
  4.  Prepare the following master mix (per sample): 4  μ L 10× RT 
Buffer, 8  μ L 25 mM MgCl 2 , 4  μ L 0.1 M DTT, 2  μ L RNase 
Out (40 U/ μ L). 
  5.  Add 18  μ L master mix to each sample, mix gently, and briefl y 
centrifuge. 
  6.  RT+: pipet 19  μ L into new tube and add 1  μ L Superscript III 
RT. RT−: add 1  μ L H 2 O to remaining 19  μ L in original tube. 
Mix gently and briefl y centrifuge. 
 
 3.4.  Reverse 
Transcription 
(Superscript III 
First-Strand Synthesis 
System, Invitrogen)
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  7.  Allow to stand at room temperature for 10 min. Incubate at 
50°C for 50 min, then inactivate at 85°C for 5 min, either in a 
thermomixer or a thermocycler. Briefl y centrifuge. 
 Example protocol with Multiplex PCR Kit (Qiagen):
  1.  Primer concentrations should be optimized within the range 
of 0.1–0.4  μ M, starting with equal concentrations (0.2  μ M) of 
all primers. 
  2.  PCR reaction mix (per sample): 
 2× Qiagen Multiplex PCR MM  12.5  μ L 
 Primer-Mix  2.5  μ L 
 Optional: Q-Solution ( see  Note 12 )  2.5  μ L 
 cDNA/H 2 O  7.5  μ L 
 Total  25  μ L 
  3.  Amplifi cation conditions (GeneAmp PCR System 9700, AB):
 Initial denaturation at 95°C for 15 min.  –
 30–35 Cycles of 94°C 30 s, 57°C* 90 s, 72°C 60 s  –
(*+0.2°C/cycle). 
 Final elongation at 72°C for 60 min.  –
 Example singleplex protocol:
  1.  Primer concentrations should be optimized (we typically use 
primer concentrations from 0.04 to 0.8  μ M). 
  2.  PCR reaction mix (per sample): 
 10× PCR Buffer I  2.5  μ L 
 dNTPs  (2.5 mM each)  1.25  μ L 
 Primer-Mix  2  μ L 
 Taq-Pol. 5 U/ μ L  0.25 
 cDNA/H 2 O  17  μ L 
 Total  25  μ L 
  3.  Amplifi cation conditions (GeneAmp PCR System 9700, AB):
 Initial denaturation at 95°C for 11 min.  –
 30–35 Cycles of 94°C 20 s, 55°C 30 s, 72°C 40 s.  –
 Final elongation at 72°C for 60 min.  –
  1.  Add 125  μ L Buffer PB to 25  μ L PCR reaction mix. 
  2.  Transfer the sample to a MinElute column and centrifuge for 
1 min at 13,000 rpm. Discard fl ow-through. 
 3.5.  PCR
 3.6.  Post-PCR 
Purifi cation with 
the MinElute PCR 
Purifi cation Kit
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  3.  Add 750  μ L Buffer PE to the MinElute column and centrifuge 
for 1 min at 13,000 rpm. Discard fl ow-through. 
  4.  Centrifuge the column for an additional 1 min at 13,000 rpm. 
Place the MinElute column in a clean 1.5-mL microcentrifuge 
tube. 
  5.  Add 10–30  μ L Buffer EB or H 2 O to the center of the membrane. 
Let the column stand for 1 min at room temperature and then 
centrifuge for 1 min at 13,000 rpm to elute the DNA. Discard 
the column. 
 1  μ L of the amplifi ed sample is added to 12.5  μ L Hi-Di Formamide 
and 0.5  μ L of GeneScan-500 LIZ or ROX Size Standard. 
Performance-optimized polymers POP-4, POP-6, POP-7 have 
been used successfully for electrophoresis  ( 19,  23 ) . Standard, mul-
ticolor fl uorescent genetic analyzers (AB 310, 3100, 3130) and 
standard electrophoresis conditions ( see  Note 13 ) can be used for 
the detection of the body fl uid-specifi c amplicons. Raw data are 
analyzed with the Genemapper Software (AB). We use an analytical 
threshold of 100 RFUs in determining positive results. 
 
  1.  The use of Carrier-RNA is recommended when working with 
small RNA amounts. 
  2.  DNA LoBind tubes reduce loss of genetic material caused by 
interaction with the plastic surface of the tube. 
  3.  Instead of using spin baskets, one also can press/squeeze the 
stain with the pipette tip (caution because of foam building!), 
then transfer the liquid into a new LoBind tube or AllPrep 
DNA spin column. 
  4.  Be sure not to take up any phenol, because this may inhibit 
subsequent RT or PCR reactions. 
  5.  GlycoBlue will precipitate with the nucleic acids, facilitating 
good RNA or DNA recovery while increasing the size and visi-
bility of the pellet. 
  6.  RNAsecure Resuspension Solution is designed for direct resus-
pension of precipitated RNA and is capable of inactivating 
trace amounts of RNase. 
  7.  DNase treatment of RNA extracts is recommended, to avoid 
primer and nucleotide titration by contaminating DNA. In our 
experience, the TURBO DNA-free Kit removes contaminating 
 3.7.  Capillary 
Electrophoresis
 4.  Notes
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DNA more effi ciently than the on-column RNase-Free DNase 
Set. 
  8.  Up to 3 h incubation at 56°C is recommended for small, old, 
or compromised stains. 
  9.  Quantifi cation with the fl uorescence-based systems shows 
variable or negative results with small stains that were extracted 
with Qiagen kits. Therefore, results should be interpreted 
accordingly. A negative result does not indicate the inability to 
obtain positive downstream results for low quantity samples. 
  10.  Use the working solution within a few hours of their preparation. 
  11.  RNA input amount into RT should not exceed 20% of the RT 
volume, when DNase digestion with the TURBO DNA-free 
kit was applied, because components from the TURBO DNase 
Buffer and the DNase Inactivation reagent could interfere with 
the reaction. 
  12.  Q-Solution changes the melting behavior of DNA and can 
improve a suboptimal PCR caused by templates that have a 
high degree of secondary structure or that are GC-rich. 
  13.  Electrophoresis conditions for 3100 Genetic Analyzer: 10 s 
injection time, 3 kV injection voltage, 15 kV run voltage, 60°C, 
21 min run time, Dye Set G5 (6-FAM, VIC, NED, PET, LIZ) 
or F (5-FAM, JOE, NED, ROX). 
 References 
  1.  Bauer M, Kraus A, Patzelt D (1999) Detection 
of epithelial cells in dried blood stains by reverse 
transcriptase-polymerase chain reaction. J. Forensic 
Sci. 44:1232–1236. 
  2.  Bauer M, Patzelt D (2002) Evaluation of 
mRNA markers for the identifi cation of menstrual 
blood. J. Forensic Sci. 47:1278–1282. 
  3.  Bauer M, Patzelt D (2003) Protamine mRNA 
as molecular marker for spermatozoa in semen 
stains. Int. J. Legal Med. 117:175–179. 
  4.  Juusola J, Ballantyne J (2003) Messenger RNA 
profi ling: a prototype method to supplant con-
ventional methods for body fl uid identifi cation. 
Forensic Sci. Int. 135:85–96. 
  5.  Alvarez M, Juusola J, Ballantyne J (2004) 
An mRNA co-isolation method for forensic 
casework samples. Analytical Biochemistry 335:
289–298. 
  6.  Ferri G, Bini C, Ceccardi S, Pelotti S (2004) 
Successful identifi cation of two years old men-
strual bloodstain by using MMP-11 shorter 
amplicons. J. Forensic Sci. 49:1387. 
  7.  Juusola J, Ballantyne J (2005) Multiplex mRNA 
profi ling for the identifi cation of body fl uids. 
Forensic Sci. Int. 152:1–12. 
  8.  Nussbaumer C, Gharehbaghi-Schnell E, 
Korschineck I (2006) Messenger RNA profi ling: 
A novel method for body fl uid identifi cation by 
Real-time PCR. Forensic Sci. Int. 157:181–186. 
  9.  Fang R, Manohar CF, Shulse C, Brevnov M, 
Wong A, Petrauskene OV, Brzoska P, Furtado 
MR (2006) Real-time PCR assays for the detec-
tion of tissue and body fl uid specifi c mRNAs. 
International Congress Series 1288:685–687. 
 10.  Noreault-Conti TL, Buel E (2007) The use of 
real-time PCR for forensic stain identifi cation. 
Promega Profi les in DNA Vol. 10/1:3–5. 
 11.  Juusola J, Ballantyne J (2007) mRNA profi ling 
for body fl uid identifi cation by multiplex quanti-
tative RT-PCR. J. Forensic Sci. 52:1252–1262. 
 12.  Bauer M (2007) RNA in forensic science. 
Forensic Sci. Int. Genetics 1:69–74. 
 13.  Bauer M, Patzelt D (2008) Identifi cation of 
menstrual blood by real time RT-PCR: Technical 
improvements and the practical value of nega-
tive results. Forensic Sci. Int. 174:54–58. 
 14.  Zubakov D, Hanekamp E, Kokshoorn M, van 
Ijcken W, Kayser M (2008) Stable RNA 
markers for identifi cation of blood and saliva 
stains from whole genome expression analysis 
18312 Capillary Electrophoresis of a Multiplex Reverse Transcription-Polymerase…
of time-wise degraded samples. Int. J. Legal 
Med. 122:135–142. 
 15.  Virkler K, Lednev IK (2009) Analysis of body 
fl uids for forensic purposes: From laboratory 
testing to non-destructive rapid confi rmatory 
identifi cation at a crime scene. Forensic Sci. Int. 
188:1–17. 
 16.  Haas C, Klesser B, Maake C, Bär W, Kratzer A 
(2009) mRNA profi ling for body fl uid identifi -
cation by reverse transcription endpoint PCR 
and realtime PCR. Forensic Sci. Int. Genetics 
3:80–88. 
 17.  Haas C, Muheim C, Kratzer A, Bär W, Maake 
C (2009) mRNA profi ling for the identifi cation 
of sperm and seminal plasma. Forensic Sci. Int. 
Genetics Supplement Series 2:534–535. 
 18.  Nakanishi H, Kido A, Ohmori T, Takada A, 
Hara M, Adachi N, Saito K (2009) A novel 
method for the identifi cation of saliva by detect-
ing oral streptococci using PCR. Forensic Sci. 
Int. 183:20–23. 
 19.  Haas C, Hanson E, Bär W, Banemann R, Bento 
AM, Berti A, Borges E, Bouakaze C, Carracedo 
A, Carvalho M, Choma A, Dötsch M, 
Durianciková M, Hoff-Olsen P, Hohoff C, 
Johansen P, Lindenbergh PA, Loddenkötter B, 
Ludes B, Maroñas O, Morling N, Niederstätter 
H, Parson W, Patel G, Popielarz C, Salata E, 
Schneider PM, Sijen T, Sviezená B, Zatkalíková 
L, Ballantyne J (2011) mRNA profi ling for the 
identifi cation of blood—Results of a colla-bora-
tive EDNAP exercise. Forensic Sci. Int. 
Genetics. 5(1):21–26. 
 20.  Fleming RI, Harbison S (2010) The develop-
ment of a mRNA multiplex RT-PCR assay for 
the defi nitive identifi cation of body fl uids. 
Forensic Sci. Int. Genetics 4:244–256. 
 21.  Fleming RI, Harbison S (2010) The use of bac-
teria for the identifi cation of vaginal secretions. 
Forensic Sci. Int. Genetics 4:311–315. 
 22.  Haas C, Hanson E, Kratzer A, Bär W, Ballantyne 
J (2011) Selection of highly specific and 
sensitive mRNA biomarkers for the identifi ca-
tion of blood. Forensic Sci. Int. Genetics. 5(5): 
449–458. 
 23.  Haas C, Hanson E, Anjos MJ, Bär W, 
Banemann R, Berti A, Borges E, Bouakaze C, 
Carracedo A, Carvalho M, Castella V, Choma 
A, De Cock G, Dötsch M, Hoff-Olsen P, 
Johansen P, Kohlmeier F, Lindenbergh PA, 
Ludes B, Maroñas O, Moore D, Morerod ML, 
Morling N, Niederstätter H, Noel F, Parson 
W, Patel G, Popielarz C, Salata E, Schneider 
PM, Sijen T, Sviežena B, Turanská M, 
Zatkalíková L, Ballantyne J (2011) RNA/
DNA co-analysis from blood stains – results of 
a second collaborative EDNAP exercise. 
Forensic Sci. Int. Genetics. doi: 10.1016/
j.fsigen.2011.02.004. 
 24.  Lee J, Hever A, Willhite D, Zlotnik A, Hevezi 
P (2005) Effects of RNA degradation on gene 
expression analysis of human post mortem 
tissues. FASEB J. 19/10:1356– 1358. 
 25.  Bauer M, Polzin S, Patzelt D (2003) 
Quantifi cation of RNA degradation by semi-
quantitative duplex and competitive RT-PCR: a 
possible indicator of the age of bloodstains? 
Forensic Sci. Int. 138:94–103. 
 26.  Setzer M, Juusola J, Ballantyne J (2008) Recovery 
and stability of RNA in vaginal swabs and 
blood, semen and saliva stains. J. Forensic Sci. 
53:296–305. 
 27.  Zubakov D, Kokshoorn M, Kloosterman A, 
Kayser M (2009) New markers for old stains: 
stable mRNA markers for blood and saliva iden-
tifi cation from up to 16-year-old stains. Int. J. 
Legal Med. 123:71–74. 
 28.  Smith PJ, Ballantyne J (2007) Simplifi ed low-
copy-number DNA analysis by post-PCR 
purifi cation. J. Forensic Sci. 52:820–829. 
 29.  Juusola J (2005) Messenger RNA profi ling: A 
prototype method for body fl uid and tissue 
identifi cation. Doctoral thesis, University of 
Central Florida. 
185
Antonio Alonso (ed.), DNA Electrophoresis Protocols for Forensic Genetics, Methods in Molecular Biology, vol. 830,
DOI 10.1007/978-1-61779-461-2_13, © Springer Science+Business Media, LLC 2012
 Chapter 13 
 DNA Extraction from Aged Skeletal Samples for STR Typing 
by Capillary Electrophoresis 
 René  Huel ,  Sylvain  Amory ,  Ana  Bilić,  Stojko  Vidović ,  Edin  Jasaragić , 
and  Thomas  J.  Parsons  
 Abstract 
 STR analysis of DNA extracted from skeletal samples can play an important role in the identifi cation of 
missing persons. Here we present a method for the extraction of DNA from skeletal samples involving 
complete demineralization and digestion of the sample, followed by purifi cation by silica binding. This 
method, together with the multiplex STR typing approach also presented, has proven highly successful in 
the recovery of DNA profi les from degraded, aged skeletal remains from a wide range of environmental 
contexts. The methodological steps presented include bone decontamination and grinding, DNA extrac-
tion, repurifi cation in the case of highly inhibited samples, quantifi cation, STR multiplex amplifi cation, and 
profi le reporting guidelines. However, the conditions applied for amplifi cation and the criteria for allele 
calling and profi le submission must be based on the results of each laboratory’s internal validation experi-
ments involving the type of samples relevant to the project at hand. The methods presented here have 
permitted large-scale DNA-based identifi cation of persons missing from mass disasters and armed 
confl ict. 
 Key words:  DNA extraction ,  Bone ,  Demineralization ,  Silica ,  STR Analysis ,  Missing persons’ 
identifi cation 
 
 The use of nuclear STR typing for human identifi cation has become 
well established as a primary tool in victim identifi cation from a 
wide range of contexts  ( 1 ) , including natural disasters (e.g., the 
2004 SE Asian tsunami, and Hurricane Katrina), terrorist attacks 
(e.g., the September 11 attacks), numerous transportation accidents, 
and armed confl ict/human rights violations. DNA typing is unique 
among identifi cation methods in having a rigorously established 
 1.  Introduction
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scientifi c basis  ( 2 ) and often permits a reliable means for identifi cation 
when other methods cannot be applied. This is often the case in 
instances of body fragmentation where the postmortem samples 
do not retain identifi able characteristics, or when medical, dental, 
or fi ngerprint data are not available for the missing persons. 
 The protocols presented here are based on current, validated 
standard operating procedures of the International Commission 
on Missing Persons (ICMP), developed in the course of the world’s 
largest missing persons’ identifi cation project. The ICMP was 
established to assist in addressing the issue of ~40,000 persons 
missing as the result of armed confl ict and human rights violations 
in the former Yugoslavia in the 1990s ( ( 3 ) ;  www.ic-mp.org ). Since 
2001, the ICMP has generated nuclear autosomal STR profi les 
from over 33,000 bone and tooth samples, primarily from mass 
graves in the former Yugoslavia, or from victims of natural disasters 
(2004 SE Asian tsunami, 2005 hurricane Katrina, and 2008 
Typhoon Frank in the Philippines). Genetic kinship comparisons 
between victim DNA profi les and those of surviving relatives of 
victims have produced over 29,000 highly statistically signifi cant 
DNA matches, representing over 16,500 missing individuals and 
numerous additional reassociations of fragmented remains. 
 Innumerable methods have been published for DNA extrac-
tion from bone, many coming from the ancient DNA research 
community (e.g., see  ( 4 ) ) and others established in applied foren-
sic laboratories. For many years, aged or degraded skeletal remains 
(e.g., buried for years in the soil) were considered mainly subjects 
for mtDNA testing, due to the higher chance for success with this 
multicopy target. In forensics, the most commonly applied extrac-
tion methods for bone involved proteinase K digestion followed by 
phenol/chloroform extraction (e.g.,  ( 5 ) ). Early trials in forensic 
protocols showed no advantage to demineralization of bone sam-
ples by extensive EDTA washes  ( 6 ) , a commonly used step in 
ancient DNA protocols. In setting out to apply nuclear STR typing 
to aged bone samples on a large scale, the ICMP initially did not 
have good success with standard phenol/chloroform methods and 
developed a silica based method for large volume bone extractions, 
which gave much better results and permitted thousands of nuclear 
STR-based identifi cations to be made  ( 7,  8 ) . 
 The survival of DNA in bone is based on its protective mineral 
and protein matrix, which serves as mechanical barrier to micro-
organismal attack and at least partially isolates the DNA from det-
rimental conditions of the external environment. DNA typing 
success rates are best with dense cortical bone from weight-bearing 
elements  ( 9– 11 ) . DNA appears to be best protected in small, dense 
crystalline aggregates within the bone  ( 12 ) , suggesting the con-
cept that DNA extraction methods should be optimized to ensure 
access to densely mineralized “preferred niches” within the sample. 
To this end, the benefi t of demineralization steps was revisited in a 
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systematic manner  ( 13 ) demonstrating a greater of DNA when 
demineralization is accomplished without discarding the EDTA 
solution used to effect decalcifi cation. The DNA extraction method 
presented here combines the benefi ts of complete demineralization 
with a convenient silica purifi cation method  ( 14 ) that is compara-
tively effective at removing PCR inhibitors. While using smaller 
amounts of sample, this method provides greater success rates with 
diffi cult samples than ICMP’s previous method. This method is 
similar to that of other recent publications  ( 15,  16 ) . The method 
has been validated in accordance with ISO 17025 accreditation 
standards and has successfully been applied to thousands of miss-
ing persons’ casework samples. 
 
 Separate laboratory facilities are required for pre-PCR (sample 
preparation, bone sample washing and grinding, DNA extraction, 
quantifi cation, and PCR amplifi cation setup) and post-PCR (prod-
uct purifi cation and capillary electrophoresis) to avoid PCR product 
contamination. Bone sanding and grinding require ventilated hoods 
or other dust collection apparatus to capture/remove the bone 
powder that is released into the air during the process; these steps 
are best performed in a separate laboratory from other pre-PCR 
steps. Ear protection is recommended for bone grinding. For per-
sonal protection and contamination avoidance, the following should 
be used throughout: clean or disposable lab coats and pants, hair 
nets, face masks, gloves, disposable sleeves to cover wrists, and dis-
posable overshoe covers. Proper hoods should be used for DNA 
extraction and PCR setup (the ICMP uses dead-space hoods, but 
other laboratories employ biofi lter hoods for similar work). 
  1.  Dremmel or dental type rotary sanding tool with a variety of 
sanding bits to accommodate different sizes and shapes of bone 
samples, with foot pedal operated variable power control. 
  1.  Tweezers/forceps 
  2.  Waring blender cups, model SS110 
  3.  Waring blender base, 1 L, model 7009 or 7011 
  4.  50 mL conical tubes 
  5.  Commercial Bleach (5% sodium hypochlorite) (see Note 1) 
  6.  Ethanol 96% 
  1.  Demineralization buffer: Ultrapure 0.5 M EDTA pH 8.0 
(Gibco, Invitrogen Corporation, Carlsbad, CA), 1% Sodium-
 N -laurylsarcosinate (Fluka BioChemika, Buchs, Switzerland). 
 2.  Materials
 2.1.  Sanding 
the Sample
 2.2.  Washing/Grinding 
the Sample
 2.3.  Extraction/
Purifi cation
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Add 1 g of Sodium- N -laurylsarcosinate per 100 mL of EDTA. 
Mix gently until the Sodium- N -laurylsarcosinate is completely 
dissolved. Store unused portions at 4°C for up to 1 month (see 
Note 2). 
  2.  Amicon Ultra-15–100,000NMWL (Millipore Corporation, 
Bedford, MA) (see Note 3). 
  3.  Qiagen QIAquick PCR purifi cation kit (Qiagen Inc., Valencia, 
CA) contains:
 (a)  Qiaquick spin columns. 
 (b)  Buffer PB. 
 (c)  Buffer PE (note: ensure ethanol is added according to the 
manufacturer’s instructions). 
 (d)  Buffer EB (see Note 4). 
  4.  Proteinase K, 10 mg/mL (Promega Corporation, Madison, 
WI). 
  5.  Ethanol 96%. 
 
 Ethanol is added to buffer PE prior to use. Follow directions for 
volumes according to the manufacturer. 
 Buffer PB contains chaotropic salts. Appropriate safety mea-
sures should be taken when handling this reagent. 
 In order to prevent contamination, all steps in this procedure 
should be performed in dedicated preamplifi cation and postampli-
fi cation labs as appropriate. Scientists conducting the manipula-
tions must have an excellent awareness of the potential for 
contamination of exogenous DNA which can be introduced into 
the process at many stages by clumsy technique, such as passing 
sleeves over open tubes or touching the inside of tube caps when 
opening or closing tubes. It is not possible to detail all aspects of 
preventative manipulations, but it is recommended that scientists 
be familiar with literature pertaining to “ancient DNA” precau-
tionary guidelines and adapt their manual technique to minimize 
the potential for accidental introduction of contaminating cellular 
material or DNA. 
 Any specimens suspected of containing large quantities of 
DNA (e.g., fresh bone) should be extracted separately from older 
samples. 
 A surgical facemask, gloves, hair cap, disposable sleeves, dedi-
cated lab pants, and shoes (or shoe covers) must be worn at all 
times to prevent contamination. Personal protective clothing 
(PPC) should not leave the areas in which they are used. 
 3.  Methods
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 All trays, pipettes, benches, and hoods must be thoroughly 
cleaned with bleach and/or UV irradiated (in a crosslinker for 
30 min at maximum emission at 254 nm). 
 Any method, protocol, or instrument should be internally 
validated by the lab according to accepted forensic standards. 
  1.  Sizeable bones or portions thereof should fi rst be cut to a man-
ageable size for subsequent processing (see Note 5). This can 
be done using specialized bone saws, or manually by hack saws, 
etc. Samples between 3 and 10 g are optimal to begin with, 
generally providing enough material for several extractions. 
  2.  Sanding applies only to bone samples. Teeth do not undergo 
sanding. If processing tooth samples, go directly to washing 
and grinding. 
  3.  Prepare each sample separately (see Note 6). 
  4.  Before sanding, remove any adhering tissue from the bone 
using a scalpel and tweezers/forceps. 
  5.  Place the sample in a holding vice to avoid the sample moving 
while sanding. 
  6.  Sand the exterior (see Note 7), ensuring that the entire super-
fi cial surface of the sample is removed (1–3 mm, depending on 
the type of sample). Attempt to sand away any particularly dis-
colored or porous portions of the sample, if suffi cient sample 
exists, as dense cortical bone has the best DNA preservation in 
aged samples. 
  7.  Depending on the weight of the sample, cut the sample in half 
to retain reserve material if needed. Typically, 2–3 g is enough 
for several extractions. 
  8.  Thoroughly clean all surfaces, equipment, and the interior of 
the hood with bleach between each sample. 
  1.  If the bone/tooth sample becomes moldy as a result of storage 
after sanding, it should be washed in tap water and the mold 
mechanically removed with forceps or rubbing, prior to the 
washing procedure. Teeth should be thoroughly cleaned under 
running water and any dirt or adhering material removed using 
forceps. 
  2.  Unless the sample is less than 1 g, it will likely be desirable to 
break the sample into smaller pieces of ~0.5–1 g to facilitate 
subsequent steps of washing and grinding (see Note 8). If the 
sample is a tooth, move directly to step 4. 
  3.  Weigh the sample. Typically, only 2–3 g is necessary for several 
extractions. Place 2–3 g (or as much as required) into a new 
50 mL tube. The remaining sample can be kept in reserve if 
needed in the future. 
 3.1.  Sanding 
and Preparation 
of the Bone Sample
 3.2.  Washing 
and Grinding 
the Bone Sample
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  4.  Wash samples as follows (see Note 9):
 Each wash is discarded before the next wash step is  ●
undertaken. 
 Two washes with a 10% dilution of commercial bleach (see  ●
Note 1), immersing the sample completely with vigorous 
shaking for 30 s. 
 Two washes in deioinized water, where available, or tap  ●
water, with the sample fully immersed with vigorous shak-
ing for 30 s. Following vigorous shaking for the second 
wash, the sample is to be left submerged in water for a 
minimum of 5 min before the wash discarded. 
 Two washes in 96% ethanol with vigorous shaking for 20–30 s.  ●
  5.  Place washed samples in open tubes in an oven/incubator set 
between 50 and 60°C and allow samples to completely dry 
(see Note 10). 
  6.  Remove samples from oven/incubator when drying is 
complete. 
  7.  Place the sample fragments into the blender cup, cover it with 
the lid and secure it on the blender base (see Note 11). Run 
the blender for no more than 2 min, then check if the sample 
is fi nely ground. The sample can be transferred to a sterile 
weighing dish for closer inspection. Larger fragments are to be 
returned to the blender cup for further grinding until a fi ne 
powder is obtained (see Note 12). 
  8.  Transfer the fi nal powder from the blender cup into a weighing 
dish, then transfer the powder into a new (prelabeled) 50-mL 
tube. 
  9.  Clean blender cups, base, and hood well between each sample 
(see Note 13). 
 One reagent blank (extraction negative control) should be carried 
throughout the extraction procedure and assayed in parallel with 
the test samples (see Note 14).
  1.  Preheat oven/incubator to 56°C. 
  2.  Weigh between 0.5 and 1.0 g of bone powder into a new 
50-mL tube (see Note 15). 
  3.  To each extraction tube, carefully add 15 mL of digestion buf-
fer (see NOTES 16 and 17). 
  4.  Repeat for each sample extraction tube, with the fi nal tube 
being the extraction negative control. 
  5.  Add 1 mL of Proteinase K (10 mg/mL) to each extraction 
tube, including the extraction negative control. 
  6.  Ensure the lid of each tube is tightly secured. Wrap each one 
with Parafi lm to ensure no leaks occur during incubation. 
 3.3.  Extraction 
and Purifi cation 
of DNA from 
the Bone Sample
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  7.  Place samples horizontally onto the rocking platform located 
in the incubator/oven (see Note 18). Set the rocking speed 
to ~90 rpm (enough to ensure that the liquid and powder are 
in contact with each other and that they are mixing). 
  8.  Incubate samples overnight (typically all bone material is 
digested within 5–6 h). 
  9.  The following day, remove the tubes from the incubator. 
Ensure that all bone material is completely digested. 
  10.  If signifi cant undigested material is remaining, check the level 
of demineralization buffer to ensure no leaking occurred dur-
ing the incubation. If leaking occurred, add additional demin-
eralization buffer up to 15 mL and add another 1 mL of 
Proteinase K (10 mg/mL). Place the sample(s) back on the 
rocking platform and continue incubation for another 5 h (see 
Note 19). 
  11.  Place tubes into a centrifuge with a swinging bucket rotor and 
50 mL adaptors, and spin samples for 5 min at 3,000 rpm to 
pellet any small amounts of remaining bone debris. 
  12.  Once the centrifugation is complete, carefully transfer the 
supernatant from each sample tube into a corresponding prela-
beled 15-mL centrifugal fi lter unit. 
  13.  Place the Amicon Ultra-15 units back into the centrifuge and 
spin for 30 min at 4,000 rpm. 
  14.  Prelabel corresponding 1.5 and 2 mL tubes for each sample 
plus the negative control. Preload the 2 mL tubes with 1.5 mL 
of PB buffer. 
  15.  After centrifugation, place the Amicon Ultra-15 units back 
inside the hood. Verify that the volume of lysate remaining 
on the fi lter of the Amicon Ultra-15 is between 300 and 
450  μ L:
 (a)  If it is the case, use a 200  μ L pipette to transfer the 
volume into a 2-mL tube containing PB buffer. 
 (b)  In case the Amicon Ultra-15 contains less than 300  μ L 
of lysate, add water up to 300  μ L before continuing. 
 (c)  In case the Amicon Ultra-15 containing the extraction 
negative has been dried out, add 300  μ L of water and 
transfer it to the PB tube after 3–5 min. 
 (d)  If the Amicon Ultra-15 contains more than 450  μ L, 
replace the tube in the centrifuge and spin it at 4,000 rpm 
until a volume less than 450  μ l has been reached.  Transfer 
to a 2-mL tube preloaded with 1.5-mL of PB buffer. 
  16.  Mix each sample and buffer PB well by inverting the tubes 
several times. Spin the tubes very briefl y in a centrifuge prior to 
the next step. 
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  17.  Transfer approximately 630  μ L of PB/sample to a prelabeled 
corresponding QIAquick column and spin for 1 min at 
13,000 rpm in a fi xed rotor centrifuge. 
  18.  Discard the fl ow-through and repeat step 17 until the volume 
of each sample has transferred. 
  19.  Wash each column with 750  μ L of buffer PE (ensure the rec-
ommended amount of ethanol has been added to the buffer) 
and spin again for 1 min at 13,000 rpm. 
  20.  Discard the fl ow-through and repeat the wash step 2 additional 
times, each time discarding the fl ow-through, for a total of 
three washes. 
  21.  Remove any residual ethanol from the fi nal wash by spinning 
each column for 3 min at 13,000 rpm. 
  22.  Place the QIAquick column on a new, and labeled, 1.5 mL 
tube. Add 50  μ L of buffer EB to each column membrane and 
allow the buffer to incubate on the membrane for 1 min. 
  23.  Elute the DNA from the column by centrifuging samples for 
1 min at 13,000 rpm. 
  24.  Store samples at −20°C. 
 Some DNA extracts may have inhibitors copurify during extrac-
tion which can affect downstream STR analysis. These can be 
detected in some quantifi cation methods (delayed Ct IPC) or in 
the STR profi le itself. In extreme cases, this can be seen as color-
ation in the DNA extract itself. To reduce the level of inhibitors in 
such extracts, use the simple protocol below to repurify these 
samples (see Note 20). 
 One reagent blank should be carried throughout the repurifi -
cation procedure and assayed in parallel with the samples.
  1.  To each sample selected for repurifi cation, add 5 volumes of 
buffer PB to the volume of DNA extract and mix the PB buffer 
and the DNA extract by turning the tube up and down ~10 
times, ensuring the contents are mixed well. 
  2.  From each 1.5 mL tube, transfer all the PB buffer/DNA 
extract into the QIAquick spin column. Place the tubes into a 
fi xed angle centrifuge and spin for 1 min at 13,000 rpm. 
  3.  After centrifugation, place the tubes back on the rack and dis-
card the fl ow-through. 
  4.  Add 750  μ L of PE buffer (ensure EtOH has been previously 
added to the buffer) to each QIAquick spin column. Place the 
tubes into the centrifuge and spin for 1 min at 13,000 rpm. 
  5.  After centrifugation, place the QIAquick spin columns back on 
the rack and discard the fl ow-through. 
 3.4.  Repurifi cation 
of Inhibited DNA 
Extracts
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  6.  Repeat steps 4–5 two additional times for a total of three 
washes. 
  7.  To dry the column completely, place the tubes in the centri-
fuge and spin for 3 min at 13,000 rpm. 
  8.  Place the columns back on the rack and inside the hood trans-
fer the fi lter of the QIAquick spin column in a clean, labeled 
1.5 mL tube. 
  9.  Add 50  μ L of EB buffer (see Note 21) directly on the center 
of the QIAquick membrane and let it stand for 1 min. Place 
the elution tubes + QIAquick column fi lters into the centrifuge 
and spin for 1 min at 13,000rpm. 
  10.  Place the elution tubes + QIAquick column fi lters back on the 
rack, verify that the elution tubes contain approximately 50  μ L 
of DNA extract (or whatever volume is being eluted) and 
throw away the QIAquick column fi lters and close the elution 
tube. 
  11.  Store the tubes at −20°C. 
  1.  DNA extracts from bone or tooth samples should be quantifi ed 
prior to STR analysis due to the varying amount of DNA that 
can be obtained due to differences in the type of skeletal ele-
ment, the age and environmental origin of the samples, and 
the possibility of coextraction of inhibitors. The ICMP uses 
Applied Biosystems’ Quantifi ler Human DNA quantifi cation 
kit on all bone samples. Samples exhibiting a Ct IPC greater 
than 30 are repurifi ed using the protocol listed above. These 
DNA extracts are then requantifi ed to determine if the inhibi-
tion is still present. It is possible to repurify a DNA extract 
using this method up to 2 times. 
  2.  For DNA extracts with a yield >1ng/  μ L, an aliquot is diluted 
to 1 ng/  μ L and 1  μ L is used in PCR. For all samples with a 
DNA yield between 0.5 and 1 ng/  μ L, aliquots of 1 and 2  μ L 
are used in subsequent PCR amplifi cations using Promega’s 
PowerPlex16. For samples with <0.5 ng/  μ L, aliquots of 2  μ L 
and 5  μ L are used for PCR (see Note 22). 
  3.  Amplify samples using Promega’s PowerPlex16 (see Note 23). 
Mastermix is set up according to the manufacturer’s recom-
mended volumes except an additional 0.2  μ L of  taq is added 
per reaction. Cycling parameters are listed in Fig.  1 and are 
carried out on a Applied Biosystems 9700 GeneAmp thermal 
cycler. 
  4.  Capillary electrophoresis of samples should follow manufac-
turer’s recommendations, with possible additional modifi ca-
tions based on results of internal validation studies of particular 
instruments. For Promega’s PowerPlex16 STR kit, the ICMP 
 3.5.  Quantifi cation, 
Amplifi cation, 
Fragment separation, 
and Analysis
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uses the manufacturer’s recommended volumes of reagents 
with a 3 kV injection for 11 s on an Applied Biosystems’ 3130xl 
Genetic Analyzer (see Note 24). 
  5.  A minimum of two amplifi cations are performed on each sam-
ple. As quantifi cation kits may not always give an accurate 
assessment of DNA quantity or quality, carefully review initial 
amplifi cations and alter amplifi cation strategies according to 
the resulting profi le(s). For example, if inhibition is suspected 
at a certain volume of template, try amplifying with half the 
original input. 
  6.  Reporting of alleles in STR typing should be based on internal 
validation experiments (addressing stutter, peak balance, mini-
mum allele calling thresholds, etc.). Based on ICMP’s valida-
tion, the following general guidelines are used: Profi les are 
considered reportable if results are obtained from a minimum 
of 11 STR loci and Amelogenin; homozygotes are called with 
a minimum RFU threshold of 300, and heterozygotes are 
called with a minimum rfu threshold of 50; alleles are reported 
only if they are reproduced in a minimum of two different 
amplifi cations. In addition to these guidelines, an overall con-
servative approach is taken, and in many instances, duplicate 
extractions are performed to confi rm results or to obtain addi-
tional reportable alleles (see Note 25). 
 
  1.  For work space and equipment decontamination, and for bone 
washing, a 10% solution of commercial bleach is used (0.5% 
sodium hypoclorite). Fresh solutions of 10% bleach should be 
made daily. 
 4.  Notes
 Fig. 1.  Modifi ed cycling parameters for PowerPlex16 amplifi cation of bone samples on a 
ABI 9700 GeneAmp thermal cycler. 
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  2.  Purchasing ultrapure 0.5 M EDTA, pH 8.0 saves effort in the 
preparation and the pH balancing of this solution. 
  3.  Different molecular weight cutoffs are available. Some labora-
tories use smaller size cutoffs (30,000 or 50,000); however, we 
have not seen a difference in results between 100,000 and 
50,000 except for longer centrifugation times. 
  4.  The reagents included in one kit (250 reactions) are enough 
for ~100 extractions. 
  5.  The ICMP has detailed protocols for selecting the optimum 
sample from various skeletal remains assemblages and can be 
obtained from the authors upon request. 
  6.  It is good practice to photodocument the sample before it 
undergoes processing. This way there is a visual historical 
record of the sample. If the original sample code is changed to 
conform to a laboratory numbering system, it is very benefi cial 
to photodocument the sample with its original code and its 
new laboratory code. 
  7.  A variety of sanding attachments can be used. Having various 
sizes and shapes will ensure that all types of samples can be 
effi ciently sanded. 
  8.  Any alternate means of subdividing the bone sample is accept-
able, such as with a dremel cutting bit, etc. 
  9.  For fresh samples (<1-year postmortem), double the amount of 
washes in each step to reduce the amount of potential external 
contamination. In such cases, four washes with 10% bleach, 
four water washes, and four ethanol washes are recommended. 
  10.  Drying times vary depending on the sample. Fresh samples 
may require additional time to completely dry. 
  11.  Other ways of grinding samples may be used, including liquid 
nitrogen freezer mills and powdering a sample using a drill. 
With complete demineralization, there is no advantage to 
extremely fi nely ground powder. 
  12.  If many samples are being processed, at once have additional 
cups and lids available. 
  13.  Blender cups and lids are to be cleaned as follows: After grind-
ing, add a small volume of 1% Liquinox to the blender cup and 
seal with lid. Place on the blender base and run for 10–20 s to 
rinse the cup and lid. Discard the Liquinox, then place the 
blender cups in the sink to soak in 1% Liquinox, until ready to 
proceed to the next step. Thoroughly clean the blender cups 
and lids using a sponge and hot water making sure to wash the 
area under the blade. Rinse the cups and lids with tap water. 
Soak them in 10% bleach (in a plastic container) for at least 
30 min. Rinse with deionized water (or tap water if deionized 
is unavailable) and then 96% ethanol and leave them to air dry. 
196 R. Huel et al.
If another method is used to grind samples, ensure that the 
equipment is thoroughly decontaminated between samples. 
  14.  Throughout the procedure, sample transfers between different 
tubes should be witness checked by an independent person. 
This will reduce the likelihood of sample switches. 
  15.  Less than 0.5 g can be used in case of small samples. No more 
than 1 g of bone powder should be added to 15 mL of diges-
tion buffer since 15 mL of 0.5 M EDTA can theoretically bind 
only the amount of calcium contained in ~1 g of bone. 
  16.  For large numbers of extractions, prepare the demineralization 
buffer in a large glass bottle and use a large dispensette, set to 
15 mL, to accurately pipette the digestion buffer into tubes. 
  17.  Typically 11 samples and 1 extraction negative control can be 
extracted by one person at one time. This keeps samples bal-
anced in the centrifuge while also being a manageable amount 
of samples to extract per analyst. 
  18.  Various ways of shaking/incubation can be used. Constant 
rocking motion where the bone powder and digestion buffer 
are constantly mixing is optimal. 
  19.  If substantial undigested material still remains and no leaking 
occurred, pellet the undigested material as in step 11 and retain 
the pellet. Add another 15 mL of demineralization buffer to the 
tube along with another 1 mL of Proteinase K (10 mg/mL) 
and incubate again overnight. The resulting fractions can be 
processed individually or can be pooled together in step 12. 
  20.  The repurifi cation protocol also works well on samples that 
have been extracted using other protocols. 
  21.  For samples with low amounts of DNA, one can elute in a 
30  μ L volume. 
  22.  Commercial kits such as Applied Biosystems Quantifi ler 
Human DNA kit, or similar type, may not detect all inhibitors 
present in DNA extracts from bones. For this reason, 2 and 
5  μ L are used as an initial amplifi cation of most samples. Based 
on the resulting profi les, additional amplifi cations can be 
adjusted accordingly. It is sometimes the case that using less 
DNA extract provides better results even when quantifi cation 
shows little DNA and no evidence of strong inhibition. 
  23.  Any validated multiplex STR kit may be used with this extrac-
tion method. A wide range of commercial kits are available 
with different buffer formulations and STR amplicon sizes that 
can affect typing success depending on the quality and quan-
tity of DNA obtained. The number of loci that should be tar-
geted depends on the nature of the case/event. Events 
involving a small number of people, and/or with reference 
samples directly from the missing persons themselves, will not 
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require a large number of loci for highly signifi cant results. 
Larger events with many missing persons, particularly if refer-
ence samples from relatives are used, call for a greater number 
of loci. Depending on the reference samples that are available, 
multiple different multiplex kits may be needed to provide 
enough loci for suffi ciently signifi cant results from genetic kin-
ship analysis. 
  24.  Sensitivities between instruments may vary within a lab, and 
from lab to lab. Manufacturers may recommend a range for 
both injection voltage and injection time that should be tested 
in internal validation experiments. 
  25.  DNA extractions from aged bone samples are subject to a wide 
range of copurifying molecules. In addition to a potentially 
wide range of PCR inhibitors with a variety of effects, often 
substantial quantities of microbial or fungal DNA are also 
extracted. The latter increase the sequence complexity of the 
PCR reaction and can decrease PCR effi ciency. In some cases, 
nonspecifi c amplifi cation products of microbial origin can be 
obtained. These peaks usually have different morphology and 
do not correspond to size bins of authentic amplicons, but it is 
important that analysts be aware of the potential for such 
artifacts. 
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 Chapter 14 
 Interpretation Guidelines for Multilocus STR Forensic 
Profi les from Low Template DNA Samples 
 Zoran  M.  Budimlija and  Theresa  A.  Caragine 
 Abstract 
 Low template (LT) DNA testing is a more sensitive method of PCR DNA typing which tests lower quantities 
of DNA compared to traditional PCR DNA protocols. Methods applied in this testing involve amplifi ca-
tion or postamplifi cation efforts to increase detection sensitivity. Establishing the interpretation rules of 
the results obtained is  condition sine qua non for successful incorporation of this valuable technique into 
forensic casework. Here we describe a successfully optimized and validated approach to interpretation of 
LT-DNA samples. 
 Key words:  DNA ,  Interpretation ,  Low template DNA ,  Optimization ,  Forensics 
 
 Low template (LT) DNA (also known as high sensitivity DNA, 
low level DNA, trace DNA, touched DNA) testing is a state-of-
the-art technology used to recover and detect small amounts of 
DNA. It has been used throughout the scientifi c world for many 
years and it is not unique specifi cally to the forensic community 
 ( 1– 3 ) . In 1996, Taberlet et al .  ( 4 ) described “reliable genotyping 
of samples with very low DNA quantities using PCR,” while in 
1997 Findlay et al . reported single cell STR analysis  ( 5 ) for applica-
tions other than forensics . As early as 1999, the Forensic Science 
Service in the UK implemented LCN DNA in their casework as an 
alternative to mtDNA  ( 6 ) . 
 Low template DNA (LT-DNA) analysis can be defi ned as DNA 
typing results from samples with low input amounts and/or com-
promised quality which show enhanced stochastic effects. These 
random phenomena include allelic drop-in, allelic drop-out, 
increased stutter formation, and intralocus peak height imbalance. 
 1.  Introduction
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The recognition and interpretation of these effects are based upon 
a laboratory’s internal validation  ( 6– 10 ) . 
 Template amounts that generate these increased stochastic 
effects typically are below 100 pg of DNA, the equivalent of 16 
diploid cells (one diploid cell contains ~6 pg of DNA). LT-DNA 
testing is a modifi ed version of routine (high template) nuclear 
DNA testing (HT-DNA). It examines the same regions of DNA 
and uses the same procedures, but they are adjusted to increase 
testing sensitivity by one or more of the following means: addi-
tional amplifi cation cycles, postamplifi cation purifi cation, reduced 
reaction volume, capillary electrophoresis injection enhancement 
by increased voltage or time, and/or nested PCR. Preamplifi cation 
strategies, such as reextraction or DNA template concentration are 
not considered LT-DNA methods  ( 11– 19 ) . 
 The potential for typing inaccuracies and irreproducibility due 
to stochastic effects and contamination risks are notable concerns 
that any laboratory considering LT-DNA analysis should contem-
plate and evaluate  ( 7,  20 ) . That is why special attention must be 
paid to the optimization and incorporation of existing HT-DNA 
methodologies in the development of LT-DNA protocols. Stringent 
quality control and detailed testing procedures, as well as specifi c 
interpretation protocols designed to accommodate stochastic 
effects are necessary. 
 
 To validate and implement LT-DNA testing, the laboratory must 
start with excellent quality practices, pertaining to the following:
  1.  Facility conditions—Space should be dedicated to LT-DNA 
testing, consumables and buffers should be free of DNA, 
analysts should don proper personal protective attire, and lab-
oratory space and utensils should be cleaned before and after 
LT-DNA work  ( 21,  22 ) (see Note 1). 
  2.  Quality control tests on all reagents—All reagents used should 
be tested with their respective assays to ensure they are func-
tioning and are free of DNA (see Note 2). 
  3.  Quality control tests on all instruments (see Note 3). 
  4.  Evaluation of controls with every test—Each test should include 
the appropriate controls. Positive controls test the robustness of 
the assay and should be amplifi ed using an appropriate DNA 
input amount. Negative controls, including extraction nega-
tives, purifi cation negatives, and amplifi cation negatives identify 
possible contamination during testing and are treated using the 
most sensitive conditions applied to the samples. Since it is rec-
ommended that all controls be amplifi ed in triplicate  ( 7 ) , with 
 2.  Materials 
(Quality Practices 
and Testing 
Procedures)
 2.1.  Quality Practices
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an extraction batch size of nine samples, for example, there may 
be up to nine negative control amplifi cations. Due to the sensi-
tivity of the system, some alleles may be detected in the negative 
controls; therefore, interpretation guidelines should be estab-
lished based on a laboratory’s validation (see Note 4). 
  5.  Measures to detect exogenous DNA in a sample—Efforts 
should be made to build an elimination database containing 
the DNA profi les of all personnel who could potentially have 
contact with the evidence or the testing facility. These profi les 
are for quality control purposes only. 
  6.  Analysts qualifying tests—Samples with known DNA profi les 
which are unknown to the analyst should be used to perform 
qualifying tests. In order to mimic appropriate casework condi-
tions, sample extracts should be diluted to LT-DNA levels, if 
necessary. These tests are performed following training in each 
procedure and at consistent intervals thereafter. 
  1.  Evidence triage and extraction—Virtually any type of biologi-
cal sample could be a candidate for the LT-DNA testing 
approach. However, some of the most probable substrates for 
this kind of testing include the following touched items (where 
skin cells were potentially deposited): clothing that has been 
touched or grabbed, handled items, car swabs, handles of brushes 
or combs, tools jewelry, keys, lighters/matches, pens, sides of 
bottle and cans, weapons (gun swabs, knife, handles, sticks), 
limited contact samples (door knob, window sill), fi nger-
prints (fresh and archived), air bags, letters and envelopes, and 
objects used for binding or strangulation (cords, ropes, strings, 
zip ties, tape). Degraded and/or inhibited samples may also be 
candidates for this testing. Potential LT-DNA samples should 
be extracted using a specifi c protocol designed to enhance 
DNA recovery (see Note 5). 
  2.  Quantitation—The determining factor as to whether the sam-
ple will be treated as a LT-DNA sample is the recovered 
 quantity of DNA. Samples wherein less than 100 pg of 
 template DNA would be amplifi ed in each reaction tube are 
generally considered LT-DNA samples (see Note 6). 
  3.  Amplifi cation strategy and adjustments. 
 The amplifi cation strategy presented in this chapter is 
based on internal validation  ( 7 ) . The AmpFlSTR ® Identifi ler 
PCR Amplifi cation Kit (Applied Biosystems) is used according 
to the manufacturer’s recommendations with the exception of 
a 2-min annealing time for each of 31 cycles and the use of a 
half-reaction volume with 2.5 U of Taq. All amplifi cations are 
carried out in the ABI GeneAmp ® PCR System 9,700 thermal 
cycler (Applied Biosystems) within thin-walled 0.2 mL AB 
MicroAmp ® (Applied Biosystems) (see Note 7). 
 2.2.  Testing 
Procedures
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  4.  Separation and Analysis. 
 Five microliters of each PCR product and 0.375  μ L of Gene-Scan ® 
500 LIZ ® Size Standard (Applied Biosystems) is prepared with 
HIDI formamide (Applied Biosystems) for a total volume of 50  μ L 
and injected with parameters established with validation studies. 
Since often there are large peak height differences between short 
and large loci, in order to detect a profi le in its entirety, samples 
may be injected with more than one injection condition. In these 
cases, results for each locus from the injection of highest quality 
should be used (see Note 8). 
 In addition to injecting each sample replicate, 5  μ L of each of 
the three replicate PCR products are combined and mixed to form 
a pooled sample. Despite the fact that this sample is not to be 
evaluated autonomously, it is very useful for consecutive analysis, 
due to the fact that allelic peak imbalance is less pronounced. 
 
 Testing and interpretation protocols established through validation 
 ( 7,  23 ) , in addition to stringent quality control measures, address 
the concerns regarding stochastic effects observed with LT-DNA 
samples. For example, stutter peaks are more common, and if they 
occur in an early cycle of PCR, they will be larger relative to the 
height of true peaks. Nonrepeating alleles, otherwise termed allelic 
drop-ins are a very minor component of the template. It cannot be 
determined whether drop-ins were deposited prior to, during, or 
after evidence collection. Peak imbalance may arise through prefer-
ential sampling of very few copies of an allele. In extreme cases, an 
allele may not be amplifi ed (drop-out) resulting in false homozy-
gosity or, even locus drop-out. 
 The DNA extract may be amplifi ed in duplicate, triplicate, or even 
quadruplicate and repeating alleles may be assigned to the consen-
sus or composite profi le. These approaches ensure the accuracy of 
allelic assignments by identifying allelic drop-ins and drop-outs, 
and increase the number of determined alleles and loci in the sam-
ple  ( 6,  7,  24– 26 ) . The described procedure herein is based on the 
independent amplifi cation of three aliquots per sample. 
 Profi le determination goes beyond the generation of a consensus 
or composite profi le. Rather analysis of LT-DNA samples is a two 
step process. In the fi rst step, confi rmed alleles are assigned to the 
consensus profi le. To be confi rmed, alleles must be labeled in at 
least two of the three amplifi cations. Sample interpretation always 
has to start with a decision as to whether or not there are enough 
components in a profi le in order to proceed. The interpretation 
 3.  Methods 
(Interpretation 
Procedures and 
Guidelines)
 3.1.  Interpretation 
Procedures
 3.1.1.  General 
Considerations
 3.1.2.  Consensus Approach
 3.1.3.  Two Step Analysis
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should stop if, for example, there are fewer than eight repeating 
alleles over at least six autosomal loci in the consensus profi le. 
Caution should be exercised when there are more than six repeating 
alleles at a minimum of two loci in the consensus profi le. 
 The second step is to apply the interpretation protocols which 
are specifi c to the sample class (mixture vs. single source). 
 A sample can be interpreted as a “single source” (when it is clearly 
possible to assign alleles), a “deconvoluted mixture sample” (when 
the major donor is determined or assigned), a “mixture for com-
parison only” (when no major component could be determined), 
or “inconclusive” (when there are either too few or too many 
alleles to draw any conclusion). 
 If a locus cannot be deduced according to the interpretation guide-
lines below, the locus is deemed inconclusive. 
 Special attention must be paid when assigning heterozygotes and 
homozygotes because of random PCR effects. With HT-DNA sam-
ples, often stochastic peak height thresholds are established. 
However, due to PCR and electrophoresis enhancements, peak 
heights may be tall for even extremely low amounts of DNA (Fig.  1 ). 
 3.1.4.  Possible Outcomes
 3.1.5.  Interpretation 
Guidelines for Single 
Source and Deconvoluted 
Mixtures
 3.1.6.  Single Source
 Fig. 1.  Interpretation guidelines, not stochastic peak height thresholds, are applied to assign a homozygote in a single 
source sample amplifi ed with 16.4 pg of template DNA in each of three replicates. A homozygote cannot be assigned at 
any of the loci shown since one (major) allele is either not present in all three amplifi cations, or all other alleles are >30% 
of its intensity. Note that the potential false homozygote allele reaches heights above 7,000 RFUs. 
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This precludes the use of a stochastic peak height threshold and 
necessitates the use of a different set of interpretation protocols. 
 A heterozygote is determined based on repeating alleles. In 
general, the two alleles must be the tallest peaks at a locus in at least 
two out of three amplifi cations (no peak height ratio requirement). 
However, there are defi ned exceptions. If two repeating alleles are 
clearly major alleles, any additional repeating alleles which are con-
sistently minor, are not assigned. If there is the same repeating 
allele in the ±4 bp stutter position of another peak, and its intensity 
in RFU is <30% of the major allele in two out of three amplifi ca-
tions, and, in addition, its intensity is <50% of the major peak 
intensity in the third amplifi cation, it cannot be a part of the 
heterozygote pair. In those cases assign the tallest peak and an indi-
cator, such as a Z, that another allele  could be present. 
 Homozygosity (not based on RFU threshold), is assigned if the 
same major allele is present in all three amplifi cations, and all other 
alleles (if applicable) are <30% of its intensity (Fig.  1 ). If an allele, 
even if it does not repeat, is >30% of the repeating major allele, it 
could be an indicator of allelic drop-out. The possibility of a heterozy-
gote should be considered. In addition, homozygosity should always 
be questioned at the following less effi cient or higher molecular 
weight loci (CSF1PO, TH01, D16S539, D2S1338, D18S51, and 
FGA). In degraded samples, the largest apparent locus should also 
be considered a possible false homozygote, as well as all loci in sam-
ples with less than 20 pg of input template DNA per replicate. 
 In any case, when the two alleles in one of three amplifi cations 
are  completely different compared to the other two amplifi cations, 
the locus should be deemed inconclusive (Table  1 ). 
 If there are at least three repeating alleles at a minimum of three 
loci (3 × 3 rule) a sample may be considered a mixture. Even if 
there are not at least three loci with at least three repeating alleles, 
if the results of different replicates are not consistent with each 
other, a sample should be considered a mixture. Once a mixture 
 3.1.7.  Mixtures
 Table 1 
 The locus is deemed inconclusive when two alleles in one 
of the three amplifi cations are completely different 
compared to the other two amplifi cations 
 Replicate “a”  12, 13 
 Replicate “b”  12, 13 
 Replicate “c”  14, 15 
 Consensus or composite profi le  12, 13 
 Assigned alleles  Inconclusive 
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has been established, the most important and, at the same time 
most challenging task in LT-DNA interpretation, is to deconvolute 
the mixture, or assign a DNA profi le to the major contributor. 
 A mixture should only be deconvoluted if the ratio of the 
contributors is greater than 2:1. The pooled amplifi cation product 
is helpful in this determination, due to the fact that heterozygote 
pairs are generally more balanced in the pooled sample than in the 
individual replicates. The validated rules are: Alleles can be assigned 
to a major component if they are labeled in all three replicates and 
if they are major peaks in at least two replicates (Fig.  2 ). A heterozy-
gote duo is assigned if the balance between the two peaks is at least 
50% in two out of the three amplifi cations. Homozygosity in mix-
tures has to be deduced with extreme caution. If an allele is major 
in all three amplifi cations, and all other peaks are <30% of its inten-
sity, it can be assigned as a homozygote. In all other cases, assign an 
indicator of the possible presence of another allele. There are several 
instances where heterozygosity should always be suspected. These 
are the larger, higher molecular weight and the less effi cient loci 
 Fig. 2.  Deconvolution of a mixture amplifi ed with 50 pg of template in each replicate. Alleles are assigned to the major 
component if the alleles are labeled in all three replicates and they are major peaks in at least two replicates. Moreover, 
the peak height ratio of the heterozygote pair must be at least 50% in at least two amplifi cations. Note that in the “b” 
replicate of the third locus, the peak heights are too close to ascertain which allele is the tallest. At the fourth locus, the 
peak height ratio of the 11 allele to the 12 allele in the pooled “abc” sample, does not confi rm the 11, 12 assignment from 
the individual replicates, and therefore the pair cannot be deduced. 
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(CSF1PO, TH01, D16S539, D2S1338, D18S51, and FGA) and 
TPOX. Prone to primer binding site mutations, TPOX is especially 
concerning when components of mixture share the same alleles 
 ( 27 ) . False homozygosity should also be suspected and an indicator 
assigned at the last apparent locus in each color and all loci for 
samples with input template DNA less than 20 pg per replicate. 
 For mixture interpretation, the pooled sample (independent 
CE run of the combined amplifi ed replicates) can be useful although 
it must not be analyzed independently. Rather, caution should be 
exercised if the pooled sample does not confi rm allelic assignments 
from the triplicate amplifi cations (Fig.  2 ). 
 The deduction guidelines above apply to major components 
only. If a contributor is assumed, the DNA profi les of the minor 
component may be assigned based on the repeating alleles that 
cannot be attributed to the assumed contributor. 
 Samples that cannot be deconvoluted may be used for comparison 
with a known profi le. Results from all amplifi cations are utilized 
including nonrepeating alleles, since they could come from the real 
(minor) source of DNA. However, for qualitative comparisons, 
only loci with at least one repeating allele are considered. Several 
scenarios based on qualitative comparisons are possible: 
“Included”—a person could be a contributor to the sample if all 
alleles are labeled in the results.; “Cannot Be Excluded”—if one or 
two alleles consistent with those of a known sample are not appar-
ent in a mixture (or below threshold); “No Conclusions”—no 
determination can be made since, for example, three alleles consis-
tent with those of a known samples are not apparent in a mixture at 
less effi cient loci; “Excluded”—if there is insuffi cient evidence to 
support that a known sample could have contributed to a mixture. 
 “Cannot Be Excluded” Statement—Qualitative statements 
provide a valuable piece of information to the court, but must be 
explained adequately. Specifi cally, the parameters that defi ne the 
use of the statement should be clearly stated. There are scientifi c 
explanations for the absence of the allele(s) consistent with the 
known sample. This absence can be attributed to the amount of 
DNA amplifi ed, artifacts such as stutter, degradation, empirically 
defi ned locus characteristics, the length of the STR repeat, and/or 
the number of contributors to the sample. 
 In order to assign a statistical value to these types of compari-
sons, statistical software has been developed. This software calcu-
lates the likelihood ratio (LR) of the probability of a given mixture 
if a particular individual, such as a suspect, did or did not contrib-
ute to the mixture (NYC OCME, manuscript in preparation) . For 
these quantitative comparisons, results from all amplifi cations are 
utilized, including loci with no repeating alleles. The software 
developed and validated at the NYC OCME, the Forensic Statistical 
Tool (FST), employs empirically determined drop-out and drop-in 
rates based on single source samples and mixtures amplifi ed with a 
 3.1.8.  Mixtures (or Mixture 
Components) for 
Comparison Only
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range of template DNA amounts, mixture ratios, and the number 
of contributors. Other methods employ probabilistic estimates of 
drop-out and drop-in rates  ( 28– 31 ) . 
 Mixture identifi cation and deconvolution is certainly a challenging 
process. Interpretation protocols, training, and supervisory review 
serve to resolve this issue. It is highly recommended to have mul-
tiple levels of review: initial analysis and technical review of the 
sample and control electrophoretic results; analysis and technical 
review of case results, and for complex mixture deconvolutions, an 
additional level of technical review. 
 The relevance of the absence or the presence of someone’s DNA in 
a mixture depends upon the context of the case. Forensic analysts 
are only able to report and explain the results of the DNA they are 
able to detect in a sample. They cannot determine when the sample 
was deposited, how long the sample was there, or how the sample 
was deposited. Nevertheless, analysts can relay results from studies 
that demonstrate that with respect to “touch” DNA, it is highly 
unlikely that one could attribute a DNA profi le in a case to second-
ary or tertiary transfer  ( 32 ) . 
 In conclusion, following internally validated LT-DNA quality 
control, testing and interpretation methods consistently yield reli-
able results. When establishing these protocols, laboratories must 
demonstrate through their own validation procedures that their 
methods, which might include any adjustments, are robust and 
reproducible. To implement these procedures, analysts and techni-
cal reviewers must be properly trained to interpret and explain the 
results and their weight. 
 
  1.  Facility conditions.
 Proper protective attire: full laboratory gowns, face masks  ●
covering nose and mouth, gloves (double gloves) for 
bench work and evidence examination, hair coverings, 
booties if available. 
 Testing performed in dedicated, protected workspaces:  ●
Perform all bench work and examination of LT-DNA items 
under a hood. Each process is performed under a different 
hood space if available. 
 Decontamination of equipment: Surface decontamination  ●
of pipettes, cap openers, racks, hoods, counters, centri-
fuges, robots, etc.—Rinse several times with 10% bleach 
stored in the specialized containers that mix the bleach 
contents as they are used. Rinse with 70% Ethanol. Rinse 
 3.1.9.  Technical Review
 3.2.  Courtroom 
Specifi cs
 4.  Notes
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with distilled water. Irradiate or fume consumables such as 
plates and tubes, swabs, and water (see below). 
 Daily maintenance: Clean work area before and after each  ●
operation. For hoods, apply UV light for 10 min after use. 
 Weekly and monthly laboratory clean-up: Wipe down all  ●
benches, hoods, instruments, pipettes, cap openers, scis-
sors, and tweezers with bleach, water, and ethanol. 
Replenish laboratory supplies as needed according to the 
inventory lists. Irradiate or fume consumables such as 
plates and tubes, swabs, and water (see below). 
 Irradiation in a Stratalinker  ● ® 2400: UV irradiation “breaks 
down” DNA so that DNA testing is not compromised. All 
plasticware, water, and buffers are irradiated in a 
Stratalinker ® UV Crosslinker 2400 (Stratagene, La Jolla, 
CA, USA) prior to use. The strength of the UV light in the 
Stratalinker ® should be tested weekly. 
 Other preventive measures: Two sets of disposable gloves  ●
should be worn in order that the outer gloves may be 
changed frequently without exposing the skin. Aerosol-
resistant pipette tips should be used and changed on every 
new sample to prevent cross-contamination during liquid 
transfers. For manual processes, only one sample tube 
should be opened at a time, and tubes should be opened 
with a cap opener and/or clean tissue. For all practices, 
tissue culture technique should be employed such that 
there is no crossing over of open tubes or reagents. 
  2.  Amplifi cation kits should be tested for sensitivity down to, for 
example, 6.25 pg. For this test, the sample must generate the 
expected number of determined alleles using the interpretation 
protocols. Kits should be retested periodically. 
  3.  Routine temperature monitoring on thermocyclers and QRT-
PCR instruments and pipette calibration should be conducted. 
To ensure that the capillary electrophoresis (CE) machines are 
functioning properly, the height of a size standard peak in 
amplifi cation negative controls should be monitored within a 
determined interval. 
  4.  According to the validation studies of the protocols presented 
here, 89% of the time the controls were clean. The detected 
alleles were random and not due to gross contamination. The 
threshold for the total number of spurious alleles tolerated over 
three negative control amplifi cation replicates was determined 
by adding the average number of labeled alleles observed in 
three amplifi cations replicates that displayed drop-ins plus two 
standard deviations of the average. If more alleles are detected, 
the batch should fail. If the sensitivity of the system increases, 
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the number of total drop-ins detected over three replicates may 
increase and accordingly the threshold may increase. 
 However, as an additional precaution, if a labeled allele 
repeats in two of three replicates of a negative control, any 
sample having that labeled allele at that locus should be deemed 
inconclusive for that locus. One or two repeating alleles are 
tolerated since one cannot attribute the source of such a small 
amount of DNA. However, if more than two alleles repeat 
over three replicates of a negative control, the batch fails. In 
fact, the number of repeating alleles permitted in negative con-
trols should not increase as this indicates confi rmed DNA. 
  5.  At the New York City Offi ce of Chief Medical Examiner sam-
ples are sampled with a patent-pending swab premoistened 
with 0.01% sodium dodecyl sulfate (SDS ). Swabbing is per-
formed with a light touch and, if applicable, with the grain of 
the item. If needed, more than one swab per item or section of 
an item is used. Due to the use of detergent, DNA is extracted 
from swabs as soon as possible following collection. 
 LT-DNA extraction: Samples are incubated in 0.05% SDS 
and 0.72 mg/mL proteinase K at 56°C for 30 min with shaking 
at 1,400 rpm, then at 99°C for 10 min without shaking. 
Following centrifugation, the digest is purifi ed and concen-
trated twice with Microcon ® 100s (Millipore, Billerica, MA, 
USA) pretreated with 1  μ g of fi sh sperm to prevent DNA loss. 
The DNA is eluted with 20  μ L of water, and is measured and 
amplifi ed within 1–3 days of extraction. 
  6.  Two microliters of sample is quantitated on the Rotor-Gene Q 
3000 ® (Qiagen, Valencia, CA, USA) using an Alu-based real 
time PCR assay based on the method described by Nicklas and 
Buel  ( 33 ) , with the exception of the addition of 0.3  μ L of 
100X SYBR green I (Molecular Probes) and 0.525 mg/mL 
BSA in a 25  μ L reaction volume. The concentrations of stan-
dards and calibrators should be verifi ed in triplicate three times, 
 for a total of nine tests using a different mode of quantitation 
(such as a spectrophotometer). In order to prevent DNA loss, 
these standards and calibrators should be stored in single use 
aliquots at −20°C in high concentrations. The dynamic range 
of the assay extends from 0.39 pg/ μ L to 1600 pg/ μ L and 
measurements are within 30% of their expected value. The no 
template control threshold was set at 0.1 pg/ μ L. 
  7.  Amplifi cation protocol: Soak at 95°C for 11 min; 31 Cycles 
(Denature at 94°C for 1 min, Anneal at 59°C for 2 min, Extend 
at 72°C for 1 min); 60 min incubation at 60°C; Storage soak 
indefi nitely at 4°C. 
  8.  CE injection parameters: Samples may be injected at either 
1 kV for 22 s (low), 3 kV for 20 s (normal), or 6 kV for 30 s 
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(high) on the ABI Prism ® 3100xl Genetic Analyzer (Applied 
Biosystems). All 150, 100, and 75 pg samples are injected low; 
50, 25, and 20 pg samples are injected normal; and 12.5 and 
6.25 pg samples are injected high. For the low and the normal 
injections, 0.5  μ L of allelic ladder and 1  μ L of a 1/10 dilution 
of the positive control (100 pg template) with 0.375  μ L of 
LIZ are prepared with HIDI formamide in a total volume of 
16  μ L. For the high injection, 0.3  μ L of allelic ladder and 1  μ L 
of a 1/20 dilution of a positive control (100 pg template) are 
prepared in the same fashion. Data are collected using nonvari-
able binning and a base line window of 250. 
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 Chapter 15 
 Interpretation Guidelines for Mixed-STR Multilocus 
Electrophoretic Profi les 
 Juan  Antonio  Luque  
 Abstract 
 The interpretation of multilocus STR profi ling is a complex task that requires a high degree of expertise 
due to the high number of variables that can affect a biological and analytical process like this. 
 The purpose of this chapter is to provide guidelines to categorize the mixtures using a discrete system 
and select those in the white area to produce a profi le for reporting and/or comparing. 
 Key words:  DNA analysis ,  Mixtures ,  LR ,  STRs ,  Interpretation guidelines 
 
 The interpretation of multilocus STR profi ling is a complex task 
that requires a high degree of expertise due to the high number of 
variables that can affect a biological and analytical process like this. 
If we analyze the same sample twice, the results will not be fully 
identical. When we analyze mixed profi les, the degree of complex-
ity increases, and we must take into account additional factors like 
the number of individuals in the sample, the ratio between profi les, 
allele masking, and the fact that mixture of two profi les is not 100% 
additive (see Note 1). 
 There are two main approaches for the analysis of DNA mixed 
and single-source profi les (each one with its pros and cons): 
A discrete system based on thresholds that determine a valid 
profi le/allele when it is above those thresholds. It consists of three 
steps: profi le determination, comparison with reference samples, 
and statistical evaluation (RMNE or LR) in case of compatibility/
match. Unfortunately, there are a number of situations around the 
threshold diffi cult to solve, where the experience of the expert is 
crucial.
 1.  Introduction
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 A continuous system based on probabilities which in one step  ●
compares any peak from the evidence with reference samples, 
obtaining a fi nal value of LR conditioned to some events like 
allelic drop-out, stutters, heterozygous imbalance, … each one 
with an associated probability. 
 The robustness of a DNA profi le can be classifi ed in a gradient 
from 0, where we would have no certainty (baseline level profi le), 
to 1, where we would have absolute certainty of the result  (utopia). 
Some authors  ( 1 ) have defi ned three categories for single-source 
profi les symbolized with three colors: red, amber, and green. The 
red zone comprises low template DNA (LTDNA) profi les where 
extreme drop-out phenomena are common, while the green area 
comprises “conventional” profi les where the possibility of drop-
out is negligible. There will be an intermediate amber zone. In the 
case of mixtures, the situation is more complex, but the categories 
can be defi ned similarly. We prefer to symbolize the categories with 
a black area where the results are not conclusive, a white area 
where, with a proper routine, we can have a good degree of confi -
dence in the results, and fi nally a gray area in between where 
LTDNA components or complex combinations make the interpre-
tation diffi cult. In mixed profi les, the limits are not defi ned, so a 
good analytical phase and a high degree of expertise in the inter-
pretation can reduce the gray area in favor of the white area (at 
least in some components). 
 In the continuous system, there are no categories. The black 
side would be the equivalent to 0 (bottom of the black area in the 
discrete system) and the white side would be the equivalent to 1 
(top of the white area in the discrete system) with a continuous 
gradient of gray in between; the closer it is to the black side, the 
more intense the gray is, depending on the probability value. We 
will have a series of “good” profi les, using the discrete system 
(white area) or using the continuous system (area next to white 
where the probability of drop-out and other phenomena is negli-
gible). There will be another series of profi les unusable (black 
area—discrete system—and area next to black-continuous system). 
In the intermediate zone (gray) with the continuous system, the 
value of LR will refl ect the degree of certainty. In the discrete sys-
tem, the results in this gray area can be considered as inconclusive. 
An experienced analyst can move many profi les to the white area, 
but it is a subjective system and may be subject to errors. Therefore, 
if we fi x high thresholds (very safe), we can leave many unsolved 
cases, and if we are more permissive, we solve more cases, but 
sometimes wrongly (especially if you do not have vast experience). 
It seems clear that continuous system is more advantageous, how-
ever not without drawbacks. On the one hand it is complex to 
implement and it requires expert systems, or at least some com-
puter tools that you have to train (as an analyst) and to validate 
intensively. On the other hand, you need to incorporate an LTDNA 
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framework. Finally, the continuous model does not give a profi le 
for entry into a national criminal database, for exchange between 
laboratories or simply to compare results from different analysts. 
Therefore, the best solution is a combined system where there 
is a series of steps to categorize the profi les, and to evaluate directly 
those in the white area, while the profi les of the gray and black area 
require LTDNA strategies and expert systems based on the con-
tinuous method, to help the analyst to take decisions and report 
results in numerical form. 
The purpose of this chapter is to provide guidelines to catego-
rize the mixtures using a discrete system and select those in the 
white area to produce a profi le for reporting and/or comparing. 
We do not try to make a comprehensive compilation of all possible 
situations that may arise in the interpretation of mixtures, because 
the large number of variables and situations would far exceed the 
scope of this chapter. Instead we opted for a series of steps that 
forces us to evaluate most of the issues and prevent to make mis-
takes (maximizing the white area with a reasonable safety). In 
many cases, we have questions rather than answers, since many 
aspects are ambiguous and cannot be resolved, or there is no con-
sensus on how to solve them, but at least we can rule out incorrect 
answers. Some aspects of the interpretation of mixtures as the cri-
teria for analysis and interpretation of LTDNA will be detailed in 
other chapters. We refer to them. Regarding the continuous sys-
tem, since it depends on expert systems, it requires no guides, but 
a validation process. We refer to specifi c publications on these 
systems. 
 
 The fi rst step before interpreting mixed profi les is to have a quality 
profi le. The analyses of single-source samples (not mixed) are less 
stringent about the profi le quality than the analyses of mixtures. 
The laboratory’s quality requirements should be high in case of 
dealing with mixtures (see Note 2). 
 Do not try to interpret mixed profi les of poor quality, best, try 
to improve the analysis before making an interpretation of mix-
tures (see Note 3). If you have some loci fully drop-out, we must 
be aware that there may be additional allelic losses, degradation, 
and stochastic effects.  Where possible, the evaluation of incom-
plete mixed-profi les should be avoided. It must always evaluate the 
full profi le, not locus-by-locus independently. Most parameters are 
from the whole profi le (e.g., mix ratio or number of contributors). 
It is not appropriate to use different assumptions for each locus. 
 2.  Methods: 
Interpretation 
Guidelines for 
Mixed-STR Profi les
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 The fi rst step is to analyze the samples and controls with the editing 
program. It is important, especially when working with mixtures, 
that the control sample results should be correct. Poor quality 
results in control samples are indicative of that part of the process 
was not correct, and therefore the results may be affected and not 
follow the parameters set in the validation of the method. 
 In an EPG we can fi nd:
 Allelic peaks from sample.  ●
 Nonallelic peaks produced by artifacts in extraction/amplifi ca- ●
tion (mostly stutter and nonspecifi c amplifi cation) or in the 
detection system and software (mainly spikes and pull-up). 
 No peaks. Those constituents of the sample that do not appear  ●
in the profi le. It is important to determine in mixed samples 
when it can arise drop-out (see Note 4). 
 The more relevant nonallelic peaks in mixtures are the stutters. 
If there are components of the mixture at stutters level, these must 
be evaluated. 
 The software must be confi gured to check all peaks above the 
limit of detection (LOD) (see Note 5). It is important to turn off 
automatic stutter removal in software, so that all peaks are recog-
nized. At a later point it will be evaluated if those are stutters or 
possible alleles. 
 All peaks detected are recorded for the following steps (see 
Notes 6 and 7). 
 Having identifi ed the possible constituents of the mixture, it must 
be characterized by a number of parameters to use in subsequent 
steps. At this point, the determination of these parameters need 
not be accurate because at a later step we will refi ne the profi le. 
Where statistical evaluation will be performed, we will reevaluate 
the parameters with the refi ned profi le. 
 The determination of the parameters is done recursively, so a 
change in a parameter will change another (e.g., a change in the 
number of contributors needs to recalculate the mix ratio). 
Similarly, the separation between major and minor profi le can 
change the parameters (see Note 8). 
 This step is the starting point for the entire routine. We determine 
if we have a single-source profi le or a mixture (see Note 9). If you 
determine that it is a single-source profi le, all subsequent steps are 
avoided, going directly to the comparison with reference samples 
or the introduction into the database. In mixed samples, we must 
determine the minimum number of contributors. This number 
may be distinct from the actual number of contributors. We can 
estimate the maximum number of contributors that it is reasonably 
consistent with the results. 
 2.1.  Call Peaks 
and Alleles
 2.2.  Characterize Mix
 2.2.1.  Determine Number 
of Contributors
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 As a general rule, while determining the number of contributors, 
peaks at stutter positions that do not exceed the threshold (ST) are 
not taken into account.
 If there are two or more loci with three or four alleles, the  ●
number of contributors will be established initially as two or 
more (see Notes 10 and 11). 
 If there is a locus with more than four alleles (see Note 11), the  ●
number of contributors will be established as three or more 
(see Note 12). 
 If fi ve or more alleles are observed in at least half of the loci of  ●
a profi le, it should be suspected of more than four individuals. 
It is recommended to use these profi les only to exclude indi-
viduals (see Note 13) unless major/minor components can be 
separated. 
 The ratio of components is a global property of the mixture, 
depending on the relative amount of DNA from each component, 
and therefore must be evaluated locus-by-locus for the whole pro-
fi le. Several factors such as degradation, stochastic effects, or inhib-
itors can cause the ratio not observed homogeneous in all loci. Mix 
ratio can be evaluated only in mixtures of two components, or 
mixtures of more components if they have a separate major profi le 
of two components. In the latter case, we must take into account 
that there may be the phenomena of masking and/or overlap 
between alleles and stutter peaks. 
 For evaluating the profi le mix ratio, the process is as follows:
 We will use the loci showing four alleles.  ●
 If there is no degradation, all loci have a similar signal, and  ●
therefore we will use all the loci with four alleles. 
 If there is degradation, select those loci with four alleles above  ●
T RFU . If all loci show the minor component below T RFU , we will 
select those loci where the major component is above T RFU . If 
all alleles at all loci of four alleles were found below T RFU , we 
will use all of them but the estimate may not be accurate. 
 The mix ratio at each locus is the sum of the two higher peak  ●
alleles divided by the sum of the two lower peak alleles (see 
Note 14). 
 The profi le mix ratio is the average of all loci. If there is any  ●
outlier locus, it may be discarded from the calculation. 
 Heterozygous balance (really, it would be imbalance) varies between 
loci due to stochastic and analytical effects. Each laboratory, based 
on working conditions and status of equipment, will observe more 
or less heterozygous balance. Each markers system has more or less 
heterozygous balance (Hb) according its optimization. The condi-
tions and purity of each DNA extract infl uences Hb. 
 2.2.2.  Determine Profi le 
Mix Ratio
 2.2.3.  Determine Mix 
Heterozygous Balance
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 In single-source samples, the heterozygous balance is the ratio 
in height between the smallest peak and the highest peak. The 
maximum allowed for nondegraded samples in excess of 500 pg is 
>0.6  ( 2 ) .  The value of all loci in mixtures cannot be accurately 
predicted because of overlapping phenomena, it can only be calcu-
lated on loci showing four alleles (for the major component and for 
the minor component separately). We will use the mixture heterozy-
gous balance (mHb) defi ned as the average of the heterozygous 
balances of each component from all loci where four alleles were 
detected. This parameter is used as an indicator of the quality of 
the profi le. A high heterozygous imbalance makes us think that the 
quality of the sample is not good and may have a predominance of 
stochastic phenomena. 
 In mixed profi les, each component can be different and one or 
more components may be LTDNA or be degraded (see Note 15). 
In these cases, if you can clearly separate profi les, each one can 
carry a different analysis routine (“conventional” or LTDNA strat-
egy). If you cannot separate them, the values determined in the 
previous section can vary between loci, applying LTDNA strategy 
for the entire profi le becoming necessary. 
 The aim of this step is to determine what type of mix we have 
in terms of the proportion of components and try to separate the 
major component (locus-by-locus). 
 We will use a mnemonic, 3-3-3, to set the criteria (>3:1 profi le mix 
ratio, >3:1 major/minor height ratio, 0.3 imbalance = mHb >0.7). 
As a general rule, two component mixtures with a ratio less than 
3:1 should not be separated because there is a high risk of making 
erroneous assignment (see Note 16). Also as a general rule, the 
allele ratio to be separated must be higher than ( n + 1):1, where  n 
is the number of contributors (in mixtures of two individuals to 
separate a major from a minor allele, it is a must to have a height 
ratio of 3:1 between alleles). This rule can also be used to discard 
peaks in stutter position. Finally, the mix heterozygote balance 
should be high (>0.7) (see Note 17). 
 For two components mixes over the T RFU , with a  profi le mix 
ratio >3:1, we can use the following logic (don’t use in profi le mix 
ratio <3:1, degraded samples nor LTDNA samples):
 In four alleles loci with two components, there is no problem,  ●
the two highest peaks are the major components (see Note 
18). 
 In two alleles loci if the major/minor ratio is >3:1, the major  ●
one can be separated as homozygous. If the proportion of 
major/minor is less than 2:1, the major component is heterozy-
gous for both alleles (see Note 19). 
 In one allele loci, the major component is that allele.  ●
 2.3.  Categorizing Mix
 2.3.1.  Separation 
of Components
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 In three alleles loci, the origin can be two heterozygous sharing  ●
one allele or a homozygous plus heterozygous. If the allelic 
ratio is >3:1, the major component can be separated (homozy-
gous or heterozygous). If the profi le is well balanced (Hb >0.8) 
and the major components are heterozygous, with a ratio >2:1, 
it is suffi cient to separate the major one. 
 As a result of the previous point, samples can be classifi ed into 
three categories  ( 3 ) , taking into account the full profi le:
 Type A: Mixtures of indistinguishable contributors, where it is  ●
not possible to distinguish a single-source major component 
and all alleles of all loci are above the T RFU . Samples with clear 
indications of degradation are not included in this section. The 
comparison and evaluation should be done on the complete 
profi le. 
 Type Am: Mixtures with a mixed major component. These are  ●
mixtures in which a major profi le, composed of two or more 
individuals, has been separated. In this case, the mixed major 
profi le must be evaluated separately as a mixture of Type A. 
 Type B: Mixtures with a major single-source component.  ●
Mixtures with a separated major single-source component 
across all loci. This separated profi le can be compared, evalu-
ated, and reported as a single-source profi le, indicating that it is 
a major profi le plus a minor component. If you have to evalu-
ate/report the no major profi le, it must be done like a profi le of 
type A (the complete profi le). Only in some loci, it will be pos-
sible to establish with certainty the minority profi le, which can 
be used for exclusion. No minor should be reported separately 
ever, because the alleles may be masked with the major profi le. 
 Type C: Mixtures with stochastic effects and/or degradation.  ●
These include mixed profi les with one incomplete component. 
The analyst must state the type C profi les in one of the following 
categories (see Note 20):
 Interpretable profi le with enough quality to continue the  –
process. 
 Profi le useful only to exclude (not conclusive for inclu- –
sion). In this category fall the most partial profi les if not 
confi rmed. 
 Uninterpretable profi le.  –
 Edition of profi les for the evidence must be independent of the 
reference samples. The profi le must be established before proceed-
ing to the comparison or to be entered into databases. It is there-
fore necessary to check the result by double editing the results. 
This double editing can be from the same EPG by another analyst 
or from different amplifi cation or extraction, depending on the 
 2.3.2.  Mixtures Categories
 2.4.  Refi ning Mixture
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sample and the laboratory routine. If you make double extraction or 
amplifi cation, it is not necessary to edit each profi le in duplicate (in 
type C and nonmajor type B mix is recommended to always double 
editing each replica). If the result is the same for all peaks declared 
as alleles, you will proceed to the next stage. If there are discrepan-
cies, one analyst, both analysts or a supervisor must conduct new 
editions/replicas to confi rm the result. 
 At this step, if the profi les are of type A, the stutters would be 
discarded by difference between alleles. If some stutters (below 
ST) remain and there are no alleles from the mixture at stutters 
level, they can be removed. 
 Before comparing with the suspect profi le, the results must be 
compared with samples from known contributors. Depending on 
the mixture, if the number of contributors or the allelic balance 
throughout the whole profi le is not consistent, it may be necessary 
to recalculate the parameters and repeat the previous steps. For 
example, in a locus with four alleles where the known contributor 
is homozygous, if we have declared the sample coming from two 
contributors, it should be rephrased as composed of three 
components. 
 If the result is a mixture of two contributors including the 
known contributor, alleles in mixed profi le not present in the 
known contributor profi le will be considered mandatory, and all 
must be present in the profi le of the suspect to be considered as a 
match. 
 At this point, the result can be compared with reference sam-
ples. In case of no suspect, the data can be sent to the criminal 
database. It is highly recommended for samples that are sent to the 
database to be analyzed in duplicate from the original sample, if 
possible. If not possible, you should perform at least a second 
amplifi cation. 
 If the match with the suspect is full (taking into account the 
allelic proportion and balance between peaks), it is reported as 
compatible with the mixture, always accompanied by the appropri-
ate statistical evaluation. 
 If minor component alleles are at stutters level and match, it 
will be reported as compatible, together with the statistical evalua-
tion taking into account the possibility that it may be a stutter. 
It  will be declared inconclusive when the match is based solely on 
stutters and alleles masked by the major (to report it as compatible, 
at least three loci must have compatible alleles at no-stutter 
 positions—nor masked). 
 If the suspect has alleles not present in the sample or there are 
mandatory alleles in the mixture not present in the suspect, the 
exclusion must be confi rmed with a second extraction from the 
original samples (evidence and reference sample), if possible, to 
confi rm that there has been no contamination or tubes interchange. 
In parallel, we must review all the parameters to look for erroneous 
 2.5.  Compare Mixed 
Profi les with 
Reference Samples
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inferences, especially in type C or minor type B mixtures. If you 
change a parameter, you must well document the reason and justi-
fi cation for the change; you should not attempt to change the 
results determined before the comparison, because it is not correct 
to modify conditions after comparison with reference samples, 
unless the error was obvious. If you make any substantial changes, 
it must be confi rmed by a new analysis (see Note 21). If duplicates 
confi rm the results, report as not compatible. If you get a compat-
ible result, it will be reported as compatible and accompanied by 
the corresponding statistical evaluation (it is mandatory to review 
and document if the initial error has affected other samples). 
 If the sample is not available for a new analysis, you can ana-
lyze/compare with other samples from the same source to confi rm 
the results. 
 If the profi les have been reported as inconclusive or uninterpreta-
ble, statistical evaluation should not be done. 
 Whenever compatibility is declared, it must be accompanied by 
the appropriate statistical evaluation. We prefer the use of LR with 
alternative hypotheses, because it allows different responses to dif-
ferent situations and individuals. RMNE calculations is an alterna-
tive, but this value is characteristic of the mixture, and therefore its 
value is equal for all individuals supported. 
 The way to perform the statistical evaluation is complex in 
some cases and has many nuances. It is beyond the scope of this 
chapter, so we refer to the specifi c recommendations and existing 
publications  ( 2,  4– 7 , elsewhere). 
 In some countries, the prosecution and the defense propose 
hypotheses, but in other countries the laboratory reports an LR 
with standard assumptions deduced from the available informa-
tion. If you do so, these hypotheses must be mutually exclusive, 
and should be attempted to be symmetrical. Report the possibility 
of evaluating the results with other hypotheses. 
 The reports should include the parameters, hypothesis and 
numerical statistical result for LR, together with a concise 
 explanation of the meaning of this value. 
 
  1.  If we mix two profi les, the heights of common alleles in both 
constituents are not exactly the sum of individual peaks. This 
effect can be easily checked with internal size standard: in a 
typical electrophoresis, all samples have the same amount of 
internal size standard; however, when comparing the peak 
height of size standard in different samples we will see differences 
from sample to sample. In the electrophoresis reagent blank 
 2.6.  Statistical 
Analysis
 3.  Notes
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(which only have formamide and size standard), the peak 
heights can be several times higher than in the samples. 
  2.  Some important aspects to consider regarding the quality of 
the profi les when interpreting samples (not exhaustive):
 Degraded samples can show heterozygous imbalance.  ●
Furthermore, the existence of nondegraded and degraded 
DNA makes the mix ratio and the number of contributors 
diffi cult to determine. Two common causes of DNA deg-
radation are poor preservation of samples and extraction 
systems that degrade the sample. 
 Good electrophoresis. If the capillary, the buffer, or the  ●
polymer is not in good condition, fl attened peaks occur in 
the higher molecular weight alleles, loosing mix ratio and 
heterozygous balance. Tip: always use fresh buffer and 
polymer (max 72 h on the sequencer) and not exceed the 
number of injections for the capillary recommended by the 
manufacturer or verifi ed in the validation of the method. 
 Always work in the optimal signal range where the response  ●
is linear to the amount of DNA. Typically, this range is 
between 500 and 2,000 RFUs. Above 4,000 RFUs pull-up 
effect can arise. In mixtures it is diffi cult to get all the com-
ponents in this range, so you have to adjust the amplifi ca-
tion and electrophoresis parameters depending on the mix 
and target component. For example, in fi ngernail trace anal-
ysis, it is preferable to overamplify slightly the sample with-
out saturating the major component, to bring the minor 
component to the optimum level. If we analyze a seminal 
fraction from differential lysis with a residual component of 
the victim and a male major component, adjust the signal to 
the major component although some of the minor compo-
nents can disappear, unless it is of interest. It is important to 
note that if we suspect the presence of mixed male–male, 
female–female, or more than two individuals, it is preferable 
to overamplify the sample, because the result of quantifi ca-
tion is the result of the sum of the components, and there-
fore there is less of each component. In male–female mix, it 
is easier to adjust the optimum if we make the quantifi cation 
of both components. 
 Keep equipment well maintained to get a good baseline on  ●
electrophoresis. The presence of a high baseline is indica-
tive of problems in electrophoresis, with the reagents, with 
the software analysis parameters and/or matrix, and it may 
produce the appearance of unexpected peaks. Typically, a 
detection limit value of 50 RFUs is employed, but not 
always the analyses meet this criterion. Each laboratory 
should establish an empirical limit of detection value in real 
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analysis conditions and review it periodically, checking that 
the analysis conditions are maintained. 
  3.  If control samples (ladder, electrophoresis blank, extraction 
blank, positive control, negative control) do not produce the 
expected results, analyze the cause and repeat the analysis from 
the point where it failed, once the problem is solved. Sometimes 
even when all controls are correct, electrophoresis can fail for a 
sample. Usually, you can detect it in the internal standard size. 
Repeat electrophoresis of the sample before discarding the 
results defi nitively. 
 If the signal does not reach the recommended optimum 
level, amplify again with more amount of DNA, if possible. If 
you cannot (usually low template DNA (LTDNA)), there are 
post-PCR techniques to increase the sensitivity (increasing 
injection time, raising the amount of amplifi ed DNA in the 
injection tube, concentration of the amplifi ed sample, etc. …). 
In this case, the interpretation of results cannot be done with 
the standard conditions. The laboratory must validate the 
effects of working in these conditions (and generally it should 
be the employed criteria of LTDNA). 
  4.  Nonallelic peaks:
 Spikes: They are peaks produced by brief analytical system  ●
failure. Their morphology is narrower than allelic peak and 
sometimes appears in multiple channels. They are usually 
not reproducible, so they should disappear when repeating 
the electrophoresis. 
 Stutters: They are generated in the amplifi cation. They  ●
tend to be reproducible when electrophoresis and/or 
amplifi cation are repeated in the same conditions. These 
are associated with each allele, and can be − n or + n (−4bp 
or +4bp stutters in tetrameric STR). They are inherent in 
the system and therefore we can determine a stutter 
threshold (ST) during method validation. +n peaks have 
less intensity and they usually are not detected. Each labo-
ratory, each locus has a different stutter threshold, so it is 
important that each laboratory evaluates their stutter 
thresholds in the same analytical conditions as those used 
with the samples. The stutters are indistinguishable from 
alleles and are always present in greater or lesser extent. 
The larger the peak the greater the stutter associated. In 
the case of mixtures, LTDNA level components can be 
combined with stutters to produce signals above the 
threshold indicating the presence of an allele or may not 
to exceed this threshold. 
  5.  There is some controversy over the term LOD. Recently, 
Budowle et al. have redefi ned the threshold as PAT (peak 
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amplitude threshold) defi ned as “The lowest peak height value 
for which a laboratory will operationally treat an instrumental 
response as the detection of DNA fragment rather than simple 
instrument noise.” We still use the term LOD for homogene-
ity with other laboratory analytical techniques, understanding 
it like the effective limit of detection obtained in the validation 
of the technique. Any peak above this value is considering 
valid. 
 Additionally, Budowle et al. have redefi ned the stochastic 
threshold (T RFU as recommended by the ISFG  ( 2 ) ) as MIT 
(match interpretation threshold). 
  6.  The record of results is a very relevant issue in the evaluation 
of mixtures. If such entry is not complete, information will be 
lost. There are several ways to record the DNA profi les:
 Original electronic fi le (raw data): It is not practical because  ●
it is not edited. 
 Electronic edited fi le: They require software to review. Not  ●
all software can export edited profi les for exchanging. Not 
suitable for databases and reports. 
 Hard copy: Requires a manual review whenever you need  ●
for comparing. Can be included in reports. Not suitable 
for databases. 
 Table of alleles: It is the simplest for exchanging results,  ●
reports, and databases. It loses all the quantitative informa-
tion. It is best suited for single-source profi les. In mixing 
profi les, a decision on the peaks to be recorded is required. 
 Table of alleles with height/peak area: It would be the  ●
most complete exchange format. Record is more complex. 
It requires to report the thresholds to evaluate it. It 
 complicates the operation with databases. 
 Table of qualifi ed peaks: Peaks are categorized. The thresh- ●
olds are implicit. It would be the optimal profi le inter-
changing format between laboratories and databases for 
mixtures. It requires qualifi ed laboratories and to redesign 
databases. 
  7.  We think that the future in exchanging of mix profi les should 
be either an allele table height/peak area or a table with quali-
fi ed peaks, because criminal databases are designed for sharing 
and searching of single-source profi les, but in the case of mixtures 
they could be improved. For this purpose, we propose a ‘quali-
fi ed nomenclature’, taking into account that is a tentative. 
It needs to be further tested and validated before it can be 
established as a routine nomenclature  (see e.g., in Fig.  1 ): 
 Record all peaks above the LOD separated by “/”.  ●
 Peaks below stochastic threshold are noted in parentheses.  ●
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 Peaks that do not meet the stutter threshold of an adjacent  ●
peak are marked with an “s” after the allele name. 
 Peaks that are in a pull-up position with a peak with DNA  ●
excess in another channel are marked with a “p” after the 
allele name. 
 Alleles consistent with known contributors are marked  ●
with “−” after the allele name. 
 Peaks separated as major are marked with “+” after the  ●
allele name. 
 In case of suspicion that may have allelic drop-out, a new  ●
allele will be introduced: “d” (lowercase). If the entire 
locus is drop-out, a “D” (uppercase) will be introduced 
instead. 
This approach can be very useful for comparison of sample 
replicas. Each analyst records the edited analytical profi le fol-
lowing qualifi ed notation. A second analyst or reviewer can 
compare all replicas/editions, debug and/or comparing with 
reference samples, recording the fi nal reportable profi le. 
  8.  For the calculations, there are no signifi cant differences when 
using the peak area or peak height. Loci with high range of 
alleles, e.g., FGA, HMW peaks tend to be more fl attened 
(wider and lower) than LMW peaks, being preferably the peak 
area. On the other hand, if there is partially overlapping alleles, 
 Fig. 1.  An Example of peaks annotation in a mixed-STR profi le. Record all peaks above the LOD separated by “/.” Peaks 
below stochastic threshold are noted in parentheses. Peaks that do not meet the stutter threshold of an adjacent peak are 
marked with an “s” after the allele name. Peaks that are in a pull-up position with a peak with DNA excess in another 
channel are marked with a “p” after the allele name. Alleles consistent with known contributors are marked with “−” after 
the allele name. Peaks separated as major are marked with “+” after the allele name. In case of suspicion that may have 
allelic drop-out, a new allele will be introduced: “d” ( lowercase ). If the entire locus is drop-out, a “D” ( uppercase ) will be 
introduced instead. 
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e.g., 9.3–10 TH01, or “split peaks” problems (−A/+ A), it is 
usually better to use peak height. For simplicity, we will indi-
cate peak height (the term can be exchanged for peak area). 
  9.  In theory there is never a single-source profi le, because always 
it can appear additional peaks (stutters, drop-in, contamina-
tion). In fact, in standard analysis they can’t be seen. If using 
increased sensitivity analysis, these additional peaks can be 
revealed, so the analysis in these conditions requires special 
rules (LTDNA/LCN). In practice, once a profi le is declared as 
no apparent mixture, it will be considered for all purposes as a 
single-source profi le. Only if the nature of the case suggests the 
possible existence of no observed minor components, increase 
sensitivity analysis will be carried out. For example, in the anal-
ysis of traces attached to fi ngernails, if you perform a conven-
tional analysis based on the amount quantifi ed, a high number 
of samples in this initial analysis will reveal not possible minor 
components;  a sample overamplifi cation gets the minor com-
ponents at a detectable level, although most times we are in the 
range of LTDNA. Today, with real-time quantifi cation of total 
and male DNA, it is easier to adjust the amount to be amplifi ed 
in male–female mix. 
  10.  The presence of a single locus profi les with three alleles can be 
explained by the possible existence of triallelic patterns/ 
trisomies. In these cases, electrophoresis should be repeated to 
confi rm that it is not a spurious extra peak. If this continues, it 
must be amplifi ed again, preferably with a different set of 
 primers from those used previously. 
  11.  The loci with four alleles should be examined carefully:
 If they are not consistent with respect to the mix ratio, we  ●
must think that the mixture consists of at least three 
individuals. 
 If a major and a minor component can be separated clearly,  ●
the presence of a major or a minor with three alleles is 
indicative of a mixture of at least three individuals. 
  12.  If you see more than four alleles, it is diffi cult to assign a number 
of contributors. In a simulation with SGM +™  ( 8 ) 66% of the 
mixtures of four individuals shows six or fewer alleles. In con-
trast, for mixtures of three individuals, only 3.3% have four or 
fewer alleles and for mixtures of two individuals 4.4 × 10−8 
have one or two alleles. Thus, the assessment of contributors is 
quite robust if four or less alleles are observed when taking into 
account the allelic balance and proportion, whereas not for 
more alleles. 
  13.  The presence of more than four alleles causes multiple  problems. 
First, we must check thoroughly the absence of contamination 
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or amplifi cation failure caused by non-specifi c primers or 
 inadequate temperatures. It is recommended to repeat with 
another primer pair. Secondly, it is diffi cult to establish the 
number of individuals and the relative proportions between 
them, so a statistical evaluation using the LR is very complex. 
Finally, the presence of many alleles makes some individuals 
(with frequent alleles) easily compatible with the mixture. 
  14.  For ratios near 1, may be the selected alleles are from different 
components due to stochastic fl uctuations. This fact does not 
signifi cantly infl uence the result. 
 In case of extreme mixes, because the minor component 
presents low signal, estimating the proportion may not be 
accurate. 
  15.  A very common example in forensic laboratories occurs in 
 vaginal samples. These samples have two components, the epi-
thelial cells of the victim and the aggressor’s sperm. Victim’s 
cells in living people are always fresh cells at the time of collec-
tion, while the cells of the aggressor (sperm, buccal cells, or 
other) may be hours or days old, and therefore may have 
undergone degradation processes. If this situation occurs, usu-
ally loci of high molecular weight (HMW) are most affected in 
male component than in female component, while the low 
molecular weight loci (LMW) and miniSTRs have less notice-
able effects. 
  16.  In some cases cannot be separated both components up to a 
mix ratio of 8:1, depending on the combination of alleles and 
the quality of the profi le. Usually from a mix ratio of 10:1 the 
separation of major is safe. 
  17.  If the mHb is high, we can be less restrictive for the difference 
between alleles. If the mHb is close to 0.6, we need to be more 
restrictive. If mHb <0.6 it should not try to be separated. 
 The values to use can be the following (always with a mix pro-
fi le ratio >3:1):
 Imbalance <0.3 (mHb >0.7) apply ratio major/minor >3:1.  ●
 Imbalance <0.4 (mHb >0.6) apply ratio major/minor >4:1.  ●
 Imbalance >0.4 (mHb <0.6) did not separate.  ●
 18. If you cannot separate (with a profi le mix ratio >3:1), a mix-
ture of three or more individuals is most likely involved. In this 
case, if there is one allele with a proportion to the other three 
alleles in height >4:1 or <1:3, it can be separated. 
 19. If the ratio of major/minor is between 3:1 and 2:1, there may 
be doubts between a mixture of two homozygous and a major 
heterozygous/minor homozygous mixture. 
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 20. In the Spanish judicial system (guarantor), the principle in 
dubio pro reo (in case of doubt favor the accused) is used. Our 
laboratory, as a laboratory of the judiciary system, must give 
consistent results to the prosecution, and also to the falsely 
accused person an opportunity to be exonerated. If thresholds 
are set too high, it will result in excessive inconclusive results, 
decreasing the chances of defense, and therefore our system 
favors the prosecution. Therefore, one must assume some 
degree of risk in setting thresholds for maximum results at least 
for exclusion purposes. In contrast, if partial results or low sta-
tistical weight (complex mixtures) are reported, may be misun-
derstood by the jury or court, overestimating the statistical 
signifi cance or assume that not excluded is synonymous with 
being source from the sample absolutely (DNA testing tends 
to be overestimated). It is therefore very important in every 
case where no exclusion or compatibility is reported to include 
a statistical evaluation, and make clear the signifi cance of that 
value, and even we can indicate if the statistical signifi cance is 
low. (Some questions to think about: when is low signifi cation? 
There is consensus or rationale answer?. Do all juries, judges, 
prosecutors, or advocates, without a mathematical and scien-
tifi c background (and every analyst) really understand the 
 signifi cance of an LR or RMNE?). 
 21. The most common errors that can occur in interpretation 
(especially if the heterozygous balance is not good or in 
degraded samples) is the misallocation of one or more peaks to 
a major/minor component, identify the wrong number of 
contributors, or eliminate stutters improperly. At the analytical 
level, tube changes, contamination between samples or from 
the analyst, or stochastic events (that produce gain/loss of 
spurious alleles or changes in the proportions) may occur. We 
must distinguish two situations: the discrepancy is within a few 
loci or balance of peaks, or the discrepancy will affect many 
loci. In the latter case if there is no analytical error or contami-
nation, repeating testing will confi rm the results as exclusive. If 
the discrepancy affects few markers, repetition can reproduce 
the same effects, so it is recommended that the repetition will 
be done with another set of primers. If the discrepancy is in 
one marker, you can do complementary analysis to improve 
results. 
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 Chapter 16 
 Capillary Electrophoresis Analysis 
of a 9-plex STR Assay for Canine Genotyping 
 Barbara  van  Asch and  António  Amorim 
 Abstract 
 STR analysis of canine-derived biological evidence for the identifi cation of individuals is becoming an 
important tool for forensic investigations. A protocol for the multiplex PCR amplifi cation and capillary 
electrophoresis of nine autosomal STRs and two fi xed-size markers for sex identifi cation in dogs and 
wolves is described here. The selection of the loci included in the multiplex complies with the recommen-
dations of the International Society for Forensic Genetics in regard to human DNA analysis. The protocol 
is optimized for automatic fragment size detection in an ABI platform. 
 Key words:  Canine ,  Forensic analysis ,  Genotyping ,  Multiplex  PCR ,  Short tandem repeat 
 
 Short tandem repeats (STRs) are becoming an important tool for 
the genetic analysis of biological samples of animal origin in the 
course of forensic investigations  ( 1,  2 ) . Ubiquitous in human envi-
ronments, dogs are probably the most relevant species in this 
regard, as they can be victims, offenders, or contribute to link a 
suspect to a crime scene. 
 A large number of canine-specifi c STRs have been reported in 
the literature  ( 3 ) ; however, only a small fraction was developed for 
use in forensic analysis  ( 4– 9 ) . In that context, we have selected a 
panel of nine canine-specifi c STR loci and developed a protocol 
for multiplex PCR amplifi cation and capillary electrophoresis 
analysis  ( 10 ) . 
 The method described here, allows for the simultaneous ampli-
fi cation and analysis of nine autosomal STRs (FH3210, FH3241, 
FH2004, FH2658, FH4012, REN214L11, FH2010, FH2361, 
and C38) that can be used for the genetic identifi cation of an 
 1.  Introduction
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individual and parentage testing in dogs. FH3241, REN214L11, 
FH2010, and FH4012 loci present a perfect tetranucleotide repeat 
structure, whereas FH3210, FH2004, FH2658, FH2361, and 
C38 present complex repeat structures. PCR product sizes are rel-
atively short, ranging from 106 to 347 bp (shortest and longest 
alleles in the panel, respectively). The STRs included in this multi-
plex were selected based on the following criteria, in agreement 
with the recommendations of the International Society for Forensic 
Genetics (ISFG) for human forensic standards: (a) tetranucleotide 
repeats; (b) fl anking regions without palindromic sequences or 
long polynucleotide stretches; and (c) separate chromosomal loca-
tions, avoiding known coding regions and telomeric and centro-
meric localizations. The multiplex also includes an additional 
system for sex identifi cation comprised by two fi xed-size fragments, 
one located in the sex-determining region in chromosome Y and 
the other in the androgen receptor gene in chromosome X. 
Moreover, this multiplex can also be used for the typing of wolf 
samples and allows for the statistical discrimination between dogs 
and wolves, provided that a population database of reference geno-
types is previously constructed  ( 11 ) . 
 Canine-specifi c STR analysis by PCR amplifi cation followed by 
capillary electrophoresis follows the same principles as human STR 
typing. Therefore, general recommendations concerning samples, 
equipment, and reagent handling should be followed  ( 12 ) . 
Recommendations for the analysis of nonhuman DNA should also 
be consulted  ( 1,  13 ) . 
 
 Prepare all solutions at room temperature using ultrapure RNAse-
free water. Store PCR reagents at −20°C when not in use. 
Fluorescently labeled primer solutions are light-sensitive and should 
be stored in dark. Formamide is potentially hazardous and should 
be handled with care. Use and store pre- and post-PCR samples, 
reagents, and instruments separately. Use disposable gloves and 
aerosol resistant pipette tips to prevent cross-contaminations. 
  1.  2× QIAGEN Multiplex PCR Master Mix (QIAGEN GmbH, 
Germany) (see Note 1). 
  2.  Labeled and unlabeled oligonucleotide primers (Applied 
Biosystems) (see Table  1 ). 
  3.  RNAse-free water (QIAGEN). 
 The analysis of PCR products is optimized for ABI PRISM ® PCR 
System 3130xl (Applied Biosystems). The following material list is 
recommended by the manufacturer.
 2.  Materials
 2.1.  PCR Reagents
 2.2.  Capillary 
Electrophoresis
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  1.  MicroAmp ® Optical 96-Well Reaction Plate (Applied 
Biosystems, Foster City, CA). 
  2.  HiDi formamide (Applied Biosystems). 
  3.  GeneScan™LIZ ® -500 internal size standard. 
  4.  Four-capillary array 36 cm × 50  μ m (Applied Biosystems). 
  5.  Performance Optimizer Polymer 7, POP-7 (Applied Biosystems). 
  6.  GeneMapper ® Software v4.0 (Applied Biosystems) for frag-
ment size determination. 
  7.  Allelic ladder composed by sequenced alleles for comparative 
sample typing. 
 
 The nine autosomal STR loci (designation, chromosomal location, 
repeat motif, PCR product size range, allele size, and allelic range) 
and the two fi xed-size markers for sex determination are summa-
rized in Table  1 (see Note 2). 
 3.  Methods
 3.1.  Loci Information
 Table 1 
 Loci included in the multiplex: chromosomal location, repeat motif as determined 
by sequencing, PCR product size range and allele range of the nine STR loci 
included in the multiplex 
 Locus  Chromosome  Repeat motif  Size range (bp)  Allele range 
 FH3210  CFA2  (AAGA) n 
a  230–315  14–35.1 
 FH3241  CFA8  (TTCT) n  250–270  9–14 
 FH2004  CFA11  (AAAG) n 
a  161–257  9–33 
 FH2658  CFA14  (GAAA) n  106–138  9–17 
 FH4012  CFA15  (TTTC) n  119–143  14–20 
 REN214L11  CFA16  (GAAT) n  154–162  6–8 
 FH2010  CFA24  (TTCA) n  154–170  9–13 
 FH2361  CFA33  (TTTC) n 
a  231–347  12–41 
 C38  CFA38  (TTCT) n 
a  132–217  11–32.1 
 AR  X  Not applicable  185  Not applicable 
 Sry  Y  Not applicable  106  Not applicable 
 Chromosomal location and PCR product size are given for two fi xed-size markers for sex identifi cation 
(AR and Sry) 
 a Basic repeat motif in locus with complex structure 
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 A primer mix for a large number of samples should be prepared in 
advance thus avoiding pipetting errors, reducing pipetting time, 
and contributing to increase PCR reproducibility. Primer sequences, 
fl uorescent labels, and concentration in the multiplex are given in 
Table  2 . 
 A graphical representation of the multiplex is presented in Fig.  1 . 
  1.  Prepare 100  μ M primer stock solutions by rehydrating the 
lyophilized primers with the appropriate volume of ultrapure 
RNAse-free water. Mix well until the primer is completely 
dissolved. 
  2.  Produce 100  μ L of multiplex primer mix (see Note 3). Dispense 
58  μ L of ultrapure RNAse-free water in a tube. Add 2  μ L of 
each forward primer and each reverse primer, except for the 
Sry marker (1  μ L of each primer). Mix the solution thoroughly 
and store in dark at −20°C when not in use (see Table  3 ). 
 3.2.  Primer Mix 
for Multiplex 
Amplifi cation
 Table 2 
 Primer sequences and fl uorescent labels for the nine autosomal STRs and the two 
fi xed-size markers for sex determination (AR and Sry) included in the multiplex 
 Locus  Primer  Primer sequence (5 ¢ –3 ¢ )  Fluorescent label 
 FH3210  F  CAAGGACCACGATGAAATGACT  VIC 
 R  GCTGGATTCAGGAGCTGTTCA  – 
 FH3241  F  TCCTTGTTTCCTTCCTCTGG  PET 
 R  TTGGGCAAAATCAAAACTCC  – 
 FH2004  F  GGGGCTTTGTACTGTGACCTAC  FAM 
 R  ACAGACTGAGAATGCTGGGTT  – 
 FH2658  F  GAGCTCTACATCTGAAACTATAC  VIC 
 R  GAAGACGGTTTGGCAGTTTCT  – 
 FH4012  F  GGGAGGGAAGCGATCTTCT  FAM 
 R  CGGTTAGCCATTCCCTGAG  – 
 REN214L11  F  GGCTCTCCATGCTAAGACC  VIC 
 R  TGGGTCTAATGGTTTGGGATAG  – 
 FH2010  F  CTATTAACAATGTCAGACTCTCAG  NED 
 R  GAGCATGCATGTACACCAGAA  – 
 FH2361  F  GCAGGTCAGAGCAGTCAGAA  NED 
 R  GAATGTACCAGGCACTATGCA  – 
 C38  F  ACAAGAGGGGATGCTGAA  PET 
 R  TCATGTGTCTGTTGGGCATT  – 
 AR  F  CAGCAGCAGCAGCAGGAG  VIC 
 R  CCAGGCTCTGGAACGCAGG  – 
 Sry  F  GATCAAAGGCGCAAGATGGCT  FAM 
 R  CCAGGCTCTGGAACGCAGG  – 
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 Fig. 1.  Genetic profi le of a male sample comprising nine autosomal STR loci (FH4012, FH2004, FH2658, REN214L11, 
FH3210, FH2010, FH2361, C38, and FH3241) and two fi xed-size markers for sex identifi cation (AR and Sry). 
 Table 3 
 Primer concentrations and volumes for the preparation of the PCR primer mix 
including 11 loci (nine autosomal STRs and two markers for sex identifi cation) 
 Primer 
 Concentration 
in primer mix ( m M) 
 Volume ( m L) for multiplex 
primer mix (100  m L at 2  m M) 
 Final concentration 
in PCR mix ( m M) 
 FH3210 F  2  2  0.2 
 FH3210 R  2  2  0.2 
 FH3241 F  2  2  0.2 
 FH3241 R  2  2  0.2 
 FH2004 F  2  2  0.2 
 FH2004 R  2  2  0.2 
 FH2658 F  2  2  0.2 
 FH2658 R  2  2  0.2 
 FH4012 F  2  2  0.2 
 FH4012 R  2  2  0.2 
 REN214L11 F  2  2  0.2 
 REN214L11 R  2  2  0.2 
 FH2010 F  2  2  0.2 
 FH2010 R  2  2  0.2 
 FH2361 F  2  2  0.2 
 FH2361 R  2  2  0.2 
 C38 F  2  2  0.2 
 C38 R  2  2  0.2 
 AR F  2  2  0.2 
 AR R  2  2  0.2 
 Sry F  1  1  0.1 
 Sry R  1  1  0.1 
 Primer volumes for the production of the multiplex primer mix are given based on 100  μ M primer stock 
solutions 
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 Multiplex PCR amplifi cation is optimized for GeneAmp ® PCR 
System 2700 (Applied Biosystems) thermal cycler. The use of other 
equipment may require further optimization.
  1.  Determine the total number of reactions including samples 
and controls (see Note 4), and add one reaction for each set of 
 12 samples, in order to compensate for pipetting errors. 
  2.  Thaw reagents at room temperature (if stored at −20°C) and 
mix the solutions completely to homogenize the concentration 
of different components in the solution. 
  3.  Dispense appropriate volumes of each reagent in the PCR 
tubes according to Table  4 (see Note 5). 
  4.  Add the DNA template (see Note 6) to each PCR tube con-
taining the reaction mix and mix gently. Ensure that the tubes 
are effectively closed. 
  5.  Place the PCR tubes in the thermal cycler using the following 
program: initial polymerase activation step at 95°C for 15 min, 29 
cycles of 94°C for 30 s, 60°C for 1 min 30 s, and 72°C for 1 min, 
and a fi nal extension at 72°C for 60 min. PCR products can be 
stored overnight at 4°C or at −20°C for long-term storage. 
 The protocol is optimized for use in ABI PRISM ® 3130 Genetic 
Analyzer, under the manufacturer’s recommendations. The use of 
other equipment may require adaptation of this protocol and 
further optimization. An example genotype obtained using this 
protocol is presented in Fig.  2 . 
  1.  Prepare a loading mixture for all samples to be analyzed by 
mixing 10  μ L HiDi formamide (Applied Biosystems) and 
0.25  μ L Genescan-LIZ 500 internal size standard (Applied 
Biosystems) for each sample. Add one reaction for each set of 
12 samples, in order to compensate for pipetting errors. 
  2.  Dispense 10.25  μ L of the loading mixture into MicroAmp ® 
Optical 96-Well Reaction Plate wells and add 0.5  μ L of PCR 
product. 
  3.  Place the samples in the ABI PRISM ® 3130 Genetic Analyzer. 
  4.  Analyze the previously prepared samples using Performance 
Optimized Polymer-7 (POP-7) and with default Module 
FragmentAnalysis36_POP7_1 and DyeSet G5. Analyze data 
using spectral G5 generated using Multi-Capillary DS-33 Matrix 
Standard Kit (6-FAM™, VIC ® , NED™, PET ® , and LIZ ® Dyes) 
following the ABI 3130 Genetic Analyzer User’s Manual. 
  5.  Determine fragment sizes using GeneMapper ® Software v4.0 
( see  Note 7 ). 
  6.  Type samples by comparison with the fragment sizes deter-
mined for sequenced allelic ladders. 
 3.3.  Multiplex PCR 
Amplifi cation
 3.4.  Capillary 
Electrophoresis
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 Table 4 
 Reagent concentrations and volumes necessary for one PCR multiplex reaction 
 2× QIAGEN Multiplex 
PCR Master Mix  Primer mix  DNA (ng)  RNAse-free H 2 O 
 Total 
volume 
 Concentration 
in the reaction 
 1×  0.2  μ M  5–10  Variable  10  μ L 
 Volume in the 
reaction 
 5  μ L  1  μ L  Variable  Variable  10  μ L 
 The use of sequenced allelic ladders is recommended in order to 
allow for intra- and interlaboratory comparison of results. An allelic 
ladder can be constructed by isolating and sequencing different 
size STR alleles found in a population sample. The DNA samples 
for which different alleles are identifi ed can be mixed and amplifi ed 
together to produce a ladder. The volume of each individual DNA 
sample in the mixture must be adjusted to produce a well-balanced 
ladder. It is advisable that the ladder for each locus is fi rst produced 
separately. All ladders can then be combined in a complete multi-
plex ladder.
  1.  To produce a DNA mix for the single ladder of each locus, 
combine approximately equal amounts of each DNA sample 
(10–20 ng for heterozygous and 5–10 ng for homozygous), 
aiming at a good balance among alleles ( see  Note 8 ). 
  2.  Prepare PCR amplifi cation by combining 1× QIAGEN 
Multiplex PCR Master Mix (QIAGEN), 0.2  μ M of each primer 
and 3  μ L of DNA mix. 
 3.5.  Allelic Ladders
 Fig. 2.  Schematic representation of observed allelic size ranges and fl uorescent primer labels (FAM in  blue , VIC in  green , 
NED in  black and PET in  red ) for the 9-STR multiplex. The two fi xed-size markers for sex identifi cation (Sry and AR) are 
represented by  circles. 
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  3.  Run PCR program as follows: 15 min initial activation at 95°C, 
32 cycles for 30 s at 94°C, primer annealing at 60°C for 90 s 
and extension at 72°C for 60 s, and a fi nal extension at 60°C 
for 80 min. 
  4.  Combine all the individual ladders in a single mixture (multi-
plex ladder) and assess the amplifi cation balance of alleles by 
capillary electrophoresis, as described in Subheading  3.4 . 
  5.  If adjustment of the relative quantities of each single ladder is 
necessary to obtain a well-balanced multiplex ladder, repeat 
from  step 5 . 
  6.  Dilute the combined multiplex allelic ladder 10 5 times and ream-
plify for stock, using the same PCR conditions as described above. 
 
  1.  We routinely use the 2× QIAGEN Multiplex PCR instead of 
producing a PCR mix from separate components because it 
greatly facilitates reagent logistics, reduces pipetting effort, 
and contributes to increased quality and reproducibility of the 
amplifi cation. The use of other reagents may require further 
optimization of the PCR amplifi cation protocol. 
  2.  The markers for sex identifi cation consist of: a 106-bp fragment 
within the coding region of the  Canes lupus familiaris sex-deter-
mining region Y (Sry) gene (Y chromosome, GenBank AF107021, 
positions 451–556); and a 185-bp fragment within the coding 
region of the androgen receptor (AR) gene (GenBank AY271347) 
in the X chromosome between positions 54897911–54898095 
(Dog Genome, May 2005 assembly; UCSC Genome Browser 
Database). These regions were previously described and validated 
for this purpose  ( 14 ) but we designed and validated new primers 
in order to adequately accommodate these markers in the 9-STR 
multiplex  ( 11 ) . 
  3.  Preparing a volume of 100  μ L primer mix for 100 reactions has 
several advantages: Calculations of the necessary relative volumes 
of the different primers and H 2 0 are straightforward; pipetting 
volumes are not extremely low thus minimizing pipetting 
errors. This volume also represents a good compromise between 
a volume suffi ciently large for 100 reactions and a relatively low 
thawing time at room temperature before the preparation of 
the PCR master mix. 
  4.  We routinely perform negative controls for DNA extraction 
and PCR amplifi cation. Positive controls are also advisable 
when working with ancient, degraded, or low copy number 
DNA samples. 
 4.  Notes
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  5.  PCR amplifi cations can be performed in volumes lower than 
10  μ L. In our experience, good results are obtained in volumes 
as low as 5  μ L, provided that relative concentrations of reagents 
and DNA template are maintained. However, the use of total 
reaction volumes lower than 5  μ L may contribute to low repro-
ducibility due to pipetting errors. 
  6.  Low-purity DNA samples may result in poor amplifi cation 
and a low signal in capillary electrophoresis. It is advisable that 
an adequate method of DNA extraction is performed in order 
to obtain high-purity DNA samples. 
  7.  Degraded and/or vestigial DNA samples may result in reduced 
or failure of amplifi cation of alleles, particularly in the larger 
product-size loci such as FH3210, FH2361, and FH3241. 
The fl uorescent label dyes NED™ and PET ® also contribute to 
a decreased signal in capillary electrophoresis. 
  8.  Allelic ladders should include at least the most frequently found 
alleles. It is advisable to consult the repeat-based standardized 
nomenclature of these markers, as determined by sequencing 
 ( 10 ) . Allele frequencies in sample populations are available for 
dogs  ( 10 ) and wolves  ( 11 ) . 
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 Chapter 17 
 Capillary Electrophoresis of DNA from  Cannabis sativa 
for Correlation of Samples to Geographic Origin 
 Heather  Miller  Coyle  
 Abstract 
 For routine genetic analysis of  Cannabis sativa , two methods are currently in use, (a) AFLP; amplifi ed 
fragment length polymorphism analysis and (b) STR; short tandem repeat analysis. The AFLP method 
used on capillary electrophoresis instrumentation is fully described in this chapter. AFLP analysis generates 
numerous nonspecifi c marker fragments for a complex DNA pattern and is available in kit format for quality 
assurance of reagents. This method is particularly useful when discerning the genetics of highly inbred 
plant species that may share much of the same DNA with only slight differences due to their common 
genetic background. AFLP analysis, however, is most effective on fresh or well-preserved plant specimens 
where the integrity of the DNA is high and the sample is a single source specimen (i.e., not a mixture of 
plants or different species). 
 Key words:  Forensic botany ,  AFLP ,  STR ,  Cannabis ,  Marijuana ,  DNA ,  Environmental ,  Database 
 
 In the United States, organized criminal organizations have increasingly 
used remote areas of American Park Lands for the illegal cultivation 
of high-potency marijuana. These criminal organizations are (a) threat-
ening the safety of visitors to the Parks, (b) damaging the environ-
ment and, (c) funding violent drug cartels  ( 1 ) . These organizations 
employ gangs and illegal aliens to stay with the illegal crops from 
planting until harvest and use a combination of threatening devices 
(booby traps, shotguns, etc.) to keep law enforcement and the 
unsuspecting tourist from entering the crop area. In addition to 
public safety, severe damage to the environment is occurring. For 
every acre of forest planted with marijuana, the equivalents of 
ten acres are damaged by toxic chemicals (illegal use of fertilizers, 
 1.  Introduction
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herbicides, etc.). It is estimated that the cost to US taxpayers for 
restoring the public land to its natural state is approximately 
$11,000.00 per acre  ( 1 ) . These illegal cultivation sites generate 
large amounts of standard garbage, biohazard refuse, and toxic 
waste which seep into the soil and water to affect people, animals, 
and fi sh. 
 Although the local, state, and federal law enforcement agents 
have taken appropriate action through a coordinated effort by 
the National Marijuana Initiative (NMI) and funding by Offi ce of 
National Drug Control Policy (ONDCP) and Department of 
Justice (DOJ), it is diffi cult to eliminate the problem since the 
geographic source (originator) of the material is largely unknown. 
To aid in geographic sourcing, DNA methods are being employed 
to characterize the genetics of the  Cannabis plant and compare 
against known reference samples as is done with many other forensic 
databases  ( 2– 5 ) . 
 In forensic science, DNA databases are routinely used for 
matching evidence to known reference samples to identify a source. 
This same concept is being developed for DNA matching of seized 
marijuana from the United States public land back to a series of 
source samples provided by the Drug Enforcement Agency (DEA) 
and the NMI to link geographic sources together for intelligence 
operations and for subsequent prosecution in Federal court. Two 
methods are currently under consideration: (a) amplifi ed fragment 
length polymorphism (AFLP) analysis  ( 6,  7 ) and (b) STR analysis 
 ( 1,  8– 11 ) . Both methods have their own set of benefi ts and limitations 
but are relatively simple to perform in the laboratory by experienced 
molecular biologists. In the biological research at academic institu-
tions, hundreds of different plant species have been successfully 
genetically analyzed using DNA-based methods  ( 12– 17 ) . In 
this chapter, AFLP analysis will be presented in detail. 
 AFLP analysis is performed using capillary electrophoresis 
(CE) instrumentation. Capillary electrophoresis is a standard method 
for the detection and fi ne resolution of DNA fragments in an 
electrically charged fi eld  ( 18 ) . The instrumentation used at our 
laboratory is the ABI 3130 DNA sequencer and has corresponding 
ABI Genemapper analysis software. The older standard agarose gel 
electrophoresis methods employed by many scientists for analysis 
of polymerase chain reaction (PCR) amplifi ed DNA fragments 
have been replaced by capillary electrophoresis because CE is more 
sensitive for DNA detection, limits the use of toxic chemicals for 
detection, has quality controlled reagents for uniformity in testing, 
and is semiautomated for faster sample processing. CE uses electro 
kinetic injection to inject the DNA sample into a fi ne diameter 
fl exible silicon coated glass tube fi lled with a gel polymer. An electri-
cal charge is applied and fl uorescently tagged DNA fragments will 
separate based on fragment size and molecular charge. Fragment 
information is collected by the DNA sequencer and the fl uorescent 
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DNA fragments are imaged by a CCD camera and the collected 
information (DNA profi le) is then available for further analysis. 
 AFLP analysis uses previously extracted DNA from a single 
source plant specimen and the scientist creates a DNA pattern 
characteristic of the sample by using a series of controlled enzymatic 
reactions to fragment the DNA at specifi c locations based on sequence 
(see Fig.  1 ) and then PCR amplify the fragments and fl uorescently 
label for DNA detection  ( 2,  6,  19,  20 ) (see Fig.  2 ). No prior 
sequence information is required; the reproducibility of the profi le 
is based on the consistent generation of DNA fragments of known 
size after enzymatic digestion with two different restriction enzymes 
(e.g., EcoRI and MseI). A variety of other enzymes have been 
successfully used as modifi cations to this protocol if the plant 
species of interest does not exhibit many fragments. This method 
works well to provide consistent DNA profi les from surface decon-
taminated seeds and fresh plant leaves, both of which yield high 
quality DNA  ( 20 ) ( see  Notes 1 and  2 ). Dried plant material and root 
material that may have bacterial or mold contamination requires 
that each sample be evaluated prior to AFLP analysis for suitability. 
This is best done visually and microscopically. The impact for not 
recognizing contamination is that additional peaks will be present 
in the fi nal DNA profi le that could result in a false exclusion by 
DNA. In addition, if poor quality (highly fragmented DNA of 
500 bases or less) DNA is used with this method; random DNA 
fragmentation may generate inconsistent AFLP results from 
sample extraction to sample extraction. To control for this, duplicate 
extraction may be performed to check for consistency of DNA 
profi les. If the plant samples are selected carefully and the DNA is 
of suffi cient quality, then AFLP analysis is an excellent method for 
discerning the genetics of potentially highly inbred plant species 
 Fig. 1.  The initial steps in the AFLP reaction are DNA extraction and digestion using two 
common restriction enzymes, EcoR1 and Mse1.  This enzymatic digestion fragments the 
DNA at specifi c sites creating a variety of DNA fragments of different lengths. In order to 
PCR amplify the fragments, short segments of known DNA, called linkers or adaptors, 
must be added to the ends of each DNA fragment for PCR primer recognition. 
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( see  Note 3 ). AFLP analysis has been successfully utilized on many 
different crop species including rice  ( 19 ) , corn  ( 19 ) , grapes  ( 12 ) , 
hops  ( 13 ) , sorghum  ( 14 ) , banana  ( 15 ) , and poplar  ( 16,  17 ) . 
 
 All materials and solutions should be prepared with molecular 
biology grade (DNase and RNase-free) ultrapure water. All reagents 
should be stored at −20°F (i.e., frozen; kit components will last 
for up to 1 year) unless in routine day-to-day usage. If reagents are 
being used every day, they may be stored at 4°F (i.e., refrigeration) 
with little effect on expiration date as the kit would be completely 
used within 1–2 months. Standard safety precautions should be used 
when preparing reagents and handling the polymer for capillary 
electrophoresis. Care should be taken to avoid any human or 
other biological contamination to the samples during processing. 
The use of laminar fl ow hoods commonly used for PCR techniques 
is recommended when performing the enzymatic and PCR steps 
for AFLP analysis. 
 AFLP analysis was performed with an AFLP Plant Mapping 
Kit (Applied Biosystems, Inc.)  ( 19 ) . This kit includes the following 
reagents: pre-selective PCR primers, selective PCR primers, core 
 2.  Materials
 Fig. 2.  Once the linkers have been attached to the fragments, PCR amplifi cation can be 
performed using a variety of PCR primer combinations to amplify different subsets of DNA 
fragments based on primer overlap into the DNA fragment. The researcher selects the 
PCR primer combination that gives the most informative patterns and analyzes using 
Genemapper software to convert the complex visual peak image to a binary code. The 
binary code is generated by peak presence or absence whereby presence is scored as a 
“1” and absence is scored by a “0.” The binary code is then the genotype for that sample 
and can be easily data-based into a variety of searchable software programs. 
 
24517 Capillary Electrophoresis of DNA from  Cannabis sativa for Correlation…
mix for PCR amplifi cation, positive PCR amplifi cation control 
DNA, and DNA adaptors. The following reagents are not included 
and must be purchased separately: enzymes MseI (concentration 
50 units/ μ L; New England Biolabs Inc. (NEB]), EcoRI (concen-
tration 50 units/ μ L; Gibco BRL) and T4 DNA ligase and ligase 
buffer with ATP (concentration 5 Weiss units/ μ L; Gibco BRL), 
10× Running Buffer (Applied Biosystems, Inc.), internal ROX size 
standard (Applied Biosystems, Inc.), POP7 polymer (Applied 
Biosystems, Inc.), Hi-Di formamide (Applied Biosystems, Inc.), 
bovine serum albumin (BSA, concentration 5 mg/mL (Gibco 
BRL)), Tris-EDTA (TE) buffer (concentration 20 mM Tris–HCl, 
0.1 mM EDTA, pH 8; molecular biology grade reagents from 
Sigma), and sodium chloride (NaCl; concentration 0.5M; molecular 
biology grade reagent from Sigma). Modifi cations  ( 20 ) to the 
manufacturer’s recommended procedure  ( 19 ) were the following:
  1.  To reduce pipetting error with small volumes of reagents, master 
mixes were prepared for enzymes and adaptors for the digestion–
ligation step in the kit. Master mixes were created, vortexed, 
and used at the recommended volumes for no less than 20 
samples even if there were only two actual samples to process. 
This step increases consistency of DNA profi les substantially. 
All steps were carried out with enzymes maintained in a cold 
block (−20°C) or on ice while reagents were being prepared. 
  2.  Speed and accuracy in preparation of the reagents greatly 
improved the consistency of the AFLP result. It is our recom-
mendation that duplicate sample processing be performed by 
the same or different analysts for confi dence in the results while 
training with the AFLP method. 
  3.  Positive (known DNA from any species for use as a batch 
standard) and negative (reagents and water but no DNA) 
controls should be used with each batch of samples processed 
and analyzed to increase confi dence in the results. The kit 
comes with a positive corn DNA control for the PCR amplifi -
cation step ( see  Note 4 ). For the previous digestion–ligation 
steps, it is recommended that a laboratory standard be gener-
ated for your laboratory and used consistently in addition to the 
corn control. The negative control sample should be volume 
adjusted with sterile water so that all reaction volumes are equal. 
In addition, the personnel that are processing the AFLP samples 
should be genotyped by AFLP as elimination standards for 
contamination as the AFLP method is not species-specifi c. 
  4.  All buffers and polymers should be taken from the freezer or 
refrigerator and warmed to room temperature (approximately 
30 min) prior to use on the 3130 DNA sequencer. This allows 
for increased consistency in results. 
  5.  For genetic analysis, a custom bin set must be generated with 
the Genemapper software for automated comparisons of DNA 
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samples in a database. This is best done with the technical 
assistance of the software supplier (Applied Biosystems, Inc.; 
Foster City, CA). It does not matter which bin sets you choose 
to score the presence or absence of DNA fragments, however, 
to compare or combine AFLP database information, you must 
be using common bin sets to share data between laboratories. 
 
  1.  Sample preparation. DNA samples of high molecular weight 
and the laboratory positive control DNA should be diluted 
or concentrated to approximately 20 ng in a fi nal volume of 
5  μ L of water in a thin-walled 0.2 mL PCR tube. 
  2.  Digestion–ligation enzymatic reaction. The adaptor pairs 
provided in the kit should be heated to 95°C for 5 min, and 
then cooled to room temperature for 10 min to prevent adaptor-
to-adaptor annealing which could result in tandem adaptors 
being accidently amplifi ed as an inadvertent template source. 
Centrifuge for 10 s at 14,000 ×  g . 
  3.  The enzyme master mix was prepared by combining 20× (1 unit 
MseI, 5 units EcoRI, and 1 Weiss unit ligase) in a 0.5 mL sterile 
tube and placing in a −20°F cold block. 
  4.  The adaptor master mix was prepared by combining 20× 
(2.2  μ L 5× ligase buffer, 1.1  μ L 0.5M NaCl, 0.11  μ L BSA, 
1  μ L Mse1 adaptor and 1  μ L EcoRI adaptor). The volume was 
then brought to a fi nal volume equal to 20× (6  μ L minus the 
volume of the enzyme mix) with distilled water. 
  5.  The entire adaptor mix was transferred to the tube containing 
the enzyme master mix, vortexed gently to mix. Centrifuge for 
10 s at 14,000 ×  g . 
  6.  6  μ L of the enzyme/adaptor mix was added to each tube 
containing DNA and gently mixed. The 0.2 mL tubes were incu-
bated at 37°C in a thermal cycler with a heated lid for 2 h. 
  7.  Pre-selective PCR amplifi cation reaction . Dilute each sample 
from step 6 above with 189  μ L of TE buffer. Gently mix and 
transfer a 4  μ L aliquot to a new 0.2  μ L PCR tube and set aside. 
The negative control can be set to an equivalent volume with 
4  μ L of TE buffer with no DNA. 
  8.  Prepare a master mix by combining [the total number of 
samples + 2 additional samples] × [1  μ L AFLP EcoRI and MseI 
pre-amplifi cation primers + 15  μ L AFLP core mix]. Transfer 
16  μ L of the pre-selective master mix to the 4  μ L diluted sample 
in 0.2  μ L PCR tube and gently mix. 
 3.  Methods
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  9.  PCR amplify these samples with the following settings:
 (a)  72°C, 2 min hold step. 
 (b)  20 cycles × [94°C/20 s, 56°C/30 s, 72°C/2 min]. 
 (c)  60°C, 30 min hold step. 
 (d)  4°C storage. 
  10.  Transfer these samples to 0.5 mL sterile tubes and dilute again 
with 380  μ L TE buffer. 
  11.  Selective PCR amplifi cation. If you are beginning this process 
with a new plant species, then the kit provides 64 possible 
selective PCR primer combinations to test against your samples 
to select the optimal primer sets to generate suffi cient numbers 
of well-spaced and easily scorable DNA fragments with a size 
range of 50–500 nucleotide bases. For marijuana, we used the 
selective primer pairs in the following combinations: (1) 
EcoRI-ACT FAM + MseI-CAA, (2) EcoRI-ACT FAM + MseI-
CAT, (3) EcoRI-AAG JOE + MseI-CAT, and (4) EcoRI-AAG 
JOE + MseI-CTA. These primer sets gave fragments that met 
our scoring criteria for the initial 100 marijuana samples tested 
that yielded consistent duplicate DNA profi les. 
  12.  3  μ L of the diluted reaction from  step 10 above was transferred 
to a 0.2 mL tube and set aside. 
  13.  A master mix for selective amplifi cation was prepared using any 
of the primer sets individually listed in  step 11 . The master mix 
was prepared using the formula [total number of samples + two 
additional samples] × [1  μ L of the AFLP EcoRI primer, 1  μ L of 
the AFLP MseI primer, 15  μ L core mix]. 
  14.  Transfer 17  μ L of the master mix to each of the tubes containing 
3  μ L of sample and gently mix. 
  15.  Samples are then PCR amplifi ed using the following “touch-
down” PCR method:
 (a)  94°C/2 min hold step. 
 (b)  1 cycle × [94°C/20 s, 66°C/30 s, 72°C/2 min] 
 (c)  1 cycle × [94°C/20 s, 65°C/30 s, 72°C/2 min] 
 (d)  1 cycle × [94°C/20 s, 64°C/30 s, 72°C/2 min] 
 (e)  1 cycle × [94°C/20 s, 63°C/30 s, 72°C/2 min] 
 (f)  1 cycle × [94°C/20 s, 62°C/30 s, 72°C/2 min] 
 (g)  1 cycle × [94°C/20 s, 61°C/30 s, 72°C/2 min] 
 (h)  1 cycle × [94°C/20 s, 60°C/30 s, 72°C/2 min] 
 (i)  1 cycle × [94°C/20 s, 59°C/30 s, 72°C/2 min] 
 (j)  1 cycle × [94°C/20 s, 58°C/30 s, 72°C/2 min] 
 (k)  1 cycle × [94°C/20 s, 57°C/30 s, 72°C/2 min] 
 (l)  20 cycles × [94°C/20 s, 56°C/30 s, 72°C/2 min] 
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 (m)  60°C/30 min hold step. 
 (n)  4°C, storage. 
  16.  Preparation of samples for detection. Final PCR product (1  μ L) 
is added to 23  μ L Hi-Di formamide + 1  μ L of ROX size standard 
(50–500 size range) to prepare for loading the sample into the 
3130 DNA sequencer ( see  Note 5 ). Each sample is heated to 
95°C for 3 min, quick chilled on ice, and placed in the sample 
tray for injection. Any remaining sample can be stored at −20°C 
until the DNA profi le has been collected and verifi ed as 
acceptable. 
  17.  Electrophoresis conditions for size separation of DNA frag-
ments are the following:
 (a)  For simple DNA patterns: 5 s injection time, 13 kV injection 
voltage, 26 min run time. 
 (b)  For more complex DNA patterns: 12 s injection time, 
15 kV injection voltage, 30 min run time. 
  18.  Data management. DNA profi les generated by AFLP are repre-
sented as fl uorescently labeled peaks that size between 50 and 
500 nucleotide bases. The presence or absence of variable 
peaks in user-designated bin sets in Genemapper 4.0 was origi-
nally determined by analysis of 100 different marijuana AFLP 
profi les. Bins of varying size were created around common 
DNA fragments and each fragment was sized by comparison to 
the internal ROX size standard as no allelic ladder is commer-
cially available for sizing AFLP fragments. A score of “1” was given 
to a peak that fell within the bin and a score of “0” was given if 
no peak was present in the bin of interest. By scoring DNA 
profi les in this fashion, a binary code representation of a 
complex DNA profi le can be entered into a database and auto-
mated for candidate matching. The bin set and scoring criteria 
is necessarily user defi ned as there will always be the possibility 
that any given sample will contain a peak that falls between 
the designated bins. As long as the data scorer uses consistent 
criteria, this is not a signifi cant issue for data management 
( see  Note 6 ). 
 
  1.  Collection of plant evidence, especially drug seizures such as 
marijuana should be collected, documented, and preserved 
using all of the established standard forensic science procedures. 
This method has been validated for forensic use  ( 21 ) . Care should 
 4.  Notes
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be taken to avoid human contamination of the plant sample; 
this is essential as the AFLP method is not species-specifi c. While 
this feature makes the AFLP method highly valuable and 
universal to all species; it can be easy to cross-contaminate the 
sample without proper precautions  ( 20 ) . 
  2.  To decontaminate a sample, a freshly prepared 10% bleach 
solution (sodium hypochlorite) should be used to soak the 
seed or plant sample for 2–3 min with gentle agitation. This 
should be quickly followed by several sterile water rinses to 
remove any residual bleach solution. The surface of the sample 
should now be decontaminated  ( 20 ) . 
  3.  AFLP analysis is highly successful on fresh plant samples and 
seed samples that yield high quality, high molecular weight 
DNA using any of a variety of plant DNA extraction kits 
currently commercially available  ( 20 ) . 
  4.  Each of the AFLP steps can be tested to be sure that they are 
functioning properly by running proper controls during the 
analysis steps. If an enzyme is not functioning, then the inter-
nal positive control set up by the laboratory for the digestion–
ligation step should be inconsistent from sample batch to 
sample batch; otherwise, the same DNA profi le should be 
generated every time. To test the PCR kit reagents for func-
tionality in the pre-selective and selective PCR steps, the corn 
control supplied with the kit is suffi cient and should generate 
the same DNA profi le every time. Negative controls at each step 
of the process should exhibit only background fl uorescence 
or free fl uorescent primers but no DNA peaks should be visu-
alized in the 50–500 nucleotide base size range  ( 19,  20 ) . 
  5.  The quality of the formamide is critical in the detection step. 
We recommend using the Hi-Di formamide since it is supplied 
as a deionized quality controlled product. It should be aliquoted 
in 500  μ L aliquots and stored frozen prior to use. Poor quality 
formamide inhibits proper denaturation of the sample and 
results in poor resolution of data that can make the sample 
diffi cult to score. 
  6.  Candidate matching AFLP samples that are matched against a 
binary code in a database could also be assessed by viewing 
the original data fi les. There is an overlay feature in the Gene-
mapper software that allows for one sample profi le to be directly 
overlaid on the second profi le to determine if they are an exact 
match for number of peaks, both within and outside of the user-
designated bins. This is a nice confi rmation feature to supplement 
the binary coding of DNA samples. 
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 Chapter 18 
 Capillary Electrophoresis of Multigene Barcoding 
Chloroplast Markers for Species Identifi cation 
of Botanical Trace Evidence 
 Gianmarco  Ferri ,  Beatrice  Corradini , and  Milena  Alù 
 Abstract 
 The analysis of nonhuman biological evidence both animal and botanical to fi nd out the correct species of 
a sample comes as a great help to crime investigators. Particularly, forensic botany may be useful in many 
criminal and civil cases, e.g., for linking an individual to a crime scene or physical evidence to a geographic 
location, or tracking marijuana distribution patterns. 
 Despite many molecular techniques for species identifi cation so far applied, botanical evidences are 
still overlooked by forensic scientists due to the lack of reproducible and effi cient protocols standardized 
across a wide range of different organisms and among different laboratories. 
 Recently, the term “DNA barcoding” has been coined to describe the use of a short gene sequence 
from a standardized region of the genome as a molecular tool for species identifi cation. DNA barcodes 
have been successfully applied to a number of animal groups and introduced in forensic science with the 
application of the mitochondrial gene COI. Building on this success, ongoing investigations have searched 
for the best barcode to apply to all land plants. Here we describe the basic protocol based on amplifi cation 
and sequence analysis of barcoding markers for land plants considering the latest developments of Plant 
DNA barcoding Project. The aim of this chapter is to provide forensic scientists an accurate and reliable 
tool for assigning unidentifi ed botanical specimens to the correct species as powerful mainstay in investiga-
tions, increasing the contributions from nonhuman DNA to forensics. 
 Key words:  Forensic species identifi cation ,  Forensic botany ,  DNA barcode ,  DNA sequencing , 
 Universal primers 
 
 Molecular species identifi cation, involving plant or animal samples, 
has become a valuable tool in forensic science, both for crime scene 
investigation and wildlife law enforcement. In genomic era, different 
methods have been developed (before immunochemistry, biochemical 
test, and tissue and cells investigation) based on sequence analysis 
 1.  Introduction
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 ( 1– 3 ) , but the use of molecular markers was recently standardized 
on a large scale by an international taxonomic consortium 
(Consortium for the Barcode of Life, CBOL) through the use of 
one short (relatively) DNA region called “BARCODE”  ( 4 ) . A DNA 
sequence of 648 bp (base pair) of the mitochondrial gene cytochrome 
c oxidase sub I (COI) has been accepted for animal kingdom 
because the fi xed criteria of universality, coverage, sequence quality, 
and discrimination of species were satisfi ed  ( 5 ) . 
 In agreement with forensic quality procedure and standardiza-
tion, the Barcode identifi cation system was applied in forensic animal 
species identifi cation  ( 6,  7 ) and a new Barcode section was opened 
on GenBank with specifi c submission tool  ( 8 ) , because DNA banking 
is a fundamental prerequisite for identifi cation. 
 The Barcode approach also has great potential for identifying 
plants, but faces different challenges when applied to this group 
(we start remembering that the number of species was globally 
different, ~420,000 species of plants vs. ~50,000 species for animal 
vertebrates)  ( 9– 11 ) . 
 The ubiquitous presence of plants makes botanical trace evi-
dence useful for many aspects of criminal investigation  ( 12 ) , but 
remains underused in forensic due to a lack of experience and 
botanical knowledge among investigators, evidence-collection 
teams, and prosecutors and to the diffi culty in routinely identifying 
trace material by traditional morphological methods. The informa-
tion generating from plant DNA identifi cation can be used to pro-
vide links between crime scene and individuals, test alibis, verify a 
sample’s geographic origin, ascertain the possession of illegal or 
endangered species, and much more  ( 13– 15 ) . 
 Differently from animal, the attempts to identify a single 
barcoding locus for plants have largely been unsuccessful, as the 
slow evolutionary rate of plant mitochondrial DNA did not allow 
the use of COI marker and now it is generally agreed that only a 
multilocus approach based on plastid (equivalent to mtDNA source 
for plant genome) data is the most effective strategy. A variety of 
loci have been recently suggested in both the nuclear and plastid 
genome  ( 16– 18 ) , and in 2009, the Barcode Consortium approved 
a two core-locus combination (rbcL+matK, the trnH-psbA marker 
should be collected as a back-up to matK) for land plants identifi -
cation  ( 19 ) . 
 Before the barcode executive committee fi nal evaluation, we 
selected two noncoding plastid regions (trnL-F and trnH-psbA) 
among the 7–10 candidate markers to develop a molecular-based 
identifi cation system for forensic purpose which provides criteria to 
progressively identify an unknown plant sample to a given taxonomic 
rank  ( 20 ) . We analyzed 63 individual plants which usually grow in 
our region and, considering all the species examined, we were able 
to identify at species level more than 60% of samples. The major 
drawback encountered was related to the poor coverage of species in 
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sequence database and the lack of authenticate reference DNA 
sequence. Consequently, given the development of barcoding initia-
tive and the ability of this International Consortium of processing 
thousand of reference sequence in a short time, we review our previ-
ous developed protocol by analyzing the same collected samples 
with the approved barcoding markers (rbcL and matK) by compar-
ing the different use and the different performance when applied in 
the forensic fi eld (manuscript in preparation). We remember that 
forensic botany is underused and most potential users of this method 
are not botanical experts, so that the characteristics of reproducibil-
ity and standardization are fundamental to accurately identify the 
specimens. The fi nal step consists in matching the sequence of the 
evidence sample to a reference sequence through query of public 
nucleotide repositories. Basic Local Alignment Search Tool (BLAST) 
web server at NCBI provides the easiest way to run a quick search 
through online query submission against the largest existing and 
constantly updated database of sequences  ( 21,  22 ) . 
 Since the use and the application in a forensic contest are not 
immediately intuitive, we take advantage of this protocol to describe 
accurately every step to perform the database search. 
 During the commission of outdoor crimes, plant material may 
be frequently transferred from the crime scene to the victim or 
perpetrator; even if identifi cation to the species level is not always 
possible, the identifi cation to higher taxonomic rank can be helpful 
in many situations where the application of a broad species concept 
is accepted. 
 The developed protocol was the same independently from 
used markers (we discuss the best markers’ uses in the next paper 
in preparation) and the approach described here shows all the four-
pair of primers, but the user should consider that the discrimination 
success does not increase after the use of two or three loci. 
 
  1.  QIAamp DNeasy Plant Mini-kit (Qiagen, Hilden, Germany). 
  2.  1M DTT Dithiothreitol (SIGMA-Aldrich), in 10 mM Sodium 
Acetate, pH 5.2. 
  3.  1.5 mL Safe-Lock tubes (Eppendorf AG, Germany). 
  1.  All primers were selected from the literature  ( 16,  19,  20 ) . 
 PCR/sequencing primers for  TrnL-TrnF intergenic spacer 
(amplicon between bp 49868–50305 of  Nicotiana tabacum 
NC_001879 chloroplast genome, including primers).
 TrnL_F 5 ¢ -GGTTCAAGTCCCTCTATCCC-3 ¢ , 0.2  μ M 
 TrnF_R 5 ¢ -ATTTGAACTGGTGACACGAG-3 ¢ , 0.2  μ M 
 2.  Materials
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 PCR/sequencing primers for  PsbA-TrnH intergenic 
spacer (amplicon between bp 28–589 of  N. tabacum 
NC_001879 chloroplast genome, including primers).
 PsbA_F 5 ¢ -GTTATGCATGAACGTAATGCTC-3 ¢ , 0.2  μ M. 
 TrnH_R 5 ¢ -CGCGCATGGTGGATTCACAATCC-3 ¢ , 0.2  μ M. 
 PCR/sequencing primers for  matK gene (amplicon 
between bp 173–1046 in Arabidopsis thaliana gene sequence, 
including primers):
 MatK_3F 5 ¢ -CGTACAGTACTTTTGTGTTTACGAG-3 ¢ , 0.2  μ M. 
 MatK_1R 5 ¢ -ACCCAGTCCATCTGGAAATCTTGGTTC-3 ¢ , 
0.2  μ M. 
 PCR/sequencing primers for  rbcL gene (amplicon between bp 
1–599 in Arabidopsis thaliana gene sequence, including primers):
 RbcL_F ATGTCACCACAAACAGAGACTAAAGC. 
 RbcL_R GTAAAATCAAGTCCACCRCG. 
 All primers were purchased from OPERON-MWG bio-
tech, desalted and lyophilized.
  2.  QIAGEN Multiplex PCR kit (Qiagen). 
  3.  MicroAmp reaction tubes (0,2  μ L) (Applied Biosystems). 
  4.  Thermal Cycler (Veriti thermal cycler or GeneAmp 9700 PCR 
system) (Applied Biosystems). 
  5.  BSA fraction V (0.04% in PCR) (Sigma Aldrich). 
  1.  Exonuclease I and Shrimp-Alkaline Phosphatase, ExoSAP-IT 
(GE healthcare, Bucks, UK). 
  1.  2% Agarose (Sigma Aldrich). 
  2.  TBE: Tris-base, Boric Acid, EDTA pH 8.00 (Sigma Aldrich). 
  3.  Ethidium bromide (0.5  μ g/mL) (Sigma Aldrich). 
  4.  UV light transilluminator (254–366 nm). 
  1.  BigDye Terminator Cycle Sequencing Kit v 1.1 (Applied 
Biosystems). 
  2.  Sequencing primers, F and R (see above). 
  3.  Thermal Cycler (2720 AB). 
  4.  DyeEx 2.0 Spin Kit (QIAGEN). 
  5.  Eppendorf Microcentrifuge MiniSpin Plus. 
  1.  ABI PRISM 3130 DNA Genetic Analyzer (Applied Biosystems). 
  2.  HiDi formamide (Applied Biosystems). 
  3.  Performance Optimizer Polymer 4 (Applied Biosystems). 
  4.  36 cm array (Applied Biosystems). 
  5.  Applied Biosystems DNA Sequencing Analysis Software V5.2. 
 2.3.  PCR Purifi cation
 2.4.  Electrophoresis
 2.5.  Cycle Sequencing 
and Postsequencing 
Purifi cation
 2.6.  Capillary 
Electrophoresis
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 Perform DNA extraction starting from ~1.0 g of tissue ( fresh or 
dried) with the QIAGEN DNeasy Plant mini-kit. Disrupt the 
tissue directly in lysis buffer and add 10  μ L of 1M DTT solution, 
then follow the manufacturer’s guidelines (see Notes 1 and 2). 
  1.  Set up PCR for amplifi cation of target sequence by mixing the 
following reagents in a total reaction volume of 10  μ L using 
Qiagen Multiplex PCR Kit: 
 Reagents  Volume per sample 
 2× Qiagen PCR Master Mix  5  μ L (see Note 3) 
 10× Primer Mix  1  μ L (see Notes 4 and 5) 
 BSA  0.2  μ L 
 ddH 2 O sterile  1.3  μ L 
 Template DNA (1–5 ng/ μ L)  2.5  μ L 
  2.  Amplify using the following thermal cycling conditions: an 
initial cycle at 95°C for 15 min, followed by 35 cycles of 
denaturation at 94°C for 30 s, annealing at 55°C 1 min, exten-
sion at 72°C for 45 s, and a fi nal extension step at 72°C for 
10 min (see Notes 6 and 7). 
 Run the PCR products at approximately 100–150 V in 2% agarose 
gel (TBE buffer, Tris-borate-EDTA) containing 0.5  μ g/mL of 
ethidium bromide with a molecular weight markers to confi rm the 
amplifi cation and to enable analysis of correct single fragment size. 
Examine the bands corresponding to amplifi ed fragments using a 
UV transilluminator (254–366 nm) and record by taking a Polaroid 
photograph. 
 The size of PCR products according to 63 species previously 
analyzed ( ( 20 ) manuscript in preparation) could be highly variable 
(see Note 8):
 psbA-trnH = from 268 to 740 bp 
 trnL-trnF = from 173 to 608 bp 
 rbcL = from 553 to 554 bp 
 matK = from 825 to 843 bp 
 Remove the remaining primers and unincorporated dNTPs by 
incubation of 5  μ L of PCR product with 2.5  μ L of ExoSAP 
enzymes for 15 min at 37°C followed by inactivation by heating at 
80°C for 15 min. 
 Single PCR products can be sequenced using both the forward and 
reverse PCR primer (the same used for PCR reaction). 
 3.  Methods
 3.1.  DNA Extraction
 3.2.  Amplifi cation
 3.3.  Agarose Gel 
Analysis
 3.4.  PCR Purifi cation
 3.5.  DNA Sequencing
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 Perform sequencing reaction on a dedicated thermal cycler 
(AB 2720) in a total volume of 20  μ L with 2–4  μ L of cleaned PCR 
product, 4  μ L of BigDye terminators v.1.1, 2  μ L of 10× Sequencing 
buffer, 2  μ L of 10× primer solution (F or R). 
 Carry the cycle sequencing reaction using the following condi-
tions: initial denaturation at 96°C for 1 min following by 25 cycles 
of 96°C for 10 s, 50°C for 5 s, and 60°C for 4 min, followed by a 
rapid thermal ramp to a 4°C. 
 The samples are now ready for purifi cation. 
 The DNA sequencing product was treated with the DyeEx 2.0 
Spin Kit to remove the unincorporated primers following manu-
facturer’s guidelines by centrifuging the spin column at 3,500 rpm 
in a Eppendorf MiniSpin plus (see Note 9). 
 Purifi ed products were resolved by electrophoretically separation 
in a ABI 3130 DNA sequencer. For preparation of samples to 
electrophoresis separation, 1  μ L of sequencing purifi ed product 
was mixed to 12–15  μ L of formamide and run on an 3130 genetic 
analyzer using POP 4.  Data were analyzed using AB DNA 
Sequencing Analysis Software V5.2. 
 Hereafter are described the main steps to compare the sequence of 
interest with NCBI library of sequences performing a BLAST 
search via web interface.
  1.  Point the browser to access the home page of the National 
Center for Biological Information (NCBI) BLAST server at 
 http://www.ncbi.nlm.nih.gov/blast . 
  2.  In the “Basic BLAST” section, choose to run  nucleotide BLAST 
program which enables to search a nucleotide database using a 
nucleotide query. The following page is organized in fi ve sec-
tions: Enter Query Sequence, Choose Search Set, Program 
Selection, (submit) BLAST, and Algorithm parameters. 
  3.  At the top of the web page in the “Enter Query Sequence” section, 
paste the query sequence in the search text area (see Note 10). 
  4.  After entering the query sequence, select the sequence data-
base to run the search with “Choose Search Set.” First check 
the “Others” button and then use the pull-down menu to 
choose “Nucleotide collection (nr/nt).” 
  5.  In the “Program Selection” menu, choose optimize for 
“Somewhat Similar Sequences (blastn)” as BLAST algorithm 
to adopt for search and alignment (see Note 11). 
  6.  Set the search parameters of the selected BLAST algorithm as 
default options (see Note 12). 
  7.  Click on the BLAST button to submit the job. The query 
sequence will be compared to all of the entries in the specifi ed 
database  ( 23 ) . 
 3.6.  Postextension 
Treatment
 3.7.  Capillary 
Electrophoresis 
and Analysis of 
Sequencing Products
 3.8.  Database Search
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  8.  BLAST will now open a new window ( Job running page ) which 
reports the status of the running job and an estimate of com-
pletion time. 
  9.  In few minutes, the computed results will be presented in the 
 output window. For details on the content of the output report, 
see Note 13. 
  10.  The fi rst entry in the output fi le represents the nucleotide 
sequence available in the database which displays the best simi-
larity with the query sequence (best close match). The objective 
way to assess the signifi cance and reliability of the reference 
match (e.g., whether the alignment portrays possible biological 
relationship or it is attributable to chance) is through the statis-
tical values produced for each alignment pair, such as the Scores 
and Expectation Value (E-value). That is, the higher the score 
and the lower the E-value, the more signifi cant the hit. However, 
there are situations in which interpretation of results may be 
complicated by several factors and following these rules may 
not lead to a biologically meaningful correspondence  ( 24 ) . The 
different possible outcomes that may be encountered in species 
identifi cation attempt of unknown botanical evidence in pub-
licly accessible database are illustrated in a simplifi ed way 
together with some basic indications in Table  1 (see Note 14). 
 Table 1 
 Outcomes that may be encountered in species identifi cation searching 
in sequences databases 
 Situation  Description  Outcome 
 The searched sequence 
doesn’t already exist in 
the database 
 The genomic region for a given 
barcode is not yet available 
for comparison 
 Ambiguous or incorrect (false-
positive) ID as comparison is 
only achievable at higher 
taxonomic ranks (genus, family, 
order) 
 The searched sequence exists in the database 
 Single best match with 
exact sequence 
 query sequence is returned as 
the unique best hit with the 
highest statistical values 
 Correct ID at  species level 
 Multiple best matches 
with exact sequence 
 query sequence plus one or 
more identical sequences 
are returned as best hits with 
highest statistical values 
 Correct ID only at  genus or 
 family level (based on the 
taxonomic category giving the 
best matches) 
 Best match with different 
unrelated sequence(s) 
 the true species is present in the 
reference alignment, but the 
method failed to assign as best hit 
 Incorrect ID 
 ID identifi cation 
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  11.  To facilitate the sequence comparison and the species identifi -
cation, specifi c databases are now in preparation ( www.barcod-
inglife.com )  ( 25 ) (see Note 15). 
 
  1.  Liquid Nitrogen is not always easily available in a forensic lab. 
We tried to eliminate this step also by adding DTT. Even if the 
tissue disruption was not complete, the high copy number of 
chloroplast DNA leads to a successful analysis even from low 
and degraded DNA. 
  2.  Purifi ed DNA was eluted from DNeasy spin column using 
50  μ L of AE buffer. 
  3.  The QIAGEN Multiplex PCR kit contains a master mix with 
preoptimized concentrations of HotStarTaq DNA Polymerase, 
MgCl 2 dNTPs, and PCR buffer with the factor MP to ensure 
comparable effi ciencies for annealing and extension of all prim-
ers without the need of optimization and should be used with 
standard-quality primers. 
  4.  All primer stock solutions should be normalized to a concen-
tration of 100  μ M using sterile ddH 2 O or TE buffer and stored 
at −20°C. 
  5.  The 10× Primer mix should be prepared in a 250  μ L of total 
volume by adding 5  μ L of 100  μ M stock solution of each 
primer (the 10× primer mix contain each primer at 2  μ M). 
  6.  It was confi rmed with  matK locus the lack of availability of 
robust primer sets for all land plants and especially for gymno-
sperms  ( 19 ) . 
  7.  PCR standard conditions apply widely with high amplifi cation 
success to rbcL, trnH-psbA, trnL-trnF barcodes, whereas matK 
requires modifi ed protocols to allow successful amplifi cation in 
a substantial proportion of samples. 
  8.  Negative amplifi cation and product showing more than one 
band or aspecifi c bands in agarose gel were reamplifi ed, respec-
tively, by adding more DNA and by more stringent PCR 
condition. 
  9.  Some artifact peaks can appear in the electropherogram if the 
spin protocol does not remove effi ciently the unincorporated 
dye terminators. In this case, the purifi cation can be repeated 
on the same product. 
  10.  The BLAST web page accepts input sequences in a number of 
different formats. Accepted input types are IUPAC FASTA or 
bare sequence format (lines of sequence data, without the 
 4.  Notes
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FASTA defi nition line) or sequence identifi ers such as NCBI 
Accession Number, GenBank Identifi cation Number (GI). 
Instead of manual sequence entry into the text box, it is possi-
ble to use the browse button to upload a fi le from your local 
disk. The fi le may contain a single sequence or a list of sequences. 
The data may be either a list of database accession numbers, 
NCBI gi numbers, or sequences in FASTA format. Furthermore, 
a descriptive title (Job Title) may be entered to obtain a unique 
identifi er for each search. The optional “Query Subrange 
boxes” limits the search to a subrange of the query sequence. 
  11.  In the nucleotide search, the alignment comparison between 
query sequences and database entries may be provided by alter-
native algorithms, MegaBLAST, discontiguous MegaBLAST, 
and the standard Blastn. They differed in the default parame-
ters governing the sensitivity of searches. Generally, Blastn pro-
vides more sensitive and less stringent alignments at a price of 
slower computed speed, whereas MegaBLAST is specifi cally 
designed for more selective and faster alignments with long 
sequences. For a more exhaustive research, it is recommended 
to perform the analysis with both algorithms and then com-
pare the results returned. 
  12.  Using the default settings for a BLAST search, regardless of 
the algorithm implemented, is a sensible approach because 
they are set up to give the best all-round results and in most 
cases they don’t need to be changed. Moving beyond the 
default conditions may depend on the type of a specifi c strat-
egy and it may be necessary to improve sensitivity and selectiv-
ity in some specifi c applications. To change search parameters, 
it is recommended to consult NCBI Educational Resources at 
 http://www.ncbi.nlm.nih.gov/Education/ . 
  13.  BLAST provide a three-section output report: on the top a 
header with query sequence information and details on the 
work submitted ( Job identifi er ) followed by a summarized 
graphical overview with the hits found, a hit table showing 
matching sequence descriptions, and fi nally the pairwise align-
ments for the sequence of interest with database records. In the 
graphic summary, the distribution of Blast Hits on the Query 
Sequence is displayed as colored lines according to the similar-
ity score from red (the highest) to black (the lowest). Mousing 
over an alignment shows the alignment defi nition and score in 
the box at the top and clicking an alignment displays the align-
ment detail. In the next section called “Descriptions,” the high-
est scoring alignments (“high-scoring pairs,” or HSPs) are 
present along with several one-line descriptors. The description 
lines are sorted by default on the basis of E-value, so that the 
most signifi cant alignments (lowest E values) are at the top. 
Other indicators provided are GenBank identifi er and a short 
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description of the matching sequence, Max and Total Scores, 
Query Coverage, and Max Ident. The guiding criterion with 
which to sort the results could be changed clicking on one of 
the other indicators. At the bottom of the report page the 
 Alignment section, each alignment pair query to hit (which is 
labeled as  Sbjct ) together with information about the specifi c 
alignment are provided. For details see ref.  ( 4 ) . 
  14.  Several contributing factors affect the probability of correct 
assignment of a sequence and hinder the interpretation phase 
of BLAST output page when searching an unknown plant 
sample against a publicly available nucleotide database. First of 
all, the complexity of plant kingdom (interspecifi c vs. intraspecifi c 
variation) and the large number of plant species compared to 
animal counterpart (>400,000 species known), the status of the 
nucleotide database with rate of marker redundancy, and 
the quality and uniformity of records. Furthermore, also the 
type of algorithm implemented could infl uence the output 
results, as for example BLAST due to its intrinsic properties 
sometimes rewards higher query coverage rather than higher 
nucleotide identity with query sequence. These issues warrant 
careful interpretation of each specifi c result so that only some 
simplifi ed situations are explained in Table  1 . Anyhow, integra-
tion of search over additional databases such as that developed 
by CBOL (briefl y described below) and implementations of a 
multilocus barcode approach with several markers may improve 
the chance of reliability of results and aid the decision process 
to be used when making species identifi cations. 
  15.  The Barcode of Life Data System (BOLD) is the online work-
bench that aids collection, management, analysis, and use of 
DNA barcodes data  ( 5 ) . The BOLD-Identifi cation System 
(IDS) is the dedicated species diagnosis tool and only recently 
accepts queries also from the plant kingdom from the candi-
date barcode genes  rbcL and  matK . At the moment, however, 
there are very few records in BOLD so most queries will likely 
not return a successful match.  The aim of CBOL to support 
the development of a carefully validated library of reference 
DNA barcodes sequences from voucher specimens will lead to 
reliable identifi cation process and to overcome some of the 
showed troubles. 
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 Capillary Electrophoresis of Big-Dye Terminator Sequencing 
Reactions for Human mtDNA Control Region Haplotyping 
in the Identifi cation of Human Remains 
 Marta  Montesino and  Lourdes  Prieto  
 Abstract 
 Cycle sequencing reaction with Big-Dye terminators provides the methodology to analyze mtDNA 
Control Region amplicons by means of capillary electrophoresis. DNA sequencing with ddNTPs or 
terminators was developed by  ( 1 ) . The progressive automation of the method by combining the use of 
fl uorescent-dye terminators with cycle sequencing has made it possible to increase the sensibility and 
effi ciency of the method and hence has allowed its introduction into the forensic fi eld. PCR-generated 
mitochondrial DNA products are the templates for sequencing reactions. Different set of primers can be 
used to generate amplicons with different sizes according to the quality and quantity of the DNA extract 
providing sequence data for different ranges inside the Control Region. 
 Key words:  mtDNA control region ,  Human identifi cation ,  mtDNA sequencing 
 
 In the past years, mtDNA analysis has been proven to be a powerful 
tool for the identifi cation of human remains in cases of severely 
degraded samples or in cases in which, in the absence of direct rela-
tives, comparisons must be made with maternal relatives. Although 
labor intensive and time consuming, the sequencing of mtDNA 
control region PCR products is reliable and the most informative 
technique with this purpose . 
 The analysis of mtDNA Control Region (CR) involves two main 
processes: (1) amplifi cation with specifi c primers spanning the 
entire CR from nucleotide positions 16024-576 and (2) the 
sequencing of the amplicons with sequencing primers and Big-Dye 
 1.  Introduction
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terminator cycle-sequencing kit. The fi nal analysis is performed by 
capillary electrophoresis, the chosen method to detect the fl uores-
cent fragments generated during the cycle-sequencing reaction. 
 The growing knowledge about the mitochondrial DNA pecu-
liarities and the availability of the technology has made the use of 
this strategy in forensic laboratories with identifi cation purposes 
possible in two main fi elds: (1) analysis of degraded samples or low 
nuclear DNA (nDNA) quantity samples (hair shafts) and (2) iden-
tifi cation and kinship analysis of human remains with maternal 
relatives as reference samples (human remains identifi cation, mass 
disasters, mass graves, etc.). 
 The entire process involves the following stages:
  1.  DNA extraction and quantifi cation. 
  2.  Amplifi cation from DNA extracts and quality control 
(electrophoresis). 
  3.  Purifi cation of PCR products. 
  4.  Sequencing reaction. 
  5.  Clean-up of sequenced products. 
  6.  Electrophoresis. 
  7.  Sequence analysis and quality control. 
 The selected strategies regarding extraction and amplifi cation 
methods will depend on the quality and quantity of the sample but 
we will not be looking into these strategies in any depth here. 
Nevertheless, a brief description of amplifi cation is necessary since 
the sequencing primers depend on the amplifi cation strategy. 
 Since the fi rst publication about protocols for mtDNA sequenc-
ing analysis for forensic application in 1995  ( 2 ) , several strategies 
have been developed  ( 3– 5 ) . In the fi rst publication only the analy-
ses of Hypervariable Regions 1 and 2 (HV1 and HV2) were 
addressed: HV1 covering positions 16024–16365 and HV2 cover-
ing positions 73–340. Nevertheless, the increasing knowledge 
about features and particular drawbacks of mtDNA (point and 
length heteroplasmy, the issue of the population-associated com-
mon haplotypes, and match interpretation) has led to the analysis 
of the complete Control Region and today, polymorphisms 
between 16024–16569 and 1–576 are often analyzed. Furthermore, 
expanding the analysis to the coding region offers the possibility of 
increasing discrimination in cases of common haplotypes, or to 
perform the correct assignment of a sample to its specifi c haplo-
group when, with the HV1 and HV2 data alone, this is not possi-
ble  ( 6– 8 ) . Obviously, not all the approaches can be applied to the 
identifi cation of human remains in a forensic context. Quality and 
quantity of available samples as well as the capabilities and experi-
ence of the laboratory will determine the analytical strategy. 
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 As far as identifi cation of human remains is concerned, and for 
a laboratory routinely performing mtDNA analysis, a practical and 
useful strategy would consist of the analysis of the entire Control 
Region in both reference and questioned samples whenever possi-
ble. For nondegraded, good level DNA samples (saliva or blood 
reference samples, human remains with good level nDNA) (see 
Note 1), the amplifi cation of the Control Region can be carried 
out in one or two reactions. In our lab we usually perform two 
reactions using the following primers (see Table  1 ): 
 Primer pair L15997/H17 
 Primer pair L16555/H619 
 For slightly degraded samples or those with less DNA concen-
tration, the amplifi cation can be carried out in three or more reac-
tions in order to generate shorter segments  ( 9,  10 ) . The strategy 
we follow to analyze these types of samples (moderate degradation 
or less than 40 pg/ μ L) is as follows (see Table  1 ):
 Primer pair L15997/H16395 
 Primer pair L48/H408 
 Primer pair L350/H619 
 The validation of the two strategies has been performed in our 
laboratory with different types of samples. 
 For more degraded samples or samples with minute amounts 
of nDNA, the amplifi cation of mini-amplicons can be the only pos-
sible approach (see Note 2). In Chapter  23 , the strategy for high 
degraded samples is described in depth. 
 The yield and success of the amplifi cation reaction can be 
monitored either by agarose gel electrophoresis or by microchip 
electrophoresis (see Chapter  28 ). 
 Table 1 
 Amplifi cation primers and their combination to generate amplicons 
of different sizes 
 Primer  a  5 ¢ –3 ¢ sequence  Amplicon size 
 L15997  CAC CAT TAG CAC CCA AAG CT (20-mer)  L15997/H16395 = 437 bp 
 L15997/H17 = 629 bp  H16395  CAC GGA GGA TGG TGG TCA AG (20-mer) 
 H17  CCC GTG AGT GGT TAA TAG GGT (21-mer) 
 L16555  CCC ACA CGT TCC CCT TAA AT (20-mer)  L48/H408 = 401 bp 
 L16555/H619 = 612 bp  L48  CTC ACG GGA GCT CTC CAT GC (20-mer) 
 H408  CTG TTA AAA GTG CAT ACC GCC A (22-mer) 
 H619  GGT GAT GTG AGC CCG TCT AA (20-mer)  L350/H619 = 310 bp 
 L350  GCA CTT AAA CAC ATC TCT GCC A (22-mer) 
 a Named according to their 3 ¢ -end position the rCRS 
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 PCR products must be purifi ed to eliminate primers, dNTPs, 
and other molecules that could otherwise interfere with sequenc-
ing reaction. The purifi cation may be performed with several meth-
ods. In our experience, the Qiaquick PCR purifi cation kit (Qiagen) 
gives good results rendering clean PCR products suitable for sub-
sequent sequencing (see Note 3)  ( 11 ) . During the purifi cation 
step, a loss of product occurs. DNA yield is about 80% (see Note 
4) and this fact must be taken into consideration when estimating 
the volumes to perform sequencing reactions. Purifi ed PCR prod-
ucts are now ready to undergo sequencing reaction with Big-Dye 
terminator kit. The reaction Mix contains the primer, Taq poly-
merase, the four dNTPs, and dye-labeled ddNTPs each with a dif-
ferent dye. During cycle-sequencing, both types of nucleotides are 
incorporated at random into the growing chain. When a dye-
ddNTP is added, the absence of the 3 ¢ -OH precludes the addition 
of a new dNTP and prevents the elongation. The product of 
sequencing reactions will contain dye-labeled DNA fragments of 
each and every size ranging from the primer plus 1 nucleotide to 
the size of the PCR fragment. Furthermore, as each ddNTP has a 
different fl uorescent-dye, each fragment is dye-labeled with a dif-
ferent color, depending on the incorporated base. Finally, these 
fragments are separated by electrophoresis and the laser-induced 
fl uorescence is detected. The software installed in the Sequencer 
allows the data to be collected as electropherograms (EPGs) and 
performs the analysis of the sequences. 
 In forensic laboratories, in order to assure the quality of the 
data, each PCR product is analyzed in forward and reverse strand 
of the template providing at least two readings for double strand 
coverage. Furthermore, as the length of fragments extends beyond 
the maximum clear range of the sequence reading (see Note 5), 
internal primers are used to generate overlapping sequences to 
cover the entire region (see Fig.  1 ). 
 After the completion of the sequencing reactions, unincorpo-
rated dye terminators must be removed from sequencing products 
otherwise they interfere in the base calling, especially at the begin-
ning of the sequence. Several methods may be used (see Note 6). 
DyeEx kits in column or 96-well plate format are our routine 
HV1 REGION
L15997 L16159
H 17H16395
HV2 REGION
L16555 L 00350
H 285 H 619
 Fig. 1.  Sequencing primers used to cover the entire control region generating overlapping fragments (→ forward primer; 
← reverse primer). 
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methods. Gel-fi ltration material retains dye terminators, primers, 
and fragments up to 20 bases while DNA fragments are recovered 
after a centrifugation step in the fl ow-through. 
 After clean-up and subsequent drying, samples are resuspended 
by using formamide and denatured prior to electrophoresis. 
 Several platforms are suitable to perform the electrophoresis. 
We describe here the method for 3130 Genetic Analyzer (Applied 
Biosystems). This machine works with four capillaries and performs 
the analysis of four sequencing reactions in 1 h. The data collected 
during electrophoresis is processed by the analysis software to ren-
der an EPG. For each sample (PCR product) SeqScape software 
performs comparisons and alignments of the sequences generated 
with each primer to produce a “consensus” sequence. Then, the 
consensus sequence is automatically compared with the reference 
sequence (rCRS)  ( 12 ) . 
 
  1.  Good quality DNA template, in this case purifi ed PCR 
products. 
  2.  Primers at a concentration of 10  μ M (aliquoted and stored 
at −18°C) (see Note 7). 
  3.  Ultra pure water. 
  4.  Big-Dye terminator ready reaction cycle sequencing kit v1.1 or 
3.1 (Applied Biosystems P/N 4337455 and 4337450) (see 
Note 8). 
  1.  DyeEx 2.0 columns or DyeEx 96 (Qiagen) (see Note 9). 
  2.  Ultra pure water. 
  1.  Hi DI Formamide (Applied Biosystems, P/N 4311320) (see 
Note 10). 
  2.  10× Genetic Analyzer Buffer (Applied Biosystems, P/N 
402824) (see Note 11). 
  3.  POP 6 polymer. 
  4.  Capillary array, plates, plate assembly, buffer reservoirs, and 
accessories provided by the sequencer manufacturer. 
 
 Sequencing reactions are performed according to the manufacturers’ 
manual instructions  ( 13 ) with slight modifi cations. Two versions 
of the kits are available: v1.1 and 3.1. Both of them work with 
 2.  Materials
 2.1.  For Sequencing 
Reactions
 2.2.  For Purifi cation
 2.3.  For 
Electrophoresis
 3.  Methods
 3.1.  Performing 
Sequencing Reactions
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robustness in samples with a minimum amplicon concentration 
(see below). The kits contain all the required components to perform 
the sequencing reactions: only the primers are provided by the 
user. The main points to take into consideration are as follows:
  1.  The volume of PCR product. The quantity of amplifi ed product 
necessary to perform the sequencing reaction depends on the 
amplicon size and hence on the regions analyzed. Only samples 
that meet the estimated required quantity criteria undergo 
sequencing. The concentration cut-off point, which deter-
mines the minimum concentration yielding a good quality 
sequence, will be established in each laboratory. The product 
loss must be considered during the purifi cation step. In our 
experience, the optimal quantity for HV1 and HV2 (437 and 
401 bp respectively) is 5–10 ng of PCR product in a fi nal vol-
ume reaction of 10  μ L. For L15997/H17 and L16555/H619 
amplicons, 12–15 ng of PCR products are needed (see 
Table  2 ). 
  2.  The primers . According to the amplifi ed region, several primers 
may be used as depicted in Table  2 . Sequencing “long” seg-
ments involves the use of internal primers in addition to the 
amplifi cation primers. This strategy allows the reading of the 
complete segment in both directions. The fi nal concentration 
in the reaction Mix is 0.4  μ M (4 pmol). 
 Table 2 
 Primers and quantities of template to perform cycle sequencing 
 Amplifi cation primers (size)  Sequencing primers a 
 PCR product 
quantity (total ng) 
 L15997/H17 (629 bp)  L15997, H17, L16159 and H16395  12–15 
 L16209 and H16164 b 
 L15997/H16395 (437 bp)  L15997 and H16395  5–8 
 L16209 and H16164 b 
 L16555/H619 (612 bp)  L16555, L318 or L350, H619, H285  12–15 
 L48/H408 (401 bp)  L48, H408 and H285 c  5–8 
 L350/H619 (310 bp)  L350, H619  5–8 
 a Nomenclature of primers according to their 3 ¢ position in the rCRS 
 b The use of primers L16209 and H16164 is necessary in case of length heteroplasmy in poly-C stretch 
surrounding 16189 (see Note 12) 
 c The use of the internal primer H285 is recommended to confi rm the readings at the beginning of this 
segment (see Note 13) 
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 For a 10  μ L sequencing reaction, the sample volume is 5.6–6  μ L. 
DNA templates may need to be diluted if PCR products are too 
concentrated. Appropriate dilutions need to be made with ultra 
pure water to obtain the quantities of product specifi ed in the pre-
vious paragraph in a volume of 5.6  μ L. 
 A set of primer-specifi c mixes must be prepared. For a fi nal reaction 
volume of 10  μ L, we need (see Note 14):
  1.  For each sample and primer: add 0.4  μ L of primer to 4  μ L of 
ready reaction premix and mix. 
  2.  Spin briefl y and dispense 4.4  μ L in each tube. 
  3.  Add 5.6  μ L of PCR product previously diluted and mix 
carefully. 
  4.  Centrifuge tubes to avoid bubbles. 
  5.  Place the tubes in the Thermal cycler (see Note 15). 
  6.  Prepare as many reaction mixes as primers are being used. 
During the preparation process, keep the premix and primers 
on ice (see Table  3 ). 
  1.  Place the tubes with extended products at 4°C until the purifi -
cation step (see Note 16). 
  2.  Follow the manufacturer’s protocol (see Note 17)  ( 14 ) . 
  3.  Dry the samples in a vacuum centrifuge without heat (see 
Note 18). 
  1.  Dried extension products on tubes (or plate) have to be resus-
pended thoroughly with formamide (see Note 19). The resus-
pended products are then transferred to the suitable plates for 
running on ABI 3130. 
  2.  Add 25  μ L of hi-di formamide to each tube. 
  3.  Vortex and centrifuge the tubes (or plate) in order to place the 
sample at the bottom of the tubes. 
  4.  Denature for 3 min in the thermal block and then place on 
ice. 
  5.  Transfer the content of each tube to the plate-well according 
to the order specifi ed on the Sample Manager sheet provided 
by the running software. 
 3.1.1.  Preparing DNA 
Templates
 3.1.2.  Preparing the Mix
 3.2.  Purifi cation 
of Extension Products
 3.3.  Electrophoresis
 3.3.1.  Preparing Samples 
for Electrophoresis
 Table 3 
 Typical volumes for cycle sequencing “ n ” samples 
 Premix  Primer 10  m M  PCR product  Water (qs 10  m L) 
 4  μ L (× n )  0.4  μ L (× n )  2–5.6  μ L/sample  0–3.6  μ L/sample 
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  6.  Centrifuge the plate to eliminate bubbles and place the sample 
in the bottom. 
  7.  Place the plate on the plate platform and start electrophoresis. 
  – 36 cm capillary arrays. 
 Running conditions: –
 Run module: “RapidSeq36_POP6” with “DyeSet/primer DT 
3130{BDv3}v1.” 
 Analysis protocol: Basecaller 3130POP6RRv2; Mixed Bases iden-
tifi cation >25%; Clear range: manually established depending 
on the quality of the sequence; Filter Settings: Maximum 
Mixed bases: 20%; Maximum N’s: 10; Minimum clear length 
(bp): 50; Minimum sample score: 20. 
 Sequencing analysis softwares usually include a tool to automati-
cally check the quality of the electros, but manual inspections are 
also necessary. A good EPG is characterized by evenly spaced peaks 
and lack of noise. Peak heights may vary due to different intensities 
of the fl uorophores. 
 In addition to molecular problems, such as length heteroplas-
mies, common analytical artifacts can lead to erroneous readings. 
Some examples are as follows:
 Spikes, produced by urea crystals or bubbles in the polymer.  –
A reinjection of the sample normally solves this problem 
(see Fig.  2 ). 
 Dye blobs, due to a defective purifi cation.  –
 Loss of resolution, due to multiple causes such as bubbles in  –
the polymer, defective injections, changes in the running tem-
perature, etc. 
 Analysis software (Sequencing analysis) performs the analysis of 
raw data in the form of an EPG. The analysis and edition is per-
formed simultaneously with the ABI PRISM ® SeqScape ® Software. 
 3.3.2.  Electrophoresis 
Conditions
 3.4.  Analyzing 
the Data
 3.4.1.  Inspection of EPGs
 3.4.2.  Edition of Sequences
 Fig. 2.  EPG showing a spike interfering the reading ( top ). The same sample reinjected ( bottom ). 
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For each sample, the different sequences obtained with direct and 
reverse primers are aligned and the consensus sequence is compared 
with the revised mtDNA reference sequence (rCRS). Although the 
process is automatically done, the visual inspection of the entire 
length of the EPG must be done to review the data, especially at 
the beginning and ends of the EPG. Special attention should be 
paid to identifying point heteroplasmy not detected by the soft-
ware (see Notes 20 and 21). This revision process is performed by 
two independent scientists. 
 Differences from rCRS are shown as a table in the report made 
by the SeqScape software. To describe the sample’s haplotype, 
nomenclature guidelines and recommendations suggested by the 
ISFG and EDNAP must be followed  ( 15,  16 ) . This standardiza-
tion allows different samples to be compared. 
 Unfortunately, errors in mtDNA analysis are more frequent than in 
nDNA analysis but there is enough literature available describing 
the types and causes of the errors  ( 17– 22 ) . The most obvious 
problems are mtDNA is more prone to contamination, the mtDNA 
analysis requires more steps than nDNA, no PCR multiplexes are 
usually carried out promoting the artifi cial recombination, and the 
data is usually transcribed manually to the fi nal reports (allowing 
for human error). The two main consequences of these errors are 
(1) false exclusions/no exclusions in the analysis of samples involved 
in forensic cases and (2) distortion of match probabilities when 
database searches are performed. 
 For all the above-mentioned reasons, checking mechanisms 
in mtDNA data should be applied before considering an 
mtDNA sequence as definitive. These mechanisms include the 
following:
  1.  Checking if all polymorphisms in the haplotypes can be seen in 
both strands. Samples showing length heteroplasmy must be 
analyzed using extra internal sequencing primers. Also, poly-
morphisms located at the beginning or the ends of the ampli-
cons, which are only seen in one strand, must be confi rmed 
using an additional sequencing primer. 
  2.  Reading the sequences twice, by different analysts at two dif-
ferent moments. Only when both readings match the haplo-
type can it be considered as consensus haplotype. 
  3.  Checking the reading ranges or sequence edition. The reading 
range is like the name of the genetic marker. If, for some rea-
son, some part of the EPG cannot be unambiguously read (and 
there is no more sample available for further sequencing), it is 
mandatory to clearly report the real reading range in that 
specifi c sample. 
 3.5.  Quality Control 
and Revision
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  4.  Checking if all polymorphisms were previously described. This 
task is diffi cult to carry out in some cases but literature and 
databases are perfect tools to achieve it  ( 23 ) . It is also impor-
tant to see if the polymorphism was previously described in the 
haplogroup of the haplotype we are interpreting. 
  5.  Checking point heteroplasmies. In these cases, it is instructive 
to check the rate of mutation of the nucleotide position where 
the heteroplasmy is located  ( 24 ) . The mutation rate is not 
uniform throughout the mtDNA molecule, and there are 
some positions that are prone to accumulate changes, i.e., 
hotspots such as 16093 in HVS-I or 152 in HVS-II. A specifi c 
mutation rate for each nucleotide position has not been estab-
lished yet, but some useful information can be gathered in 
refs.  ( 19,  25,  26 ) . Also, it is important to take into account 
that the mutation rate varies among different tissues. The pos-
sibility of mutation increases in tissues with high level of meta-
bolic activity and depending on the age of the individual  ( 27 ) 
(see Note 22). 
  6.  Reading haplotypes from a phylogenetic point of view (assign-
ing the haplotype to a haplogroup). This is useful to avoid 
some common errors such as artifi cial recombination or for-
gotten polymorphisms. The mtDNA phylogeny is continu-
ously improving but the Phylotree web page ( http://www.
phylotree.org ) is a good page to consult as it is continuously 
updated  ( 28 ) . 
  7.  Checking alternative alignments. Haplotypes can be differently 
named depending on the alignment with respect to rCRS, 
mainly in poly-C tracts. This could lead to different results 
when database searches or comparisons between different labs 
are performed  ( 29 ) . 
  8.  Performing simple database searches helps to prevent errors. 
These searches should be carried out even if the statistical eval-
uation of the results was not necessary (e.g., reference sample 
not available), that is to say, only for quality control purposes. 
The EMPOP ( http://www.empop.org/ ) database has proved 
to be one of the best and more accurate databases publically 
available  ( 30 ) and it has a variety of different tools that could 
assist forensic geneticists in different tasks related to error 
detection. 
  9.  Finally, if haplotypes cannot be electronically transferred to the 
fi nal report, they must always be double checked by two inde-
pendent analysts. Documentation errors are the most frequent 
type of error and avoiding them only requires being careful 
 ( 31,  32 ) . 
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  1.  Samples with nDNA concentration greater than 50–100 pg/ μ L 
are appropriate for this strategy. Lower levels of DNA 
(5–40 pg/ μ L) need an increase in the number of cycles from 
32 to 36. Nevertheless, in some samples, the amplifi cation is 
prevented by the presence of inhibitors. In these cases, dilution 
of the sample may overcome this problem. 
  2.  In this case, the number of amplifi cation cycles is 36. Increasing 
the number of cycles beyond 36 is not recommended as the 
risk of false positive and contamination in blanks and negative 
controls increases. 
  3.  Other fi ltration methods for PCR clean-up include Microcon 
100 (Millipore); Amicon 30 (Millipore); Wizard ® SV Gel and 
PCR Clean-Up System A9281 (Promega Corporation); Illustra 
MicroSpin S-300 HR Columns (GE); ExcelaPure™ UF PCR 
Purifi cation System (Edge Bio). An enzymatic digestion with 
ExoSAP-IT (USB) is also possible. 
  4.  The manual indicates a recovery of 90% but in our experience 
this value can reach low values as 70–80%. 
  5.  With a 36 cm capillary, well-defi ned peaks are obtained until 
340–350 bases. From this position, uneven peaks and poor 
resolution sequence are progressively generated. 
  6.  Commercial fi ltration methods on spin column or 96-well 
plate: Centri-Sep columns, DyeEx 2.0 or DyeEx 96 (Qiagen), 
Performa ® DTR V3 96-Well Short Plate Kit (EDGE-Bio). 
Precipitation methods: ethanol-EDTA precipitation or ethanol-
EDTA-sodium acetate precipitation. Digestion with SAP and 
precipitation. 
  7.  Primers 10  μ M are aliquoted in small volumes suffi cient for 
7–8 sequencing reactions. Avoid thawing and freezing cycles. 
Although not all the primers are equally sensitive to the stor-
age conditions, as a general rule, after 8–10 freeze and thaw 
cycles aliquots are discarded. During use, primers are kept 
on ice. 
  8.  Both versions are suitable. V3.1 is better for longer read lengths 
while v1.1 is better for shorter fragments. Routinely, v3.1 is 
used in our laboratory. Reaction Mix (400  μ L) is aliquoted in 
4 tubes × 100  μ L to avoid freezing and thawing cycles. 
  9.  As the purifi cation in plate involves the use of multichannel 
pipettes and the risk of touching the surface of the gel is greater 
than in columns, DyeEx 96 plate format is only used for refer-
ence samples, keeping columns for more critical samples. 
 4.  Notes
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  10.  Formamide is highly toxic, mutagenic, and teratogen. 
Formamide causes eye, skin, and respiratory tract irritation. It 
is a possible reproductive and birth defect hazard. Read the 
MSDS, and follow the handling instructions. Wear appropriate 
protective eyewear, clothing, and gloves. Formamide should 
be stored aliquoted at −20°C. 
  11.  Buffer with EDTA may cause eye, skin, and respiratory tract 
irritation. Read the SDS, and follow the handling instructions. 
Wear appropriate protective eyewear, clothing, and gloves. 
  12.  Poly-cytosine tracts surrounding np 16189 in HV1 with length 
heteroplasmy generate blurred sequence readings beyond this 
region (see Fig.  3 ). The use of internal primers (L16209 and 
H16164) provides readings to cover the complete region 
edition. 
  13.  In the case of primer L-048, the “clean” sequence starts beyond 
np 73. For this reason, the use of primer H-285 provides addi-
tional data to confi rm the sequence in the edited range (see 
Fig.  4 ). Also in the case of length heteroplasmy produced by 
multiple insertions in the poly-cytosine tract around np 309, 
the use of primer H285 serves to read the segment beyond this 
region with a reverse primer. 
  14.  Although manufacturer protocol recommends a fi nal volume 
of 20  μ L, the premix volume reduction does not affect nega-
tively the quality of the EPG. 
  15.  In a Gene-Amp ® PCR System 9700 Thermal Cycler (Applied 
Biosystems), the program installed is Big Dye™:
 1 min at 96°C, 1 min at 56°C, and 4 min at 72°C for 25 cycles. 
 If using other models, slow the ramping time. 
  16.  Purifi cation of extension products must be carried out in the 
next 24 h. 
 Fig. 3.  EPG obtained in a sample with HV1 length heteroplasmy. Primers L15997, H17, and H16395 from  top to  bottom. 
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  17.  If purifi cation is being performed with DyeEx columns or 
other gel fi ltration devices, special care must be taken to avoid 
touching the gel surface and to apply the sample in the center 
of the gel bed. Otherwise the sample can fl ow down the sides 
of the well. In this case the EPG will appear as a noisy, low-
intensity sequence. 
  18.  Speed Vac centrifuge is suitable for drying sequencing reac-
tions. The drying time depends on the number of tubes. 
40–50 min is suffi cient for 20–24 tubes. Do not over-dry. 
 If samples are not to be run in the sequencer, keep them in the 
freezer protected from light. 
  19.  If the samples have been purifi ed on DyeEx 96, the addition of 
formamide may be performed on a robotic platform. The 
product may be then transferred by the robotic arm to the 
electrophoresis sample plate avoiding sample transference-
associated errors. In this case, several steps of formamide aspi-
ration-dispense must be included in the program. 
  20.  In the analysis protocol, the Mixed Bases Settings are 25% by 
default. This means that a secondary peak will be detected if 
the peak high is at least 25% of the main peak. This must be 
considered for heteroplasmy detection. In sequences with poor 
signal-to-noise ratio, the ability to distinguish between “true” 
point heteroplasmies from noisy peaks will be affected. 
  21.  Visual inspection of EPGs sometimes shows noisy, bad quality 
sequences that have been “approved” by the software. One of 
the reasons is the use of contaminated or degraded primers. 
Repeat the sequencing reaction with a new primer aliquot. It 
should also be noted that as a consequence of its particular 
characteristics, not all the primers behave in the same way. 
 Fig. 4.  EPG showing sequences generated by primers H285, H408, and L48 from  top to  bottom. 
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Primers H285, L16555, and L15997 are particularly prone to 
generate good quality (clean, well-balanced, low-noise) 
sequences when compared with the others. 
  22.  Especially, mtDNA from muscle tissue is prone to point hetero-
plasmy, mainly in aged individuals. For this reason, in samples 
coming from human remains consisting of muscle cells, it is 
very frequent to fi nd heteroplasmic positions that are absent in 
the reference sample of the relative (see Fig.  5 ). 
 References 
 Fig. 5.  EPG showing point heteroplasmy at np72 in muscle ( a ) but not in reference sample 
coming from a son ( b ). Haplotype (16024-576): 263G 315.1C (son) and 72Y 263G 315.1C 
(mother). The analysis of nuclear DNA in the trio father–mother–son (17 loci) confi rmed 
the mother–child relationship. 
  1.  Sanger F, Nicklen S, Coulson AR (1977) DNA 
sequencing with chain-terminating inhibitors. 
Proc Natl Acad Sci 74(12):5463–7. 
  2.  Wilson MR, DiZinno JA, Polansky D, Repogle 
J, Budowle B (1995) Validation of mitochon-
drial DNA sequencing for forensic casework 
analysis. Int J Legal Med 108:68–74. 
  3.  Parson W, Bandelt H-J (2007) Extended 
guidelines for mtDNA typing of population 
data in forensic science. Forensic Science 
International: Genetics 1(1):13–9. 
  4.  Lutz S, Weisser H-J, Heizmann J, Pollak S 
(1996) mtDNA as a tool for identifi cation of 
human remains. Int J Legal Med 109:
205–9. 
  5.  Parsons T J. Mitochondrial DNA Genome 
Sequencing and SNP Assay Development for 
increased Power of Discrimination.  http://www.
ncjrs.gov/pdffi les1/nij/grants/213502.pdf. 
  6.  Parsons TJ, Coble MD (2001) Increasing the 
forensic discrimination of mitochondrial DNA 
testing through analysis of the entire mito-
chondrial DNA genome. Croatian Med J 42: 
304–9. 
  7.  Coble MD, Just RS, O’Callaghan JE, Letmanyi 
IH, Peterson CT, Parsons TJ (2004) Single 
nucleotide polymorphisms over the entire 
mtDNA genome that increase the forensic 
power of testing in Caucasians. Int J Legal Med 
(2004) 118:137–46. 
 
28119 Capillary Electrophoresis of Big-Dye Terminator Sequencing…
  8.  B. Quintans, V. Alvarez-Iglesias, A. Salas, C. 
Phillips, M.V. Lareu, A. Carracedo (2004) 
Typing of mitochondrial DNA coding region 
SNPs of forensic and anthropological interest 
using SNaPshot minisequencing. Forensic Sci. 
Int. 140:251–7. 
  9.  Eichmann C, Parson W (2008) ‘Mitominis’: 
multiplex PCR analysis of reduced size ampli-
cons for compound sequence analysis of the 
entire mtDNA control region in highly degraded 
samples. Int J Legal Med 122:385–388. 
 10.  Berger C, Parson W (2009) Mini-midi-mito: 
Adapting the amplifi cation and sequencing 
strategy of mtDNA to the degradation state of 
crime scene samples. Forensic Science 
International: Genetics 3:149–153. 
 11.  Qiaquick spin Handbook. QIAquick PCR 
Purifi cation Kit. QIAGEN 1051746. 
 12.  Andrews RM, Kubacka I, Chinnery PF, 
Lightowlers RN, Turnbull DM, Howell N 
(1999) Reanalysis and revision of the Cambridge 
reference sequence for human mitochondrial 
DNA. Nature Genetics 23(2):147 [Gen Bank 
NC_012920]. 
 13.  Big-Dye Terminator v3.1 Cycle Sequencing 
Kit. Applied BioSystems. Part Number 
4337035. 
 14.  Dye Ex™ Handbook. DyeEx 2.0 Spin Kit and 
DyeEx 96 Kit. QIAGEN. Ref 1019971. 
 15.  Carracedo A, Bär W, Lincoln P, Mayr W, 
Morling N, Olaisen B, Schneider P, Budowle 
B, Brinkmann B, Gill P, Holland M, Tully G, 
Wilson M (2000) DNA Commission of the 
International Society for Forensic Genetics: 
guidelines for mitochondrial DNA typing. 
Forensic Sci Int. 110(2):79–85. 
 16.  Tully G, Bär W, Brinkmann B, Carracedo A, 
Gill P, Morling N, Parson W, Schneider P 
(2001) Considerations by the European DNA 
profi ling (EDNAP) group on the working 
practices, nomenclature and interpretation of 
mitochondrial DNA profi les. Forensic Sci Int 
124:83–91. 
 17.  Bandelt HJ, Lahermo P, Richards M, Macaulay V 
(2001) Detecting errors in mtDNA data by phy-
logenetic analysis. Int. J. Legal Med 115:64–9. 
 18.  Röhl A, Brinkmann B, Forster L, Forster P 
(2001) An annotated mtDNA database. Int J 
Legal Med 115:29–39. 
 19.  Bandelt HJ, Quintana-Murci L, Salas A, 
Macaulay V (2002) The fi ngerprint of phan-
tom mutations in mitochondrial DNA data. 
Am J Hum Genet 71:1150–60. 
 20.  Yao YG, Bravi CM, Bandelt HJ (2004) A call for 
mtDNA data quality control in forensic science. 
Forensic Science International 141(1):1–6. 
 21.  Brandstätter A, Sänger T, Lutz-Bonengel S, 
Parson W, Béraud-Colomb E, Wen B, Kong 
QP, Bravi CM, Bandelt HJ (2005) Phantom 
mutation hotspots in human mitochondrial 
DNA. Electrophoresis 26(18):3414–29. 
 22.  Parson W (2006) The Art of Reading Sequence 
Electropherograms. Annals of Human Genetics 
71:276–78. 
 23.  Bandelt HJ, Salas A, Bravi CM (2006) What is 
a ‘novel’ mtDNA mutation--and does ‘nov-
elty’ really matter? J Hum Genet 51(12):
1073–82. 
 24.  Irwin JA, Saunier JL, Niederstatter H, Strouss 
KM, Sturk KA,. Diegoli TM, Brandstatter A, 
Parson W, Parsons TJ (2009) Investigation of 
Heteroplasmy in the Human Mitochondrial 
DNA Control Region: A Synthesis of 
Observations from More than 5000 Global 
Population Samples. J Mol Evol 68:516–27. 
 25.  Salas A, Bandelt HJ, Macaulay V, Richards MB 
(2007) Phylogeographic investigations: the 
role of trees in forensic genetics. Forensic Sci 
Int 168(1):1–13. 
 26.  Malyarchuk BA, Rogozin IB, Berikov VB, 
Derenko MV (2002) Analysis of phylogeneti-
cally reconstructed mutational spectra in human 
mitochondrial DNA control region. Hum 
Genet 111(1):46–53. 
 27.  Del Bo R, Crimi M, Sciacco M, Malferrari G, 
Bordoni A, Napoli L, Prelle A, Biunno I, 
Moggio M, Bresolin N, Scarlato G, Pietro 
Comi G (2003) High mutational burden in the 
mtDNA control region from aged muscles: a 
single-fi ber study. Neurobiol Aging 
24(6):829–38. 
 28.  van Oven M, Kayser M. 2009. Updated com-
prehensive phylogenetic tree of global human 
mitochondrial DNA variation. Hum Mutat 
30(2):E386-E394.  http://www.phylotree.org. 
 29.  Bandelt HJ, Parson W: Consistent treatment of 
length variants in the human mtDNA control 
region: a reappraisal. Int J Legal Med 2008, 
122:11–21. 
 30.  Parson W, Dür A (2007) EMOP - a forensic 
mtDNA database. Forensic Sci Int Genet 
1:88–92. 
 31.  Turchi C, Buscemi L, Previdere C, Grignani P, 
Brandstätter A, Achilli A, Parson W, Tagliabracci 
A (2008) F.I.Group Italian mitochondrial 
DNA database: results of a collaborative exer-
cise and profi ciency testing. Int J Legal Med 
122:199–204. 
 32.  Prieto et al (2010) The GHEP–EMPOP col-
laboration on mtDNA population data - A new 
resource for forensic casework. Forensic Sci Int 
Genet 5:146–51. 
283
Antonio Alonso (ed.), DNA Electrophoresis Protocols for Forensic Genetics, Methods in Molecular Biology, vol. 830,
DOI 10.1007/978-1-61779-461-2_20, © Springer Science+Business Media, LLC 2012
 Chapter 20 
 Capillary Electrophoresis of Human mtDNA 
Control Region Sequences from Highly Degraded 
Samples Using Short mtDNA Amplicons 
 Odile  M.  Loreille and  Jodi  A.  Irwin  
 Abstract 
 The forensic applications of mtDNA sequencing center primarily on samples that are either highly degraded 
or contain little or no nuclear DNA, since the testing of these sample types is often unsuccessful with more 
widely used nuclear STR profi ling assays. In these cases, sequence data from the noncoding mtDNA 
control region are targeted due to its high variability. However, the ease of authentic DNA recovery and 
the strategy used for recovery depend strictly on the quality of the sample. In this chapter, we will cover 
mitochondrial DNA sequencing procedures for short mtDNA amplicons which range in size from 100 to 
350 bp. Generally speaking, amplicons of this size are required only for the most degraded specimens, and 
the protocols described here have been specifi cally developed for recalcitrant human skeletal remains 
encountered during the course of a large-scale missing persons’ identifi cation effort. DNA templates from 
these types of specimens tend to exhibit various forms of intrastrand damage that, in turn, manifest as 
artifacts in the sequence data. Because these artifacts are not generally observed among sequence data 
from pristine templates, we address the particular data idiosyncrasies that warrant additional scrutiny. 
Although this chapter will primarily highlight this particular application, the basic experimental parameters 
and data considerations should easily extend to other applications and/or sample types. The protocols 
described here have been deliberately designed to produce raw sequence electropherograms and fi nal mtDNA 
profi les that adhere to the strictest forensic guidelines in terms of overall data quality. 
 Key words:  Mitochondrial DNA ,  Forensic genetics ,  DNA identifi cation ,  Control region ,  DNA 
sequencing 
 
 Despite the interest of the forensic community in recovering DNA 
data from the smallest traces of evidentiary material, mtDNA testing 
is not routinely employed by most forensic DNA laboratories. 
The community has instead, and understandably, favored the use 
 1.  Introduction
284 O.M. Loreille and J.A. Irwin
of multiple autosomal short tandem repeats (STRs) because they 
provide much higher discriminatory power than data from the 
mitochondrial genome  ( 1 ) . And while the fairly recent develop-
ments of mini-STR multiplexes and higher effi ciency STR kits have 
extended the application of STR testing to more degraded samples 
 ( 2– 9 ) , there remain many specimens for which nuclear DNA is 
too degraded or too scarce to yield forensically informative STR 
profi les, no matter how small the amplicon or how aggressive the 
amplifi cation parameters. MtDNA testing is often the only remain-
ing DNA-based testing option for samples such as shed hairs, 
fi ngernails, and severely degraded skeletal elements, due to the 
relative abundance of intact mtDNA (present in several thousand 
copies per cell) as compared to nuclear DNA in these types of spec-
imens  ( 10– 18 ) . MtDNA data are also quite useful in particular 
forensic investigations because the molecule is maternally inherited 
without recombination  ( 19– 21 ) . As a result, all maternal relatives 
possess identical mtDNA haplotypes in the absence of mutation 
and thus even distant relatives can provide reference material for 
particular mtDNA comparisons  ( 16 ) . This is extremely benefi cial 
in those cases for which direct references, or references from imme-
diate family members, are unavailable for standard autosomal STR 
testing. Even in those cases for which mtDNA is  not the only poten-
tial source of genetic information, mitochondrial data can often be 
effectively used to increase (or decrease) the statistical support for 
a given hypothesis (e.g., if the only other DNA evidence is a com-
mon Y-haplotype). Whatever the case may be, as DNA typing meth-
ods are increasingly employed on evermore small, damaged, and 
degraded specimens, and as DNA-based missing persons, cold 
case, and mass fatality initiatives expand, more and more forensic 
laboratories will turn to mtDNA testing for its obvious benefi ts 
with the most diffi cult samples  ( 22– 28 ) . 
 Forensic laboratories already performing large-scale mtDNA 
testing of severely degraded remains owe much of their progress to 
developments in the fi eld of ancient DNA, and particularly, its 
early successes and failures. The mitochondrial genome has been 
the focus of various ancient DNA studies for nearly 30 years, and it 
was the early years of molecular archeology research that clearly 
demonstrated the diffi culty of recovering authentic ancient DNA. 
Few projects were successful, and the results of many early studies 
reporting DNA recovery from million year-old specimens turned 
out to be contamination artifacts that were only identifi ed following 
publication  ( 29– 33 ) . While such lessons learned are neither surprising 
nor unique in the history of science, it took several years for the scien-
tifi c community to realize that ancient mtDNA testing was, among 
other things: (1) highly prone to contamination (much more so than 
STR testing) and (2) complicated by miscoding lesions caused by 
postmortem DNA damage and degradation  ( 34– 38 ) . As a result, strict 
guidelines are now in place for laboratory set-up, experimental 
protocols, replicate testing, and data analysis  ( 39,  40 ) . 
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 From the standpoint of laboratory testing for routine forensic 
mtDNA casework, the noncoding control region (CR), and its two 
hypervariable segments (HVS) in particular, are regularly targeted 
because of their high variability  ( 41,  42 ) . These approximately 
600 bases have the highest average substitution rate in the mito-
chondrial genome, and thus present the greatest opportunity 
for interindividual differentiation while minimizing data genera-
tion effort. The chance that any two randomly sampled individuals 
match in this region is generally less than 1%, but depends on the 
population  ( 16 ) . 
 The size of the mtDNA amplicons that can be targeted in any 
given case is strictly correlated to the state of preservation of 
the DNA and, in turn, the sample. Nucleic acids generally survive 
better in cold environments because of the lower activity of enzymes 
and microorganisms involved in the fi rst stages of degradation 
(autolysis and putrefaction). On the other hand, specimens subjected 
to hot and/or humid climates where both endogenous and exog-
enous microbial activity is high, or samples exposed to hydrogen, 
oxygen, and/or ultra-violets, tend to experience greater nucleic 
acid damage and degradation  ( 43 ) . In particular instances, DNA 
damage may also be caused by chemical treatment of the remains—
as a result of various mortuary practices  ( 44 ) or perhaps as a result 
of deliberate efforts to destroy any evidence of the human remains 
 ( 45,  46 ) . Regardless of the precise postmortem processes at work, 
nucleic acids present in the most recalcitrant specimens are nearly 
always highly fragmented and in low quantity, precluding the ampli-
fi cation of mtDNA fragments of decent size. Given this, along with 
the large variability in DNA quantity and quality on a sample-by-
sample basis, it is generally helpful to estimate the average length 
of the surviving endogenous fragments prior to selection of ampli-
fi cation primers. A few specifi c quantitative PCR assays which target 
mitochondrial DNA fragments of various sizes have proven quite 
useful for this purpose  ( 47– 50 ) . In our laboratory, the qPCR results 
dictate whether primers that target fragments between 211 and 330 bp 
(Primer Sets: PS, see Tables  1 and  2 ) or primers producing smaller 
amplicons ranging from 124 to 189 bp should be used (Mini Primer 
Sets: MPS, see Tables  1 and  2 ). Any attempt to amplify fragments 
that are longer than the average surviving fragment in the extract 
generally results in amplifi cation failure or, if a very small number 
of molecules actually permit the reaction to start, sequences with a 
high rate of error due to damaged starting templates and, in some 
rare cases, jumping PCR products  ( 51 ) . The protocol described 
here has been optimized for short mtDNA amplicons derived 
from severely damaged and degraded human skeletal remains. It is 
based on fl uorescent dye-terminator chemistries and capillary-based 
electrophoresis. 
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  1.  Agarose gel or FlashGel (Cambrex, East Rutherford, NJ, 
USA), quantifi cation ladder and dye. 
  2.  Exonuclease 1 (Exo. USB Corporation, Cleveland, OH). 
  3.  Shrimp Alkaline Phosphatase (SAP. USB Corporation, Cleveland, 
OH). 
 Or
  4.  MinElute PCR Purifi cation Kit and/or QiAquick PCR purifi -
cation kit (Qiagen, Valencia, CA). 
  1.  BigDye ® Terminator v1.1 Cycle Sequencing Kit (Applied 
Biosystems, Foster City, CA) ( see  Note 1 ). 
  2.  dGTP BigDye ® Terminator Cycle Sequencing Kit (Applied 
Biosystems) ( see  Note 2 ). 
 2.  Materials
 2.1.  Presequencing 
Components
 2.2.  Cycle Sequencing 
Components
 Table 1 
 Primer sets (PS) and miniprimer sets (MPS) combinations 
 Primers sets (+amplicon size in brackets) 
 Primer Set 1  F15989/R16251* [263] or F15971/R16258 [288] 
 Primer Set 2  F16190/R16410-M19 [221] or F16190/R16400 [211] 
 Primer Set 3  F15/R285 [271] or F15/R270 [256] or F29/R270 [242] or F29/R274 [246] 
 Primer Set 4 F140/R389 [250] or  F155/R389 [235] or F155/R381 [227] or F155/R484 [330] 
 Primer Set 5 F16363/R16 [223] 
 Miniprimer sets 
 MPS1A F15989/R16158 [170] 
 MPS1B  F16112/R16251 * [140] or F16112/R16237 [126] 
 MPS2A F16190/R16322 [133] 
 MPS2B F16222/R16410-M19 [189] or  F16268/R16410-M19 [143] or F16222/R16400 [179] 
or F16268/R16400 [133] 
 MPS3A F34/R159 [126] 
 MPS3B F109/R240 [132] 
 MPS4A F151/R292 [142] 
 MPS4B F220/R389 [170] 
 MPS5A F16363/R16509 [147] 
 Miniprimer sets when variable region testing is necessary 
 MVR1 F16450/R16 [136] 
 MVR2 F403/R569 [167] 
 For amplifi cation conditions, see ref  ( 59 ) . The pairs in bold are the standard combinations that are most 
commonly used. *For higher data quality, R16237 should replace R16251 for sequencing. 
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 Table 2 
 Primer sequences 
 Primer sequences 
 F15971 5 ¢ -TTA ACT CCA CCA TTA GCA CC-3 ¢ 
 F15989 5 ¢ -CCC AAA GCT AAG ATT CTA AT-3 ¢ 
 F16112 5 ¢ -CAC CAT GAA TAT TGT ACG GT-3 ¢ 
 F16190 5 ¢ -CCC CAT GCT TAC AAG CAA GT-3 ¢ 
 F16222 5 ¢ -CCT CAA CTA TCA CAC ATC-3 ¢ 
 F16268 5 ¢ -CAC TAG GAT ACC AAC AAA CC-3 ¢ 
 F16363 5 ¢ -CCC CAT GGA TGA CCC CCC-3 ¢ 
 F16450 5 ¢ -GCT CCG GGC CCA TAA CAC TTG-3 ¢ 
 R16158 5 ¢ -TAC TAC AGG TGG TCA AGT AT-3 ¢ 
 R16237 5 ¢ -TGT GTG ATA GTT GAG GGT TG-3 ¢ 
 R16251 5 ¢ -GGA GTT GCA GTT GAT GT-3 ¢ 
 R16258 5 ¢ -TGG CTT TGG AGT TGC AGT TG-3 ¢ 
 R16322 5 ¢ -TGG CTT TAT GTA CTA TGT AC-3 ¢ 
 R16400 5 ¢ -GTC AAG GGA CCC CTA TCT GA-3 ¢ 
 R16410-M19 5 ¢ -GAG GAT GGT GGT CAA GGG A-3 ¢ 
 R16509 5 ¢ -AGG AAC CAG ATG TCG GAT AC-3 ¢ 
 F15 5 ¢ -CAC CCT ATT AAC CAC TCA CG-5 ¢ 
 F29 5 ¢ -CTC ACG GGA GCT CTC CAT GC-3 ¢ 
 F34 5 ¢ -GGG AGC TCT CCA TGC ATT TGG TA-3 ¢ 
 F109 5 ¢ -GCA CCC TAT GTC GCA GTA TCT GTC-3 ¢ 
 F140 5 ¢ -CCT GCC TCA TCC TAT TAT TTA-3 ¢ 
 F151 5 ¢ -CTA TTA TTT ATC GCA CCT-3 ¢ 
 F155 5 ¢ -TAT TTA TCG CAC CTA CGT TC-3 ¢ 
 F220 5 ¢ -TGC TTG TAG GAC ATA ATA AT-3 ¢ 
 F403 5 ¢ -TCT TTT GGC GGT ATG CAC TTT-3 ¢ 
 R16 5 ¢ -TGA TAG ACC TGT GAT CCA TCG TGA-3 ¢ 
 R159 5 ¢ -AAA TAA TAG GAT GAG GCA GGA ATC-3 ¢ 
 R240 5 ¢ -TAT TAT TAT GTC CTA CAA GCA-3 ¢ 
 R270 5 ¢ -TGG AAA GTG GCT GTG CAG AC-3 ¢ 
 R274 5 ¢ -TGT GTG GAA AGT GGC TGT GC-3 ¢ 
(continued)
288 O.M. Loreille and J.A. Irwin
  3.  HPLC purifi ed primers at 10  m M; Sequence data from both 
forward and reverse primers are desirable, but not always pos-
sible to obtain. See Table  2 for primer sequences and  Note 3 . 
  4.  Big Dye dilution buffer (400 mM Tris, 10 mM MgCl 2 , pH 
9.0) ( see  Note 4 ). 
  5.  Sterile, deionized water. 
  6.  MicroAmp ® Optical 96-Well Reaction Plate (Applied Biosystems) 
or microtubes. 
  7.  Ice is recommended to reduce nonspecifi c priming. 
  8.  Cycle PCR sealers (Fisher scientifi c, Pittsburgh, PA) or optical 
caps (Applied Biosystems). 
  9.  Tips, fi ltered/aerosol-resistant. 
  1.  AGTC gel fi ltration purifi cation columns or 96-well blocks 
(Edge Biosystems, Gaithersburg, MD, USA). 
  2.  Highly deionized (Hi-Di) Formamide (Applied Biosystems). 
  3.  96-Well Plate Septa (Applied Biosystems). 
  4.  96-Well Plate Base (Applied Biosystems). 
  5.  96-Well Plate Retainer (Applied Biosystems). 
  6.  POP-6™ Polymer for 3130/3130 x l (Applied Biosystems). 
  7.  Running Buffer, 10× (Applied Biosystems) ( see  Note 5 ). 
  1.  Gel Electrophoresis apparatus. 
  2.  Thermo cycler. 
  3.  Vortex. 
 2.3.  Sequence 
Reaction Purifi cation 
and Loading
 2.4.  Equipment
Table 2
(continued)
 Primer sequences 
 R285 5 ¢ -GTT ATG ATG TCT GTG TGG AA-3 ¢ 
 R292 5 ¢ -ATT TTT TGT TAT GAT GTC T-3 ¢ 
 R381 5 ¢ -GCT GGT GTT AGG GTT CTT TG-3 ¢ 
 R389 5 ¢ -CTG GTT AGG CTG GTG TTA GG-3 ¢ 
 R484 5 ¢ -TGA GAT TAG TAG TAT GGG AG-3 ¢ 
 R569 5 ¢ -GGT GTG TTT GGG GTT TGG TTG-3 ¢ 
 R599 5 ¢ -TTG AGG AGG TAA GCT ACA TA-3 ¢ 
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  4.  Centrifuge with tray carriage. 
  5.  Centrifugal evaporator (Speed Vac evaporator). 
  6.  ABI 310, 3100, or 3130 x l Genetic Analyzer (Applied Biosystems) 
( see  Note 6 ). 
  7.  Electronic pipettes are strongly recommended. 
 
 In terms of degraded evidence testing, the largest hurdles to data 
acquisition have largely been surmounted once the DNA sequenc-
ing stage is reached. The testing of evidence material is guided by 
the original quantity and quality of the specimen, which also 
dictates the quantity and quality of the DNA. Therefore, the labo-
ratory steps that precede DNA sequencing are critical to the 
recovery of authentic, high-quality sequence data that can be 
reported in forensic cases. In order to avoid contamination at 
these critical steps, a few specifi c guidelines should be followed 
when processing evidentiary specimens  ( 39,  40 ) . Laboratories 
where samples are extracted and amplification reactions are 
prepared should be physically separated from laboratories where 
amplifi ed DNA is handled. Each laboratory should have dedicated 
equipment, reagents, and supplies so that transfers between pre- 
and post-PCR laboratories are avoided. Experimental controls 
should be included at all steps of laboratory processing since 
extraction blanks and negative PCR controls are critical for moni-
toring contamination. Replicate testing should be conducted on 
all samples, starting at the extraction step if possible, to ensure 
consistent and reproducible results; and fi nally, the data should be 
critically evaluated to ensure that they logically “make sense” (for 
review, see ref.  ( 39 ) ). 
 Evaluate the amplifi cation results on a 2% agarose gel or a FlashGel 
and assess DNA quantity using either a quantifi cation ladder or a 
spectrophotometer. For amplicons between 100 and 200 bp, use 
1–3 ng of PCR product for sequencing. For amplicons between 
200 and 400 bp, use 3–5 ng of PCR product as recommended by 
the manufacturer ( see  Note 7 ). 
 Purify successful reactions by adding 10  m L of Exo and 5  m L of SAP 
to the reactions. Place the tubes in the thermo cycler for 45 min at 
37°C, 20 min at 80°C, followed by a fi nal hold at 4°C ( see  Note 8 ). 
If 2  m L of amplifi ed product contain signifi cantly less than 1 ng of DNA, 
use the MinElute kit following the manufacturer’s instructions 
 3.  Methods
 3.1.  PCR Product 
Quantifi cation
 3.2.  PCR Product 
Purifi cation
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instead of the Exo and SAP to purify the reactions, and elute your 
DNA in a volume smaller than your reaction volume to concen-
trate it. The MinElute or the QiAquick PCR purifi cation kits 
should also be used when many primer dimers are present in the 
reactions. 
 The use of electronic pipettes is recommended for the set-up of 
many sequencing reactions, to save time and decrease pipetting 
errors. In a 96-well reaction plate or, if only a small number of 
reactions are being prepared, in carefully labeled microtubes: add 
2  m L of one sequencing primer (10  m M) in each well, along with 1 
or 2  m L of purifi ed DNA. Prepare a sequencing reaction master 
mix that includes, per sample: 8 or 9  m L of deionized water, 6  m L 
of big dye dilution buffer, 1.5  m L of big dye, 0.5  m L of dGTP. 
Distribute 16 or 17  m L of the master mix in each well to have a 
fi nal volume of 20  m L per well. Add the plate sealer and briefl y 
vortex the plate. Spin it and place it in a thermo cycler for 25 cycles 
of 15 s at 96°C, 5 s at 50°C, 2 min at 60°C followed by a rapid 
thermal ramp to 4°C. 
 Purify sequencing reactions with AGTC gel fi ltration purifi cation 
columns according to the manufacturer recommendations and 
then dry the samples in a centrifugal vacuum evaporator for 60 min 
or until dry (caution: do not heat and do not overdry). Resuspend 
the samples in 10  m L of Hi-Di Formamide, add a plate septum, 
and vortex. After a brief centrifugation, add the 3130 base plate 
and retainer, and fi nally place the plate in the sequencer. A heat 
denaturation step is not necessary. 
 The Standard RapidSeq36_POP6 Run Module (Instrument 
Protocol) from Applied Biosystems can be customized slightly to 
accommodate the short injection times used for small amplicon 
sequencing. The specifi c injection time will vary according to the 
DNA concentration and amplicon size, but generally speaking, 
very short injection times of 3–7 s should be used. Short injections 
will help prevent overloading and the resultant high background 
that is caused by off-scale data and spectral pull-up. 
 For sequence analysis, the standard RRSeqAnalysisPOP6 
module/protocol should be used. As with the run module, the 
analysis module will need to be slightly modifi ed to accommodate 
the short fragments. The start and, more importantly, stop points 
of the data analysis (which correspond to the start and stop points 
of the instrument scans that will be analyzed by the software) 
should be properly set to accommodate the short fragment sizes. 
In other words, take a look at the raw data to determine a scan number 
just beyond the end point of the longest sequence fragments, and 
then use that as the stop point for the data analysis. This will limit 
 3.3.  Cycle Sequencing 
Reaction
 3.4.  Sequence 
Purifi cation
 3.5.  Electrophoresis 
Parameters 
and Analysis
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the data analysis to a shorter range, yet also capture the length of 
all sequences ( see  Notes 9 and  10 ). 
 Details of standard mitochondrial DNA data review are covered in 
detail in Chapters  19 and  21 , so here we will focus only on data 
features/characteristics that are specifi c to damaged and degraded 
DNA templates. 
 In their publication  ( 39 ) , Gilbert et al. explain that the criteria 
of authenticity described in various reviews on ancient DNA are 
“intended to assist in determining the authenticity of a study, 
but [..] cannot replace a crucial consideration of the problem.” 
The idea is that, the data must always be reviewed carefully to 
determine whether or not the results obtained make sense. Below, 
we list a few “sense”-based strategies to help establish data authen-
ticity. In addition, we present some particular scenarios that warrant 
further scrutiny of the data and should be treated with caution.
  1.  The best way to confi rm the authenticity of a sequence is by 
replicating the amplifi cations several times from at least two 
independent extracts. In our laboratory, different scientists 
perform the two DNA extractions as an additional precautionary 
measure. In order to avoid false positives and/or contamina-
tion from contemporary molecules that could have potentially 
penetrated a particular sample (a porous bone for example), it 
is strongly recommended that different skeletal elements be 
used for the independent extractions (for example, a bone and 
a tooth, or a humerus and femur). 
  2.  When possible, try to perform 3 or 4 replicate amplifi cations of 
a given DNA extract in a single PCR set-up. If all of the reactions 
containing DNA show PCR product, even if the bands of the 
agarose gel are faint, you can consider the results encouraging. 
If, on the other hand, you only detect PCR product in a single 
amplifi cation of the many replicates, then this should raise a 
red fl ag. Independent amplifi cations should be performed 
anyway, but multiple replicates in a single set-up provide a much 
better picture of reproducibility than a single amplifi cation does. 
  3.  Electropherograms should be reviewed base-by-base, in order 
to identify any peculiarities. A mixed base can have different 
origins. If a position shows mixtures in all the replicate ampli-
fi cation products and the PCR negative controls are negative 
(see Fig.  1 ), it is very likely that either the DNA extract is con-
taminated or the PCR has been contaminated by a quantity of 
DNA so small that it is insuffi cient to initiate an amplifi cation 
in the controls, but when combined with a few molecules of 
authentic DNA, will amplify. This is known as the carrier effect 
 ( 52,  53 ) ; and while it can be caused by a number of things, 
past amplifi cation products are known to be one source  ( 54 ) . 
Contamination is also very likely when the mixed bases occur 
 3.6.  Data Review 
and Establishment 
of Authenticity
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at sites that are phylogenetically informative, or at sites gener-
ally known to vary in the human mtDNA phylogeny  ( 55,  56 ) . 
On the other hand, when the mixed sites seem random among 
replicate amplifi cations and sequences (see Fig.  2 ), and they 
occur at positions that are phylogenetically uninformative and/
or rarely vary, it is likely that the mixed bases are the result of 
Taq polymerase errors induced by damaged DNA templates. 
The number of polymerase misincorporations is strictly linked 
to the quantity and severity of DNA damage. 
 Fig. 1.  Example of a contaminated sequence. Mixtures are observed at variable and phylogenetically informative positions 
16126 and 16129 and the respective forward and reverse sequences represent independent amplifi cations. 
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  4.  A short amplicon will often produce sequences containing a 
lot of background noise and sequence data artifacts. Sometimes, 
however, the background noise is simply caused by too much 
sequencing product. In these cases, rerunning the sample with 
a shorter injection time will generally solve the problem (see 
Fig.  3 ). 
  5.  Although extremely rare when using human-specifi c mtDNA 
control region primers, a sequence may be encountered on 
occasion that exhibits an unusually large number of differences 
from the rCRS, with many of those differences occurring at 
sites that are generally considered invariant in the human mtDNA 
phylogeny. These sequences are by-and-large quite obvious 
and should be searched against GenBank. In such cases, it is highly 
likely that a pseudogene has been inadvertently amplifi ed 
instead of the mtDNA target  ( 57 ) . 
 Fig. 2.  Example of a sequence obtained from an aggressively embalmed sample that shows a high quantity of irresolvable 
bases due to DNA damage. The ten sequences shown represent the forward and reverse sequences from fi ve separate 
amplicons. Each sequence pair (F and R) exhibiting the same constellation of mixed bases originates from a different 
amplifi cation replicate. Note how the mixed bases are not reproduced among replicates and tend to occur at positions that 
rarely, or never, vary in the human mtDNA phylogeny. 
 Fig. 3.  Example of an overblown sequence ( top ) compared to the same sequencing reaction after a shorter 3130 injection 
time ( bottom ). The RFU values from the top sequence range between 6360 and 2851. With a shorter injection time, the 
background noise disappeared and the RFUs fell down to between 229 and 77. 
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 Fig. 4.  Example showing deamination. T peaks can be observed under the C-stretch. Of the four sequences shown, the two 
upper sequences represent the forward and reverse primers from one amplicon and the two lower sequences represent 
the same primers from a replicate amplifi cation. Deamination, like other damage, tends to be diffi cult to replicate; and that 
is the case here. Deamination products in the two amplicons occur at different positions (16055–16056 in the upper 
sequences, 16052–16053 in the lower sequences). 
  6.  Deamination of, in particular, adenine and cytosine is a common 
form of DNA modifi cation in highly degraded specimens  ( 35 ) . 
This type of damage produces sequence data artifacts that 
manifest as mixed bases of Cs and Ts or, the complementary 
Gs and As. This is often observed in C-stretches, where small 
red peaks (T) are found under blue peaks (C) (see Fig.  4 ). 
However, like other forms of DNA damage, deamination can 
generally be easily identifi ed by its random occurrence at 
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different positions in different PCR products from the same 
DNA extract. This is due to a limited number of starting 
molecules and the stochastic amplifi cation of one template 
over another during the early PCR cycles, which leads to the 
overrepresentation of one template over any other in a given 
amplifi cation. It is important to note, however, that in all cases 
of DNA damage, the background haplotype/haplogroup should 
remain consistent across all amplifi cations. In other words, any 
phylogenetically informative or authentic DNA variation should 
remain stable across the replicates (unless, by pure coincidence, 
the damage occurred at one of those sites). 
 
  1.  The BigDye ® Terminator v1.1 Cycle Sequencing Kit has been 
optimized to deal with base calling directly adjacent to the 
primer. We tried both version 1.1 and v3.1 of these kits and 
our experience confi rmed that the BigDye ® Terminator v3.1 
Cycle Sequencing Kit does not perform as well as the v1.1 with 
short amplicon sequencing. 
  2.  The dGTP BigDye Terminator kit is optimized for G and 
GT-rich templates and generally improves the quality of the 
reverse (H-strand) sequencing reactions—particularly in poly-
G regions. The reaction mix of this kit contains a mixture of 
dGTPs, dATPs, dTTPs, and dCTPs. However, on a 3100 or a 
3130 Genetic Analyzer, the use of the dGTP kit alone may 
cause peak compression issues. Therefore, for these instru-
ments, it is best to use the BigDye ® Terminator v1.1 Cycle 
Sequencing reaction mix (that contains inosine, dITP, instead 
of dGTP) spiked with the dGTP BigDye ® Terminator Cycle 
Sequencing reaction mix as described in Subheading  3.3 . 
  3.  For amplicons smaller than 100 bp, regular Sanger sequencing 
will provide low quality data. However, an option in these cases 
is the use of poly-tailed sequencing primers to artifi cially 
lengthen the sequenced fragments to >100–125 bp—the size 
generally necessary for good quality sequence data with these 
instruments. Binladen et al. recommend the addition of a neu-
tral 40 bp sequence (5 ¢ -AACTGACTAAACTAGGTGCCACG-
TCGTGAAAGTCTGACAA-3 ¢ ) and additional 5 ¢ poly(C) tail 
to the 5 ¢ end of the basic sequencing primer  ( 58 ) . Our prelimi-
nary work using primers + the 40 bp sequence (but no poly-C 
tail) gave very promising results (data not shown). 
  4.  The dilution sequencing buffer can be purchased from Applied 
Biosystems. To prepare it yourself, dissolve 48.4 g Tris base and 
2.0 g MgCl 2 in 800 mL dH 2 O. Adjust to pH 9.0 at room tem-
 4.  Notes
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perature by adding drops of concentrated HCl. Adjust the fi nal 
volume to 1 L with dH 2 O and mix thoroughly. Filter the buffer. 
Caution: Hydrochloric acid (HCl) causes severe burns and is 
irritating to the eyes. When preparing this reagent, use a fume 
hood and avoid inhalation and contact with the skin. Wear a lab 
coat, gloves, and protective eyewear when handling. 
  5.  10× running buffer can be purchased from Amresco (Solon, 
OH) and used instead of the Applied Biosystems buffer to 
reduce costs. 
  6.  The 3730 DNA Analyzer of Applied Biosystems requires the 
use of the POP-7™ Polymer. Our experience has shown that 
this instrument/polymer combination did not provide the 
resolution necessary for very short fragments. 
  7.  The frequency of nonspecifi c amplifi cation products is signifi -
cantly higher when DNA templates are very degraded, and/or 
sample extracts are contaminated by large quantities of micro-
organismal DNA. If the agarose gels show multiple bands in a 
single lane, several options are available to overcome this problem. 
(1) Try another amplifi cation using more stringent conditions 
(often, a lower concentration of magnesium chloride and/or 
higher annealing temperature is suffi cient), (2) cut and purify the 
desired PCR product from the agarose gel, or (3) use internal 
primers during the cycle sequencing step. Alternatively, different 
PCR primers can often be used to produce a more specifi c ampli-
fi cation product and avoid nonspecifi c primer binding. Multiple 
PCR primer options, along with various internal sequencing 
primers for any given amplicon (if the amplicon is large enough), 
can generally mitigate most problems related to nonspecifi c 
amplifi cation (see Table  1 ). 
  8.  Due to the small total volume pipetted (15  m L) and the high 
viscosity of Exo and SAP, prepare a master mix for at least 2 or 
3 extra reactions. 
  9.  If the signal is too strong, try rerunning the plate with a shorter 
injection time and/or diluting the sequences with additional 
HiDi formamide. If this isn’t enough, perform a new cycle 
sequencing reaction with less, or diluted, PCR product. 
  10.  Data analysis extending beyond the end of the sequenced frag-
ment can sometimes yield nonsensical electropherograms, with 
the fl uorescent signal seemingly extrapolated across the entire 
analysis frame. These e-grams often exhibit extremely broad 
peaks spanning multiple base positions, resulting in a sequence 
of AGTC being called as AAAGGGTTTCCC. To avoid this, 
the analysis start and end points can either be changed in the 
analysis module that is run immediately after the run module, 
or they can be adjusted later, on a sequence-by-sequence basis 
in the Sequencing analysis software. 
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 Chapter 21 
 Interpretation Guidelines of mtDNA Control Region 
Sequence Electropherograms in Forensic Genetics 
 Manuel  Crespillo  Marquez  
 Abstract 
 Forensic mitochondrial DNA (mtDNA) analysis is a complementary technique to forensic nuclear DNA 
(nDNA) and trace evidence analysis. Its use has been accepted by the vast majority of courts of law around 
the world. However for the forensic community it is crucial to employ standardized methods and proce-
dures to guaranty the quality of the results obtained in court. In this chapter, we describe the most impor-
tant aspects regarding the interpretation and assessment of mtDNA analysis, and offer a simple guide 
which places particular emphasis on those aspects that can impact the fi nal interpretation of the results. 
These include the criteria for authenticating a sequence excluding the contaminant origin, defi ning the 
quality of a sequence, editing procedure, alignment criteria for searching the databases, and the statistical 
evaluation of matches. It is not easy to establish a single guide to interpretation for mtDNA analysis; how-
ever, it is important to understand all variables that may in some way affect the fi nal conclusion in the 
context of a forensic case. As a general rule, laboratories should be cautious before issuing the fi nal conclu-
sion of an mtDNA analysis, and consider any signifi cant limitations regarding current understanding of 
specifi c aspects of the mtDNA molecule. 
 Key words:  Mitochondrial DNA ,  Interpretation ,  Forensic ,  Database ,  Heteroplasmy 
 
 Analysis of mtDNA (regions HVS-I, HVS-II, and eventually HVS-
III) for forensic purposes is currently routine practice in forensic 
laboratories, especially when the amount and/or quality of DNA 
obtained is insuffi cient to conduct conventional analysis of short 
tandem repeats (STRs). The interpretation and evaluation of the 
results of mitochondrial DNA is the fi nal step in the analysis. This 
is not a trivial issue. The analysis of mtDNA and the other methods 
carried out in laboratories must have been internally validated 
according to ISO/IEC 17025, as a basic step toward ensuring the 
 1.  Introduction
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results issued. It has been shown that applying good laboratory 
practice (GLP) helps to minimize potential errors during analysis. 
However, other factors, such as the phenomenon of heteroplasmy 
(position and length), editing of the sequence, sequence quality 
requirements, databases and database searches, the statistical 
treatment of matches, the higher mutation rate of mtDNA com-
pared with nuclear DNA (nDNA), and the current lack of knowledge 
of nucleotide mutation rates—mean that the chance of an mtDNA 
result being incorrectly interpreted is more likely than under 
autosomal STR marker analysis, with the consequent legal impact. 
In some cases, ambiguities in interpreting mtDNA may mean that 
two analysts working on the same case reach different conclusions; 
this is because, in certain situations, there is a fi ne line between 
assigning the same origin to two samples and excluding that same 
origin. It is therefore crucial to understand the different aspects 
that will lead a forensic expert to issue one conclusion over another 
in this type of analysis. 
 The international community has attempted to address this 
problem through various guidelines and recommendations  ( 1– 3 ) . 
However, despite this, this interpretation stage is still the most 
complex within the entire mtDNA analysis. 
 Finally, it is true that forensic laboratories have today achieved 
a high technical standardization and they have a wide range and 
variety of computer tools that enable them to reach the levels of 
reliability that this type of analysis, by its nature, requires. In parallel, 
there have been signifi cant advances in phylogenetic knowledge of 
mtDNA while there has also been growth in the quantity and quality 
of population databases. However, despite all these, there is 
currently no software available that is capable of performing robust 
and automatic evaluation of mtDNA sequencing data without the 
manual intervention of an analyst. Adequate training and experi-
ence of the analyst therefore continues to be essential in order to 
handle this type of study successfully. 
 
 Interpreting the results of an mtDNA analysis aims to reach con-
clusions, within the context of a forensic case, regarding whether, 
given one known sample and one that is questioned, they could 
come from the same person or maternal origin. However, before 
moving to the results interpretation phase itself of an mtDNA anal-
ysis in a forensic case, two prior compulsory steps must be carried 
out. These aim to assess the sequence generated and attempt to 
answer two questions: fi rst, whether or not the sequence is the 
product of contamination; and second, whether or not the sequence 
is of suffi cient quality to be considered acceptable according to our 
 2.  Methods
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laboratory’s quality standards. It is during the sequence editing 
phase (point 3) that such matters are ultimately resolved. Therefore, 
we must:
  1.  Determine the authenticity of the sequence in order to rule 
out contamination. 
  2.  Establish the sequence quality. 
 Avoiding contamination during genetic analysis is a priority for 
forensic laboratories; even more so when dealing with mtDNA 
analysis, justifi ed by the molecule characteristics and the analytical 
methodology used. Therefore international recommendations 
regarding facilities and analytical procedure designed to minimize 
contamination during the process  ( 1 ) must be adhered to. These 
recommendations include the use of gloves, gowns, and masks 
when handling samples as well as when conducting tests in laminar 
fl ow or dead space hoods, aerosol-resistant pipette tips, preamplifi -
cation areas are physically separated from postamplifi cation areas, the 
use of reagent blanks and negative controls. 
 The analysis of negative controls—both extraction reagent 
blank and negative PCR control—is the fi rst step in interpreting 
the mtDNA sequence. Determining the amount of amplifi ed 
material through analysis of capillary electrophoresis (2100 
Bioanalyzer ® . Agilent Technologies) (see Notes 1 and 2) will 
enable an initial decision to be taken in the process of mtDNA 
results interpretation. Laboratories performing mtDNA analysis 
must establish thresholds that limit procedures from continuing 
when DNA in the reagent blanks and/or negative controls is 
detected. Some authors consider that if the amount of quantifi ed 
DNA for the blanks exceeds 10%  ( 4,  5 ) of the value obtained in 
the test samples, then the process should be stopped and restarted 
at the step where the contamination was introduced. If, however, 
reagent and amplifi cation blanks are estimated below 10%, then 
the sequencing process can proceed. One study has demonstrated 
that the 10:1 rule is conservative and reliable  ( 6 ) ; therefore, low 
levels of contamination can be tolerated. However, the fi nal assess-
ment of these negative controls should be done after sequencing 
them during the editing phase and in the light of the sequencing 
results obtained for the coextracted and/or amplifi ed test samples 
along with the these checks. 
 The vast majority of forensic laboratories today analyze mtDNA 
through sequencing, using dye terminator sequencing chemistries 
(BigDye Terminator® v 3.1 Applied Biosystems) and subsequent 
detection through capillary electrophoresis. A number of circum-
stances—depending on the sequencing reaction, electrophoresis 
conditions (e.g., capillary, buffer, and polymer), analysis software 
or the DNA sequence itself—can generate poor quality sequences. 
 2.1.  Quality Assurance
 2.2.  Establishing 
the Quality of the 
Sequence
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Various artifacts such as background noise, low peaks, messy data 
at the beginning of the sequence or throughout the sequence, 
irregular spacing, position or length heteroplasmy, dye blobs, 
spikes can compromise the quality of the sequences studied. The 
analyst must know this problem and have the tools to correct them. 
Described below are some of the most common problems and fac-
tors along with their origin and potential solution  ( 7 ) .
  1.  Failed reaction 
 For many failed reactions analyzed data is not present because 
the signal strength is below the threshold for analysis. There can be 
a number of causes to explain this situation—including the small 
amount of template, poorly designed or inadequate concentration 
of primers, faults in the PCR reaction, or loss of extension products 
during cleanup reaction, as well as problems during the injection 
step. These circumstances must be evaluated in order to correct 
this type of sequence. 
  2.  Background noise 
 The most common cause comes from the use of an insuffi cient 
amount of template DNA during sequencing reaction, although 
other causes such as the simultaneous use of multiple primers or 
type of DNA in the same tube can generate this type of sequence, 
as well as DNA template that contains impurities, such as salts or 
ethanol. On the other hand, we must not forget that poor electro-
phoresis (buffer, polymer), the use of parameters or improper use 
of a matrix can also cause this type of problem. The result is the 
generation of multicolored peaks in certain positions, and the correct 
allocation base by the software is not possible, with these positions 
normally being characterized as “N” (see Fig.  1 ). The degree of 
background noise, the analyst’s expertise, and the internals of the 
laboratory protocols will determine the interpretive value of these 
sequences. 
  3.  Dye blobs 
 A fairly common factor when working with dye terminator 
sequencing chemistries is the appearance in the fi rst sequence 
section (approximately up to 100–140 bp) of dye blobs as a result 
of traces of unincorporated terminators that have not been elimi-
 Fig. 1.  Electropherogram with background noise. 
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nated during the purifi cation step. Dye blobs generally occur over 
the top of the sample peaks without distorting the true DNA 
sequence (see Fig.  2 ). Laboratories should use effi cient purifi cation 
systems to eliminate the remaining terminators. 
  4.  Gradual loss of signal 
 The gradual loss of signal sometimes prevents complete edit-
ing of the sequence. This may be due to a number of causes, but 
the most likely appears to be an imbalance between the amount of 
DNA and the concentration of primers used for the PCR reaction, 
an imbalance of any of these components can cause this type of 
artifact. It is therefore very important to adjust properly the amount 
of template DNA to be sequenced and the concentration of primer. 
Moreover, although less likely, excessive salt can also cause this 
type of sequencing patterns since the salts have an inhibitory effect 
on Taq polymerase, which can translate into an overabundance of 
short fragments at the expense of longer fragments (see Fig.  3 ). 
  5.  Multicolor narrow peaks anywhere in the electropherogram 
 The appearance of condensed and narrow peaks where differ-
ent colors of the fl uorochromes coexist, and which often mask one 
or two real nucleotides, may occur anywhere in the electrophero-
gram, and often signifi cantly exceed the height of the surrounding 
peaks. In these positions, the software assigns values “N” (see 
Fig.  4 ). This type of artifact is usually associated with the presence 
of small bubbles within the polymer matrix, or even small residues 
of dried polymer suspended in the polymer. It is therefore neces-
sary to work with fresh polymer and view the presence of such 
 Fig. 2.  Traces of unincorporated terminators that have not been removed can cause dye blobs. 
 Fig. 3.  Note the gradual loss in the intensity of the signal of the peaks. 
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microbubbles prior to electrophoresis. In any event, and when 
editing the sequence, there should be a new electrophoresis. 
  6.  The appearance of broad peaks with the consequent loss of 
resolution 
 Broad and imprecise bands appear in the electropherogram, 
often covering the space corresponding to several bases. The soft-
ware incorrectly assigns short homopolymeric tracts (2 or 3 nucle-
otides—for example TT, CCC…) or “Ns” (see Fig.  5 ) to the space 
corresponding to the band. The cause is usually due to the pres-
ence of a bubble in the capillary or capillary blockage by some kind 
of artifact, and the presence of excess salts in the injected sample. 
Often a reinjection of the sample or cleansing it thoroughly solves 
the problem. 
  7.  Peaks widened at the base 
 A strong characteristic of overused capillaries, usually above 
150 punctures. At this point the manufacturer’s recommendation 
is to change the capillary (see Fig.  6 ). 
  8.  Using the analysis software 
 If the data are analyzed with the wrong software settings (use 
of a wrong mobility fi le, incorrect or poor-quality instrument 
matrix fi le), the resulting electropherograms will show overlapping 
peaks and gaps between peaks rather than the evenly spaced peaks 
characteristic of correctly analyzed data and this causes misassigned 
 Fig. 5.  Broad peaks. 
 Fig. 4.  Multicolor narrow peak. 
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nucleotides. The result is poor quality electropherograms; for 
example, the use of an incorrect mobility module is characterized 
by the presence of abundant background noise, the appearance of 
overlap in certain bases and the loss of some other assignment. 
Similarly, the use of a poor quality or incorrect matrix also tends to 
cause a degree of background noise to appear that affects the quality 
of the sequence. The result is misassigned bases or “N.” As recom-
mended in these situations, the parameters used in the analysis 
should be checked. 
  9.  Poli C-stretch 
 The homopolymeric C-stretch region located at nucleotide 
positions 16184–16193 in HVS-I shows a T (16189) placed 
between two tracts of Cs. Length heteroplasmy likely results 
from slippage replication after a T to C transition occurs in 
position 16189. The impact of the mixture of the length vari-
ants generates that the sequence quality drops after the string of 
cytosine residues. 
 A similar situation occurs in HVS-II C-stretch when insertion 
of cytosines occurs in the tract 303–310 or a transition T to C 
occurs at position 310, generating a, as “out of phase sequence 
carryover” downstream of the homopolymeric tract, which pre-
vents a double complete reading of the fragment analyzed. To 
solve the situation different primer combinations are used in order 
to recover sequence information from both sides of the homopoly-
meric stretch of cytosines or alternatively the same strand may be 
sequenced twice in separate reactions to obtain a double lecture of 
each nucleotide (see Fig.  7 ). 
 Following the amplifi cation reaction and mtDNA sequencing, the 
capillary electrophoresis and after the raw sequencing data were ana-
lyzed (DNA Sequencing Analysis Software ® , Applied Biosystems), 
data is dumped to the assembly software and sequence comparison. 
 During this editing stage, we can take decisions about the 
suitability of the sequences to be subjected to comparative study 
 2.3.  Editing Data
 Fig. 6.  Overuse of the capillary can cause peak widened at the base. 
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and subsequent assessment or, conversely, if they require further 
investigation. Also, by editing, we will evaluate defi nitively if 
the reagent blanks and amplifi cation controls can be treated as 
negative (see Fig.  8 ). 
 We consider it important that this editing step be carried out by 
two independent analysts; this will reduce the possible arbitrariness 
in the allocation of certain bases that sometimes occurs. A sequence 
analysis is considered correct when both analysts arrive at the same 
conclusion. If not, additional tests are needed to confi rm. 
 Various programs are now available that allow the assembly, 
alignment, and comparison of the sequences. The usefulness of 
such programs in allocating the bases is without question, but 
unfortunately these programs do not always allow for fully auto-
matic and error-free editing. It is therefore up to the analyst to 
complete the fi nal editing of the sequences and evaluate whether 
they attain suffi cient reliability and quality to be subjected to a 
comparative study and subsequent interpretation.
  1.  The raw data are imported into a comparison program 
(Sequencher™-Gene Codes-, SeqScape ® -Applied Biosystems-). 
The majority of programs currently used allow both strands 
(heavy and light) to be aligned and the subsequent generation 
of a consensus sequence, which can be compared with other 
sequences as well as with the revised Cambridge reference 
sequence (rCRS)  ( 8 ) . 
  2.  At this point, the result of the sequence generated from the 
reagent blank and negative amplifi cation is assessed. If the result 
of the sequencing enables an interpretable result to be generated, 
in view of the results, the source of contamination should be 
assessed and the process restarted at the stage where it is suspected 
that the contamination occurred. If on the other hand the result 
of sequencing blanks (reagents and amplifi cation) is negative, we 
are able to ensure the absence of contaminants in the process, and 
therefore the authenticity of the sequences of the samples. 
 Fig. 7.  PoliCs stretch appears in both regions HVS-I and HVS-II producing an abrupt crash in the quality of sequence. 
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  3.  General supervision of the sequence generated in the samples, 
evaluating the position “N” that can occasionally occur, and 
editing any that are permitted as described (see point 2). The 
presence of an abundance of “N” will not offer proper editing, 
and in this case will require a determination of the cause and 
try to correct the problem (see Note 3). 
  4.  rCRS discrepancies assigned by the software should be reviewed 
manually one by one by the operator and require confi rmation 
of the base allocated on both strands by well-defi ned peaks and 
Evaluate the efficiency of the amplification reaction and
check blank reagents and negative PCR control *
Sequencing mtDNA
Confirm negative results
(blank reagent/negative PCR control)
Check the quality of sequence
Check phylogenetic sense of the sequence
Compare with other sequences from samples of the case
and interpretation of the results
Contrast the consensus sequence against haplotypes of the
staff
Statistical evaluation of the match ( if necessary)
Report sequences as discrepancies respect rCRS
mtDNA amplification (HVS-I/HVS-II/HVS-III)
Edition (analyst 1) Edition (analyst 2)
Confirm each discrepancy respect rCRS
(forward and reverse lecture)
 Fig. 8.  Steps involved in performing mitochondrial DNA analysis. In general, after each 
control step, and depending on the result, the laboratory must take decisions based on 
internal and validated criteria. *Acceptance of the results of negative controls will depend 
on the method used for analysis of PCR products (capillary electrophoresis or agarose gel) 
as well as the acceptance criteria established by the laboratory. 
 
310 M.C. Marquez
zero or negligible background noise levels. Reviewing and cor-
recting of any erroneous discrepancies that the program can 
create “artifi cially” because of the poor quality of the sequence 
(see Note 4). 
  5.  Assessment and confi rmation of possible position heteroplasmic: 
Sometimes the software can assign a value of “N,” for example 
when the two populations of mtDNA molecules appear 
approximately in proportion 1:1 in a particular position, or at 
other times the base assigned for the majority population of 
mtDNA molecules present at that position. In the latter case 
we must be careful because if the majority population does not 
differ from rCRS, heteroplasmic position may go unnoticed. 
The assignment of a position heteroplasmy must be confi rmed 
in both strands (see Notes 5 and 6). 
  6.  Length heteroplasmy: The poliCs tracts present in both HVS-I 
and HVS-II, as described above, are prone to length hetero-
plasmy in these fragments. Such situations involve achieving a 
double reading of the strands either through the use of internal 
primers or alternatively with a double sequencing reaction for 
the same strand. When it is not possible to determine accu-
rately the exact number of cytosine residues present, no attempt 
should be made to count the number of residues (for interpre-
tation purposes), and all comparisons will treat this region as 
having the same number of cytosines. 
  7.  The procedure described in the preceding paragraphs (2.3.1–
2.3.6) should be repeated independently by another specialist, 
thereby obtaining a second edition that will be checked against 
the fi rst. Where this coincides with the fi rst edition, proceed to 
next step . 
  8.  At this point, we need to determine the phylogenetic sense of 
the sequence; in order to discard errors attributable to human 
and technical issues (see Note 7), if the sequence has that phy-
logenetic sense then we proceed to next point . 
  9.  As a last step before fi nal acceptance of the sequence, the 
sequence will be contrasted against the haplotypes of labora-
tory personnel involved in the analysis. If no match to any 
member of staff is found, then we can accept the sequence. 
Otherwise, and depending on the haplotype obtained, the lab-
oratory must take steps to confi rm the result, including carry-
ing out a repeated analysis of evidence from the start, provided 
that the sample permits, for confi rmatory purposes. 
 After editing and reviewing the sequences resulting from the 
mtDNA analysis, a comparison between the sequences obtained 
from a questioned and the known sample is required. The result of 
comparative analysis can lead to situations such as
 2.4.  Interpretation
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  1.  A full match between the doubted and the reference sample: In 
this case we cannot exclude the possibility that both samples 
come from the same person or persons with the same maternal 
parentage; in this case, we recommend performing a statistical 
evaluation of the match (discussed below). Even if both sam-
ples share some heteroplasmic position, this represents the 
cooccurrence of an additional unlikely event, and therefore its 
presence may increase the strength of the evidence (see Note 8) 
and one cannot exclude two samples as originally coming from 
the same source or maternal lineage. 
  2.  When there are more than two differences between the 
sequences from doubted and undoubted samples we can con-
clude that both samples come from different people or people 
with different maternal kinship. But to reach this conclusion 
we must consider these positions as unequivocally different, it 
is necessary to take into account aspects such as tissue specifi c-
ity and mutation rates (see Notes 9 and 10). 
  3.  Differences in a single base between the known and questioned 
sample. In a heteroplasmic position: When a heteroplasmic 
position that not is present in the known sample is detected in 
the questioned sample (or vice versa) we cannot exclude the 
possibility that the doubted and reference samples are from the 
same person or persons with the same maternal kinship, since 
both samples share at least one of the two subpopulations of 
mitochondria molecules. It is therefore advisable to carry out a 
statistical evaluation of the match. In a length heteroplasmy: if 
the reference and the doubted sample only differ in length het-
eroplasmy, that difference alone should not be considered for 
the purposes of interpretation and therefore in this case we 
cannot exclude the possibility that the doubtful and reference 
samples come from the same person or persons with the same 
maternal parentage; it is advisable to carry out a statistical eval-
uation of the match. Homoplasmic differences. When both 
samples, reference and doubted, vary in a position where there 
is no evidence of heteroplasmy is undoubtedly a complicated 
situation in the process of interpretation, which could change 
the fi nal interpretation from a match in the origin of to nonco-
incidence (see Notes 11 and 12). In this situation, whenever 
possible at least these steps should be followed. 
 Additional known samples (blood, saliva, hair) can be 
sequenced to determine if the heteroplasmy is visible in other 
tissues. Obviously, further testing cannot always be performed 
on a crime scene sample of limited quantity, but it can prove 
helpful for interpretation of known samples. Special attention 
must be taken with hairs (see Note 13) and it is advisable to 
analyze different portions of the same hair. 
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 When the sequences of the reference and doubted samples match, 
and therefore cannot be excluded as coming from the same origin, 
it is desirable to convey some information about the weight of the 
evidence. For this purpose, the laboratory can employ several 
options:
  1.  Estimate the rarity of the sequence by expressing the number of 
times that a particular sequence is found in a database (see Notes 
14–17). This method is referred to as the “counting method.” 
  2.  By calculating the frequency of that haplotype. Considering 
that not all haplotypes are represented in a database, sampling 
error correction needs to be applied. Balding and Nichols  ( 9 ) 
propose that adding the haplotype of the doubted and refer-
ence sample to the database the sampling error can be roughly 
corrected.
  2
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where  x is the number of observations of this haplotype in a 
database of size  n . 
 Holland and Parsons  ( 10 ) proposed the use of a confi dence 
limit of 95%.
  
1/1 np = - a   (2) 
where  α is the value of 0.05 for 95% confi dence interval and  n 
is the size of the database. 
 When one or more identical sequences are found in the data-
base, it is advisable to use confi dence intervals using the fol-
lowing formula  ( 10 ) .
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 Calculating  p as
  
x
p
N
=  
where  x is the number of times a profi le has been observed in a 
population and  N is the number of profi les in that population. 
 As recorded by Tully et al.  ( 2 ) , we conclude that, where the 
sample has not been observed in a database for the calculation 
of the probability of that haplotype in question, then use either 
the formula proposed by Balding and Nichols ( 1 ) or that of 
Holland and Parsons ( 2 ). However, where this haplotype 
appears in the database one or more times, the Balding and 
Nichols formula can be used or alternatively by confi dence 
intervals ( 3 ). 
 2.5.  Statistics
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  3.  However, it is recommended that the frequency of a particular 
haplotype is expressed by its LR (likelihood ratio), and will 
generally be proposed as follows:
  Probability of obtaining the SSD and SSR/
DS and RS come from the same maternal line
LR
Probability of obtaining the SSD and SSR/
DS and RS do not come from the same maternal line
=
 
 SSD: Sequence of the doubted sample 
 SSR: Sequence of the reference sample 
 DS: Doubted sample 
 RS: Reference sample 
 If the questioned and reference sequences match exactly at all 
points of disagreement with respect to rCRS, the results may 
be expressed or using the “counting method” or better still 
expressed in the form of LR, so that the numerator of the 
above formula would be 1 (since we raised this hypothesis 
under the assumption that both the questioned sample and 
the reference sample come from the same person or persons 
with identical maternal lineage) then in the denominator we 
would have the  p obtained by using sampling corrections pro-
posed by Balding and Nichols or those proposed by Holland 
and Parsons or statistical approach of EMPOP. 
 
  1.  This technique compares the amount of DNA in the PCR 
product to a known DNA standard to determine the concen-
tration of the DNA in the PCR-amplifi ed sample. Negative 
controls (reagents and amplifi cation) are also included to indi-
cate whether any exogenous DNA is present. Furthermore, 
detecting amplicons using capillary electrophoresis (CE) has 
three major advantages over quantifi cation using agarose gel: 
(a) high sensitivity, (b) high precision, and (c) ability to detect 
the presence of length heteroplasmy. This last matter is a sig-
nifi cant saving of time as it is already known a priori that sam-
ples will require additional analysis to resolve the confusing 
readings that are usually generated when length heteroplas-
mies are present. 
  2.  As an alternative to quantifying amplifi ed products through 
capillary electrophoresis, some laboratories compare amplifi ca-
tion results with a standard length and known quantity, using 
a submarine electrophoresis analysis in agarose gel. This tech-
nique offers a lower resolution, and therefore being less reliable 
 3.  Notes
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decision making in reference to reagent blanks and amplifi cation 
negatives. In this case it is helpful to analyze up to the end 
point (sequencing) the reagent and amplifi cation blanks and 
take decisions at the end of the process, with the consequent 
increase in time. 
  3.  If possible, the sequencing comparison software must be con-
fi gured in accordance with the quality requirements set by the 
laboratory based on the validation of the method performed 
(e.g., defi ning the parameters for identifi cation of mixed bases, 
clear range or fi lter settings). 
  4.  By convention, the nucleotide positions of the human mtDNA 
genome are numbered from 1 to 16569 according to the rCRS. 
Likewise, for reporting purposes, the sequences are described as 
discrepancies with respect to the sequence of Anderson revised 
(rCRS). So when it detects a difference between the analyzed 
sequence and rCRS the nucleotide position is cited followed by 
de base present at that site. Insertions are designated by a deci-
mal point and a “1” (“2” if a second insertion is reported, and 
so on) after the lower numbered nucleotide of the two between 
which it has inserted. However if an insertion occurs within a 
homopolymeric tract (poliCs) the exact location of the inser-
tion is unknown, then the standard assume that the insertion 
has occurred at the highest numbered end of the stretch. 
Deletions are noted by listing the position deleted followed by 
a “d.” At confi rmed heteroplasmic positions, IUPAC codes can 
be applied. If the position has not yet been confi rmed as hetero-
plasmic, then it can be reported as “N.” 
  5.  Some authors propose  ( 2 ) that in order for a mutation to be 
detected by sequencing, it must be present at a level approach-
ing 20% to be distinguished from background. However 
the chance of detection of heteroplasmy is dependent upon 
the sequencing chemistry used. In addition, detection may be 
more effi cient at certain nucleotide positions than at others, 
and differences in detection may be also observed between 
both strands of mtDNA. Sometimes heteroplasmy detected in 
one strand can not be confi rmed in the complementary and 
sometimes even in a second reaction. In these cases, the 
recommendation states that the position would be designated 
as ambiguous (N) in the relevant extract. 
  6.  It is necessary to distinguish between a sequence in the presence 
of heteroplasmy, or a mixture of sequences. Individuals with two 
heteroplasmic positions have been reported  ( 11 ) ; however, 
heteroplasmy at three positions is certainly quite rare and this 
situation should lead us to think that the sequence obtained is 
the product of a mixture, either by contamination or from the 
original source material. Interpreting mixtures in forensic cases 
is not currently common practice by the laboratories. 
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  7.  Several publications have shown the propensity for human error 
in mtDNA analysis  ( 12,  13 ) as mix-up can be generated when 
handling the tubes or in the course of generating samples sheets 
prior to the electrophoresis step, misinterpretation of sequence 
raw data, “phantom mutations” caused by artifi cial signals in the 
sequencing electropherograms or clerical errors during data 
transcription. Phylogenetic evaluation of sequences helps to 
uncover these kinds of errors. Phylogenetic analysis of the 
sequence obtained has been demonstrated to be an effective 
tool that enables this type of error to be detected  ( 14,  15 ) . 
However, the assignment of haplogroups to mtDNA profi les is 
diffi cult, especially if only control region information is available, 
and most haplogroups are defi ned by coding region polymor-
phisms. Currently there are bioinformatic tools that automati-
cally allow to forensic community to estimate the most probable 
mtDNA haplogroups of the mtDNA control region sequences 
(DNAmanager)  ( 16 ) . A powerful web application (Haplogrep) 
 ( 17 ) has recently been developed based on Phylotree  ( 18 ) that 
enables accurate estimation of the haplogroup. 
  8.  The current knowledge regarding the mutation rate at each 
position in mtDNA molecule is still limited. Therefore, the 
lack of current information concerning knowledge about 
mutation rates at each position prevents statistical processing 
from being carried out of matches between samples with com-
mon heteroplasmic positions. 
  9.  Various studies indicate that segregation of mutations occurs at 
different rates in different tissues (e.g., highest in muscle or 
hair)  ( 19 ) . This phenomenon is due to the different mecha-
nisms by which cells are generated in different tissues. Therefore 
the sources of the tissues investigated should be taken into 
consideration, because differences in mtDNA sequence due to 
mutations seems to be more likely for example between hair 
and blood than between two blood samples taken from the 
same individual. 
  10.  Positions that are more prone to mutation than others have 
been reported  ( 19– 21 ) , and these points have been defi ned as 
“hotspots,” including the following positions in HVR-I: 16093, 
16129, 16153, 16189, 16192, 16293, 16337, and 16309 and 
72, 153, 189, 207, and 279 in HVR-II. Therefore, differences 
at phylogenetically stable positions provide more evidence for 
exclusion than differences at known hotspots. 
  11.  It is well established that the mutation rate in mtDNA is sig-
nifi cantly higher than that which occurs in nDNA. Mutations 
are passed between generations in varying ratios and segregate 
during development and later life; mutations also accumulate 
and segregate during the lifetime of an individual. This means 
that mixtures of two or more subpopulation molecules of 
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mtDNA can occur within individuals. Then, we can observe 
discrete differences (1 or 2 positions) between different tissues 
of the same individual. This situation also can be shown 
between individuals related through the maternal line (mater-
nal relatives). These aspects are reviewed extensively by Holland 
and Parsons  ( 10 ) . 
  12.  The bottleneck theory  ( 22 ) may explain the appearance of dif-
ferent tissues in an individual that do not match within the 
mtDNA sequence, occasionally in a homoplasmic position. 
Again, it is necessary to assess the divergent base and deter-
mine whether it is a “hotspot” position. It is also necessary to 
assess the type of tissue involved in the analysis and occurrence 
of this haplotype in the database. Logically if the degree of 
variability between the two samples occurs within a stable 
nucleotide, then we will be inclined to think that the doubted 
and undoubted samples have different origins. However, if the 
difference appears in a “hotspot” base (e.g., 16093), then we 
will tend to think to both samples—doubted and undoubted—
could come from the same maternal origin. Again, current 
knowledge on mutation rates at each position prevents a more 
accurate assessment of such situations. 
  13.  Several authors have highlighted the variability of sequences 
that can be found within a hair  ( 23,  24 ) ; the hair’s own histo-
genesis could explain this fact  ( 25 ) . Therefore, special caution 
in interpreting the results of this type of samples is advisable. 
  14.  To avoid errors of transcription, it is desirable that the labora-
tory has systems that enable searches on population databases 
via automatic download of the query sequence, and therefore 
without manual intervention by the analyst. There are now 
programs that enable data to be imported from alignment and 
analysis software through different formats  ( 26 ) . 
  15.  Numerous publications have highlighted errors in the data 
contained in databases  ( 12– 14 ) , essentially the error rates are 
concentrated in phantom mutations, base misscoring, base 
shifts, and artifi cial recombination. Having high quality data-
base is crucial in order to make a reliable estimate of the fre-
quency for a random match. There are currently multiple 
databases of mtDNA  ( 27,  28 ) for consultation of the scientifi c 
community, but in recent years the European DNA profi ling 
group (EDNAP) has been launched to construct a mtDNA 
database of reliable population data. Currently, EDNAP mito-
chondrial DNA Population Database (EMPOP) has 14,847 
haplotypes and today this database is one of the most used by 
the forensic science community. 
  16.  Database searches are usually done by alignment with respect 
to the rCRS. This task is straightforward for the vast majority 
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of nucleotide positions, but is diffi cult in regions displaying 
length variation. Different alignments of the same sample can 
result in mismatches on several nucleotide positions (see 
Fig.  9 ). The choice of one or other option can have a signifi -
cant impact on the fi nal estimates of the frequency of the hap-
lotype. Wilson et al.  ( 29,  30 ) in 2002 proposed rules for most 
parsimonious sequence alignment with respect to the rCRS; 
however, Bandelt and Parson  ( 31 ) , in view of the signifi cant 
increase on the knowledge of the phylogenetic distribution of 
mtDNA propose an alternative approach to the alignment. 
  17.  Phylogenetic alignment in EMPOP database suggests three 
(main) rules  ( 31 ) :
 Phylogenetic rule: Sequences should be aligned with regard to  ●
the current knowledge of the phylogeny. In the case of multi-
ple equally plausible solutions, one should strive for maximum 
(weighted) parsimony. Variants fl anking long C tracts, how-
ever, are subject to extra conventions in view of extensive 
length heteroplasmy. 
 C-tract conventions: The long C tracts of HVS-I and HVS-II  ●
should always be scored with 16189C and 310C, respectively, 
so that phylogenetically subsequent interruptions by novel C 
to T changes are encoded by the corresponding transition. 
Length variation of the short A tract preceding 16184 should 
be notated in terms of transversions. 
 Indel scoring: Indels should be placed 3  ● ¢ with respect to the 
light strand, unless the phylogeny suggests otherwise. 
 Fig. 9.  Different alignment for a sample ( QS questioned sample) with respect to the rCRS. 
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 Chapter 22 
 Capillary Electrophoresis of mtDNA Cytochrome 
b Gene Sequences for Animal Species Identifi cation 
 Adrian  Linacre  
 Abstract 
 The identifi cation of a biological species from an unknown material can be performed using a mitochondrial 
DNA locus. The cytochrome b (cyt b) gene is one of the most commonly used genetic loci, applied in both 
taxonomy and forensic science, for the purpose of species identifi cation. The gene is 1,140 basepairs long 
in most vertebrates and shows little intraspecies variation, but suffi cient interspecies variation. The gene is 
too long for typical PCR-based methods and, as many samples are degraded, only a section of the locus 
is used. DNA sequences at the start of the gene became the favored section for phylogenetics and species 
identifi cation. The DNA sequences from any unknown sample from this part of the cyt b gene can be 
determined and compared to those on a DNA database to determine the most likely species from which 
the unknown sample originates. The process of DNA amplifi cation, sequencing, sequence comparison, 
and identifi cation form the basis of this chapter. 
 Key words:  Cytochrome b gene ,  Mitochondrial DNA ,  Species identifi cation ,  Sequence comparison 
 
 DNA typing has been utilized in taxonomy, phylogenetics, and 
forensic science for the purpose of identifi cation of a species and 
has recently been reviewed extensively  ( 1– 5 ) . The need for species 
identifi cation in forensic science occurs if there is an allegation that 
an accused is in possession of a protected species. Legal protection 
comes from both national legislation and the enforcement of inter-
national agreements such as those of the Convention on the 
International Trade in Endangered Species of Flora and Fauna 
(otherwise known as CITES). The DNA test has to be able to sepa-
rate closely related species, yet all members of the same species must 
share the same DNA sequence. The loci of choice for taxonomy, 
 1.  Introduction
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phylogenetics, and forensic science are on the mitochondrial 
genome; being either predominantly the cytochrome b (cyt b) or 
the cytochrome oxidase I genes (COI). The process of species 
identifi cation is similar for both genes, but as cyt b has marginally 
more interspecies variation and lesser intraspecies variation than 
COI for mammalian species  ( 6 ) , this chapter focuses on the use of 
the cyt b gene. 
 The cyt b gene is normally 1,140 bases in length, lies between 
positions 14,747 and 15,887 on the human mitochondrial genome, 
and encodes a protein 380 amino acid in length  ( 7– 9 ) . The protein 
is part of the oxidative phosphorylation process in the mitochon-
dria and the functional constraints of the protein result in regions 
of the protein being highly conserved. This allows for the design of 
primers in the PCR process that are universal for all mammalian 
species  ( 7,  8,  10– 12 ) , amplifying areas of the cyt b gene that are 
polymorphic at the sequence level for mammalian species. A number 
of primer sets have been reported, all of which are designed to amplify 
the fi rst part of the gene and extend around 400 bases into the 
coding region. This section of the cyt b gene has been used in 
the species identifi cation; for a recent discussion on species testing 
using cyt b, see the paper of Tobe et al.  ( 6 ) . The PCR product is of 
a suitable size for DNA sequencing. In forensic science, it is important 
to be confi dent of the sequence, and confi rmation can be achieved 
by sequencing the DNA in both directions. The confi rmed DNA 
sequence is compared to those registered on a DNA database such 
as GenBank ( http://www.ncbi.nih.gov ). As there are over 32 million 
DNA sequences of cyt b on the database as of June 2010, it is highly 
likely that the species being examined is already on the database; 
the only exception being if the species is particularly rare. 
 
  1.  If using reference material for comparison to an unknown sample, 
then the sources of this reference DNA need to be from a 
voucher specimen ( see  Note 1 ). The method described below 
is designed to amplify a 402 bp section of the mammalian 
mitochondrial genome, giving the advantages high copy number 
as well as a short fragment, such that degraded DNA may yield 
an amplifi cation product. This attribute can be important if 
the reference and questioned samples are of poor quality. 
  2.  PCR primers: the universal primers for PCR amplifi cation are 
L14724 and H15149 (see Fig.  1 ), as described by Kocher et al. 
 ( 8 ) and Irwin et al.  ( 7 ) . The sequences of primers were designed 
to correspond to consensus sequences of human, mouse, and 
cow loci  ( 8 ) , and numbering was according to the human 
 2.  Materials
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mtDNA sequences  ( 13 ) . A validation study to show that the 
section of the cyt b gene amplifi ed by primer sets L14724 and 
H15149 was universal for mammalian species and that the 
DNA sequences were species-specifi c was conducted by  Hsieh 
et al.  ( 10 ) . 
  3.  PCR mix: typically containing reaction buffer (1× buffer: 
10 mM Tris–HCl, pH 8.3, 2.5 mM MgCl 2 , 50 mM KCl, 0.1% 
(w/v) gelatin), 200  m M dNTPs, 2.5 unit of VioTaq DNA 
polymerase, and 0.15  m M each of primers (see Table  1 ). 
  4.  PCR Machine: any PCR machine will suffi ce if capable of standard 
PCR and cycle sequencing. 
  5.  Gel electrophoresis: small gels of less than 10 cm in length 
are required. A standard power pack and UV transilluminator 
is required. 
  6.  DNA sequencing: a commercial kit such as the BigDye™ 
Terminator Kit supplied by Applied Biosystems can be used. 
  7.  Genetic analyzer: equipment such as the Applied Biosystems 
310, 3500, or similar CE equipment with fl uorescence detec-
tion is ideal. 
  8.  Internet access: suitable for navigating to DNA sequence com-
parison web sites. 
 Fig. 1.  Screen shot of a similarity search using a 348 fragment of the cytochrome b (cyt b) gene of the Tibetan antelope 
( Pantholops hodgsonii ), which is a CITES-protected species. 
 
324 A. Linacre
 
  1.  PCR Amplifi cation 
 PCR amplifi cation can be performed in 50  m L of reaction 
mixture, which contains 1 ng genomic DNA ( see  Note 2 ), 1× 
reaction buffer, 2.5 unit of DNA polymerase, and 0.15  m M 
each of primers ( see  Note 3 ). Amplifi cation using the 9600 
Perkin-Elmer thermal cycler can be conducted using the following 
conditions: initial denaturation at 95°C for 10 min followed by 
35 cycles of 95°C for 45 s, 50°C for 45 s, and 72°C for 90 s 
( see  Notes 4 and  5 ). 
 The success of the PCR can be determined by separat-
ing and visualizing the PCR fragments on an agarose gel. If 
this is performed, it is best to use 5  m L of the PCR, separate on 
a 2% agarose gel (w/v), and use a size marker appropriate for a 
DNA fragment of around 400 bp (such as a 1 kb size ladder). 
Agarose gels are stained typically with Ethidium bromide (add 
5  m L of 10 mg/mL to a 50 mL agarose while still molten prior 
to casting the gel). The approximate yield of PCR product can 
be determined by the relative brightness of the PCR product 
compared to the size marker. Remember that this is a sequence 
polymorphism, so all mammalian species should produce the 
same size of PCR product and only one PCR product should 
be produced for each sample. 
 3.  Method
 Table 1 
 List of primers used in amplifying a section of the cyt b gene for the purpose 
of species identifi cation 
 Location  Sequence (5 ¢ –3 ¢ )  Size (bp)  References 
 L14841  AAAAAGCTTCCATCCAACATCTCAGCATGATGAAA  308  ( 8 ) 
 H15149  AAACTGCAGCCCCTCAGAATGATATTTGTCCTCA 
 L14724  CGAAGCTTGATATGAAAAACCATCGTTG  425  (  7  ) 
 H15149  AAACTGCAGCCCCTCAGAATGATATTTGTCCTCA 
 L14816  CCATCCAACATCTCAGCATGATGAAA  358  ( 16 ) 
 H15173  CCCCTCAGAATGATATTTGTCCTCA 
 L14724  CGAAGCTTGATATGAAAAACCATCGTTG  425  ( 10 ) 
 H15149  AAACTGCAGCCCCTCAGAATGATATTTGTCCTCA 
 Note that the position of the primers at the 3 ¢ end is based on the human DNA sequence  ( 13 ) and will be 
different for other mammalian species 
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  2.  DNA Sequencing 
 Cycle sequencing of PCR products uses standard methods and 
is described in  ( 10 ) and in Linacre and Lee  ( 14 ) . Briefl y, the 
same PCR machine can be used for the sequencing reaction, in 
this case a 9600 Applied Biosystems thermal cycler, and with 
the following conditions: 25 cycles of 95°C for 45 s, 50°C for 
15 s, and 72°C for 4 min. Sequencing can be performed using 
the same primers as in the original amplifi cation, L14724 or 
H15149, using the BigDye™ Terminator Kit (ABI PRISM™ 
BigDye™ Terminator Cycle Sequencing Ready Reaction Kit). 
Sequence analysis should be conducted in both directions and 
any ambiguities determined. In common with the mitochon-
drial D-loop, heteroplasmy is encountered rarely in the cyt b 
gene, but is known to occur at other loci (see Note 6). 
 The PCR products may need to be concentrated and puri-
fi ed prior to separation by capillary electrophoresis. This can 
either be performed by ethanol precipitation, use of a spin 
column clean-up kit (such as the MiniElute PCR kit from 
QIAGEN or the Wizard PCR Clean-Up System from Promega), 
or a microconcentrator such as Microcon 100. 
  3.  DNA Separation by Capillary Electrophoresis 
 Any platform capable of detecting the fl uorescent dyes and can 
separate DNA fragments differing in size by one base is suit-
able. The Applied Biosystems series of capillary electrophoresis 
platforms range from the single capillary 310 Genetic Analyzer, 
through the 4 capillary 3130, the 24 capillary 3500 Genetic 
Analyzer, to 96 capillary 3730xl. Each of these pieces of equip-
ment requires their own settings including run modules and 
mobility fi les dye setting. The length of capillary and polymer 
needs to be suitable for one base resolution as required in DNA 
sequencing. These pieces of equipment are familiar to many in 
the forensic science arena as they are used for the separation of 
STR fragments. It is important to note that the settings used in 
sequencing and the polymer required are different to those 
used in the separation of STR fragments. 
 The fragment reads using the process and the separation 
platforms described above are typically 600 bases. Given that 
the fragment in this case is 400 bp, complete coverage is pos-
sible in one reaction. 
  4.  DNA Sequence Comparison 
 The simplest method of identifying the species present is by 
comparison to a reference DNA sequence database  ( 15,  16 ) . 
The most commonly used databases are compiled by the NCBI/
EMBL/DDBJ consortium and can be accessed at a variety of 
web sites including  http://www.ncbi.nih.gov or  http://www.
ebi.ac.uk/embl . 
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 The primer sequence should be removed prior to making 
any search for similar DNA sequences. The sequence can be 
compared to all the other sequences using the program BLAST 
(stands for Basic Local Alignment Search Tool). BLAST 
searches the online database for sequences with similarities to 
the query sequence and will return a list of the closest matches 
in order of similarity, with those sequences with the greatest 
homology listed fi rst. 
 To use the BLAST tool, fi rst go to the section of the NCBI 
website page specifi c for BLAST— http://www.ncbi.nlm.nih.
gov/blast/Blast.cgi . Paste the DNA sequence in the section 
“Enter Query Sequence.” Under the heading “Basic BLAST,” 
nucleotide BLAST is selected from the options. This will com-
pare a nucleotide query sequence (i.e., questioned sequence 
just pasted into the box) with the nucleotide sequences on the 
database. Make sure that the option below is set to “Nucleotide 
collection” so that the entire sequence database will be compared 
to the query sequence. Also, if the sequence is known and it is 
a commonly occurring species, there is an option on this page 
to exclude DNA sequences from this particular sequence to 
the alignment ( see  Note 7 ). Figure  1 is a screen shot of such a 
similarity search using a 348 fragment of the cyt b gene of the 
Tibetan antelope ( Pantholops hodgsonii ); this species is on 
Appendix 1 of CITES affording it the highest protection. 
 Click on the BLAST icon at the bottom right, and within a few 
seconds, an alignment is provided showing the DNA sequences 
with the closest similarities. 
 An example of the BLAST results of the alignment is shown 
in Fig.  2 . In this example, the short sequence has a 100% similar-
ity with the Tibetan antelope (not shown), but the next closest 
species is the Chinese Blue Sheep ( Pseudosis nayaur ) where 
there is a 94% similarity over the 348 bases. This 6% dissimilarity 
is expected if these two DNA sequences come from two different 
mammalian species  ( 6 ) where no more that 1.5% dissimilarity 
was noted between any two samples coming from the same 
mammalian species using the cyt b gene. There is a high degree 
of confi dence that the unknown sample is from the Tibetan ante-
lope ( P. hodgsonii ) that is a CITES listed and protected species. 
 
  1.  It is essential that a voucher specimen is used as a reference 
DNA sequence for comparison to any unknown sample. 
Voucher specimens can be obtained from collections held by 
museums or zoological institutes. If voucher specimens are not 
 4.  Notes
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available, then the next option is to sequence the same locus 
but from a sample assumed to be of the correct species, in 
which case it is possible to compare this assumed sequence to 
the other DNA sequences on the DNA database and it should 
show a high amount of similarity with other members of the 
same genus. If the phylogeny of this assumed DNA sequence 
is as expected, it is a substitute for a voucher specimen. This 
assumption should be made clear in any subsequent report. 
  2.  Most methods of DNA isolation will isolate whole genomic 
DNA, comprising both nuclear and mitochondrial DNA. The 
exact amount of mitochondrial DNA is not known, unless 
real-time PCR is performed using mitochondrial primers to 
determine the copy number. 
  3.  The period of time required as the initial denaturation step 
will alter depending on the DNA polymerase enzyme used. 
The conditions in the text are for a heat stable enzyme that is 
activated by the initial high denaturation step, but would be 
reduced if using a polymerase without this heat activation 
function. 
  4.  The PCR conditions may alter if using other makes of thermalcy-
cler. The Applied Biosystems 9600 is the validated equipment 
for PCR of STR multiplex kits provided by this same company 
and therefore will be found commonly in many forensic science 
laboratories. 
 Fig. 2.  An example of the Basic Local Alignment Search Tool (BLAST) results. 
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  5.  35 Cycles should be suffi cient when using 1 ng of isolated 
DNA. If there is very much less DNA, and hence less mito-
chondrial DNA, then the number of cycles may be increased. 
  6.  Heterplasmy is the occurrence of two or more DNA sequences 
at the same single position. Heteroplasmy occurs most commonly 
in mitochondrial genomes where the cell type is rapidly repro-
ducing and an error is incorporated during replication of the 
mitochondrial DNA. Hair samples have been shown to exhibit 
heteroplasmy. The amino acid sequence is highly conserved 
with most DNA polymorphisms being synonymous mutations 
and any change in the amino acid sequence is unlikely. 
  7.  There can be hundreds of DNA sequences derived from com-
monly studies loci such as the cyt b gene for one species. If the 
aim is to determine if the sequence is not from this well-studied 
species but from a closely related species, then the option exists 
to exclude such species from the search. 
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 Chapter 23 
 Sequence Analysis of the Canine Mitochondrial DNA Control 
Region from Shed Hair Samples in Criminal Investigations 
 C.  Berger ,  B.  Berger , and  W.  Parson  
 Abstract 
 In recent years, evidence from domestic dogs has increasingly been analyzed by forensic DNA testing. 
Especially, canine hairs have proved most suitable and practical due to the high rate of hair transfer occurring 
between dogs and humans. Starting with the description of a contamination-free sample handling proce-
dure, we give a detailed workfl ow for sequencing hypervariable segments (HVS) of the mtDNA control 
region from canine evidence. After the hair material is lysed and the DNA extracted by Phenol/Chloroform, 
the amplifi cation and sequencing strategy comprises the HVS I and II of the canine control region and is 
optimized for DNA of medium-to-low quality and quantity. The sequencing procedure is based on the 
Sanger Big-dye deoxy-terminator method and the separation of the sequencing reaction products is performed 
on a conventional multicolor fl uorescence detection capillary electrophoresis platform. Finally, software-
aided base calling and sequence interpretation are addressed exemplarily. 
 Key words:  Canine DNA ,  mtDNA ,  Control region ,  Hairs 
 
 Hairs of nonhuman origin may be among the most frequently col-
lected crime scene traces, but their importance as evidence is often 
overlooked, as standardized molecular identifi cation methods are 
still lacking for most species despite great efforts undertaken by the 
forensic community to establish reliable protocols. In recent years, 
evidence from domestic dogs has increasingly been used for forensic 
DNA testing and canine Short Tandem Repeat (STR) analysis has 
meanwhile become routine practice in dedicated laboratories 
 ( 1– 7 ) . STRs are the markers of choice for traces that contain suf-
fi cient amounts of nuclear DNA, but the majority of canine traces 
secured at crime scenes are naturally shed hairs of telogenic growth 
 1.  Introduction
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phase and therefore do not contain enough nuclear DNA for 
successful STR analysis. Similar to human hair mitochondrial 
DNA (mtDNA), analysis then becomes the most promising method 
for obtaining molecular information, as mtDNA copy number is 
also elevated in canine hair. 
 The approach of forensic canine mtDNA analysis presented 
here is based on the know-how and experience acquired by human 
mtDNA analysis  ( 8– 11 ) , but is taking the specifi c features of the 
dog’s mitochondrial genome into consideration. The fi rst complete 
canine mtDNA sequence has been published by Kim et al.  ( 12 ) with 
a total specifi ed length of 16,727 bp (GeneBank accession number: 
NC_002008, U96639) relative to which all other sequences are 
reported in difference-based format  ( 13– 16 ) . The most polymor-
phic region of the canine mtDNA is the control region (CR) spanning 
approximately 1,270 bp in length. It is subdivided into two segments 
commonly referred to as hypervariable segment 1 (HVS-I) and 
hypervariable segment 2 (HVS-II). These are separated by a region 
consisting of 20–30 copies of a 10 bp variable number tandem 
repeat (VNTR, see Fig.  1 ). 
 In this chapter, we exemplify the workfl ow from stain to 
mtDNA profi le for canine evidence in general and for canine hair 
shafts in particular starting with careful sample handling and the 
description of a sample preparation procedure that is minimizing 
the risk of contamination. In brief, hair material is lysed by adding 
Dithiothreitol (DTT) and Proteinase K and DNA is obtained by 
performing Phenol/Chloroform extraction. The amplifi cation and 
sequencing strategy outlined here can be used for various qualities 
of mtDNA, but was primarily designed for telogen hair and hair 
shaft samples as well as degraded blood and tissue samples. For low 
mtDNA amounts or low quality DNA such as encountered in hair 
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 Fig. 1.  Schematic representation of the hypervariable segments (HVS) I and II and the VNTR region of the canine mitochondrial 
DNA (mtDNA) control region. The amplifi cation and sequencing strategy is illustrated by  arrows , the resulting amplicons 
are shown in  boxes . PCR and sequencing primers are noted inside the  arrows (for primer nomenclature and sequences 
see Table  1 ). For better amplifi cation success, HVS-I was divided into two shorter amplicons. 
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shafts, the amplifi cation of the entire HVS-I region (672 bp) is not 
always successful. Therefore, two overlapping segments (HVS-I A 
and HVS-I B) with amplicon sizes of 384 and 462 bp are amplifi ed 
and sequenced, respectively. DNA sequencing is based on the 
Sanger Big-dye deoxy-terminator method and the separation of 
the sequencing reaction products is performed on a conventional 
multicolor fl uorescence detection capillary electrophoresis plat-
form. Finally, software-aided base calling and sequence interpreta-
tion are addressed exemplarily. 
 
 The workfl ow described herein takes about 3 days time if performed 
in 8-h day shifts ( see  Note 1 ). Carry out all procedures at room 
temperature unless otherwise specifi ed. Always use chemicals, 
including water, of very high purity grades (e.g., PCR grade water). 
Chemicals can be stored at room temperature unless otherwise 
specifi ed. Typically, in-house prepared solutions can be stored up 
to half a year, but to minimize storage times, it is recommended to 
adjust the quantity produced to the current consumption. The use 
of factory-made buffers and solutions is preferable to an in-house 
production of the solutions in order to minimize risk of contami-
nation and to improve quality consistency. For the same reasons, 
use sterile disposable consumables like solution containers, PCR 
tubes, pipette tips, etc. 
  1.  Forceps. 
  2.  Scissors. 
  3.  Paper cleaning tissues. 
  4.  15% Hydrogen peroxide solution (H 2 O 2 ): Store at 4–8°C. 
Prepare freshly at least every other day. 
  1.  1 M Tris–HCl buffer pH 8.0. 
  2.  5 M NaCl solution. 
  3.  1 M CaCl 2 solution. 
  4.  10% SDS solution. 
  5.  Hair extraction buffer: For 100 mL, add 1 mL 1 M Tris–HCl 
buffer pH 8.0, 2 mL 5 M NaCl solution, 100  m L 1 M CaCl 2 
solution, 20 mL 10% SDS solution to 77 mL water. 
  6.  Proteinase K (PK) solution: prepare a 20 mg/mL solution. To 
facilitate dissolving, incubate at 37° for 30 min, store at −20°C. 
  7.  1 M DTT solution, store at 4–8°C. 
  8.  PCR grade water. 
 2.  Materials
 2.1.  Sample 
Preparation
 2.2.  Lysis
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  1.  Ethanol absolute, store 50 mL aliquots intended for use during 
DNA extraction at −20°C. 
  2.  Aqua Phenol pH 8 solution (toxic), store at 4–8°C for a maximum 
of 4 months. 
  3.  Ready Red Chloroform-Isoamylalcohol mixture (toxic). 
  4.  3 M Na-Acetate-solution, pH 5.2. 
  5.  70% Ethanol. 
  6.  PCR grade water. 
  1.  Advantage ® cDNA Polymerase Mix and PCR Kit (Clontech 
Laboratories, Mountain View, CA, USA) including 1× BD 
Advantage 2 SA PCR Buffer and 1× BD Advantage 2 Polymerase 
Mix; store at −20°C ( see  Note 2 ). 
  2.  Deoxynucleotide Triphosphate (dNTPs) solution mix: GeneAmp ® 
dNTP Blend, 10 mM (Applied Biosystems, Foster City, CA, 
USA); store at −20°C. 
  3.  Bovine Serum Albumin (BSA) solution (2.5 mg/mL), store 
at −20°C. 
  4.  TLE-solution (T 10 E 0.1 ): 10 mM Tris–HCl buffer pH 8.0 and 
0.1 mM EDTA. 
  5.  Primer: Each primer is diluted to 10  m M in TLE-solution, 
store at −20°C. For primer nomenclature and sequences, see 
Table  1 . 
  6.  PCR grade water. 
 2.3.  Phenol/Chloroform 
Extraction
 2.4.  Amplifi cation
 Table 1 
 Primer sequences used for amplifi cation and sequencing 
of the two HVS of the canine mtDNA control region 
 Primer 
 Amplifi cation 
segment  Primer sequence (5 ¢ –3 ¢ ) 
 F15416  HVS-I A  CATCAGCACCCAAAGCTGAGA 
 R15799  HVS-I A  GTAAGAACCAGATGCCAGGTATA 
 F15685  HVS-I B  TCACCATGCCTCGAGAAACC 
 R16147  HVS-I B  ACGTGTACGTACGTGTACCYTAA
AACTATA 
 F16421  HVS-II  TACACGTACGYACGCGC 
 R32  HVS-II  CGACTCATCTTGGCATTT 
 The primers are named according to the 5 ¢ -end with respect to the reference 
sequence  ( 12 ) . Strand designation is by forward (F) and reverse (R). The “Y” in the 
sequence of primers F16421 and R16147 indicate a mixture of “C” and “T” 
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  1.  ExoSAP-IT for PCR Product Clean-up (USB, Cleveland, OH, 
USA). ExoSAP-IT is a mixture of the two hydrolytic enzymes, 
Exonuclease I and Shrimp Alkaline Phosphatase (SAP), for the 
removal of residual PCR primers and dNTPs. 
  1.  BigDye ® Terminator v1.1 Cycle Sequencing Kit and the BigDye ® 
Terminator v1.1 and v3.1 5× Sequencing Buffer (both Applied 
Biosystems, Foster City, CA, USA). 
  2.  Primer (see Subheading  2.4 ). 
  3.  PCR grade water. 
  1.  Illustra Sephadex G-50 Fine DNA Grade (GE Healthcare, UK). 
  2.  Multiscreen Column Loader 45  m L (Millipore, Billerica, MA, 
USA). 
  3.  Scraper for Multiscreen Column Loader (Millipore, Billerica, 
MA, USA). 
  4.  AcroPrep 96 Filter Plate (Pall Life Science, Ann Arbor, MI, USA). 
  5.  96-Well plate, minimum 400  m L/well. 
  6.  MicroAmp 96-well Reaction Plate (Applied Biosystems, Foster 
City, CA, USA). 
  7.  PCR grade water. 
  1.  3100 Genetic Analyzer (Applied Biosystems, Foster City, CA, 
USA). 
  2.  POP-6™ Polymer for 3100/3100-Avant™ Genetic Analyzers 
(Applied Biosystems, Foster City, CA, USA). 
  3.  ABI PRISM ® 3100 Genetic Analyzer Capillary Array, 36 cm 
(Applied Biosystems, Foster City, CA, USA). 
  4.  MicroAmp 96-well Reaction Plate (Applied Biosystems, Foster 
City, CA, USA). 
  5.  MicroAmp Trays and Tray/Retainer Sets (Applied Biosystems, 
Foster City, CA, USA). 
  6.  96-Well Plate Septa (Applied Biosystems, Foster City, CA, 
USA). 
 
 mtDNA analysis of challenging samples like hair shafts demands 
great care to avoid contamination. An overview of common prac-
tice to minimize contamination in forensic laboratories performing 
mtDNA is given in  Note 3 . 
 Mix all solutions before use. 
 2.5.  Postamplifi cation 
Sample Clean-Up
 2.6.  Sequencing
 2.7.  Postsequencing 
Sample Clean-Up
 2.8.  Capillary 
Electrophoresis
 3.  Methods
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 Extraction blanks, negative and positive controls should be 
carried through the complete extraction, amplifi cation, and sequenc-
ing processes for quality checks of the reagents and for contamina-
tion control. 
  1.  Make sure that all reaction tubes are labeled unambiguously in 
order to avoid sample mix-up. 
  2.  Put the functional parts of the forceps and scissors into the 
15% H 2 O 2 solution for at least 2 min and afterwards dry care-
fully with a clean paper tissue. 
  3.  Cut the hair shaft into about 1 cm long pieces using the cleaned 
forceps and scissors and put 1–2 pieces of one single hair into 
a 1.5 mL sterile reaction tube that already contains 500  m L of 
hair extraction buffer ( see  Note 4 ). Continue directly with 
Subheading  3.2 or store the sample at 4°C. 
  1.  Add 500  m L hair extraction buffer, 20  m L PK solution, and 
20  m L DTT solution. 
  2.  Mix gently. 
  3.  Incubate the tube at 56°C for at least 2 h using a thermal mixer 
adjusted to 650 rpm throughout the incubation period ( see 
 Note 5 ). 
  1.  Centrifuge the sample tubes for 30 s at about 16,300 ×  g ( see 
 Note 6 ). 
  2.  Add 500  m L of the Aqua Phenol pH 8 solution to the sample 
tube. 
  3.  Mix gently. 
  4.  Centrifuge for 10 min at 16,300 ×  g to separate the aqueous 
phase and the phenol phase, the top phase being aqueous and 
containing the DNA. 
  5.  Add 500  m L of the Ready Red Chloroform-Isoamylalcohol 
mixture to a new 1.5-mL reaction tube. 
  6.  Transfer the upper (aqueous) phase from the sample tube into 
the reaction tube containing the Chloroform-Isoamylacohol 
using a pipette. 
  7.  Mix gently. 
  8.  Centrifuge for 10 min at 16,300 ×  g forming two liquid phases, 
the top phase being aqueous and containing the DNA. 
  9.  Add 50  m L of 3 M Na-Acetate pH 5.2 to a new 1.5-mL reac-
tion tube. 
  10.  Withdraw the upper (aqueous) phase to the new tube containing 
the Na-Acetate. 
 3.1.  Sample 
Preparation
 3.2.  Lysis
 3.3.  Phenol/Chloroform 
Extraction
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  11.  Mix gently. 
  12.  Add 800  m L Ethanol absolute, cooled to −20°C. 
  13.  Mix gently. 
  14.  Cool at −20°C for at least 2 h. 
  15.  Centrifuge for 30 min at 16,300 ×  g to obtain an ethanolic 
supernatant and a DNA pellet ( see  Note 7 ). 
  16.  Remove the Ethanol supernatant. 
  17.  Add 1 mL of 70% Ethanol to the DNA pellet. 
  18.  Mix gently. 
  19.  Centrifuge for 20 min at 16,300 ×  g . 
  20.  Remove the ethanolic supernatant. 
  21.  Dry the samples for 30 min using a vacuum centrifuge. 
  22.  Resuspend the DNA pellet in 50  m L of 10 mM Tris-buffer pH 
8 overnight at 4°C or at 56°C for at least 2 h. 
 The amplifi cation strategy presented here (see Fig.  1 ) is primarily 
designed for the analysis of telogen hair and hair shaft samples as 
well as degraded blood and tissue samples ( see  Note 8 ). In the fol-
lowing, the entire amplifi cation and sequencing processes will be 
described exemplarily for HVS-I A. For amplifi cation, the primer 
combination F15416 and R15799 is used ( see  Note 9 ). Sequencing 
of the resulting amplicon is carried out by means of two separate 
sequencing reactions using F15416 and R15799 as sequencing 
primers, to obtain double strand sequencing results. In analogy to 
the procedure described for HVS-I A, the other segments of the CR 
are amplifi ed and sequenced using the primers shown in Fig.  1 .
  1.  Prepare a sample sheet that contains all important information 
you need for the PCR setup, e.g., plate position, sample name. 
  2.  Use a UV light source for sterilization of the reaction tubes 
and plates used for amplifi cation for at least 15 min. 
  3.  Prepare an adequate volume of reagent PCR master mix 
(PCRMM) in a sterile reaction tube according to the intended 
number of PCR reactions ( see  Note 10 ). The PCRMM for a 
25  m L PCR-assay contains per sample (fi nal concentrations in 
brackets): 2.5  m L 1× BD Advantage 2 SA PCR Buffer, 2.5  m L 
BSA solution (0.25 mg/mL), 2  m L dNTPs (200  m M each 
dNTP), 0.75  m L of each primer F15416 and R15799 (300 nM), 
0.5  m L 1× BD Advantage 2 Polymerase Mix. This results in 
9  m L MM and a residual volume of 16  m L for the DNA sample 
or water per assay. 
  4.  First pipette the residual amount of water into the wells of 
the PCR plate (where necessary), then add 9  m L PCRMM and 
 3.4.  Amplifi cation of 
the Canine mtDNA CR
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at last add the DNA extract. Pipette tips have to be changed 
on every new sample to prevent contamination during liquid 
transfers. 
  5.  Cover the plate with a PCR sealing fi lm. 
  6.  Centrifuge for 30 s at about 1,840 ×  g to remove air bubbles. 
  7.  Carry out the PCR in a conventional thermal cycler using 
following protocol: initial denaturation at 95°C for 2 min fol-
lowed by 39 cycles of 95°C for 15 s, 60°C for 30 s and 72°C 
for 45 s and a fi nal step at 4°C forever. 
 All amplicons (regardless of the primer combination used) are puri-
fi ed from residual primers and dNTPs using ExoSAP-IT.
  1.  Put 2  m L ExoSAP-IT into the well of a reaction plate for each 
sequencing reaction and add 5  m L of the PCR product. 
  2.  Cover the plate with a PCR sealing fi lm. 
  3.  Centrifuge for 30 s at about 1,840 ×  g to remove air bubbles. 
  4.  Carry out the following temperature protocol in a conventional 
thermal cycler: incubation at 37°C for 15 min and enzyme 
inactivation at 80°C for 15 min. 
 Two sequencing reactions per sample are required using primers 
F15416 and R15799, respectively, to obtain double strand sequencing 
results for HVS-I A.
  1.  Prepare a sample sheet that contains all important information 
you need for the sequencing assay, e.g., plate position, sample 
name. 
  2.  Prepare an adequate volume of reagent master mix (SeqMM) 
in a sterile reaction tube according to the intended number of 
sequencing reactions. The SeqMM for a 10  m L assay contains 
per sample (fi nal concentrations in brackets): 2  m L BigDye ® 
Terminator v1.1 Cycle Sequencing Kit, 2  m L BigDye ® Terminator 
v1.1 and v3.1 5× Sequencing Buffer, 0.5  m L primer F15416 or 
R15799 (0.5  m M), and 0.5  m L water. 
  3.  Put 5  m L SeqMM into each well of a reaction plate and add 
5  m L of the purifi ed amplifi cation products (PCR product/
ExoSAP-IT mixture). 
  4.  Cover the plate with a PCR sealing fi lm. 
  5.  Centrifuge for 30 s at about 1,840 ×  g to remove air bubbles. 
  6.  Carry out the following temperature protocol in a conven-
tional thermal cycler: initial denaturation step at 96°C for 60 s 
followed by 30 cycles at 96°C for 15 s, 50°C for 5 s and 60°C 
for 4 min and a fi nal step at 4°C forever. 
 3.5.  Postamplifi cation 
Sample Clean-Up
 3.6.  Sequencing
33923 Sequence Analysis of the Canine Mitochondrial DNA Control Region…
 All sequencing reaction products (regardless of the sequencing 
primer used) are purifi ed from residual dye terminators using 
Sephadex G-50 Fine.
  1.  In order to load the Sephadex resin simultaneously into all 
wells of a 96-well plate, pour an excess of the resin onto the 
column loader. 
  2.  Push the resin into all wells using the scraper and abrade the 
surface of the loader to the open end. The remaining Sephadex 
material can be stored and reused. 
  3.  Place an empty AcroPrep 96 Filter Plate upside down on the 
top of the column loader. Push the plate against the end stop 
to align the columns to the plate wells. 
  4.  Invert both the column loader and the AcroPrep 96 Filter 
Plate and tap on the backside of the loader in order to release 
the Sephadex powder to the wells. 
  5.  Place the AcroPrep 96 Filter Plate on a 96-well plate and add 
300  m L water to each well of the Filter Plate. Allow the powder 
to swell for at least 3 h at room temperature ( see  Note 11 ). 
  6.  Centrifuge at 910 ×  g for 5 min to rinse the water into the 
96-well plate. 
  7.  Discard the water in the 96-well plate. 
  8.  Add 150  m L water to each well of the Filter Plate. 
  9.  Centrifuge at 910 g for 5 min to rinse the water into the 
96-well plate. 
  10.  Discard the water in the 96-well plate. 
  11.  Add 15  m L water to the sequencing reaction samples. 
  12.  Place the Filter Plate on a 96-well plate. By choosing MicroAmp 
96-well reaction plates which are compatible to the 3100 Genetic 
Analyzer, it is possible to continue directly with the capillary 
electrophoresis after the Postsequencing Sample Clean-up has 
been completed. 
  13.  Pipette the sequencing products to the center of each well. 
Avoid touching the resin-columns with the pipette tip as this 
can decrease the separation performance of the column. 
  14.  Centrifuge the plate/Filter Plate assembly at 910 ×  g for 5 min 
to elute the sequencing products into the wells of the MicroAmp 
96-well plate. 
  15.  Discard the Filter Plate. 
  16.  The sequencing products are now ready for capillary 
electrophoresis. 
 3.7.  Postsequencing 
Sample Clean-Up
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  1.  Cover the plate containing the sequencing products with a 
96-well plate septum and mount into a tray/retainer set. 
  2.  Capillary electrophoresis is carried out on an ABI 3100 Genetic 
Analyzer using POP-6, 36-cm capillary arrays, and default instru-
ment settings for sample loading and separation as recommended 
by the manufacturer. 
  3.  Raw-data are analyzed with the Sequencing Analysis software 
Version 3.7 (Applied Biosystems, Foster City, CA, USA). 
 The data of the individual sequencing reactions are edited and 
aligned using the software Sequencher Version 4.7 (GeneCodes, 
Ann Arbor, MI, USA). If possible, confi rm a successful analysis of 
a hair by a second independent analysis of the residual hair (shaft). 
The total range of analysis described herein covers the entire 
mtDNA CR excluding the VNTR repeat region. The mtDNA 
control region of the dog ranges from position 15458 to position 
16727 including a 10 bp VNTR region located between position 
16130 and 16429 ( see  Note 12 ). If the amplifi cation primers 
are located inside the analyzed range of the sequence, the primer-
binding sequence must be excluded, as it refl ects the sequence of 
the primer and not the genuine sequence information. Each posi-
tion of the analyzed mtDNA sequence should be covered at least 
twice by double strand analysis including the sequence information 
of the L-strand (light) and the H-strand (heavy) in order to iden-
tify sequencing artifacts, unambiguous base calling, and hetero-
plasmic positions. Haplotype nomenclature is adopted from the 
human mtDNA fi eld  ( 17,  18 ) and representing a difference-coded 
annotation with respect to the reference sequence U96639  ( 13 ) . 
In Fig.  2 , alignment and annotation for a canine mtDNA sequence 
to the reference sequence is shown and in Table  2 mtDNA haplotypes 
observed in an Austrian population sample are listed exemplarily. 
 Typical estimates to describe the discrimination power of 
mtDNA typing are the exclusion capacity  ( 14,  19– 21 ) and the match 
probability  ( 15,  22 ) . Population studies on dogs meeting high 
forensic standards are necessary for estimations of canine mtDNA 
haplotype frequencies and for calculating match probabilities. 
However, these basic requirements are rarely fulfi lled (e.g., see ref. 
 ( 13– 16 ) and therefore the establishment of population data or 
even canine mtDNA databases is an essential task for future research 
to improve the statistical power of canine mtDNA analysis. Due to 
its maternal mode of inheritance, the exclusion capacity retrieved 
from mtDNA polymorphisms is generally lower compared to that 
achieved by nuclear DNA analysis.  The exclusion capacity of the 
entire canine CR (with exception of the VNTR region) typically 
amounts between 0.93 and 0.95  ( 14,  23 ) . In some instances, how-
ever, the ability to exclude an evidence sample and a reference sample 
is already suffi cient to answer forensically relevant questions. 
 3.8.  Capillary 
Electrophoresis 
on the Genetic 
Analyzer AB3100
 3.9.  Sequence Data 
Analysis and 
Reporting
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  1.  The entire analysis from stain to profi le will take at least 3 days:
 First day: Lysis (at least 2 h, often it is advisable to incubate 
the samples overnight) and DNA extraction (at least 4–5 h 
when performed by Phenol/Chloroform-Isoamylalcohol). 
 Second day: Amplifi cation process (approximately 2 h), post-
PCR purifi cation step (approximately 30 min), sequencing 
process (approximately 3 h), and postsequencing purifi cation 
step (approximately 30 min). 
 Third day: Electrophoretical separation (approximately 1 h 
per injection run) and analysis of the obtained sequences. 
  2.  The Advantage cDNA Polymerase Mix includes KlenTaq-1 
DNA polymerase (a 5 ¢ -exo-minus, N-terminal deletion of Taq 
DNA polymerase), a second DNA polymerase to provide 3 ¢ –5 ¢ 
proofreading activity, and TaqStart ® Antibody to provide 
automatic “hot start” PCR. In our experience, the Advantage 
cDNA Polymerase Mix provides reliable and effi cient amplifi -
cation results of canine mtDNA templates. If another DNA 
polymerase is intended to be used, the composition of the 
 4.  Notes
 Fig. 2.  Example of raw lane data aligned to the canine reference sequence NC_002008  ( 12 ). 
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reagents and the thermocycler protocol has to be adopted 
according to the characteristics of the selected enzyme (e.g., by 
using Taq polymerase, the initial denaturation step has to be 
increased from 2 to 11 min). 
  3.  It is imperative to separate pre-PCR and post-PCR areas physi-
cally, usually by separate laboratories. Generally perform 
frequent cleaning procedures with bleach or UV irradiation in 
the pre-PCR working space and always clean the lab bench 
surfaces and hoods with the 15% H 2 O 2 solution, bleach, or 
another appropriate disinfectant before preparing forensic 
samples for mtDNA analysis. 
 Disposable sterile (DNase and RNase-free) PCR reagent 
container and tubes as well as aerosol-resistant fi lter pipette 
tips should be used. 
 Reagents should be carefully prepared to minimize contam-
ination. Usually a safety cabinet that is equipped with UV light 
is used for setting up PCR. PCR consumables (except primers, 
dNTPs, and Taq DNA Polymerase) are UV irradiated for at 
least 15 min prior to use. 
 Use protective clothing and always wear gloves during sam-
ple handling or when working in the PCR area. Change gloves 
frequently. 
  4.  If a hair root is visible, carry out an independent analysis 
(possibly by STR) or store separately. 
  5.  Make sure that the entire hair shaft is completely immersed 
into the hair extraction buffer. If necessary, centrifuge the 
sample tube to move the hair to the bottom. 
  6.  After lysis, the hair should be completely dissolved, therefore 
after centrifugation no residual hair fragments should be visible 
at the bottom of the tube. If parts are still visible, add 15  m L of 
PK and DTT, and incubate at 56°C for another 30 min using 
a thermal mixer adjusted to 650 rpm. 
  7.  Because of the very small quantities of DNA from hair, a pellet 
is often not visible. The exact position of the pellet must there-
fore be deduced from the orientation of the tube during cen-
trifugation. The label of the reaction tube can function as a 
good indicator if the position of the tube in the centrifuge is 
marked. The exact location of the DNA pellet is important 
for prevention of its unintentional removal together with the 
ethanol supernatant. For the removal of ethanol, it is advisable 
to move the pipette tip to a position opposite for the position 
of the DNA pellet at the bottom of the tube. 
  8.  Depending on mtDNA amount and quality, different amplifi -
cation strategies can be applied. For reference samples that 
contain high amounts of high-quality DNA such as blood or 
346 C. Berger et al.
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saliva, the entire CR can be amplifi ed in one PCR reaction, 
e.g., by using the primer combination F15416 and R32 
(see Fig.  1 ). In addition, the cycle number can be reduced 
from 39 to 35. 
  9.  The primers used for the amplifi cation of HVS-I A (F15416 
and R15799) also amplify parts of the mtDNA control region 
of other animal species, e.g., cat and horse (see Table  3 ). DNA 
from humans and other primates gave 536 bp amplicons, both 
located on chromosome 7 (BAC clone RP11-1217F2 Access. 
Nr. AC099654.5 and Pan troglodytes BAC clone CH251-549B3 
AC150686.2) (see Table  3 ). A similar primer combination was 
used by Nakamura et al.  ( 24 ) for forensic species identifi cation 
based on size variation of mtDNA regions. The primer combi-
nations for the other two CR segments give no amplifi cation 
products with DNA of other tested animal species. 
  10.  If possible, prepare a fresh PCRMM to avoid too long storage 
times in the freezer, as the quality and the performance of the 
PCR will otherwise be decreased. Allow an additional volume 
of 5–10% to compensate for pipetting errors. 
  11.  As Sephadex is supplied as a dry powder, it must be allowed to 
swell in water before use. Swelled Sephadex plates can be stored 
overnight in a fridge. Add water only to these wells that are 
intended for use, remaining wells can be used later. 
  12.  Variation within the VNTR region is rarely used in canine 
forensics  ( 25,  26 ) . In contrast to our reporting strategy, the 
VNTR region is included by Pereira et al.  ( 13 ) . 
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 Chapter 24 
 Integrated Sample Cleanup and Microchip Capillary Array 
Electrophoresis for High-Performance Forensic STR Profi ling 
 Peng  Liu ,  Susan  A.  Greenspoon ,  Stephanie  HI  Yeung ,  James  R.  Scherer , 
and  Richard  A.  Mathies  
 Abstract 
 Microfl uidics has the potential to signifi cantly improve the speed, throughput, and cost performance of 
electrophoretic short tandem repeat (STR) analysis by translating the process into a miniaturized and inte-
grated format. Current STR analysis bypasses the post-PCR sample cleanup step in order to save time and 
cost, resulting in poor injection effi ciency, bias against larger loci, and delicate injection timing controls. 
Here we describe the operation of an integrated high-throughput sample cleanup and capillary array elec-
trophoresis microsystem that employs a streptavidin capture gel chemistry coupled to a simple direct-
injection geometry for simultaneously analyzing 12 STR samples in less than 30 min with >10-fold 
improved sensitivity. 
 Key words:  Capillary electrophoresis ,  Forensic human identifi cation ,  Lab-on-a-chip ,  PCR cleanup , 
 Short tandem repeat analysis 
 
 Driven by the awareness of the power of DNA for human identifi cation 
and the increasing sophistication in DNA profi ling and evidence 
collection, the number of samples submitted for short tandem 
repeat (STR) analysis continues to rise dramatically, resulting in a 
nationwide backlog. In addition, forensic scientists often face the 
challenges of analyzing evidence with a wide range in DNA quan-
tity and quality. A faster, cheaper and better analysis is needed to 
address these challenges  ( 1– 3 ) . Microfabrication technology has 
the potential to signifi cantly advance STR analysis by translating 
the entire process into a nanoliter scale in a miniaturized and inte-
grated microfl uidic format  ( 4– 6 ) . Such an integrated system will 
 1.  Introduction
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decrease the reagent and time consumption, make the process 
more automated and robust, and reduce manual sample handling 
to minimize the risk of sample mix-up and contamination. 
 Current STR analysis employs a direct injection from high-
salt PCR samples without cleanup for capillary electrophoresis 
(CE), resulting in poor injection effi ciency (<1%) and bias against 
larger loci. Additionally, the cross injection geometry in conven-
tional CE microchips requires delicate timing optimization and 
electric fi eld balance. To address these issues, numerous post-
PCR purifi cation, concentration, and separation methods, such 
as membrane fi ltration  ( 7,  8 ) , sample stacking  ( 9,  10 ) , and sample 
extraction  ( 11 ) , have been explored. Although these approaches 
have demonstrated sensitivity improvement, the typically delicate 
operations are incompatible with high-throughput on-chip 
integration. 
 Researchers at the UC Berkeley have developed an integrated 
STR sample cleanup and separation microdevice and method that 
employs a streptavidin capture gel chemistry coupled to a simple 
direct-injection geometry  ( 12 ) . As illustrated in Fig.  1 , a streptavi-
din-polyacrylamide capture gel is immobilized in a microchannel 
 Fig. 1.  Schematic of the streptavidin capture method for post-PCR cleanup and concentration 
of forensic PCR products. STR samples are generated with one primer labeled with fl uo-
rescent dye and one with biotin. The double-strand DNA products are electrophoresed 
through the photopolymerized cross-linked polyacrylamide gel network where DNA binds 
to the streptavidin and unbound reactants are washed off. The fl uorescently labeled DNA 
strands are thermally released for electrophoresis. 
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by photopolymerization. Biotin-labeled double-stranded DNA 
products amplifi ed by PCR using one biotin and one fl uorescence-
labeled primer are electrophoresed through the capture gel where 
DNAs are bound effi ciently via the biotin-streptavidin interaction, 
while unbound materials are washed off. The fl uorescently labeled 
DNA strands are thermally released for a high quality, quantitative 
electrophoretic injection. Compared to conventional microchip 
CE with a cross-injector, the fl uorescence intensity was improved 
14–19 fold for 9-plex STR products. To improve the throughput 
of this method, a 12-lane capture-CAE microsystem that utilizes 
the inline capture injection process with an improved automated 
process in a radial microfabricated capillary array electrophoresis 
( μ CAE) format was successfully developed  ( 13 ) . As shown in 
Fig.  2 , the process of analyzing 12 STR samples required no 
manual intervention and can be completed in only 30 min. A 
comparison between capture inline injection and conventional 
cross injection demonstrated at least 10-fold improvement in 
sensitivity. This microsystem provides a robust and sensitive plat-
form for routine as well as low copy number (LCN) and degraded 
DNA analysis. 
 Fig. 2.  ( a ) STR profi les of 0.15-ng standard DNA obtained from the 12-lane capture-CAE microdevice. All the traces from 
the 12 lanes are plotted on the same signal intensity scale. The average percentage standard deviation of the allele signal-
to-noise (S/N) ratios is 18.8% and the average standard deviation of the allele migration time is 9.8 s. ( b ) Comparison of 
STR profi les obtained using the capture inline injection and the conventional cross injection methods under the same 
conditions. The signal intensities of STR samples amplifi ed from 0.15 ng of 9948 standard DNA are improved > 10-fold. 
(Reproduced with permission from Ref.  ( 13 ) ). 
 
354 P. Liu et al.
 In this chapter, we are presenting the operation protocol of 
this integrated 12-lane capture-capillary array electrophoresis 
microsystem developed in the UC Berkeley-Virginia Department 
of Forensic Science collaboration, including microchannel and 
STR sample preparation, photopolymerization of capture gels, 
microchip setup, on-chip sample cleanup and capillary electropho-
resis, and data analysis. 
 
  1.  A 12-lane capture-CAE microdevice: the microdevice is fabri-
cated on 100-mm diameter glass wafers using published pro-
cedures (see Note 1). As shown in Fig.  3 , a total of 12 
separation channels are arranged radially around a common 
anode well on a 100-mm-diameter glass microchip. Adjacent 
pairs of channels are grouped into doublet structures that 
share a cathode and a waste well. Each separation channel has 
a double-T junction with an offset of 500  μ m between the 
sample and waste arms for PCR product cleanup, concentra-
tion, and inline injection. The separation channels are 120  μ m 
wide, 40  μ m deep, and have an effective separation length of 
10 cm. 
 2.  Materials
 2.1.  Capture-CAE 
Microsystem
 Fig. 3.  Schematic of the capture-CAE microdevice. ( a ) A total of 12 separation channels with a common anode are arranged 
on a 4″ glass wafer. ( b ) Each doublet contains two capture gel inline injectors and two sample wells sharing one cathode 
and one waste well. ( c ) Expanded view of the gel capture region. ( d ) Expanded view of the hyper-turn structure in the sepa-
ration channels. (Reproduced with permission from Ref.  ( 13 ) ). 
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  2.  Four-color detection scanner: the Multi-channel Capillary 
Array Electrophoresis Portable Scanner (McCAEPs), shown in 
Fig.  4a–c , is employed for the control and detection of the 
microchip (see Note 2). 
  3.  Two PDMS (polydimethysiloxane) reservoirs: as shown in 
Fig.  4d , one contains two cut-through arc slots for defi ning 
continuous buffer reservoirs of the cathode and the waste, the 
other has a 1-cm-diameter hole for the anode (see Note 3). 
  4.  An electrode manifold: as shown in Fig.  4d , the manifold con-
tains Pt electrodes that are positioned within the reservoirs on 
the microchip for the application of high voltages during 
electrophoresis. 
  5.  High-pressure fi lling station (see Note 4). 
 Fig. 4.  Illustration of the microchip control and detection system. ( a ) Photograph of the Multi-channel Capillary Array 
Electrophoresis Portable Scanner (McCAEPs). ( b ) Exploded view of the instrument. The major structure of the instrument 
includes the detection platform, a main support plate on which the optical and pneumatic components are installed, two side 
support plates, and a bottom plate. ( c ) Schematic of the four-color confocal detection system with a rotary objective. 
( d ) Schematic of the electrode manifold, PDMS reservoirs, and the microchip. (Reproduced with permission from Ref.  ( 15 ) ). 
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  1.  Coating solution: polyDuramide (MW ~ 2,000,000) is the 
trade name for poly- N -hydroxyethylacrylamide. It is prepared 
at a concentration of 0.25% (w/v) in DI water: for example, 
dissolve 50 mg of polyDuramide in 20 mL of DI water (see 
Note 5). 
  2.  1 M HCl solution: the concentrated 37.5% HCl is 12.2 M, 
dilute to 1 M HCl by DI water. 
  3.  1 M NaOH. 
  4.  Acetonitrile. 
  5.  Gel Slick ® glass plate coating solution (Lonza, Rockland, ME, 
USA). 
  1.  30% Bis-acrylamide solution (19:1) (see Note 6). 
  2.  8 M urea in DI water. 
  3.  Tris TAPS EDTA (TTE) buffer: the 10× TTE buffer contains 
500 mM Tris-base, 500 mM TAPS acid, and 10 mM Na 2 EDTA. 
Store the 10× TTE stock solution at 4°C. When use, dilute it 
to 1× by DI water. 
  4.  Streptavidin acrylamide (Invitrogen, Carlsbad, CA, USA): 
1 mg of powder. 
  5.  Ribofl avin: prepare a 0.01% (w/v) stock solution in DI water 
and store it at room temperature in dark (see Note 7). 
  6.  N,N,N  ¢ ,N  ¢ -Tetramethylethylenediamine (TEMED): store at 
4°C. When ready for use, dilute TEMED to 50% (v/v) with 
DI water (see Note 8). 
  1.  5% linear polyacrylamide gel (LPA) in 1× TTE (see Note 9). 
  2.  Photomask: the glass photomask produced by Photo Sciences 
Inc. (Torrance, CA, USA) features clear exposure windows 
and two alignment markers in the positions corresponding to 
the capture inline injectors and the markers on the microchip. 
Three vacuum access holes are diamond-drilled on the mask. 
  3.  UV exposure system: a UV exposure setup installed on a Nikon 
inverted microscope (TE2000U) with a 200-W mercury arc 
lamp is employed for photopolymerization. The aluminum 
vacuum stage connects to an external vacuum line and is 
mounted on the microscope stage. The photomask featuring 
clear exposure windows is placed underneath the microchip 
and visually aligned to the microchannel under the microscope. 
The assembly is secured on the stage via vacuum access holes 
on the photomask. The UV light travels from the microscope 
objective up through the exposure windows and initiates 
polymerization in only the unmasked microchannel regions 
(see Note 10). 
 2.2.  Microchip Coating 
Components
 2.3.  Streptavidin 
Capture Gel 
Components
 2.4.  UV Exposure 
System
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  1.  STR typing kits: a 9-plex autosomal STR typing system including 
amelogenin for sex typing and eight Combined DNA Index 
System (CODIS) core STR loci (D3S1358, TH01, D21S11, 
D5S818, D13S317, D7S820, vWA, and D8S1179) is employed 
for this system. To enable the capture cleanup, the primer pair 
of each locus has one primer labeled with fl uorescent dye and 
the other labeled with biotin (see Note 11). 
  2.  A biotin-modifi ed internal lane standard (see Note 12). 
  3.  Hi-Di™ formamide (Applied Biosystems, Foster City, CA, 
USA): aliquot formamide to small amounts (200  μ L in each 
eppendorf tube) and store at −20°C. Use a fresh tube each 
time for sample preparation (see Note 13). 
  1.  LPA for electrophoresis: 5% LPA with 8 M urea in 1× TTE (see 
Note 9). 
  2.  2-propanol. 
  1.  BaseFinder 6.0 (see Note 14). 
  2.  A data conversion program for the MeagBACE™ Fragment 
Profi ler software (see Note 15). 
  3.  MegaBACE™ Fragment Profi ler 1.2 (GE Healthcare, 
Piscataway, NJ, USA). 
 
 Carry out all procedures at room temperature unless otherwise 
specifi ed. 
  1.  Fill the channels with 1 M NaOH, let the chip sit at 65°C for 
15 min, and then empty the channels followed by rinsing with 
DI water. 
  2.  Fill the channels with 1 M HCl and fl ush ~100  μ L, let the chip 
sit at room temperature for 15 min, and then remove HCl fol-
lowed by channel rinsing with DI water. 
  3.  Load the polyDuramide coating solution into the channels, 
and let the chip sit for 15 min (see Note 16). 
  4.  Remove coating solution and rinse the channels with DI water 
followed by acetonitrile to dry the channels completely. 
  5.  Apply Gel Slick ® solution onto a dry paper towel, and spread 
Gel Slick ® evenly over the entire surface of the chip using a 
circular and overlapping motion. Allow the coating to dry 
completely, and wipe the chip surface again with soft paper 
towels to remove stains (see Note 17). 
 2.5.  Sample 
Preparation
 2.6.  Microchip 
Preparation 
and Capillary 
Electrophoresis
 2.7.  Data Analysis
 3.  Methods
 3.1.  Microchip Coating
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  1.  To prepare a 500  μ L of photopolymerization solution, sequentially 
add 35.5  μ L DI water, 250  μ L 8 M Urea, 50  μ L 10× TTE, and 
83.3  μ L 30% bis-acrylamide into an opaque 2-mL scintillation 
vial with Tefl on closure. 
  2.  Close the vial tightly and insert two syringe needles through 
the Tefl on closure. One needle is inserted into the solution for 
bubbling nitrogen; the other is above the solution as a vent. 
Sparge the solution with a N 2 fl ow rate of 5 bubbles/s for 
10 min (see Note 18). 
  3.  Add 50  μ L of DI water into the tube of streptavidin acrylamide. 
Slowly pipette the water 2–3 times to dissolve the streptavidin 
acrylamide to a concentration of 20  μ g/ μ L (see Note 19). 
  4.  Stop sparging the solution. In the dark room, mix the 50  μ L 
streptavidin acrylamide solution, 30  μ L 0.01% ribofl avin, and 
1.25  μ L 50% TEMED together in a tube, and then inject the 
mixture into the vial through the Tefl on closure using a syringe. 
Gently mix the solution, and store in dark at 4°C (see Note 20). 
  1.  Stack the photomask and the capture-CAE microchip on the 
aluminum vacuum stage installed on the inverted microscope. 
Turn on the vacuum to hold the mask and the chip together, 
and then align the microchip with the photomask under the 
microscope with the aid of alignment markers (see Note 21). 
  2.  Take 100  μ L of the photopolymerization solution out of the 
vial using a syringe with a needle. Fill the channels with the 
solution via capillary action. Evacuate excess solution from each 
well and replace with a drop of 5% LPA gel (see Note 22). 
  3.  Move the exposure window of the photomask to the center of 
the microscope view. Open the UV light shutter to initiate the 
gel photopolymerization. Every 5 min, move the microscope 
stage to bring the next exposure window to the center of the 
view for exposure. 
  4.  Once the exposure of all 12 lanes is fi nished, close the UV light 
shutter and turn off the mercury lamp. Evacuate the gel in the 
wells, and replace the photopolymerization buffer in the chan-
nels with 1× TTE buffer using vacuum. 
  1.  Amplify DNA samples using biotin-labeled STR typing kits on 
a PCR thermal cycler. 
  2.  Add 1  μ L of each PCR product into a loading cocktail contain-
ing 0.5  μ L Hi-Di formamide, 2.5  μ L DI H 2 O, and 1  μ L inter-
nal lane standard (see Note 23). 
 3.2.  Preparation of 
Photopolymerization 
Solution
 3.3.  UV Exposure for 
Photopolymerization
 3.4.  DNA Sample 
Preparation
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  1.  Carefully vacuum out any solution left on the chip surface 
without emptying the channels, and clean the chip surface with 
DI water. 
  2.  Soak the PDMS buffer reservoirs in 2-propanol, and then 
blow-dry the PDMS using a Nitrogen gun. Align and attach 
the PDMS reservoirs onto the microchip (see Note 24). 
  3.  Fill the channel with 5% LPA with 8 M urea from the common 
anode using the high-pressure fi lling station until the gel com-
ing out from the waste wells. 
  4.  Manually fi ll the channels above the capture gel plugs with 5% 
LPA with 8 M urea from each common cathode well until the 
gel reaches the samples wells using a syringe with a pipette tip. 
The opening of the tip is cut to fi t into the cathode wells for 
applying pressure. 
  5.  Evacuate the excessive gel out from the sample wells using 
vacuum, and then load 1.5  μ L prepared DNA samples into 
each sample well. 
  1.  Transfer the microchip onto the stage of the detection instrument 
and turn on the vacuum to hold the chip in place. 
  2.  Fill the cathode, the waste, and the anode reservoir with 1× 
TTE. 
  3.  Place the electrode manifold on the top of the microchip, and 
connect the electrodes to high-voltage power supplies. 
  4.  Turn on the detection instrument and start the control pro-
gram of the scanner. Level the stage to bring all the separation 
channels into focus and defi ne the positions of the channels 
(see Note 25). 
  5.  Inject the samples from the sample wells toward the waste wells 
for 10 min by applying an electric fi eld of 25 V/cm from the 
sample to the waste wells while fl oating the cathode and anode 
wells. PCR products are bound effi ciently to the capture gel via 
the biotin-streptavidin interaction to form a concentrated plug 
(see Note 26). 
  6.  After capture, apply an electric fi eld of 25 V/cm from the cath-
ode to the waste to wash all the uncaptured sample contents 
through the gel to the waste for 5 min. 
  7.  To clean the channels above the capture gel, apply the same 
electric fi eld from the cathode to the sample. To clean the sep-
aration channels, use the same electric fi eld to wash any 
unbound materials from the anode toward the waste. 
  8.  Stop all the voltages to the microchip, and set the temperature 
of the detection stage of the instrument to 67°C. Once the 
stage temperature reaches the setting point, wait one more 
minute to equilibrate the setup. 
 3.5.  Microchip 
Preparation
 3.6.  Capture-CAE 
Microchip Operation
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  9.  Switch the voltages on each well to: 2,500 V to the anode, 
200 V to the sample and the waste, and ground to the cathode 
wells. The resulting electric fi eld is about 150 V/cm in the 
separation channels for electrophoresis. Start the detection sys-
tem to record data (see Note 27). 
  10.  After electrophoresis is completed in about 20 min, stop the 
high voltages and save the data. Take off the microchip from 
the stage and shut down the instrument. 
  11.  Vacuum out the samples and buffers in the reservoirs and push 
out the sieving matrix and the capture gel plugs in the channels 
from the common anode well using the high-pressure fi lling 
station (see Note 28). 
  12.  Thoroughly rinse the channels with DI water using the fi lling 
station. Dry the channels completely using acetonitrile. Store 
the microchip in a tightly sealed wafer tray (see Note 29). 
  13.  Soak the electrode manifold and the PDMS buffer reservoirs 
into 2-propanol and ultrasonicate for 15 min to eliminate any 
sample residues. Rinse them with DI water and blow-dry using 
a nitrogen gun. 
  1.  Open raw data of a typical STR profi le in BaseFinder to obtain 
the color separation matrix parameters for color cross-talk cor-
rection (see Note 30). 
  2.  Input the color separation matrices into MegaBACE TM 
Fragment Profi ler 1.2. Create appropriate peak fi lters for the 
STR typing kits, the internal lane standard, and bin sets. 
  3.  Convert the data fi les recorded by the scanner to binary format 
and append with proper header information by the homemade 
conversion program. 
  4.  Import the preprocessed data fi les into the MegaBACE TM . 
Sequentially perform baseline fi tting, color cross-talk correc-
tion, and allele calling in the program. 
 
  1.  A detailed protocol of glass microfabrication can be found in 
Ref.  ( 14 ) . Briefl y, the microchannel structure is fi rst patterned 
on a 100-mm-diameter borofl oat glass wafer (Schott, Yonkers, 
NY, USA) coated with a 2,000-Å fi lm of silicon using standard 
photolithographic procedure. The photopolymer representing 
the microchannel pattern is removed in the development pro-
cess, exposing the silicon fi lm, which is removed by reactive ion 
etching with SF 6 to expose the glass surface. Formation of the 
glass microchannels is accomplished by isotropic wet chemical 
 3.7.  Data Analysis
 4.  Notes
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etching of the exposed glass in HF, resulting in a channel depth 
of 40  μ m. The fl uidic access holes are diamond drilled using a 
CNC mill. The wafer is then cleaned, and the remaining silicon 
fi lm is removed completely by reactive ion etching. The wafer 
is thermal bonded with a blank wafer to form enclosed channel 
structures. 
  2.  The design and the operation of the McCAEPs can be found 
in Ref.  ( 15 ) . Briefl y, the instrument contains a 488-nm diode 
laser, a confocal optical system with a rotary objective for 
detecting four different fl uorescence signals, pneumatics for 
control of on-chip microvalves, four PCR temperature control 
systems, and four high-voltage power supplies for electropho-
resis. In the optical system shown in Fig.  4c , the laser beam is 
refl ected by two dielectric mirrors, passed through a dichroic 
beam splitter, and directed up through a hollow shaft of a step-
per motor. The beam is displaced 7 mm by a rhomb, and 
focused into the channels of the microchip. Fluorescence col-
lected by the objective is refl ected by the dichroic into a confo-
cal assembly, where the light is focused on a pinhole with an 
achromat lens, and directed into a 4-color PMT detector by a 
collimating lens. 
  3.  The use of these continuous reservoirs defi ned by the PDMS 
reservoirs is to reduce the total number of electrodes and to 
provide suffi cient buffer capacity for electrophoresis. Since the 
phosphodiester backbone of DNA is susceptible to protona-
tion and subsequent mobility shift, it is essential to buffer pro-
tons and hydroxyls which are electrolytically generated in the 
wells through the entire analysis to achieve stable and repro-
ducible analysis. The effect of electrophoresis on the chemical 
composition in the cathode and anode buffer wells and its sig-
nifi cance to the reproducibility of electrophoresis was discussed 
in detail in Ref.  ( 16 ) . 
  4.  A high-pressure fi lling station is used to load the viscous sepa-
ration matrix into the microchannels and to wash the chip 
thoroughly with distilled DI water. The design of the setup is 
illustrated in Ref.  ( 17 ) . As an alternative, manual loading can 
be achieved using a syringe mounted with a pipette tip. The 
opening of the tip should be cut to tightly fi t into the wells of 
the microchip for applying pressure. Any air bubbles in the 
syringe should be expelled out to avoid possible solution spill-
ing out. Wear safety glasses or a facial mask when using the 
syringe. 
  5.  We synthesized the polyDuramide in lyophilized form in house. 
See Ref.  ( 18 ) for a more detailed protocol. The prepared coat-
ing solution is best to store at ~4°C (up to 3 months). 
  6.  Monomeric acrylamide is neurotoxic and can be absorbed 
through skin or inhaled (powder). Appropriate precautions 
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should be taken to avoid skin contact when handling the 
bis-acrylamide solution. 
  7.  The photoiniator, ribofl avin, is sensitive to room light. Prepare 
the solution in a dark room with a red light illumination. 
  8.  Be careful with TEMED since it has a strong irritating smell. 
  9.  The LPA is synthesized in-house. The protocol can be found 
in Ref.  ( 19 ) . 
  10.  The UV exposure system should be located in a dark room 
with a red lamp for illumination. Protect eyes and skin from 
exposure to UV light. Carefully read and follow the manual of 
the mercury arc lamp provided by the manufacturer to avoid 
any damage to the lamp or bulb explosion. 
  11.  STR typing kits, PowerPlex ® 16, PowerPlex ® Y, and AmpFlSTR ® 
Profi ler Plus ® , have been successfully tested on the  μ CAE 
microsystem (see Refs.  ( 20 ) and  ( 21 ) ). To make these STR kits 
compatible with on-chip sample and inline injection, the unla-
beled primers in the primer pairs need to be replaced with the 
biotin-labeled. For proof of concept, a 9-plex autosomal STR 
typing system that contains biotin-labeled primers was devel-
oped by our group based on the primer sequences and fl uores-
cence dye labeling scheme used in the PowerPlex ® 16. 
  12.  The biotin-modifi ed sizing standard was constructed in-house 
by mixing a series of purifi ed PCR amplicons with different 
fragment lengths (60, 80, 95, 120, 140, 160, 172, 250, 275, 
and 350 bp). These fragments are amplifi ed from pUC19 with 
primer pairs such that one is labeled with ROX and the other 
labeled with biotin. This sizing standard can be cocaptured 
and separated with PCR products for allele size calibration. 
  13.  Store formamide frozen at −20°C. Minimize the number of 
freeze-thaw cycles as much as possible since the quality of the 
formulation may decrease if exposed to air through frequent 
sampling. 
  14.  Download BaseFinder from  http://bioinfo.unc.edu/glabsoft-
ware/ BaseFinder/BaseFinder.html. It is only available for 
Mac OS X (see Ref.  ( 22 ) ). 
  15.  The conversion program converts data collected by the detec-
tion platform to a form that can be read by the MeagBACE ™ 
Fragment Profi ler software. The detailed information of the 
conversion program can be found in Ref.  ( 23 ) . 
  16.  We found when coating a brand new microchip with polyDur-
amide, the fi rst run usually produces a poor separation resolu-
tion. It is better to do a dummy run after the fi rst coating, and 
then repeat the normal coating procedure. Start the experi-
ments from the second time. 
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  17.  The purpose of the Gel Slick ® coating is to make the chip surface, 
especially that around the sample wells, hydrophobic to keep 
each sample drop within its respective sample well and avoid 
mix-up. 
  18.  Gradually turn up the gas fl ow to avoid sample spill. 
  19.  Streptavidin acrylamide is prone to generating bubbles with 
excess mixing. Slowly pipette water in the tube 2–3 times to 
dissolve the powder; do not vortex the tube. 
  20.  The fi nal concentrations of the components in the photopoly-
merization buffer are: 5% bis-acrylamide (19:1), 4 M Urea, 1× 
TTE, 2  μ g/ μ L streptavidin, 0.0006% ribofl avin, and 0.125% 
TEMED. The prepared solution can be stored at 4°C in dark 
for up to 4 weeks without noticeable degradation. 
  21.  Since the sizes of the exposure windows and the microchannels 
are >200  μ m, visually performed manual alignment is accurate 
enough for the UV exposure purpose. 
  22.  The purpose of adding a drop of LPA gel in each well is to stop 
hydrodynamic fl ow in the channels during UV exposure. Other 
methods, such as adding an equal amount of solution in each 
well, or sealing the wells with a tape, may also work, but pro-
vide less consistency in performance. 
  23.  To improve sensitivity, the amount of samples added into the 
loading cocktail can be increased to 3.5  μ L. Remember to 
reduce the DI water volume accordingly. 
  24.  If desired, the PDMS reservoirs can be treated in a UV-ozone 
cleaner for 5 min to enhance the bonding between PDMS and 
glass. 
  25.  The focus of the objective on the matrix-loaded microchannels 
is achieved by adjusting the heights of three supporting posts 
of the stage while monitoring the Raman scattering signal from 
water in the yellow optical channel (580 nm). Uniform signals 
should be obtained across all the channels. These signals can 
also be used to locate the channel positions for the control 
program to extract data from scanning. 
  26.  To increase the amount of samples injected into the capture 
gel, the injection time can be increased from 10 min up to 
20 min. Do not increase the injection electric fi eld. Too high 
electric fi led results in a lower binding effi ciency of biotin-
labeled DNA products to the streptavidin capture gel due to 
the fast movement of DNA. 
  27.  At 67°C, TTE buffer in the waste, cathode, and anode reser-
voirs will evaporate quickly. Top off the buffer reservoirs with 
1× TTE to prevent chip dry out during electrophoresis. The 
sample reservoirs will not dry out because of formamide. 
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  28.  If the capture gel plugs cannot be pushed out by the high-pressure 
fi lling station, fi ll the channels with acetonitrile and let the chip 
sit for 10 min. Acetonitrile can shrink the polyacrylamide gels 
and make them easily pushed out. 
  29.  If channels are clogged or very dirty, ashing of the chip in a 
furnace at 500°C for 3 h can be performed to remove residuals 
in the microchannels. 
  30.  The typical STR profi le should contain well-resolved peaks for 
each dye labeling. Select these peaks to defi ne the color cross-
talk matrix parameters. Additionally, BaseFinder can also be 
used to process raw data, including baseline fi tting, color cross-
talk correction, and baseline smoothing. Processed data can be 
exported to an ASCII text fi le, and then plotted using data 
analysis programs, such as Microsoft Excel and Origin. 
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 Chapter 25 
 Microchip Capillary Electrophoresis Protocol 
to Evaluate Quality and Quantity of mtDNA Amplifi ed 
Fragments for DNA Sequencing in Forensic Genetics 
 Coro  Fernández and  Antonio  Alonso 
 Abstract 
 Here, we describe a microcapillary electrophoresis technique with application to the quantitative analysis 
of mtDNA hypervariable regions HVR1, HVR2, and HVR3 PCR amplicons previous to sequence analysis, 
which yields several important advantages compared to traditional separation and detection methods. 
Based on laser-induced fl uorescence (LIF) detection, and performed in a microchip, this analysis system 
enables the handling of very small volumes via microchannels etched in the chip. Moreover it is faster than 
traditional methods; chip priming and sample loading are the only manual interventions, as the rest of the 
process is fully automated by software control: injection, electrophoretic separation, detection of the fl uo-
rescent signal, and calculation of both quantity and size. MtDNA amplicons are separated in microchan-
nels with an effective length of 15 mm and detected by means of the fl uorescence displayed by an 
intercalated dye. A software records the fl uorescence and entails the data into size and concentration 
through the use of two internal standards and an external ladder of 11 fragments. The effectiveness of this 
procedure has been illustrated with a validation experiment carried out in our laboratory, in order to assess 
the detection limit of mtDNA sequencing by determining the minimal amount of PCR amplicon needed 
to edit a reproducible and high quality mtDNA sequence from complementary sequence data obtained 
using forward and reverse primers. 
 Key words:  Forensic samples ,  Hypervariable regions ,  Microchip capillary electrophoresis , 
 Mitochondrial DNA ,  Quantifi cation ,  Validation studies 
 
 The sequence analysis of mitochondrial DNA (mtDNA) hyper-
variable regions I, II, and III (HVR1, HVR2, and HVR3) has 
been proved to be a useful tool in forensic laboratories for ancient 
DNA specimens or highly degraded samples which fail to obtain 
reliable results with nuclear DNA typing because of low DNA 
 1.  Introduction
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quantity present in the sample or no amount at all as it is the case 
of hair shafts  ( 1– 4 ) . In addition to these forensic applications 
mtDNA sequencing is also used in kinship analyses of missing 
people as well as in Mass Fatality Incidents when the reference 
person is a maternal relative. The sequence analysis of other 
mtDNA targets (such as Cytochrome b gene) has also been applied 
to the identifi cation of nonhuman forensic samples  ( 5 ) . A critical 
quality control step for mtDNA sequencing is establishing the 
size, purity, and concentration of PCR amplicons. A reliable quan-
titative analysis of mtDNA HVR1, HVR2, and HVR3 PCR ampl-
icons allows the standardization of the amplicon input in the 
sequencing reactions, improving the overall quality of sequence 
data as well as the assessment of the detection limit in different 
mtDNA sequencing protocols  ( 6 ) . 
 Traditional methods include agarose or acrylamide gels for the 
analysis of PCR amplifi ed mtDNA: samples are run in a slab gel 
together with predetermined standards of known concentration 
and molecular mass, and separated according to their size. The 
analysis of the DNA fragments can be achieved in a simple way by 
a Polaroid photograph taken over a UV light source from which 
the user calculates size and quantity by matching the band intensity 
to the standards or by means of more accurate imaging software 
which interfaces with scanners or digital cameras. This widely used 
method, it is time-consuming, dangerous materials need to be han-
dled (bromure ethidium), and the accuracy of this type of analysis is 
minimal. 
 More recently electrophoresis of mtDNA PCR amplicons has 
been improved by means of a microchip capillary electrophoresis 
(MCE) technique, in combination with a laser-induced fl uores-
cence (LIF) DNA detection method  ( 6,  7 ) . Samples are loaded in 
a small chip together with a sieving polymer and fl uorescence dye. 
The loaded chip is placed into an analyzer where 16 platinum elec-
trodes fi t into the wells, becoming the chip an integrated electrical 
circuit . MtDNA amplicons are separated in microchannels with an 
effective length of 15 mm and detected by means of the fl uores-
cence displayed by the intercalated dye. A software records the 
fl uorescence and entails the data into size and concentration 
through the use of two internal standards and an external ladder of 
11 fragments. MCE offers several advantages over conventional 
slab methods: reduction in sample and reagent consumption, sub-
stantially increased high-throughput and high-speed in quantita-
tive and qualitative analysis of PCR amplicons; moreover, it may 
perform several DNA analysis tasks, becoming a fully integrated 
and automated molecular analysis system. 
 We have already described the application of this commercially 
available MCE device in different genetic identifi cation studies 
performed with mtDNA targets, including the haplotype analysis 
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of HVR1 and HVR2 and the study of interspecies diversity of 
cytochrome  b (Cyt  b ) and 16S ribosomal RNA (16S rRNA) mito-
chondrial genes in forensic and ancient DNA samples. The method 
has been proved to be a fast and sensitive detection method of 
length heteroplasmy in cytosine stretches produced by 16 189 T/C 
transitions in HVR1 and by 309.1 and 309.2C-insertions in 
HVR2  ( 6 ) . 
 Here we present a complete description of the procedure used 
for PCR amplifi cation, MCE setup, DNA electrophoresis, and 
software data analysis with application to the quantitative analysis 
of mtDNA hypervariable regions HVR1, HVR2, and HVR3 PCR 
amplicons previous to sequence analysis. The performance of this 
procedure is illustrated with a validation experiment to assess the 
detection limit of mtDNA sequencing by determining the minimal 
amount of PCR amplicon necessary to edit a reproducible and 
high quality mtDNA sequence from complementary sequence data 
obtained using forward and reverse primers. 
 
 Microchip electrophoresis can be applied to estimate both the 
size (ranging ± 5% 100–500 pb) and the quantity (ranging 0.1–
50 ng/ m L) of mitochondrial DNA amplicons obtained from 
amplifying human DNA extracts (saliva, blood, hair shafts, tis-
sues) and nonhuman DNA of forensic casework interest. Two 
regions within the control region or displacement loop (D-loop) 
found in mtDNA are normally examined by PCR amplifi cation 
prior to sequencing. These regions are known as hypervariable 
region I (HVR1) and hypervariable region II (HVR2). Less fre-
quently, a third region called hypervariable region III (HVR3) is 
also amplifi ed. 
 Standard Reference Material ® 2392-I  ( 8 ) which is a DNA 
extracted from cell culture line HL-60 at a nominal concentration 
of 1.4 ng/ m L and DNA from cell culture line 9947A at a nominal 
concentration of 0.1 ng/ m L were used for the sensitivity validation 
experiments. 
  1.  10× PCR Buffer, 500 mM KCl, 100 mM Tris-HCl, pH 8.3, 
15 mM MgCl2, and 0.01% (w/v) gelatin (Applied Biosystems). 
  2.  GeneAmp ® dNTP Blend, 10 mM (Applied Biosystems). 
  3.  AmpliTaq Gold DNA polymerase (250 Units) (Applied 
Biosystems). 
  4.  Autoclaved Bovine Serum Albumin (BSA) (0.05%). 
  5.  Sterile water. 
 2.  Materials
 2.1.  Specimens
 2.2.  PCR Reagents
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  6.  HVR1(L15597-H16395), HVR2 (L048-H408), and HVR3 
(L369-H600) PCR primers (100 pmol/ m L) (see PCR primer 
sequences in Table  1 ). 
  7.  Positive amplifi cation control DNA: genomic DNA culture 
line 9947A (0.1 ng/ m L) (Applied Biosystems). 
  8.  Negative amplifi cation control: Sterile water. 
  1.  Thermal cycler GeneAmp ® PCR System 9700 (Applied 
Biosystems). 
  2.  Laminar fl ow cabinet. 
  1.  DNA chips (Fig.  1a ). 
  2.  DNA ladder (11 fragments in the range of 25–1,000 bp). 
  3.  DNA markers (an upper marker of 1,500 bp and a lower marker 
of 15 bp). 
  4.  DNA dye concentrate. 
  5.  DNA gel matrix. 
  1.  Laminar fl ow cabinet. 
  2.  Agilent 2100 Analyzer (Agilent) (Fig.  1d, e ). 
  3.  Chip priming station (Agilent) (Fig.  1b ). 
  4.  Vortex mixer (IKA) (Fig.  1c ). 
 2100 Expert Software (Agilent) 
 2.3.  PCR Equipment
 2.4.  MCE Kit 
Components 
( see  Note 1 )
 2.5.  MCE Equipment
 2.6.  Software
 Table 1 
 Primers pairs (forward and reverse) employed for the 
amplifi cation of the three hypervariable regions (HVR1, 
HVR2, and HVR3) 
 Regions  Primers 
 HVR1  FORWARD: L15997 5 ¢ -CACCATTAGCACCCAAAGCT-3 ¢ 
 REVERSE: H16395 5 ¢ -CACGGAGGATGGTGGTCAAG-3 ¢ 
 HVR2  FORWARD: L048 5 ¢ -CTCACGGGAGCTCTCCATGC-3 ¢ 
 REVERSE: H408 5 ¢ -CTGTTAAAAGTGCATACCGCCA-3 ¢ 
 HVR3  FORWARD: L369 5 ¢ -AAACCCCAAAAACAAAGAAC-3 ¢ 
 REVERSE: H600 5 ¢ -AACATTTTCAGTGTATTGCT-3 ¢ 
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  1.  Sample preparation: In both cases, HL60 and 9947A DNA 
cell lines, dilution series for a PCR input of 100, 10, 1, 0.1, 
and 0.01 pg of nuclear DNA, were prepared. 
  2.  PCR setup: All PCR reactions were carried out in 50  m l volume 
reaction, each reaction contained 13.5–20.5  m L of sterile water, 
20  m L of BSA, 5  m l of 10× PCR Buffer, 2  m L of dNTPs, 0.5  m L 
of AmpliTaq Gold DNA polymerase, 0.5  m L of forward primer, 
0.5  m L of reverse primer, and 1–8  m L of DNA extract. 
  3.  Calculation of fi nal PCR master mix volume was obtained 
according to Table  2 . N is total number of reactions, including 
number of samples, positive amplifi cation control, negative 
amplifi cation control, and an extra reaction to compensate for 
pipetting errors. The volume of sterile water ranges from 13.5 
to 20.5  m L depending on the  m l of DNA extract used in the 
reaction. In particular, for the sensitivity assay 1  m L of DNA 
extract was used, thereby 20.5  m L of sterile water was added. 
 3.  Methods
 3.1.  PCR Amplifi cation 
of HVR1, HVR2, and 
HVR3 from HL60 and 
9947A DNA Cell Lines
 Fig. 1.  DNA Chip and MCE equipment. ( a ) DNA chip. ( b ) Chip priming station. ( c ) IKA chip vortex mixer. ( d ) Agilent 2100 
Analyzer. ( e ) internal view of Agilent 2100 Analyzer with the DNA chip placed inside. 
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  4.  Use primers sets as follows: HVR1(L15597-H16395), HVR2 
(L048-H408), and HVR3 (L369-H600) (Table  1 ). 
  5.  PCR amplifi cation: it was carried out using a Thermal cycler 
GeneAmp ® PCR System 9700 with the following Thermal 
cycling conditions: 10 min at 95°C followed by 36 cycles of 
95°C for 10 s; 60°C for 30 s, 72°C for 30 s and a fi nal exten-
sion of 10 min at 72°C. 
 The gel-dye mix is obtained by mixing DNA dye concentrate and 
DNA gel matrix in the volumes indicated below. Once prepared 
the mix should be used within a month.
  1.  After vortexing DNA dye concentrate for 10 s, pipette 25  m L 
of it into a 500  m L DNA gel matrix vial. Vortex again for 10 s. 
Make sure gel and dye are well mixed. 
  2.  Transfer the gel-dye mix into a spin fi lter, place it in a micro-
centrifuge and spin for 15 min at room temperature at 
2,240 ×  g ± 20% (for Eppendorf microcentrifuge, this corre-
sponds to 6,000 rpm). 
  3.  Discard the fi lter following disposing waste material regulations. 
  1.  Use one microchip each time. Open the chip priming station 
(Fig.  1b ) by pressing the lock of the latch, place the chip on the 
platform. 
  2.  Pipette 9.0  m L of the gel-dye mix at the bottom of the well 
marked with a G circled in black. (see Note 2) (Fig.  1a ) 
 Allow the gel to fi ll the microchannels by closing the Priming 
Station and pressing the plunger of the syringe down until it is 
held by the clip. 
 3.2.  Preparing 
the Gel-Dye Mix
 3.3.  Loading 
the Gel-Dye Mix
 Table 2 
 Calculation of the fi nal PCR master mix volume 
 Components  Volume 
 Sterile water  N × 13.5–20.5  m l a 
 BSA  N × 20  m l 
 PCR Buffer 10X  N × 5  m l 
 dNTPs  N × 2  m l 
 Taq GOLD  N × 0.5  m l 
 Forward primer  N × 0.5  m l 
 Reverse primer  N × 0.5  m l 
 N is total number of reactions 
 a The water volume depends on the  m l of DNA extract added 
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  3.  After 60 s exactly release the plunger with the clip release 
mechanism. It is necessary to check that the plunger moves 
back at least to the 0.3 mL mark. Wait for 5 s more and then 
before opening the chip priming station, slowly pull back the 
plunger to the 1 mL position. 
  4.  Finally, pipette 9.0  m L of the gel-dye mix in each of the two 
remaining wells marked with G. 
  1.  Pipette 5  m L of DNA marker into each of the wells, except for 
those which have been loaded with the gel-dye mix. 
  2.  Add 1  m L of the DNA ladder in the well marked with the 
ladder symbol. 
  3.  Place 1  m L of sample in each of the 12 sample wells. Do not 
leave any well empty (see Note 3). 
  4.  Place the chip in the IKA vortex mixer and vortex the chip for 
60 s at 2,400 rpm (see Note 4). 
  1.  Switch on the Bioanalyzer. 
  2.  Click on the 2100 Expert software icon. 
  3.  Open the lid of the Bioanalyzer and place the microchip prop-
erly (Fig.  1e ) Close the lid carefully (see Note 5) and choose 
the appropriate assay: dsDNA/DNA 1000 series. 
  4.  Start the chip running by clicking on the Start button (see 
Note 6). 
  5.  Once the electrophoresis starts running, in order to enter the 
sample information select the Data icon, and then select the 
Chip Summary tab. 
  6.  Complete the sample name table by hand or by importing data. 
  7.  During the electrophoresis raw data can be visualized in the 
 Instrument context. 
  8.  After the assay is completed, the used chip should be removed 
immediately and disposed according to good laboratory prac-
tices. Electrodes should be cleaned (see Notes 7 and 8). 
 Through the use of a ladder of known size, 2100 Expert Software 
establishes a standard curve by plotting the size of the ladder versus 
migration time, using a point to point fi t. From the standard curve, 
the software determines the DNA size in base pairs (bp) by means 
of their migration times. A new standard curve is created in each 
new assay. 
 Two internal standards of known sizes (lower marker and upper 
marker) are added to both the sample and the ladder wells. They are 
used to align the ladder data with data from sample wells allowing 
correction for small drifts that may occur during electrophoresis. 
 3.4.  Loading the 
Marker, the Ladder, 
and the Samples
 3.5.  Running the Chip 
in the Bioanalyzer
 3.6.  Automatic Data 
Analysis
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 In order to quantify DNA fragments, the area under the upper 
marker peak is compared with the sample peaks areas, as the 
concentration of this marker is known, concentration for each 
sample can be calculated. 
  1.  Select the gel or electropherogram tab in the Data context. 
  2.  In the ladder well window check:
 If there are 11 peaks displayed for DNA ladder ranging from  ●
25 to 1,000 pb and bracketing them identify the presence of 
both markers (lower marker 15 pb and upper marker 
1,500 pb). 
 If all peaks are well resolved.  ●
 The presence of a fl at baseline.  ●
  3.  In the sample well window check:
 That all the peaks appear between the upper and the lower  ●
marker and they are well resolved. 
 The presence of a single band or peak electrophoretic  ●
pattern. In case of a multiband electrophoretic pattern, this 
will indicate samples with length heteroplasmy (see Note 9). 
 The presence of a fl at baseline.  ●
 Once the assay is fi nished and data checked, a report can be set up 
containing different information selected by the user: Run sum-
mary including the gel photograph, the electropherograms of each 
sample, concentration, and size of every fragment. 
 Evaluation and acceptance of results rely on the following items: 
sizes of amplicons should be the one expected for each of the regions 
amplifi ed (HVR1: 450–472 bp, HVR2: 403–421 bp, HVR3: 327–
332 bp), concentration should be equal or superior to 1 ng/ m L (as 
it has been proved in the sensitivity test performed, described below) 
in order to obtain a reliable sequence result. Samples fulfi lling these 
requirements will be purifi ed and sequenced. 
 According to quality forensic DNA standards  ( 9– 11 ) each labora-
tory should perform internal validation studies to assess the sensi-
tivity levels and stochastic effects of PCR and CE detection 
protocols. Moreover they should quantify the amount of human 
DNA in forensic samples. However for mtDNA forensic typing 
there is not a certifi ed human mtDNA quantifi cation standard, not 
even a standardized PCR real time protocol for mtDNA quantifi -
cation of forensic samples. 
 With those limitations we set out the following approach to 
carry out sensitivity validation studies for accreditation of our 
mtDNA laboratory under ISO 17025 standard: We carried out 
mtDNA analysis of serial dilutions from two DNA standards: HL60 
and 9947A Cell Lines (both quantifi ed for Nuclear DNA) by PCR 
followed by quantifi cation of mtDNA amplicons using MCE 
 3.7.  Checking Assay 
Results
 3.8.  Results Evaluation
 3.9.  Application of 
Microchip Capillary 
Electrophoresis to 
Sensitivity Validation 
Studies
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trying to determine the minimal amount of nuclear DNA which 
entails enough concentration of mtDNA amplicons for a reliable 
sequence analysis of the three regions HVR1, HVR2, and HVR3. 
 Figure  2 shows the results of mtDNA (region HVR1) ampli-
con quantifi cation for cell line HL60 (similar results were obtained 
for HV2 and HV3 regions, data not shown). On the left side the 
DNA input in the PCR reaction in pg and on the right side the 
concentration of amplicon in ng/ m L are displayed. As it can be 
seen the last dilution that resulted in a detectable amount of HVR1 
amplicons was 0.1 pg which corresponded with an amplicon 
 Fig. 2.  Gel views, electropherograms, and quantifi cation data of mtDNA HVR1 PCR amplicons using 100, 10, 1, 0.1, and 
0.01 pg of nuclear DNA from HL60 cell line as PCR template. The DNA input of 0.1 pg was the last detectable DNA dilution 
yielding an amplicon concentration of 0.83 ng/ m l. 
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concentration of 0.83 ng/ m L. High quality sequence electro-
pherograms were obtained with a DNA input of 10 and 1 pg while 
in the case of 0.1 pg sequence data were only obtained from one 
primer (data not shown). 
 Similar results were obtained for 9947A DNA dilution series 
(Fig.  3 ) in this case the DNA input of 0.1 pg was also the last detectable 
 Fig. 3.  Gel views, electropherograms, and quantifi cation data of mtDNA HVR1 PCR amplicons using 100, 10, 1, 0.1, and 
0.01 pg of nuclear DNA from 9947A cell line as PCR template. The DNA input of 0.1 pg was the last detectable DNA dilution 
yielding an amplicon concentration of 1.87 ng/ m l. 
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DNA dilution yielding an amplicon concentration of 1.87 ng/ m L. 
In this case, high quality sequence electropherograms were obtained 
with a DNA input of even 0.1 pg (data not shown). 
 To sum up, reliable and reproducible sequence results were 
obtained for HVR1, HVR2, and HVR3 regions when concentra-
tion of mtDNA amplicons was higher than 1 ng/ m L. 
 This mtDNA amplicon concentration threshold was reached 
even with a nuclear DNA input of:
 0.1 pg in the case of 9947A DNA cell line.  ●
 1 pg in the case of HL60 DNA cell line.  ●
 (See Note 10 for correspondence between number of genomic 
mtDNA copies of 9947A DNA cell line and pg of genomic ADN). 
 
  1.  Stand all reagents and samples at room temperature for 30 min 
before use. Dye and dye mixtures should be protected from 
light in order to avoid their decomposition and therefore 
reducing the signal intensity. Dye should be treated as a poten-
tial mutagen as it contains a compound DMSO Methyl 
Sulfoxide C 2 H 6 OS which is known to facilitate the entry of 
organic molecules into tissues. It is necessary to wear lab coat, 
hand and eye protection when handling and preparing reagents. 
All waste generated should be treated following good labora-
tory practices. After use store all reagents at 4°C. 
  2.  When dispensing the gel-dye mix the pipette tip must be 
inserted to the bottom of the well to prevent air bubble forma-
tion otherwise poor results could be achieved. 
  3.  When fi lled the microchip becomes an integrated electrical cir-
cuit so it is necessary to use every well, in case there are not 
enough samples to complete them dispense 1  m L of deionized 
water, otherwise the chip will not run properly. 
  4.  Vortex exactly at 2,400 rpm, higher speed could lead to liquid 
spilling. In order to avoid reagents evaporation, once prepared 
microchip should be used within 5 min. 
  5.  Pushing the lid carelessly may damage the electrodes and drop-
ping the lid may cause liquid spills resulting in bad results. 
  6.  Avoid touching the Agilent 2100 bioanalyzer during analysis 
and do not place it on a vibrating surface. 
  7.  Remove the chip immediately after the run has fi nished and 
clean the electrodes using the electrode cleaner provided with 
each new kit in order to avoid contamination of the electrodes. 
Fill the electrode cleaner with 350  m L deionized analysis-grade 
 4.  Notes
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water. Place it on the Bioanalyzer, close the lid, and leave it for 
about 15–20 s. 
  8.  When performing different microchips in a row, use the cleaning 
procedure between different assays and wait for 10 s before 
starting the next run, so as to allow the water on the electrodes 
to evaporate. Otherwise poor results could be obtained. 
  9.  Mitochondrial DNA length heteroplasmy results from the 
presence of multiple populations of mtDNA molecules with 
various lengths within an individual that differ, usually, in the 
number of cytosines on polycitosine stretches. The sites where 
heteroplasmy is observed are particularly position 16189 within 
HVR1 in which a transition T to C creates a long string of 
cytosines and it also occurs in the HVR2 C-stretch due to C 
insertions at nucleotides 309 and 315. A multiple pattern indi-
cates the presence of length heteroplasmic C-streches, allow-
ing the use of alternative sequence primers in advance, located 
upstream and downstream of the C-homopolymeric tract, to 
generate readable sequences. 
  10.  In order to determine the minimum number of mitochondrial 
DNA copies for a reliable mtDNA sequencing analysis we have 
quantifi ed different 9947A DNA lots using two Taqman assays 
 ( 12 ) using a cloned human control region standard for quan-
tifi cation of mtDNA copies, (provided by H. Niederstaetter 
and W. Parson. Institute of Legal Medicine. University of 
Innsbruck). Different DNA lots from 9947A cell culture line 
gave around 150–300 copies per 1 pg of Genomic DNA, 
therefore the detection limit for mtDNA sequencing of 9947A 
Standard was about 15–30 mtDNA copies (0.1 pg of Genomic 
DNA). 
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 Microchip Capillary Electrophoresis of Multi-locus VNTR 
Analysis for Genotyping of  Bacillus Anthracis 
and  Yersinia Pestis in Microbial Forensic Cases 
 Andrea  Ciammaruconi  
 Abstract 
 Bacillus anthracis and  Yersinia pestis are etiological agents of anthrax and plague respectively, and are also 
considered among the most feared potential bioterrorism agents. These microorganisms show intraspecies 
genome homogeneity, making strains differentiation diffi cult, while strains identifi cation and comparison with 
known genotypes may be crucial for naturally occurring outbreaks vs. bioterrorist events discrimination. 
 Here an MLVA application for  B. anthracis and  Y. pestis strains differentiation is described on 
Microchip Capillary electrophoresis apparatus. The platform is a candidate for on-site MLVA genotyping 
of biothreat agents as well as other bacterial pathogens. This microfl uidics-based electrophoresis analysis 
system represents an alternative to the more expensive and demanding capillary electrophoresis methods, 
and to the less expensive but more time-consuming standard agarose gel approach. 
 Key words:  Lab on a chip ,  Microfl uidic electrophoresis ,  Bacillus anthracis ,  Yersinia pestis ,  Bacterial 
genotyping ,  VNTR 
 
 Bacillus anthracis , a spore forming Gram-positive bacteria, is the 
etiological agent of anthrax  ( 1,  2 ) , a zoonosis with a worldwide 
distribution. This bacterium is commonly found in soil, but the 
disease is transmitted to humans by contact with infected animals 
or contaminated animal products. Anthrax is still endemic in many 
countries, Middle East, Africa, North, Central and South America, 
and other areas of the world  ( 3 ) . 
 Yersinia pestis, a Gram-negative bacterium, is the causative 
agent of plague. The bacterium is transmitted by fl eas or aerosols, 
 1.  Introduction
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causing different forms of plague: bubonic, septicemic, or pneumonic 
 ( 4,  5 ) . Primary pneumonic plague is rapidly progressive and viru-
lent, and, as inhalation anthrax, with mortality rate close to 100% 
in the absence of a timely treatment.  Y. pestis and  B. anthracis are 
both considered serious threats and potential bioterrorism agents 
 ( 6 ) because of their evaluation as bioweapons by Soviet Union and 
United States laboratories during the past decades. Both agents are 
classifi ed by the US Centers for Disease Control and Prevention 
(CDC) in the Bioterrorism Disease Agent List as Category A 
microorganisms, the most dangerous ones, because of easy dis-
semination and transmission, high mortality and impact to public 
health. 
 B. anthracis and  Y. pestis both show very low intraspecies 
genetic diversity  ( 7– 9 ) , making very challenging the rapid and 
accurate differentiation among individual biovars and strains. 
Nevertheless, fi nding a way to differentiate the strains by molecular 
genotyping, remains essential for discrimination between naturally 
occurring vs. intentional outbreaks. This is the aim of forensic 
microbiology, as this fi eld is known, and its importance was dem-
onstrated during the 2001 events, and previously by Tokyo  ( 10 ) 
and Sverdlovsk  ( 11 ) incidents. Finally genetic characterization of 
isolates allows increasing information about worldwide bacterial 
distribution and epidemiology. 
 Standard genotyping methods require highly discriminative 
but heavy, and relatively expensive instruments, such as automated 
capillary electrophoresis devices, or cheaper, easy to use, but more 
time consuming and with lower resolution power, such as agarose 
gels (for a review of bacterial MLVA genotyping see  ( 12 ) ). In the 
last years, instruments using microfl uidic technology for the analy-
sis of biological samples are commercially available. These new 
miniaturized platforms for quantifi cation and separation of nucleic 
acid molecules are an evolution of traditional capillary electropho-
resis. These systems are also called “Lab on a Chip” and have 
shown accuracy, precision, and high feasibility along with speed 
and moderate cost reagents. Here, an application for  B. anthracis 
and  Y. pestis genotyping is described on Agilent 2100 Bioanalyzer 
(Agilent Technologies). This platform is based on microfl uidic 
technology and allows analyzing 12 DNA samples in 30 min. The 
device integrates multiple functions onto a single apparatus, so that 
sample dispensing, separation, detection, and analysis are per-
formed on the same support (a 5 × 5 cm chip-cast gel). Along with 
limited weight and size (10 kg, 162 × 412 × 290 mm), the above 
features make the instrument ideal for fi eld use and other on-site 
investigations. Finally, Agilent 2100 can also be easily used by low-
expertise staff. 
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  1.  1× PCR reaction buffer: 10 mM Tris-HCl, 1.5 mM MgCl2, 
50 mM KCl pH 8.3(see Note 1). 
  2.  Taq DNA Polymerase, 5 U/ μ L. 
  3.  dNTP 10 mM each, pH 7.5, PCR Grade. 
  4.  Nuclease-Free Water. 
  5.  Template DNA prepared as reported in  ( 13 ) (see Notes 2 and 3). 
  6.  PCR HPSF purifi ed primers from Eurofi ns MWG Operon (or 
equivalent). 
  7.  DYAD PTC-220 Thermal Cycler, MJ Research (or equivalent). 
  8.  Agilent 2100 Bioanalyzer (Agilent Technologies). 
  9.  Agilent DNA 1000 Kit (Agilent Technologies). 
 
 The 25 VNTR markers amplifi ed for bacterial genotyping were 
arranged into 12 PCR multiplex reactions either for  B. anthracis or 
for  Y. pestis . This allowed using a single DNA 1000 chip for each 
strain. 
 To fi t all the 25 loci into a 12-well chip of Agilent 2100 (see Note 
4), the  B. anthracis loci are combined into fi ve triplex, three duplex, 
and four singleplex (see Table  1 ) PCR amplifi cations. The arrange-
ment of different loci in the same multiplex is such as to avoid 
overlapping of VNTR markers size ranges. For four  B. anthracis 
loci (BAMS13, BAMS24, BAMS30, and BAMS34) multiplexing is 
impossible, because of the large allele size range (see Note 5). 
 Primer sequences, fi nal primer concentrations, and loci combi-
nation are reported in Table  1 and previously in  ( 14 ) . Multiplex 
PCR reactions are prepared as follows: 5–10 ng of template DNA 
is amplifi ed in a fi nal volume of 15  μ L containing 1× PCR reaction 
buffer, 0.2 mM dNTPs, the appropriate concentrations of each 
primer as reported in Table  1 , and 1 U of Taq Polymerase (see 
Note 6) . The 12 multiplex PCR amplifi cations were performed 
with a starting denaturation step at 96°C for 3 min, followed by 36 
cycles of denaturation at 95°C for 20 s, annealing at 60°C for 30 s, 
and extension at 72°C for 2 min. The reactions were terminated by 
a fi nal incubation at 72°C for 5 min. 
 2.  Materials
 3.  Methods
 3.1.  Genotyping 
 B. anthracis 
with the 25-loci MLVA
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 Table 1 
 Primer sequences for 25 MLVA loci of  B. anthracis are reported 
  
 Marker (fi nal primer 
concentration  m M)    Primer sequences 
 MULTIPLEX 1  CG3 (1.1)  F  TGTCGTTTTACTTCTCTCTCCAATAC 
 R  AGTCATTGTTCTGTATAAAGGGCAT 
 Bams3s (0.6)  F  GCAGCAACAGAAAACTTCTCTCCAATAACA 
 R  TCCTCCCTGAGAACTGCTATCACCTTTAAC 
 Bams44 (0.8)  F  GCGAATTAATTGCTCCTCAAAT 
 R  GCGAATTAATTGCTCCTCAAAT 
 MULTIPLEX 2  Bams5 (0.28)  F  GCAGGAAGAACAAAAGAAACTAGAAGAGCA 
 R  ATTATTAGCAGGGGCCTCTCCTGCATTACC 
 Bams15 (0.6)  F  GTATTTCCCCCAGATACAGTAATCC 
 R  GTGTACATGTTGATTCATGCTGTTT 
 VrrB2 (0.15)  F  CACAGGCTATTCTTTATCAAACTCATC 
 R  CCCAAGGTGAAGATTGTTGTTGA 
 MULTIPLEX 3  Bams1s (0.6)  F  GTTGAGCATGAGAGGTACCTTGTCCTTTTT 
 R  AGTTCAAGCGCCAGAAGGTTATGAGTTATC 
 VrrC1 (0.28)  F  GAAGCAAGAAAGTGATGTAGTGGAC 
 R  CATTTCCTCAAGTGCTACAGGTTC 
 MULTIPLEX 4  Bams13 (0.28)  F  AATTGAGAAATTGCTGTACCAAACT 
 R  CTAGTGCATTTGACCCTAATCTTGT 
 MULTIPLEX 5  VrrB1 (0.15)  F  ATAGGTGGTTTTCCGCAAGTT 
 R  GATGAGTTTGATAAAGAATAGCCTGTG 
 VrrC2 (0.6)  F  CCAGAAGAAGTGGAACCTGTAGCAC 
 R  GTCTTTCCATTAATCGCGCTCTATC 
 Bams28 (0.6)  F  CTCTGTTGTAACAAAATTTCCGTCT 
 R  TATTAAACCAGGCGTTACTTACAGC 
 MULTIPLEX 6  Bams53 (1.1)  F  GAGGTGTGTTAGGTGGGCTTAC 
 R  CATATTTTCACCTTAATTTTGGAAG 
 Bams31 (0.6)  F  GCTGTATTTATCGAGCTTCAAAATCT 
 R  GGAGTACTGTTTGTTGAATGTTGTTT 
 MULTIPLEX 7  Bams21 (1.1)  F  TGTAGTGCCAGATTTGTCTTCTGTA 
 R  CAAATTTTGAGATGGGAGTTTTACT 
 Bams25 (1.1)  F  CCGAATACGTAAGAAATAAATCCAC 
 R  TGAAAGATCTTGAAAAACAAGCATT 
 VrrA (0.1)  F  CACAACTACCACCGATGGCACA 
 R  GCGCGTTTCGTTTGATTCATAC 
 MULTIPLEX 8  Bams34 (0.4)  F  TGTGCTAAATCATCTTGCTTGG 
 R  CAGCAAAATCAATCGAATCAAA 
 MULTIPLEX 9  Bams24 (0.4)  F  CTTCTACTTCCGTACTTGAAATTGG 
   R  CGTCACGTACCATTTAATGTTGTTA 
(continued)
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 To fi t all the 25 loci into 12 chip wells, the  Y. pestis 25 markers are 
grouped into 11 duplex and one triplex (see Table  2 ). Although 
majority of primer sequences are as previously described in  ( 15 ) 
eight  Y. pestis markers primer pairs were redesigned to allow multi-
plexing (see Table  2 ). Thus, fi nal amplicon sizes are increased to 
avoid any possible overlap with other different loci into the new 
multiplexed reactions (see Note 5). Reaction conditions and PCR 
thermal profi le are the same as described for  B. anthracis. 
 Each reaction is loaded into chip wells prepared according to 
manufacturer’s recommendations (DNA 1000 LabChip Kit) (see 
Note 7). Each chip contains 16 wells, 12 for the samples (see Note 8), 
3 for gel mix (1 labeled black  G and 2 gray  G ), and 1 for the lad-
der. Briefl y, the black  G well of DNA Lab Chip support is fi lled 
with 9  μ L of a gel containing intercalating dye (see Note 9). The 
DNA Lab Chip is pressurized by a syringe in a priming station 
device and released after 60 s. Then, two gray  G wells are fi lled 
with 9  μ L of gel-dye mix. After gel preparation, each sample well is 
loaded with 1  μ L of PCR reaction and 5  μ L of internal marker 
(containing two MW size standards of 15 and 1,500 bp). Finally 
1  μ L of DNA ladder is loaded in the ladder well, the chip vortexed 
at 2,400 rpm for 60 s, and inserted into Agilent 2100 Bioanalyzer. 
During the run the instrument analyzes sequentially every sample, 
showing electropherogram, virtual gel image, and table data (see 
Note 10). 
 3.2.  Genotyping 
 Y. pestis 
with the 25-loci MLVA
 3.3.  Preparation 
of “Lab on a Chip” 
Assay
Table 1
(continued)
  
 Marker (fi nal primer 
concentration  m M)    Primer sequences 
 MULTIPLEX 10  pXO1s (0.6)  F  CAATTTATTAACGATCAGATTAAGTTCA 
 R  TCTAGAATTAGTTGCTTCATAATGGC 
 Bams22 (0.4)  F  ATCAAAAATTCTTGGCAGACTGA 
 R  ACCGTTAATTCACGTTTAGCAGA 
 Bams51 (0.4)  F  ATTTCCTGAAGCAGGTTGTGTT 
 R  TGCATCTAACAATGCAGAACAA 
 MULTIPLEX 11  pXO2s (0.28)  F  TCATCCTCTTTTAAGTCTTGGGT 
 R  GTGTGATGAACTCCGACGACA 
 Bams23 (1.1)  F  CGGTCTGTCTCTATTATTCAGTGGT 
   R  CCTGTTGCTCCTAGTGATTTCTTAC 
 MULTIPLEX 12  Bams30 (0.8)  F  AGCTAATCACCTACAACACCTGGTA 
 R  CAGAAAATATTGGACCTACCTTCC 
 Final  μ M concentrations for every primer pairs are indicated in brackets 
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 Table 2 
 Primer sequences for 25 MLVA loci of  Y. pestis are reported 
  
 Marker (fi nal primer 
concentration  m M)    Primer sequences 
 MULTIPLEX 1  Ypms01 (0.2)  F  ACTTCGATGATTATTTTGTGCGTA 
 R  TGTTTGGTGCTATTGCCGTA 
 Ypms51 (0.2)  F  GGTTTTTACCGATATAAATCCTGAG 
 R  GACCAAGAAGTTAAGTTGCTTATCG 
 MULTIPLEX 2  Ypms04 (0.2)  F  CGCTGTTGAAGTTTTAGTGTAAGAA 
 R  AAATGTAACCTGCCAAACGTG 
 Ypms62 (0.2)  F  AAACGGTCGTTAACGGAAGA 
 R  GCTGAACAGCCCCATAAAAC 
 MULTIPLEX 3  Ypms05 (0.2)  F  CCTCAGTTCATTGTGTAAAATCTCA 
 R  GTATTAGCGAGATCACAGATGAGC 
 Ypms07 (0.2)  F  ATACCGCTACGATCAGCCTCTAT 
 R  ATTTAATATTGATTTTGGGACTTGC 
 MULTIPLEX 4  Ypms74 (0.2)  F  CCCCGACTTATATCAAGCACTG 
 R  AACTGACGATCTTTTTCACTGAGTT 
 Ypms15 (0.2)  F  ACAAGCAAGTTGCGCAGATA 
 R  CAAGTTCGCTTTCTGTGTCG 
 MULTIPLEX 5  Ypms35 (0.2)  F  CTGTTACCGGTCAAAGTGGATATT 
 R  AGGCTCTCCTTATCATTATTTGGTC 
 Ypms40 (0.2)  F  TCCTGCTGCTGAGTTCATCTT 
 R  TCATGTGCAATAGGCGTTGT 
 MULTIPLEX 6  Ypms20 (0.2)  F  GCCAGAATAATGGCCGTAAA 
 R  GTGGTTGTTCTTCACGTTGC 
 Ypms38 (0.2)  F  GTGAGGTATAGCTAAACGGTGATGT 
 R  CGCCGTAGATTATTTGTCACTTTAT 
 MULTIPLEX 7  Ypms41 (0.2)  F  GAAGAAAGCCAGCTAATCTGATG 
 R  TAATGAATAGCAACGACAACCAATA 
 Ypms56 (0.2)  F  GCTCTAACAACGCCGGTAAA 
 R  ATGGCATCAACCGACTGACT 
 MULTIPLEX 8  Ypms44 (0.2)  F  CAATTCCAACAGCTATTAATGCAA 
 R  GAATTTTCATAACACGTTCTTCCTG 
 Ypms45 (0.2)  F  GCATCGGAGACTGGGTAAAC 
 R  TTTCTGAGGATTTATCGGTGTGAT 
 Ypms09 (0.2)  F  TTTTTGCCGCACTGAACATA 
 R  TCTGATGATTGTTGTGGTCGT 
 MULTIPLEX 9  Ypms71 (0.2)  F  GCTACTCGAATATGAGTTAGCCAAA 
 R  ATTGCCATATTGGATGCTAAAATAA 
 Ypms46 (0.2)  F  CAGGTTTTACGTTATTTTCTGAAGG 
 R  CAGCATGAAGTATGACGGGTATATTA 
(continued)
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 Under the described amplifi cation conditions, each expected fragment 
is amplifi ed (see Note 11), and the software Agilent 2100 Expert 
version B.02.03.SI307, fi rmware C.01.055 can identify amplicon 
size (in Fig.  1a  B. anthracis triplex electropherogram is shown) 
(see Note 12). The vast majority of data produced by Agilent 2100 
are not accurate. The discrepancies between observed and expected 
fragment sizes are, presumably, the result of abnormal migration 
patterns of some repetitive sequences into electrophoretic matrix. 
The offset and conversion from observed to expected data (and 
correspondent allele) can be found in comparison Table 1 and 
Table 2 published in  ( 14 ) . For  Y. pestis markers (for which repeat 
units are at least 7 bp long), variability observed is up to two bases 
(at the shortest repeat units) and, as previously described for 
 B. anthracis , discrepancies do not exceed 25% of the repeat unit size. 
 For chromosomal markers (all the loci, but pXO1 and pXO2 
of  B. anthracis ), reproducibility of the observed data allowed cor-
rect assignment of each allele for every locus (<25% of unit length). 
However, for  B. anthracis plasmid markers (pXO1 and pXO2), 
since their shorter repeat units and PCR product sizes compared to 
the chromosomal ones, we observed variability not exceeding one 
single additional base for each allele in repeated runs. Even with 
this additional base, correct assignment could be reproducibly 
done for the plasmid loci. For each individual strain the Agilent 
assay is completed in about 30–40 min after PCR amplifi cation. 
For a single strain to be genotyped, this time is signifi cantly lower 
than agarose gel or automated sequencer fragment separation. 
 3.4.  Data Analysis
Table 2
(continued)
  
 Marker (fi nal primer 
concentration  m M)    Primer sequences 
 MULTIPLEX 10  Ypms54 (0.2)  F  GTCCACCATTTTCATACTGTCACTT 
 R  GCTCTTTGTTCGATTTTATTGAATG 
 Ypms70 (0.2)  F  AAACCAACGGTTCATATTGAATAAA 
 R  CTTCTTCCGCTATTTTCCTACAGA 
 MULTIPLEX 11  Ypms69 (0.2)  F  GACGTTGCAACTGCAAAAATAAG 
 R  ACTTGTTGTGAAGACCATCACTCT 
 Ypms06 (0.2)  F  AATTTTGCTCCCCAAATAGCAT 
 R  TTTTCCCCATTAGCGAAATAAGTA 
 MULTIPLEX 12  Ypms21 (0.2)  F  ACCGGCTTAAAGCAGATTGA 
 R  TTCCCTGTACTCGATTGTTGTG 
 Ypms73 (0.2)  F  AATACCCTGTGGGTGATAATGAAC 
 R  ATCGATTTAGGTACCACCAATTCA 
 Final  μ M concentrations for every primer pairs are indicated in brackets 
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  1.  Sensitivity: Agilent 2100 detects fragments down to 0.1 ng, 
under routine staining condition, Agarose gel with Ethidium 
Bromure has a detection limit of 2–5 ng. 
  2.  “Lab on a Chip” allows each individual fragment is automati-
cally sized and quantifi ed. 
  3.  “Lab on a Chip” platforms have better resolution than Agarose 
gel. It is possible to separate fragments down to 5 bp. 
  4.  “Lab on a Chip” has minimal sample consumption, only 1  μ l 
of material required per analysis. 
 The reproducibility of the “Lab on a Chip” is a critical factor in the 
validation of the method and its acceptability for bacterial genotyp-
ing. In order to check if data were reproducible, we tested inter-
chip and intrachip variability in markers containing the smallest 
repeat units, for which incorrect allelic calling is more probable. 
The samples were run in triplicate on the same and on different 
chips, and size data compared. In general, a low level of interchip/
intrachip variability (less than 25% of the repeat unit length) was 
observed. For example, for  B. anthracis CG3 marker (Unit 
Length = 5 bp, so 25% of the Unit Length is 1.25 bp), we observed 
 3.5.  Comparison 
of the Microchip 
Capillary 
Electrophoresis 
Method vs. Agarose 
Gel Electrophoresis 
Method
 3.6.  Reproducibility
 Fig. 1.  B. anthracis multiplex n. seven electropherogram ( a ) and virtual gel ( b ). For every amplicon, the observed size of 
markers VrrA, BAMS25, and BAMS21 is shown. 
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168 ± 1 for allele 1 and 173 ± 1 for allele 2. To correctly convert the 
Agilent DNA fragment size estimates into repeat copy numbers, it 
was necessary to establish conversion tables (Tables 1 and 2 of 
 ( 14 ) ) containing 2100 Bioanalyzer fragment sizes as well as actual 
sizes corresponding to repeats unit numbers. 
 
  1.  B. anthracis and  Y. pestis cells must be handled exclusively 
under Bio Safety Level 3 (BSL3) containment conditions. 
  2.  After extraction,  B. anthracis DNA templates must be tested 
for the absence of spores. 30–50  μ L of DNA aliquots are plated 
on blood agar plates and incubated for up to 1 week. 
  3.  During multiplexing, possible overlapping of different loci 
alleles must be avoided. An interval of 30–40 bp is recom-
mended between the major allele of shorter locus and the 
minor allele of larger following locus. 
  4.  Care must be taken in PCR primers design. The instrument 
sizing range is 25–1,000 bp, so larger alleles could not be 
analyzed. 
  5.  Primer concentrations can be experimentally adjusted to obtain 
a balanced amplifi cation of different fragments. This optimiza-
tion is facilitated using the quantifi cation data supplied by the 
2100 Bioanalyzer (peak area and fl uorescence peak level). 
  6.  Artifact bands (also called “stuttering” bands or “ghost” 
bands) are sometimes reported when VNTR regions are ampli-
fi ed. These products are minor bands with usually one repeat 
length smaller than the main bands. Artifact decrease can be 
observed at 65°C as PCR extension temperature. 
  7.  The maximum salt concentrations allowed in samples are 
250 mM for KCl, 15 mM for MgCl2 250 mM NaCl. 
  8.  If samples are less than 12, fi ll all the remaining wells with buf-
fer or sample replicate. It is not possible to reuse the chip. 
  9.  Chip preparation takes 10–15 min, while the run takes approx-
imately 30 min. The chip must be prepared freshly. The time 
between preparation and chip run should not exceed 5 min. 
  10.  Store PCR reagents at −20°C. 
  11.  Store Agilent reagents at 4°C. 
  12.  Protect Agilent gel matrix containing intercalating dye from 
light and store in the dark. 
 4.  Notes
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